MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004346|P|2.3
PID|1||204544381^^^RZ|tst2507394|SYNOPTEST^HORIZON^THREE||19441231|F||W|||||||||204-54-4381|||||||||||N
PV1|1||Z2WE^0212||||505071^PLANET^MERCURY||||||||||pmc07361^PLANET^MERCURY|I|0001204544381|||||||||||||||||||||||||200503181748
ORC|RE||HHS05-4^CoPathPlus||CM||||200506131259|987654^PATHOID^DOCTOR||505071^PLANET^MERCURY
OBR|1||HHS05-4^CoPathPlus^tst7507183|^HH Histology|||200506131254|||||||200506131254||505071||||^60^Y|-1|200506141330||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst7507183.1|^Breast Mass^L||||||F||1^1
OBX|2|ST|BLOCK|tst7507183.1.1|A||||||||1^A|200601132338
OBX|3|CE|PROCESS|tst7507183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|4|CE|PROCESS|tst7507183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200512191416
OBX|5|TX|GDT|tst7507183|\.br\PART 1  RECEIVED LABELED WITH PATIENT NAME AND FRESH.\.br\||||||F
OBX|6|TX|MDT|tst7507183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Simple mastectomy\.br\LOCATION:      Upper outer quadrant\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  5 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      Yes\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\HISTOLOGIC TYPE:      Classical\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 4\.br\     Tubule formation: 2\.br\     Mitotic activity score: 2\.br\     Total Nottingham score: 2\.br\     Nottingham grade (1, 2, 3): 2\.br\ANGIOLYMPHATIC INVASION:      No\.br\DERMAL LYMPHATIC INVASION:      No\.br\CALCIFICATION:      No\.br\TUMOR TYPE, IN SITU:      Solid\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      Yes, focal\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      Yes, focal\.br\PAGET'S DISEASE OF NIPPLE:      No\.br\LYMPH NODES POSITIVE:      0\.br\LYMPH NODES EXAMINED:      5\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E levels\.br\SENTINEL NODE METASTASIS:      No\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT:      No\.br\LYMPH NODE METASTASIS(-ES) WITH\.br\EXTRACAPSULAR EXTENSION:      No\.br\METASTASES TO IPSILATERAL INTERNAL\.br\MAMMARY LYMPH NODE (IF APPLICABLE):      Yes\.br\SKIN INVOLVED (ULCERATION):      Yes\.br\T STAGE, PATHOLOGIC:      pTis\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pM0\.br\ESTROGEN RECEPTORS:      unknown\.br\PROGESTERONE RECEPTORS:      unknown\.br\HER2/NEU:      unknown\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|7|TX|FIN|tst7507183|\.br\INVASIVE CANCER\.br\||||||F
OBX|8|CE|IMP|tst7507183|M80003^^SNO||||||||1||A
OBX|9|CE|IMP|tst7507183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004347|P|2.3
PID|1||000012347^^^RL|tst9464394|test4^lee||19340101|F||||||||||||||||||||||N
PV1|1||4M||||||||||||||pmc87452^DHARBHAMULLA^ANURADHA|LRCR|0000123470|||||||||||||||||||||||||200503231136
ORC|RE||LRS05-4^CoPathPlus||CM||||200503281255|^MEYER^JEFFREY||LR000126^FIKRI^ERDEN
OBR|1||LRS05-4^CoPathPlus^tst7856183|LRAP^LR Pathology|||200503230000|||||||200503281253|GB|LR000126||||^71^Y|-1|200505261214||SP|F|||||||^YERGER^JOHN|^YERGER^JOHN
OBX|1|CE|ANT|tst7856183.1|GB^Gallbladder^L||||||F||1^1
OBX|2|ST|BLOCK|tst7856183.1.1|A||||||||1^A|200503301400
OBX|3|ST|BLOCK|tst7856183.1.2|B||||||||2^B|200503301400
OBX|4|ST|BLOCK|tst7856183.1.3|C||||||||3^C|200503301400
OBX|5|ST|BLOCK|tst7856183.1.4|D||||||||4^D|200503301400
OBX|6|CE|PROCESS|tst7856183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200503301408
OBX|7|CE|PROCESS|tst7856183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200503301408
OBX|8|CE|PROCESS|tst7856183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200503301408
OBX|9|CE|PROCESS|tst7856183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200503301408
OBX|10|TX|GDT|tst7856183|\.br\     The specimen is received in formalin labeled test4,lee gallbladder.  The gallbladder measures 4 x 3 x 2 cm.  The serosal surface is tan, smooth and glistening.  The gallbladder contains green bile and approximately three yellow-green stones, that vary from 0.2 to 0.6 cm. in greatest dimension.  The gallbladder wall averages 0.2 cm. in thickness.  There are no focal lesions.  Representative sections are submitted in one block.\.br\||||||F
OBX|11|TX|MDT|tst7856183|\.br\Microscopic examination substantiates the diagnosis indicated above.\.br\||||||F
OBX|12|TX|FIN|tst7856183|\.br\GALLBLADDER, CHOLECYSTECTOMY:  CHOLECYSTITIS.\.br\||||||F
OBX|13|CE|IMP|tst7856183|M40000^^SNO||||||||1||A
OBX|14|CE|IMP|tst7856183|P1100^^SNO||||||||1||A
OBX|15|CE|IMP|tst7856183|T57000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004348|P|2.3
PID|1||185185185^^^RA|tst8415394|TEST^BATGIRL||19500731|F||W|100 MAIN STREET^^PITTSBURGH^PA^15216^United States||(412)555-8888|(412)555-2222|||||185-18-5185|||||||||||N
PV1|1||A3B^363||||080750^WERNER^KATHLEEN||||||||||pmc68581^WERNER^KATHLEEN|I|0056718335109|P||||||||||||||||||||||||200504191052
ORC|RE||SMS05-4^CoPathPlus||CM||||200508031541|z32^PICCOLI^ANTHONY||080750^WERNER^KATHLEEN
OBR|1||SMS05-4^CoPathPlus^tst9917183|^SM Histology|||200508031541|||||||200508031541|HSAC|080750||||^55^Y|-1|200508031546||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst9917183.1|HSAC^Hernia Sac^L||||||F||1^1
OBX|2|ST|BLOCK|tst9917183.1.1|A||||||||1^A|200512121508
OBX|3|CE|PROCESS|tst9917183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508031541
OBX|4|TX|GDT|tst9917183|The specimen is received unfixed labeled hernia sac and consists of a soft, pink to yellow segment of fibrous and fatty tissue measuring 7.5cm in length x 3.2 x 0.9cm with a partly defined lumen.  Representative tissue submitted labeled 1A.\.br\||||||F
OBX|5|TX|MDT|tst9917183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|6|TX|FIN|tst9917183|HERNIA SAC, LEFT INGUINAL, HERNIORRHAPHY:\.br\     A.  BENIGN\.br\     B.  FIBROFATTY TISSUE CONSISTENT WITH HERNIA SAC.\.br\\.br\DTP/alp\.br\||||||F
OBX|7|CE|IMP|tst9917183|M31680^^SNO||||||||1||A
OBX|8|CE|IMP|tst9917183|P1600^^SNO||||||||1||A
OBX|9|CE|IMP|tst9917183|T1X290^^SNO||||||||1||A
OBX|10|CE|IMP|tst9917183|TY7020^^SNO||||||||1||A
OBX|11|CE|IMP|tst9917183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004349|P|2.3
PID|1||545345433|tpmc3006005|Jones^John^R|||M|||||||||||545-34-5433|||||||||||N
PV1|1||E1019||||||||||||||pmc23192^SMIGA^ERIC|LRBAL|6565465458906|||||||||||||||||||||||||200512120848
ORC|RE||SMS05-5^CoPathPlus||CM||||200512120850|UXD^Cerner^User||^SMIGA^ERIC
OBR|1||SMS05-5^CoPathPlus^tpmc2767183|^SM Histology|||200512120816|||||||200512120847|||||||-1|200512121009||SP|F|||||||002624^BECICH^MICHAEL|UXD^Cerner^User
OBX|1|CE|ANT|tpmc2767183.1|^Colon (SM)^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc2767183.1.1|A||||||||1^A|200512121508
OBX|3|CE|PROCESS|tpmc2767183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512120940
OBX|4|TX|GDT|tpmc2767183|\.br\Sectioning reveals granular tan tissue.  The gross description is correct and reviewed by the pathologist\.br\||||||F
OBX|5|TX|FIN|tpmc2767183|\.br\Malignant, colon.  This is the final dx.\.br\||||||F
OBX|6|CE|IMP|tpmc2767183|M80003^^SNO||||||||1||A
OBX|7|CE|IMP|tpmc2767183|T67000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004350|P|2.3
PID|1||999551-00^^^RG|tst8604394|TESTONE^SYNOPTIC^O||19490303|F||W|||||||||999-55-9876|||||||||||N
PV1|1||MWV||||^PLANET^KAHOUTEK||||||||||tst20263^PLANET^KAHOUTEK|MWC|0001999559876|||||||||||||||||||||||||200503081729
ORC|RE||MWS05-5^CoPathPlus||CM||||200503081803|z32^PICCOLI^ANTHONY||^PLANET^KAHOUTEK
OBR|1||MWS05-5^CoPathPlus^tst9546183|MWSP^MW Pathology|||200503081400|||||||200503081802|OVMAL|||||^56^Y|-1|200503171427||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst9546183.1|OVMAL^Left Ovary^L||||||F||1^1
OBX|2|CE|ANT|tst9546183.2|MAS^Left Adnexal Mass^L||||||F||2^2
OBX|3|CE|ANT|tst9546183.3|CGST^Solid Tumor for Cytogenetics^L||||||F||3^3
OBX|4|ST|BLOCK|tst9546183.1.1|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst9546183.1.2|B||||||||2^B|200507221753
OBX|6|ST|BLOCK|tst9546183.1.3|C||||||||3^C|200507221753
OBX|7|ST|BLOCK|tst9546183.1.4|D||||||||4^D|200507221753
OBX|8|ST|BLOCK|tst9546183.2.5|A||||||||1^A|200507221753
OBX|9|ST|BLOCK|tst9546183.2.6|B||||||||2^B|200507221753
OBX|10|ST|BLOCK|tst9546183.2.7|C||||||||3^C|200507221753
OBX|11|ST|BLOCK|tst9546183.2.8|D||||||||4^D|200507221753
OBX|12|ST|BLOCK|tst9546183.2.9|E||||||||5^E|200507221753
OBX|13|ST|BLOCK|tst9546183.2.10|F||||||||6^F|200507221753
OBX|14|ST|BLOCK|tst9546183.2.11|G||||||||7^G|200507221753
OBX|15|ST|BLOCK|tst9546183.2.12|H||||||||8^H|200507221753
OBX|16|ST|BLOCK|tst9546183.1.13|A||||||||5^A|200507221753
OBX|17|ST|BLOCK|tst9546183.1.14|B||||||||6^B|200507221753
OBX|18|ST|BLOCK|tst9546183.1.15|C||||||||7^C|200507221753
OBX|19|ST|BLOCK|tst9546183.1.16|D||||||||8^D|200507221753
OBX|20|ST|BLOCK|tst9546183.2.17|A||||||||9^A|200507221753
OBX|21|ST|BLOCK|tst9546183.2.18|B||||||||10^B|200507221753
OBX|22|ST|BLOCK|tst9546183.2.19|C||||||||11^C|200507221753
OBX|23|ST|BLOCK|tst9546183.2.20|D||||||||12^D|200507221753
OBX|24|ST|BLOCK|tst9546183.2.21|E||||||||13^E|200507221753
OBX|25|ST|BLOCK|tst9546183.2.22|F||||||||14^F|200507221753
OBX|26|ST|BLOCK|tst9546183.2.23|G||||||||15^G|200507221753
OBX|27|ST|BLOCK|tst9546183.2.24|H||||||||16^H|200507221753
OBX|28|CE|PROCESS|tst9546183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|29|CE|PROCESS|tst9546183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|30|CE|PROCESS|tst9546183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|31|CE|PROCESS|tst9546183.1.4.4|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|32|CE|PROCESS|tst9546183.2.5.5|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|33|CE|PROCESS|tst9546183.2.6.6|$hinit^Initial H&E^L||||||||5^H&E|200512121431
OBX|34|CE|PROCESS|tst9546183.2.7.7|$hinit^Initial H&E^L||||||||6^H&E|200512121431
OBX|35|CE|PROCESS|tst9546183.2.8.8|$hinit^Initial H&E^L||||||||7^H&E|200512121431
OBX|36|CE|PROCESS|tst9546183.2.9.9|$hinit^Initial H&E^L||||||||8^H&E|200512121431
OBX|37|CE|PROCESS|tst9546183.2.10.10|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|38|CE|PROCESS|tst9546183.2.11.11|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|39|CE|PROCESS|tst9546183.2.12.12|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|40|CE|PROCESS|tst9546183.1.1.13|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|41|CE|PROCESS|tst9546183.1.2.14|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|42|CE|PROCESS|tst9546183.1.3.15|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|43|CE|PROCESS|tst9546183.1.4.16|$hinit^Initial H&E^L||||||||5^H&E|200512121431
OBX|44|CE|PROCESS|tst9546183.2.5.17|$hinit^Initial H&E^L||||||||5^H&E|200512121431
OBX|45|CE|PROCESS|tst9546183.2.6.18|$hinit^Initial H&E^L||||||||6^H&E|200512121431
OBX|46|CE|PROCESS|tst9546183.2.7.19|$hinit^Initial H&E^L||||||||7^H&E|200512121431
OBX|47|CE|PROCESS|tst9546183.2.8.20|$hinit^Initial H&E^L||||||||8^H&E|200512121431
OBX|48|CE|PROCESS|tst9546183.2.9.21|$hinit^Initial H&E^L||||||||9^H&E|200512121431
OBX|49|CE|PROCESS|tst9546183.2.10.22|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|50|CE|PROCESS|tst9546183.2.11.23|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|51|CE|PROCESS|tst9546183.2.12.24|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|52|TX|GDT|tst9546183|Specimen is received in 2 parts all labeled with the patient's name.\.br\\.br\Part 1 is received in formalin labeled "left ovary" and consists of an unoriented 1.0 x 0.5 x 0.4 cm portion of pink tan fibromembranous tissue.  Cut section reveals pink tan, membranous tissue.  The specimen is bisected and totally submitted in cassette labeled 1A.\.br\\.br\Part 2 is received fresh for intraoperative consultation labeled "left adnexal mass" and consists of a previously opened from the OR 9.5 x 8.0 x 2.1 cm ovary.  The serosal surface is pink tan and wrinkled and focally roughened.  Cut section reveals ovarian parenchyma with a 5.5 cm multiloculated cystic structure.  The inner lining of the cystic structure is pink tan and wrinkled and focally yellow.  Also identified is a 9.0 x 1.2 x 1.1cm fallopian tube.  The serosal surface is pink tan and smooth with extensive tubo-ovarian adhesions.  Also received with the specimen is a separate spherical portion of, cauliflower like structure of soft to firm irregular tan yellow tissue 5.5 x 3.8 x 2.7 cm.  Representative sections are submitted as follows:\.br\2A  2Eovarian tissue is cystic structure\.br\2Ffallopian tube\.br\2G  2Pseparate portion of tan yellow spherical tissue with portion sent for frozen section\.br\2FSfrozen section\.br\||||||F
OBX|53|TX|MDT|tst9546183|     SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS\.br\TUMOR LOCATION:      Left\.br\PROCEDURE:      TAH with salpingo-oophorectomy\.br\TUMOR SIZE:      Maximum dimension:  9.5 cm\.br\TUMOR TYPE:      Endometroid carcinoma\.br\HISTOLOGIC SILVERBERG GRADE:      Moderately differentiated (6-7 pts)\.br\     ARCHITECTURAL PATTERN:           Papillary (2)\.br\     CYTOLOGIC ATYPIA:           Moderate (2)\.br\     MITOTIC COUNTS / 10hpf:           10-24 (2)\.br\VASCULAR INVASION:      Yes\.br\TUMOR CAPSULE:      Intact\.br\SURFACE IMPLANTS:      Not present\.br\ASSOCIATED OTHER LESION:      Endometriosis, Other lesion(s) [free text]\.br\MALIGNANT CELLS IN ASCITES OR\.br\PERITONEAL WASHING:      No\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 10\.br\LYMPH NODES POSITIVE:      Number of positive lymph nodes, Right: 0\.br\     Number of  positive lymph nodes, Left: 0\.br\T STAGE, PATHOLOGIC:      pT1c\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\FIGO STAGE:      IC\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|54|TX|FIN|tst9546183|PART 1:  OVARY, LEFT, BIOPSY \.br\     OVARIAN PARENCHYMA WITH FIBROUS ADHESIONS FAT NECROSIS FOCAL HEMORRHAGE AND\.br\            SMALL EPITHELIA INCLUSION.\.br\\.br\PART 2: LEFT ADNEXAL MASS:\.br\    OVARY AND FALLOPIAN TUBE, LEFT, SALPINGO-OOPHORECTOMY \.br\A.MODERATELY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA OF LEFT OVARY WITH SEROUS FEATURES, 9.5 CM (see comment).\.br\B.ANGIOLYMPHATIC PERMEATION ARE PRESENT.\.br\C.LEFT OVARY WITH ENDOMETRIOSIS, ENDOMETRIOMA AND ADENOFIBROMA WITH CALCIFICATIONS.\.br\D.MULTIPLE FOCI OF ATYPICAL HYPERPLASIA AND FOCI OF ENDOMETRIOID ADENOCARCINOMA ARISING IN THE ENDOMETRIOTIC CYST LINING OF THE OVARY.\.br\E.FOCI OF HEMORRHAGE, HEMOSIDEROSIS AND OSSEOUS METAPLASIA AND CALCIFICATIONS.\.br\F.EXTENSIVE PARA OVARIAN ADHESIONS.\.br\G.LEFT FALLOPIAN TUBE WITH CHRONIC SALPINGITIS ,ENDOMETRIOSIS AND TUBO-OVARIAN ADHESIONS.\.br\||||||F
OBX|55|CE|IMP|tst9546183|M49430^^SNO||||||||1||A
OBX|56|CE|IMP|tst9546183|M54040^^SNO||||||||1||A
OBX|57|CE|IMP|tst9546183|M54110^^SNO||||||||1||A
OBX|58|CE|IMP|tst9546183|P1140^^SNO||||||||1||A
OBX|59|CE|IMP|tst9546183|T87020^^SNO||||||||1||A
OBX|60|CE|IMP|tst9546183|M76540^^SNO||||||||1||A
OBX|61|CE|IMP|tst9546183|M84413^^SNO||||||||1||A
OBX|62|CE|IMP|tst9546183|M90130^^SNO||||||||1||A
OBX|63|CE|IMP|tst9546183|P1100^^SNO||||||||1||A
OBX|64|CE|IMP|tst9546183|T86120^^SNO||||||||1||A
OBX|65|CE|IMP|tst9546183|T87020^^SNO||||||||1||A
OBX|66|CE|IMP|tst9546183|M33400^^SNO||||||||1||A
OBX|67|CE|IMP|tst9546183|M37000^^SNO||||||||1||A
OBX|68|CE|IMP|tst9546183|M43000^^SNO||||||||1||A
OBX|69|CE|IMP|tst9546183|M49400^^SNO||||||||1||A
OBX|70|CE|IMP|tst9546183|M55400^^SNO||||||||1||A
OBX|71|CE|IMP|tst9546183|M57510^^SNO||||||||1||A
OBX|72|CE|IMP|tst9546183|M72005^^SNO||||||||1||A
OBX|73|CE|IMP|tst9546183|M73400^^SNO||||||||1||A
OBX|74|CE|IMP|tst9546183|M76500^^SNO||||||||1||A
OBX|75|CE|IMP|tst9546183|M83803^^SNO||||||||1||A
OBX|76|CE|IMP|tst9546183|T86100^^SNO||||||||1||A
OBX|77|CE|IMP|tst9546183|T86920^^SNO||||||||1||A
OBX|78|CE|IMP|tst9546183|T87000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004351|P|2.3
PID|1||131646949^^^RM|tst5364394|BEN^DEAD||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||131-64-6949|||||||||||N
PV1|1||M5CP^0556||||002103^TULSKY^ASHER|||||||||||IM|0058926435082|P||||||||||||||||||||||||200503231040
ORC|RE||MHS05-5^CoPathPlus||CM||||200503221116|z32^PICCOLI^ANTHONY||002103^TULSKY^ASHER
OBR|1||MHS05-5^CoPathPlus^tst1356183|MHHS^MH Histology|||200503221115|||||||200503221115|GANG|002103||||^31^Y|-1|200503221118||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst1356183.1|GANG^Ganglion Cyst^L||||||F||1^1
OBX|2|ST|BLOCK|tst1356183.1.1|A||||||||1^A|200503221116
OBX|3|CE|PROCESS|tst1356183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|4|TX|GDT|tst1356183|Specimen submitted in formalin, labeled with the patient's initials and "cyst, left ring finger", and this consists of two (2) small circular pieces of glistening yellowish-white apparent membranous tissue, together measuring 1 x 0.3 cm. This tissue is totally submitted as received.\.br\||||||F
OBX|5|TX|FIN|tst1356183|CYST, LEFT RING FINGER, EXCISION:\.br\- FIBROMA.\.br\||||||F
OBX|6|CE|IMP|tst1356183|M33400^^SNO||||||||1||A
OBX|7|CE|IMP|tst1356183|M88100^^SNO||||||||1||A
OBX|8|CE|IMP|tst1356183|P1100^^SNO||||||||1||A
OBX|9|CE|IMP|tst1356183|TY8840^^SNO||||||||1||A
OBX|10|CE|IMP|tst1356183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004352|P|2.3
PID|1||001201952^^^CHPADT|tst2677394|INERROR^WRONG||20010419|M||N|8757 BLUE SKY AVENUE^^PITTSBURGH^PA^15212^United States||4128876893|||||||||||||||||N
PV1|1||CH9NTH^9628||||||||||||||pmc79212^NECHES^WILLIAM|CHQ|1021251051|||||||||||||||||||||||||200506150725|200506240726
ORC|RE||CHS05-5^CoPathPlus||CM||||200506301331|z40^KOKAL^ELLEN
OBR|1||CHS05-5^CoPathPlus^tst5907183|^CHP Histology|||200506300000|||||||200506301330||||||^4^Y|-1|200506301357||SP|C|||||||C22350^TEOT^LISA|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst5907183.1|^NONE - No Specimen Received^L||||||C||1^1
OBX|2|TX|FIN|tst5907183|NO SPECIMEN RECEIVED FOR THE ABOVE NAMED PATIENT\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004353|P|2.3
PID|1||222222222^^^RR|tst0704394|FLINTSTONE^FRED^F||19560102|M|||||||||||222-22-2222|||||||||||N
PV1|1||D1022^102-2||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|I|1234222222222|||||||||||||||||||||||||200503151511
ORC|RE||PHS05-5^CoPathPlus||CM||||200503160940|z196^DEVINE^LISA||505073^PLANET^EARTH
OBR|1||PHS05-5^CoPathPlus^tst1946183|PHSP^PH Surgical Pathology|||200503160939|||||||200503160939|DUBX|505073||||^49^Y|-1|200511301444||SP|C|||||||^PRASAD^JOANNE|z196^DEVINE^LISA
OBX|1|CE|ANT|tst1946183.1|DUBX^Biopsy Duodenum, POLYP^L||||||C||1^1
OBX|2|CE|ANT|tst1946183.2|DUBX^Biopsy Duodenum^L||||||C||2^2
OBX|3|ST|BLOCK|tst1946183.1.1|A||||||||1^A|200504041345
OBX|4|ST|BLOCK|tst1946183.2.2|A||||||||1^A|200601061452
OBX|5|CE|PROCESS|tst1946183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|6|CE|PROCESS|tst1946183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|7|TX|GDT|tst1946183|The specimen is received in buffered formalin and in two parts, each with the patient's name, initials DS.\.br\\.br\Part 1 labeled "duodenal polyp-rule out carcinoid, rule out adenoma," consists of a single irregular portion of bile stained rubbery tissue, 0.4 cm in greatest dimension, bisected and entirely submitted labeled 1A.\.br\\.br\Part 2 labeled " duodenal biopsy-rule out adenoma," consists of two irregular portions of pink soft tissue, each 0.3 cm in greatest dimension and entirely submitted labeled 2A.\.br\\.br\||||||C
OBX|8|TX|MDT|tst1946183|Microscopic examination substantiates the above diagnosis.\.br\||||||C
OBX|9|TX|FIN|tst1946183|PART 1:  SMALL BOWEL, DUODENUM, POLYP, POLYPECTOMY \.br\A.TUBULAR ADENOMA (SEE COMMENT).\.br\B.NO HIGH GRADE DYSPLASIA NOR CARCINOMA SEEN.\.br\\.br\PART 2:  SMALL BOWEL, DUODENUM, BIOPSY \.br\A.DUODENAL MUCOSA WITH INTACT VILLOUS ARCHITECTURE AND NO SIGNIFICANT ABNORMALITY.\.br\B.NEGATIVE FOR DYSPLASIA.\.br\\.br\AVS/cef\.br\||||||C
OBX|10|CE|IMP|tst1946183|M09450^^SNO||||||||1||A
OBX|11|CE|IMP|tst1946183|M74000^^SNO||||||||1||A
OBX|12|CE|IMP|tst1946183|M76800^^SNO||||||||1||A
OBX|13|CE|IMP|tst1946183|M81400^^SNO||||||||1||A
OBX|14|CE|IMP|tst1946183|P1100^^SNO||||||||1||A
OBX|15|CE|IMP|tst1946183|T64000^^SNO||||||||1||A
OBX|16|CE|IMP|tst1946183|T64300^^SNO||||||||1||A
OBX|17|CE|IMP|tst1946183|M74000^^SNO||||||||1||A
OBX|18|CE|IMP|tst1946183|P1140^^SNO||||||||1||A
OBX|19|CE|IMP|tst1946183|T64020^^SNO||||||||1||A
OBX|20|CE|IMP|tst1946183|T64300^^SNO||||||||1||A
OBX|21|CE|IMP|tst1946183|T40910^^SNO||||||||1||A
OBX|22|CE|IMP|tst1946183|285.9^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004354|P|2.3
PID|1||678787878^^^RZ|tpmc2480494|TESTVTWOFIVE^HH ONE||19280806|F||W|||||||||678-78-7878|||||||||||N
PV1|1||ZLAB||||505079^PLANET^PLUTO|505073^PLANET^EARTH|||||||||pmc48361^PLANET^PLUTO|SV|0234561234567|||||||||||||||||||||||||200511210804
ORC|RE||HHS05-5^CoPathPlus||CM||||200511281300|^HANNA^REGINA||505079^PLANET^PLUTO
OBR|1||HHS05-5^CoPathPlus^tpmc2657183|^HH Histology|||200511281300|||||||200511281300|HANBX|505079||||^77^Y|-1|200512201152||SP|C|||||||000760^PERRY^LINA|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc2657183.1|HANBX^Biopsy Antrum^L||||||C||1^1
OBX|2|CE|ANT|tpmc2657183.2|HCBX^Cardia Biopsy^L||||||C||2^2
OBX|3|ST|BLOCK|tpmc2657183.1.1|A||||||||1^A|200601132338
OBX|4|ST|BLOCK|tpmc2657183.2.2|A||||||||1^A|200601132338
OBX|5|ST|BLOCK|tpmc2657183.1.3|B||||||||2^B|200601132338
OBX|6|ST|BLOCK|tpmc2657183.1.4|C||||||||3^C|200601132338
OBX|7|ST|BLOCK|tpmc2657183.1.5|D||||||||4^D|200601132338
OBX|8|CE|PROCESS|tpmc2657183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200512191416
OBX|9|CE|PROCESS|tpmc2657183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512191416
OBX|10|CE|PROCESS|tpmc2657183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512191416
OBX|11|CE|PROCESS|tpmc2657183.1.1.4|pmc5934^Helicobacter (Histo)^L||||||||4^HELICO  L4|200512191416
OBX|12|CE|PROCESS|tpmc2657183.1.1.5|pmc6934^Control (WLO)^L||||||||5^HCONC|200512191416
OBX|13|CE|PROCESS|tpmc2657183.2.2.6|$hinit^Initial H&E^L||||||||1^H&E L1|200512191416
OBX|14|CE|PROCESS|tpmc2657183.2.2.7|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512191416
OBX|15|CE|PROCESS|tpmc2657183.2.2.8|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512191416
OBX|16|CE|PROCESS|tpmc2657183.1.3.9|$hinit^Initial H&E^L||||||||5^H&E|200512191416
OBX|17|CE|PROCESS|tpmc2657183.1.4.10|$hinit^Initial H&E^L||||||||6^H&E|200512191416
OBX|18|CE|PROCESS|tpmc2657183.1.5.11|$hinit^Initial H&E^L||||||||7^H&E|200512191416
OBX|19|CE|PROCESS|tpmc2657183.1.3.12|pmc2233^Acid Fast Stain (Histo)^L||||||||6^AcidFast|200512191416
OBX|20|CE|PROCESS|tpmc2657183.1.4.13|pmc1433^Grocott Stain (Histo)^L||||||||7^Grocott|200512191416
OBX|21|TX|GDT|tpmc2657183|\.br\he specimen is received in buffered formalin in two parts.  Both parts are identified with the patient's name and initials M.M.\.br\\.br\Part 1:  is labeled "biopsy antrum".  It consists of five tan soft tissue fragments the largest of which measures 0.5 x 0.2 x 0.1 cm and the smallest of which measures 0.3 x 0.1 x 0.1 cm.  The specimen is totally submitted in cassette 1A.\.br\1A  Toto x5\.br\\.br\Part 2:  is labeled "biopsy cardia".  It consists of six tan soft tissue fragments the largest of which measures 0.5 x 0.2 x 0.1 cm and the smallest of which measures 0.2 x 0.1 x 0.1 cm.  The specimen is totally submitted in cassette 2A.\.br\2A  Toto x6\.br\||||||C
OBX|22|TX|MDT|tpmc2657183|Microscopic examination substantiates the diagnosis indicated above.\.br\||||||C
OBX|23|TX|FIN|tpmc2657183|PART 1: STOMACH, ANTRUM, BIOPSY-\.br\A.          ANTRAL MUCOSA WITH MODERATE CHRONIC INACTIVE GASTRITIS AND MODERATE REACTIVE AND REGENERATIVE EPITHELIAL CHANGES.\.br\B.     NEGATIVE FOR H. PYLORI ORGANISMS (DIFF-QUIK STAIN).\.br\\.br\\.br\PART 2: CARDIA, BIOPSY-\.br\A.          ANTRAL MUCOSA WITH MILD CHRONIC INACTIVE GASTRITIS AND MODERATE REACTIVE AND REGENERATIVE EPITHELIAL CHANGES.\.br\B.     NEGATIVE FOR H. PYLORI ORGANISMS (DIFF-QUIK STAIN).\.br\||||||C
OBX|24|CE|IMP|tpmc2657183|M43000^^SNO||||||||1||A
OBX|25|CE|IMP|tpmc2657183|M79900^^SNO||||||||1||A
OBX|26|CE|IMP|tpmc2657183|T63600^^SNO||||||||1||A
OBX|27|CE|IMP|tpmc2657183|M43000^^SNO||||||||1||A
OBX|28|CE|IMP|tpmc2657183|M79900^^SNO||||||||1||A
OBX|29|CE|IMP|tpmc2657183|000^^ICD||||||||1
OBR|2||tpmc2657183^CoPathPlus^tpmc2657183.A2|ADD^Addendum||||||||||200512201131|||||||2|200512201131||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc2657183|See additional information in special procedures section.\.br\||||||C
OBR|3||tpmc2657183^CoPathPlus^tpmc2657183.P1|PRE^Provisional Report||||||||||200512201018|||||||1|200512201018||SP|F|||||||000760^PERRY^LINA|987654^PATHOID^DOCTOR

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004355|P|2.3
PID|1||001201951^^^CHPADT|tst1677394|INERROR^CORRECT||19991225|F||O|123 ROSE BAY DRIVE^^PITTSBURGH^PA^15212^United States||4122345678|||||||||||||||||N
PV1|1||CH9NTH^9626||||||||||||||pmc79212^NECHES^WILLIAM|CHQ|1021251044|||||||||||||||||||||||||200506150719|200506240720
ORC|RE||CHS05-6^CoPathPlus||CM||||200506301347|z40^KOKAL^ELLEN
OBR|1||CHS05-6^CoPathPlus^tst6907183|^CHP Histology|||200506300000|||||||200506301347|CBLHR|||||^5^Y|-1|200506301351||SP|F|||||||C22350^TEOT^LISA|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst6907183.1|CBLHR^Bilateral inguinal soft tissue^L||||||F||1^1
OBX|2|TX|GDT|tst6907183|The specimen is received in formalin, labeled with the patient' s name and designated "bilateral hernia sacs (tie on right)."  It consists of two irregular pieces of white-tan, soft fibroconnective tissue, one of which is marked with a tie.  The right measures 0.5 x 0.4 x 0.1 cm and the left measures 0.8 x 0.2 x 0.1 cm.  No unexpected structures are palpable.  No tissue is submitted for paraffin block.  Gross diagnosis only.  \.br\||||||F
OBX|3|TX|MDT|tst6907183|Gross diagnosis only.\.br\||||||F
OBX|4|TX|FIN|tst6907183|GROSS DIAGNOSIS:  Right and left inguinal soft tissue, excision:  HERNIA SACS.\.br\||||||F
OBX|5|CE|IMP|tst6907183|M31680^^SNO||||||||1||A
OBX|6|CE|IMP|tst6907183|P1100^^SNO||||||||1||A
OBX|7|CE|IMP|tst6907183|TY7010^^SNO||||||||1||A
OBX|8|CE|IMP|tst6907183|TY7020^^SNO||||||||1||A
OBX|9|CE|IMP|tst6907183|TY7960^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004356|P|2.3
PID|1||101292929^^^RY|tpmc9390494|TESTVTWOFIVE^HH TWO||19300321|M||W|||||||||101-29-2929|||||||||||N
PV1|1||YAMB||||505079^PLANET^PLUTO|505073^PLANET^EARTH|||||||||pmc48361^PLANET^PLUTO|S|0429292929292|||||||||||||||||||||||||200511210811
ORC|RE||HHS05-6^CoPathPlus||CM||||200511281304|^HANNA^REGINA||505079^PLANET^PLUTO
OBR|1||HHS05-6^CoPathPlus^tpmc3657183|^HH Histology|||200511281303|||||||200511281303||505079||||^75^Y|-1|200512201159||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc3657183.1|^Tonsil (HH)RIGHT TONSIL^L||||||C||1^1
OBX|2|CE|ANT|tpmc3657183.2|^LEFT TONSIL^L||||||C||2^2
OBX|3|CE|ANT|tpmc3657183.3|ADEN^Adenoids^L||||||C||3^3
OBX|4|ST|BLOCK|tpmc3657183.1.1|A||||||||1^A|200511281304
OBX|5|ST|BLOCK|tpmc3657183.2.2|A||||||||1^A|200511281304
OBX|6|ST|BLOCK|tpmc3657183.3.3|A||||||||1^A|200601132338
OBX|7|ST|BLOCK|tpmc3657183.1.4|B||||||||2^B|200512191409
OBX|8|ST|BLOCK|tpmc3657183.1.5|C||||||||3^C|200512191409
OBX|9|ST|BLOCK|tpmc3657183.2.6|B||||||||2^B|200512191410
OBX|10|ST|BLOCK|tpmc3657183.3.7|B||||||||2^B|200601132338
OBX|11|ST|BLOCK|tpmc3657183.3.8|C||||||||3^C|200601132338
OBX|12|CE|PROCESS|tpmc3657183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|13|CE|PROCESS|tpmc3657183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|14|CE|PROCESS|tpmc3657183.3.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|15|CE|PROCESS|tpmc3657183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|16|CE|PROCESS|tpmc3657183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|17|CE|PROCESS|tpmc3657183.2.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|18|CE|PROCESS|tpmc3657183.3.7.7|$hinit^Initial H&E^L||||||||2^H&E|200512191416
OBX|19|CE|PROCESS|tpmc3657183.3.8.8|$hinit^Initial H&E^L||||||||3^H&E|200512191416
OBX|20|CE|PROCESS|tpmc3657183.3.3.9|pmc3653^PAS Stain (Histo)^L||||||||2^PAS|200512191416
OBX|21|CE|PROCESS|tpmc3657183.3.7.10|pmc3653^PAS Stain (Histo)^L||||||||3^PAS|200512191416
OBX|22|CE|PROCESS|tpmc3657183.3.8.11|pmc3653^PAS Stain (Histo)^L||||||||4^PAS|200512191416
OBX|23|TX|GDT|tpmc3657183|\.br\he specimen is received in buffered formalin in two parts.  Both parts are identified with the patient' s name and initials A.B.\.br\\.br\Part 1:  is labeled "tonsils".  It consists of two pieces of tissue each consistent with an intact tonsil.  No markings present to designate left tonsil from right tonsil.  One piece of tissue measures 2.6 x 2.1 x 1.1 cm and the other piece of tissue measures 2.6 x 2.1 x 1.4 cm.  It displays a pink-tan glistening epithelial surface.  No fibrinopurulent exudate is attached externally.  On cut surfaces, the specimen displays a pink homogenous crypted stroma.  One representative section of each is submitted in cassettes 1A and 1B\.br\1A, 1B  RS x1, each\.br\\.br\Part 2:  is labeled "adenoids".  It consists of two pink-tan glistening, partially mucosa-lined tissue fragments which collectively measure 2.9 x 1.8 x 1.0 cm.  One representative section of each is submitted in cassette 2A.\.br\2A  RS x2\.br\||||||C
OBX|24|TX|MDT|tpmc3657183|Microscopic examination substantiates the diagnosis indicated above.\.br\||||||C
OBX|25|TX|FIN|tpmc3657183|PART 1:  RIGHT TONSIL, TONSILLECTOMY \.br\TONSILLAR TISSUE WITH BENIGN REACTIVE LYMPHOID HYPERPLASIA.\.br\\.br\PART 2:  LEFT TONSIL, TONSILLECTOMY \.br\TONSILLAR TISSUE WITH BENIGN REACTIVE LYMPHOID HYPERPLASIA.\.br\\.br\PART 3: ADENOIDECTOMY\.br\ADENOID TISSUE WITH FOCAL REACTIVE LYMPHOID HYPERPLASIA.\.br\||||||C
OBX|26|CE|IMP|tpmc3657183|M72200^^SNO||||||||1||A
OBX|27|CE|IMP|tpmc3657183|P1100^^SNO||||||||1||A
OBX|28|CE|IMP|tpmc3657183|T61100^^SNO||||||||1||A
OBX|29|CE|IMP|tpmc3657183|T61110^^SNO||||||||1||A
OBX|30|CE|IMP|tpmc3657183|M72200^^SNO||||||||1||A
OBX|31|CE|IMP|tpmc3657183|P1100^^SNO||||||||1||A
OBX|32|CE|IMP|tpmc3657183|T61100^^SNO||||||||1||A
OBX|33|CE|IMP|tpmc3657183|T61120^^SNO||||||||1||A
OBX|34|CE|IMP|tpmc3657183|M72201^^SNO||||||||1||A
OBX|35|CE|IMP|tpmc3657183|P1100^^SNO||||||||1||A
OBX|36|CE|IMP|tpmc3657183|T61300^^SNO||||||||1||A
OBX|37|CE|IMP|tpmc3657183|000^^ICD||||||||1
OBR|2||tpmc3657183^CoPathPlus^tpmc3657183.A2|ADD^Addendum||||||||||200512201132|||||||2|200512201132||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc3657183|See additional information in special procedures section.\.br\||||||C
OBR|3||tpmc3657183^CoPathPlus^tpmc3657183.P1|PRE^Provisional Report||||||||||200512201026|||||||1|200512201026||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004359|P|2.3
PID|1||101292929^^^RY|tpmc9390494|TESTVTWOFIVE^HH TWO||19300321|M||W|||||||||101-29-2929|||||||||||N
PV1|1||YAMB||||505079^PLANET^PLUTO|505073^PLANET^EARTH|||||||||pmc48361^PLANET^PLUTO|S|0429292929292|||||||||||||||||||||||||200511210811
ORC|RE||HHS05-7^CoPathPlus||CM||||200511281308|^HANNA^REGINA||505079^PLANET^PLUTO
OBR|1||HHS05-7^CoPathPlus^tpmc4657183|^HH Histology|||200511281308|||||||200511281308||505079||||^75^Y|-1|200512201209||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc4657183.1|^Uterus Tube & Ovaries^L||||||C||1^1
OBX|2|ST|BLOCK|tpmc4657183.1.1|A||||||||1^A|200601132338
OBX|3|ST|BLOCK|tpmc4657183.1.2|B||||||||2^B|200601132338
OBX|4|ST|BLOCK|tpmc4657183.1.3|C||||||||3^C|200601132338
OBX|5|ST|BLOCK|tpmc4657183.1.4|D||||||||4^D|200601132338
OBX|6|ST|BLOCK|tpmc4657183.1.5|E||||||||5^E|200601132338
OBX|7|ST|BLOCK|tpmc4657183.1.6|F||||||||6^F|200601132338
OBX|8|ST|BLOCK|tpmc4657183.1.7|G||||||||7^G|200601132338
OBX|9|ST|BLOCK|tpmc4657183.1.8|H||||||||8^H|200601132338
OBX|10|ST|BLOCK|tpmc4657183.1.9|I||||||||9^I|200601132338
OBX|11|ST|BLOCK|tpmc4657183.1.10|J||||||||10^J|200601132338
OBX|12|CE|PROCESS|tpmc4657183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|13|CE|PROCESS|tpmc4657183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512191416
OBX|14|CE|PROCESS|tpmc4657183.1.3.3|$hinit^Initial H&E^L||||||||2^H&E|200512191416
OBX|15|CE|PROCESS|tpmc4657183.1.4.4|$hinit^Initial H&E^L||||||||2^H&E|200512191416
OBX|16|CE|PROCESS|tpmc4657183.1.5.5|$hinit^Initial H&E^L||||||||3^H&E|200512191416
OBX|17|CE|PROCESS|tpmc4657183.1.6.6|$hinit^Initial H&E^L||||||||3^H&E|200512191416
OBX|18|CE|PROCESS|tpmc4657183.1.7.7|$hinit^Initial H&E^L||||||||3^H&E|200512191416
OBX|19|CE|PROCESS|tpmc4657183.1.8.8|$hinit^Initial H&E^L||||||||3^H&E|200512191416
OBX|20|CE|PROCESS|tpmc4657183.1.9.9|$hinit^Initial H&E^L||||||||3^H&E|200512191416
OBX|21|CE|PROCESS|tpmc4657183.1.10.10|$hinit^Initial H&E^L||||||||2^H&E|200512191416
OBX|22|CE|PROCESS|tpmc4657183.1.4.11|pmc7044^Hematoxylin & Eosin Recut (HH)^L||||||||3^RHHE|200512191416
OBX|23|CE|PROCESS|tpmc4657183.1.1.12|pmc3293^H&E EDU Recut - NO CHG (Histo)^L||||||||2^RHHENC|200512191416
OBX|24|TX|GDT|tpmc4657183|\.br\The specimen is received in buffered formalin in one part.  The part is identified with the patient's name and initials B.S.\.br\\.br\Received labeled "uterus, bilateral tubes and ovaries".  It consists of a 169.0 gram uterus with attached bilateral adnexa.  The uterus is 9.5 cm in height.  The overall width of the specimen is 12.0 cm and from anterior to posterior is 5.0 cm.  There are forceps impressions on the external serosal surface with an area of maroon discoloration at the central portion.  The remainder of the uterine serosa is unremarkable without fibrous adhesions.  It is tan-red.  The ectocervix is undulous and up to 2.5 cm in length with a slit-like os measuring 1.5 cm.  The ecto/endocervical junction is well visualized.  The right fallopian tube is tortuous, measures 4.5 cm in length, averages 0.6 cm in diameter and attached to it is a yellow convoluted ovary measuring 2.2 x 1.5 x 1.0 cm.  It has a heterogenous cut surface that is tan-pink.  The left fallopian tube is 5.0 cm in length, averages 0.5 cm in diameter and has a small paratubal cyst less than 0.1 mm in diameter attached to it.  The left ovary has a yellow convoluted cortical surface partially cystically distended measuring 2.4 x 1.5 x 1.0 cm in overall dimensions.  The cyst is 1.2 cm and appears to be a corpus luteum.  On the cut surface the remainder of the parenchyma adjacent to the cystic area is tan-pink and unremarkable.  The cyst is 0.4 cm in diameter on cut surface.  On further opening the uterus, the endocervical canal averages 2.7 cm in length.  The endometrial cavity is fluffy and tan with a thickness averaging 0.6 cm.  The myometrial thickness averages 1.6 cm.  The myometrium is sectioned and no mass lesions are identified.  Sections are submitted as follows:\.br\1A  Anterior cervix\.br\1B  Posterior cervix\.br\1C  Full thickness anterior endomyometrium with uterine serosa\.br\1D  Full thickness posterior endomyometrium with uterine serosa\.br\1E  Additional sections of endometrium with possible adenomyosis\.br\1F  Right fallopian tube and ovary\.br\1G  Left fallopian tube and ovary\.br\||||||C
OBX|25|TX|MDT|tpmc4657183|Microscopic examination substantiates the diagnosis indicated above.\.br\||||||C
OBX|26|TX|FIN|tpmc4657183|UTERUS, BILATERAL FALLOPIAN TUBES AND OVARIES, TOTAL ABDOMINAL HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY (GROSS WEIGHT 134.3 GRAMS) \.br\A.          CHRONIC CYSTIC CERVICITIS.\.br\B.          POLYPOID SECRETORY ENDOMETRIUM.\.br\C.     ADENOMYOSIS.\.br\D.     ENDOMETRIAL POLYP.\.br\E.     RIGHT FALLOPIAN TUBE WITH ENDOMETRIOSIS.\.br\F.     LEFT FALLOPIAN TUBE WITH PARATUBAL ENDOSALPINGIOSIS.\.br\G.     RIGHT OVARY WITH DILATED FOLLICLES, ENDOSALPINGIOSIS AND OTHER PHYSIOLOGIC CHANGES.\.br\H.     LEFT OVARY WITH PHYSIOLOGIC CHANGES AND A BENIGN SIMPLE SEROUS CYST (2.5 CM).\.br\||||||C
OBX|27|CE|IMP|tpmc4657183|M43800^^SNO||||||||1||A
OBX|28|CE|IMP|tpmc4657183|M76510^^SNO||||||||1||A
OBX|29|CE|IMP|tpmc4657183|M76800^^SNO||||||||1||A
OBX|30|CE|IMP|tpmc4657183|M79320^^SNO||||||||1||A
OBX|31|CE|IMP|tpmc4657183|P1100^^SNO||||||||1||A
OBX|32|CE|IMP|tpmc4657183|T82000^^SNO||||||||1||A
OBX|33|CE|IMP|tpmc4657183|T84000^^SNO||||||||1||A
OBX|34|CE|IMP|tpmc4657183|T86800^^SNO||||||||1||A
OBX|35|CE|IMP|tpmc4657183|T87800^^SNO||||||||1||A
OBX|36|CE|IMP|tpmc4657183|TY4100^^SNO||||||||1||A
OBX|37|CE|IMP|tpmc4657183|M32100^^SNO||||||||1||A
OBX|38|CE|IMP|tpmc4657183|M33770^^SNO||||||||1||A
OBX|39|CE|IMP|tpmc4657183|M76500^^SNO||||||||1||A
OBX|40|CE|IMP|tpmc4657183|M76560^^SNO||||||||1||A
OBX|41|CE|IMP|tpmc4657183|T86110^^SNO||||||||1||A
OBX|42|CE|IMP|tpmc4657183|T86120^^SNO||||||||1||A
OBX|43|CE|IMP|tpmc4657183|T87010^^SNO||||||||1||A
OBX|44|CE|IMP|tpmc4657183|T87020^^SNO||||||||1||A
OBX|45|CE|IMP|tpmc4657183|000^^ICD||||||||1
OBR|2||tpmc4657183^CoPathPlus^tpmc4657183.A2|ADD^Addendum||||||||||200512201132|||||||2|200512201132||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc4657183|See additional information in special procedures section.\.br\||||||C
OBR|3||tpmc4657183^CoPathPlus^tpmc4657183.P1|PRE^Provisional Report||||||||||200512201031|||||||1|200512201031||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004360|P|2.3
PID|1||000321654^^^CHPADT|tst8683394|MELNICK^MARIE^REGINA||19850101|F||W|1^^PITTSBURGH^PA^15213^United States||4123252525||||||120-45-6789|||||||||||N
PV1|1||CHEMRG||||||||||||||pmc48691^FELDMAN^HEIDI|CHG|1021250897|||||||||||||||||||||||||200506201106|200508120954
ORC|RE||CHS05-8^CoPathPlus||CM||||200508011633|z41^LOSOS^FRANK||C000836^FELDMAN^HEIDI
OBR|1||CHS05-8^CoPathPlus^tst5917183|^CHP Histology|||200508010000|||||||200508011633|CACBX|C000836||||^20^Y|-1|200508011635||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst5917183.1|CACBX^Ascending colon biopsy^L||||||F||1^1
OBX|2|TX|GDT|tst5917183|This is the Gross Description\.br\||||||F
OBX|3|TX|MDT|tst5917183|This is the Microscopic Description     \.br\||||||F
OBX|4|TX|FIN|tst5917183|THIS IS THE FINAL DIAGNOSIS\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004361|P|2.3
PID|1||345678901|tst9204394|Test^Bookwalter||19800101|F|||||||||||123-45-6789|||||||||||N
PV1|1||MWPAT||||MW079897^KRIDGEN^PAMELA||||||||||pmc24952^KRIDGEN^PAMELA|MWO|3456789012345|||||||||||||||||||||||||200503091550
ORC|RE||MWS05-8^CoPathPlus||CM||||200503091404|^BOOKWALTER^LISA||MW079897^KRIDGEN^PAMELA
OBR|1||MWS05-8^CoPathPlus^tst2646183|MWSP^MW Pathology|||200503091404|||||||200503091404||MW079897||||^25^Y|-1|200503091437||SP|F|||||||MULLIN-LOCUM-TENENS^MULLIN^BRIAN|z41^LOSOS^FRANK
OBX|1|CE|ANT|tst2646183.1|^Uterus^L||||||F||1^1
OBX|2|ST|BLOCK|tst2646183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst2646183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst2646183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst2646183.1.4|D||||||||4^D|200507221753
OBX|6|ST|BLOCK|tst2646183.1.5|E||||||||5^E|200507221753
OBX|7|ST|BLOCK|tst2646183.1.6|F||||||||6^F|200507221753
OBX|8|ST|BLOCK|tst2646183.1.7|G||||||||7^G|200507221753
OBX|9|ST|BLOCK|tst2646183.1.8|H||||||||8^H|200507221753
OBX|10|ST|BLOCK|tst2646183.1.9|I||||||||9^I|200507221753
OBX|11|ST|BLOCK|tst2646183.1.10|J||||||||10^J|200507221753
OBX|12|CE|PROCESS|tst2646183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|13|CE|PROCESS|tst2646183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|14|CE|PROCESS|tst2646183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|15|CE|PROCESS|tst2646183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|16|CE|PROCESS|tst2646183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|17|CE|PROCESS|tst2646183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|18|CE|PROCESS|tst2646183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|19|CE|PROCESS|tst2646183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|20|CE|PROCESS|tst2646183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|21|CE|PROCESS|tst2646183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|22|TX|GDT|tst2646183|GROSS DESCRIPTION     \.br\||||||F
OBX|23|TX|MDT|tst2646183|Microscopic Description     \.br\||||||F
OBX|24|TX|FIN|tst2646183|FINAL DIAGNOSIS     \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004362|P|2.3
PID|1||678787878^^^RZ|tpmc2480494|TESTVTWOFIVE^HH ONE||19280806|F||W|||||||||678-78-7878|||||||||||N
PV1|1||ZLAB||||505079^PLANET^PLUTO|505073^PLANET^EARTH|||||||||pmc48361^PLANET^PLUTO|SV|0234561234567|||||||||||||||||||||||||200511210804
ORC|RE||HHS05-8^CoPathPlus||CM||||200511281314|^HANNA^REGINA||505079^PLANET^PLUTO
OBR|1||HHS05-8^CoPathPlus^tpmc5657183|^HH Histology|||200511281313|||||||200511281313||505079||||^77^Y|-1|200512201222||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc5657183.1|^Left Nasal Tip - Frozen SectioN^L||||||C||1^1
OBX|2|CE|ANT|tpmc5657183.2|^Lesion of Left Nasal Tip^L||||||C||2^2
OBX|3|ST|BLOCK|tpmc5657183.1.1|A||||||||1^A|200601132338
OBX|4|ST|BLOCK|tpmc5657183.2.2|A||||||||1^A|200601132338
OBX|5|ST|BLOCK|tpmc5657183.1.3|B||||||||2^B|200601132338
OBX|6|CE|PROCESS|tpmc5657183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|7|CE|PROCESS|tpmc5657183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|8|CE|PROCESS|tpmc5657183.1.1.3|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|9|TX|GDT|tpmc5657183|\.br\The specimen is received fresh for frozen section in one part (Part 1) and in buffered formalin in one part (Part 2).  The part is identified with the patient's name and initials S.B.\.br\\.br\Part 1:  Received labeled "lesion of left nasal tip of nose with a stitch identifying the 12 o'clock margin".  It consists of a pale pink-tan oval portion of skin with a stitch at 12 o'clock and measuring from 12 o'clock to 6 o'clock 1.4 cm, 3 o'clock to 9 o'clock 1.0 cm, and 0.7 in thickness.  The surface of the skin is dome-shaped and remarkable for a brown-black pigmented plaque-like area measuring 1.0 cm in diameter with its broadest dimension in the 12 to 6 o'clock dimension.  The 12 o'clock to 3 o'clock, 6 o'clock margin is inked blue.  The 12 o'clock, 9 o'clock, 6 o'clock margin is inked in yellow.  The 12 o'clock tip is additionally inked in red and the 6 o'clock tip in green.  The tissue is sectioned and submitted in its entirety for frozen section.\.br\1AFS  12 o'clock and 6 o'clock tips\.br\1BFS  mid portion\.br\\.br\Part 2:  is labeled "lesion left nasal tip" and per discussion with Dr. Valeri Roth is a portion of deeper specimen from 3 to 6 o'clock aspect with ink on the new deep resection margin.  The previously inked margin is re-inked with blue ink.  The specimen overall measures 1.0 x 0.5 x 0.2 cm in depth.  The tissue after sectioning is submitted in its entirety in cassette 2A.\.br\2A  Toto  \.br\||||||C
OBX|10|TX|MDT|tpmc5657183|Microscopic examination substantiates the diagnosis indicated above.\.br\||||||C
OBX|11|TX|FIN|tpmc5657183|PART 1: LEFT NOSE, LESION, EXCISIONAL BIOPSY FOR FROZEN SECTION-\.br\A.          MALIGNANT.\.br\B.          BASAL CELL CARCINOMA.\.br\C.     MARGINS FREE OF TUMOR.\.br\\.br\PART 2: SKIN, LEFT NOSE, EXCISIONAL BIOPSY-\.br\     BASAL CELL CARCINOMA WITH SQUAMOUS DIFFERENTIATION, COMPLETELY EXCISED (see comment).\.br\||||||C
OBX|12|CE|IMP|tpmc5657183|M09400^^SNO||||||||1||A
OBX|13|CE|IMP|tpmc5657183|M80903^^SNO||||||||1||A
OBX|14|CE|IMP|tpmc5657183|P1141^^SNO||||||||1||A
OBX|15|CE|IMP|tpmc5657183|T21000^^SNO||||||||1||A
OBX|16|CE|IMP|tpmc5657183|M80703^^SNO||||||||1||A
OBX|17|CE|IMP|tpmc5657183|P1100^^SNO||||||||1||A
OBX|18|CE|IMP|tpmc5657183|T02140^^SNO||||||||1||A
OBX|19|CE|IMP|tpmc5657183|000^^ICD||||||||1
OBR|2||tpmc5657183^CoPathPlus^tpmc5657183.A2|ADD^Addendum||||||||||200512201133|||||||2|200512201133||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc5657183|See additional information in special procedures section.\.br\||||||C
OBR|3||tpmc5657183^CoPathPlus^tpmc5657183.P1|PRE^Provisional Report||||||||||200512201037|||||||1|200512201037||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004363|P|2.3
PID|1||001202123^^^CHPADT|tst8948394|INTEGRATION^PCOONE||20050801|F||4|137 TEMPORARY WAY^^PITTSBURGH^PA^15213^United States||4123231234||||||301-36-1234|||||||||||N
PV1|1||CHRHEU||||C030007^ROSEN^PAUL||||||||||pmc82543^ROSEN^PAUL|CHO|1021253859|||||||||||||||||||||||||200508291532
ORC|RE||CHS05-9^CoPathPlus||CM||||200508301444|z40^KOKAL^ELLEN||C030007^ROSEN^PAUL
OBR|1||CHS05-9^CoPathPlus^tst8627183|^CHP Histology|||200508300000|||||||200508301436|CAIBX|C030007||||^29^D|-1|200508301446||SP|F|||||||C006429^JAFFE^RONALD|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst8627183.1|CAIBX^Allograft ileal biopsy^L||||||F||1^1
OBX|2|TX|GDT|tst8627183|The specimen is received in formalin, labeled with the patient's name, and is designated "allograft ileal biopsy."  It consists of two pieces of pink-tan and glistening mucosa, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 1A.\.br\||||||F
OBX|3|TX|MDT|tst8627183|Sections demonstrate two pieces of small bowel with preserved villous and crypt architecture.  Crypts are adequate in number for evaluation. There is no increase in crypt apoptosis. The surface epithelium is intact without ulceration or viral inclusions.  The lamina propria is normocellular with few of plasma cells, few lymphocytes, and scattered eosinophils. \.br\\.br\The case was discussed with Dr. Soltys and the transplant team on 08/03/05.\.br\||||||F
OBX|4|TX|FIN|tst8627183|Allograft ileal biopsy (second allograft, 2 months): \.br\NO EVIDENCE OF ACUTE CELLULAR REJECTION OR VIRAL INCLUSIONS.\.br\MILD STROMAL CHANGES WITH EOSINOPHILIA. \.br\\.br\My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation.\.br\||||||F
OBX|5|CE|IMP|tst8627183|E0004^^SNO||||||||1||A
OBX|6|CE|IMP|tst8627183|M77600^^SNO||||||||1||A
OBX|7|CE|IMP|tst8627183|P1140^^SNO||||||||1||A
OBX|8|CE|IMP|tst8627183|T65200^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004365|P|2.3
PID|1||222222222^^^RR|tst0704394|FLINTSTONE^FRED^F||19560102|M|||||||||||222-22-2222|||||||||||N
PV1|1||D1022^102-2||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|I|1234222222222|||||||||||||||||||||||||200503151511
ORC|RE||BDS05-10^CoPathPlus||CM||||200505111355|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||BDS05-10^CoPathPlus^tst4396183|^BD Histology|||200505111352|||||||200505111352|LUNL|505073||||^49^Y|-1|200508121504||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst4396183.1|LUNL^Right Upper Lobe for FS^L||||||F||1^1
OBX|2|ST|BLOCK|tst4396183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst4396183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst4396183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst4396183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst4396183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst4396183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst4396183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst4396183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst4396183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|11|CE|PROCESS|tst4396183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|12|CE|PROCESS|tst4396183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|13|CE|PROCESS|tst4396183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|14|CE|PROCESS|tst4396183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|15|CE|PROCESS|tst4396183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|16|CE|PROCESS|tst4396183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|17|CE|PROCESS|tst4396183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|18|TX|GDT|tst4396183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||F
OBX|19|TX|MDT|tst4396183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Left Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Anterior\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Maximum dimension:  5.2 cm\.br\     Minor dimension: 3.2 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 2\.br\TUMOR TYPE:      Invasive adenocarcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Distance of invasive tumor to closest margin: 12.0 mm\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Mild\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 0\.br\     Number of N1 lymph nodes examined: 3\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 4\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      No\.br\UNDERLYING DISEASE(S):      Bronchiectasis\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\ANCILLARY STUDIES:      FISH studies\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.\.br\\.br\Additional micro text............................................  \.br\||||||F
OBX|20|TX|FIN|tst4396183|PART 1, LUNG, LOBECTOMY:\.br\A.          MALIGNANT\.br\B.     INVASIVE ADENOCARCINOMA\.br\C.     NO INVOLVEMENT OF SURGICAL MARGINS\.br\D.     6 LYMPH NODES NEGATVE FOPR TUMOR\.br\||||||F
OBX|21|CE|IMP|tst4396183|M81403^^SNO||||||||1||A
OBX|22|CE|IMP|tst4396183|P1100^^SNO||||||||1||A
OBX|23|CE|IMP|tst4396183|T08000^^SNO||||||||1||A
OBX|24|CE|IMP|tst4396183|T28000^^SNO||||||||1||A
OBX|25|CE|IMP|tst4396183|285.9^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004366|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||BDS05-11^CoPathPlus||CM||||200505111359|^LASSIGE^KAREN||505075^PLANET^JUPITER
OBR|1||BDS05-11^CoPathPlus^tst5396183|^BD Histology|||200505111356|||||||200505111356|LUNL|505075||||^49^Y|-1|200507051757||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst5396183.1|LUNL^Right Upper Lobe for FS^L||||||F||1^1
OBX|2|ST|BLOCK|tst5396183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst5396183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst5396183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst5396183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst5396183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst5396183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst5396183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst5396183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst5396183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|11|CE|PROCESS|tst5396183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|12|CE|PROCESS|tst5396183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|13|CE|PROCESS|tst5396183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|14|CE|PROCESS|tst5396183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|15|CE|PROCESS|tst5396183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|16|CE|PROCESS|tst5396183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|17|CE|PROCESS|tst5396183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|18|TX|GDT|tst5396183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||F
OBX|19|TX|MDT|tst5396183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe, Right Lower Lobe\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Not applicable\.br\GROSS SATELLITES: \.br\TUMOR TYPE:      Carcinoid, Adenosquamous carcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\     Ipsilateral lobe(s)\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Chest wall (into skeletal muscle or soft tissue)\.br\     Pericardium\.br\     Obstructive pneumonia or atelectasis involving entire lung\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      > 50%\.br\SURGICAL MARGIN INVOLVEMENT:      Yes\.br\SURGICAL MARGIN SITE:      Bronchial margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Moderate\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 5\.br\     Number of N1 lymph nodes examined: 5\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      Yes\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 3A\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 6\.br\     Number of N2 lymph nodes examined: 7\.br\UNDERLYING DISEASE(S):      Atypical alveolar hyperplasia, Emphysema\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pM0\.br\ANCILLARY STUDIES:      Molecular studies\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.  \.br\||||||F
OBX|20|TX|FIN|tst5396183|RIGHT UPPER LOBE:\.br\A.          ADENOCARCINOMA.\.br\B.     NO INVASION OF PARABRONCHIALLYMPH NODES\.br\C.     NEGATIVE BRONCHUS\.br\D.     NEGATIVE VASCULAR RESECTION\.br\E.     ADENOCARCINOMA OF OVERLYING PLEURA\.br\F.     ADENOCARCINOMA\.br\G.     NEGATIVE PARENCHYMA\.br\||||||F
OBX|21|CE|IMP|tst5396183|T29000^^SNO||||||||1||A
OBX|22|CE|IMP|tst5396183|M81403^^SNO||||||||1||A
OBX|23|CE|IMP|tst5396183|380.12^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004367|P|2.3
PID|1||299963636^^^RA|tpmc5596305|TEST^A^TESTAROONIE||19361017|F||W|TESTAWAY DRIVE^THIRD FLOOR^PITTSBURGH^PA^15235^United States||(412)473-6024|(412)473-6024|||||299-96-3636|||||||||||N
PV1|1||AARC|||||||||||||||SV|0058801145192|B||||||||||||||||||||||||200507111200
ORC|RE||PHS06-11^CoPathPlus||CM||||200601111612|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||PHS06-11^CoPathPlus^tpmc6387183|PHSP^PH Surgical Pathology|||200601111529|||||||200601111529|LA|505073||||^69^Y|-1|200601170727||SP|F|||||||^LASSIGE^KAREN|z491^NESTLER^RICK
OBX|1|CE|ANT|tpmc6387183.1|LA^Liver^L||||||F||1^1
OBX|2|CE|PROCESS|tpmc6387183.1.0.1|tpmc7625^APALBU (PHIS)^L||||||||1^palbu|200601121140
OBX|3|CE|IMP|tpmc6387183|000^^ICD||||||||1
OBR|2||tpmc6387183^CoPathPlus^tpmc6387183.A1|ADD^Addendum||||||||||200601191331|||||||1|200601191331||SP|F||||||||z491^NESTLER^RICK
OBX|1|TX|ADX|tpmc6387183|CaBIG testing, this is the addendum text.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004368|P|2.3
PID|1||111001100^^^RR|tst0584394|POWERCHART^BTRAIN||19550101|F||W|456 MAIN STREET^^PITTSBURGH^PA^15212^United States||||||||111-00-1100|||||||||||N
PV1|1||10G^G1003||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0057976915055|P||||||||||||||||||||||||200502241353
ORC|RE||PHS05-11^CoPathPlus||CM||||200504011443|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-11^CoPathPlus^tst8166183|PHSP^PH Surgical Pathology|||200504011443|||||||200504011443|ABS|002103||||^50^Y|-1|200504011445||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst8166183.1|ABS^Abscess^L||||||F||1^1
OBX|2|TX|GDT|tst8166183|The specimen is received fresh and in three parts, each with the patient's name, initials .\.br\\.br\Part 1 labeled "C3-4 tumor," consists of five irregular portions of pink to hemorrhagic, soft tissue, 0.3 to 0.4 cm in greatest dimension and entirely submitted following frozen section evaluation labeled 1A and 1B.\.br\\.br\Part 2 labeled "C3-4 tumor," consists of 10 irregular portions of pink to hemorrhagic, soft tissue, 0.5 to 1.5 cm in greatest dimension and also entirely submitted following frozen section evaluation labeled 2A and 2B.\.br\\.br\Part 3-labeled "C3-C4 tumor," consists of six irregular portions of pink to hemorrhagic soft tissue, 0.3 to 0.6 cm in greatest dimension and entirely submitted labeled 3A.\.br\||||||F
OBX|3|TX|MDT|tst8166183|Microscopic examination substantiates the above diagnosis. The characteristic microscopic features of this specimen have been digitally photographed, and are available as part of the patient' s electronic medical record.\.br\||||||F
OBX|4|TX|FIN|tst8166183|PARTS1, 2 AND 3: SPINE, C3  C4, MASS, RESECTION \.br\MENINGIOMA (see comment).\.br\||||||F
OBX|5|CE|IMP|tst8166183|M95300^^SNO||||||||1||A
OBX|6|CE|IMP|tst8166183|P1100^^SNO||||||||1||A
OBX|7|CE|IMP|tst8166183|T10500^^SNO||||||||1||A
OBX|8|CE|IMP|tst8166183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004369|P|2.3
PID|1||001234567^^^UDERMSHY|tst2457394|FLINTSTONE^WILMA||19560103|F|||33 Winter St^^PITTSBURGH^PA^15213^United States||4123334444||||||001-23-4567|||||||||||N
PV1|1||DRS||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0004001234567|||||||||||||||||||||||||200504270833
ORC|RE||BDS05-12^CoPathPlus||CM||||200505111402|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||BDS05-12^CoPathPlus^tst6396183|^BD Histology|||200505111400|||||||200505111400|LUNL|505073||||^49^Y|-1|200511161505||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst6396183.1|LUNL^Right Upper Lobe for FS^L||||||C||1^1
OBX|2|ST|BLOCK|tst6396183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst6396183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst6396183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst6396183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst6396183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst6396183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst6396183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst6396183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst6396183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|11|CE|PROCESS|tst6396183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|12|CE|PROCESS|tst6396183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|13|CE|PROCESS|tst6396183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|14|CE|PROCESS|tst6396183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|15|CE|PROCESS|tst6396183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|16|CE|PROCESS|tst6396183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|17|CE|PROCESS|tst6396183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|18|TX|GDT|tst6396183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||C
OBX|19|TX|MDT|tst6396183|Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.  \.br\||||||C
OBX|20|TX|FIN|tst6396183|LUNG, RIGHT UPPER LOBE, LOBECTOMY-\.br\A.          ADENOCARCINOMA, MODERATELY DIFFERENTIATED, 3. 0 CM.\.br\B.     12 LYMPH NODES, FREE OF CARCINOAM.\.br\C.     RESECTION MARGINS NEGATIVE.\.br\||||||C
OBX|21|CE|IMP|tst6396183|M814032^^SNO||||||||1||A
OBX|22|CE|IMP|tst6396183|T00100^^SNO||||||||1||A
OBX|23|CE|IMP|tst6396183|T08000^^SNO||||||||1||A
OBX|24|CE|IMP|tst6396183|T28200^^SNO||||||||1||A
OBX|25|CE|IMP|tst6396183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004370|P|2.3
PID|1||080520051^^^RR|tst1418394|TWIST^OLIVER||19830503|M|||||||||||080-52-0051|||||||||||N
PV1|1||SDS||||||||||||||pmc97361^PLANET^MARS|S|0001080520051|||||||||||||||||||||||||200508051646
ORC|RE||PHS06-12^CoPathPlus||CM||||200601121622|z41^LOSOS^FRANK||505073^PLANET^EARTH
OBR|1||PHS06-12^CoPathPlus^tpmc9387183|PHSP^PH Surgical Pathology|||200601121621|||||||200601121621|NBRTUM|505073||||^22^Y|-1|200601121719||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc9387183.1|NBRTUM^Left Brain tumor^L||||||F||1^1
OBX|2|TX|GDT|tpmc9387183|\.br\The specimen is submitted unfixed identified as "left brain tumor" and is labeled with the patient's name and initials JMR. Received is a 1.5 x 1.0 x 0.6 cm aggregate of gray-tan soft tissue fragments.  Intraoperative smears are taken for diagnostic evaluation.  Representative tissue and serum is taken for tissue banking purposes.  The entire specimen is submitted labeled A.\.br\jlf\.br\||||||F
OBX|3|TX|MDT|tpmc9387183|The specimen shows an astrocytic neoplasm with nuclear pleomorphism, mitotic activity and regions of necrosis.\.br\||||||F
OBX|4|TX|FIN|tpmc9387183|BRAIN TUMOR, LEFT, RESECTION:\.br\GLIOBLASTOMA (ASTROCYTOMA WHO GRADE IV/IV)\.br\||||||F
OBX|5|CE|IMP|tpmc9387183|M94003^^SNO||||||||1||A
OBX|6|CE|IMP|tpmc9387183|M94403^^SNO||||||||1||A
OBX|7|CE|IMP|tpmc9387183|P1100^^SNO||||||||1||A
OBX|8|CE|IMP|tpmc9387183|TX2000^^SNO||||||||1||A
OBR|2||tpmc9387183^CoPathPlus^tpmc9387183.P1|ADVPCR^Adenovirus||||||||||200601121625|||||||1|200601121625||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|PIN|tpmc9387183|FLUORESCENT IN SITU HYBRIDIZATION ASSAY 1p/19q\.br\\.br\The FISH results showed a ratio of 1p36/1q25=0.98 with 4.9% of the cells with loss of 1p (61 cells counted) and a ratio of 19q13/19p13 of 0.98, with 3.3% of cells showing loss of 19q (60 cells counted).\.br\\.br\Normal Range: 1p36: 0.87-1.13 \.br\Deletion Range: 1p36: < 0.87  in greater than 20% of analyzed cells in the targeted area.\.br\\.br\Normal Range: 19q13: 0.85-1.17\.br\Deletion Range: 19q13: < 0.85 in greater than 20% of the analyzed cells in the targeted area.\.br\These ranges were established from internal validations of normal tissue mean +/- 3STD.\.br\\.br\Fluorescent in situ hybridization Assay: \.br\The Vysis LSI 1p36/LSI 1q25 and LSI 19q13/LSI 19p13 Dual-Color Probe Set consists of two separate probe mixtures: One probe set/vial contains LSI 1p36 SpectrumOrange and LSI 1q25 SpectrumGreen.  The other probe set/vial contains LSI 19q13 SpectrumOrange and LSI 19p13 SpectrumGreen. This probe combination may be useful for the detection of deletions occurring at 1p36, and 19q13 loci in some solid tumors. A  minimum of 60 tumor cells is examined for loss of one signal from the 1p and 19q hybridization reactions using a fluorescent microscope.\.br\\.br\\.br\\.br\||||||F
OBX|2|TX|PRC|tpmc9387183|Chromosome 1p: Deletion not detected.\.br\Chromosome 19q: Deletion not detected.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004371|P|2.3
PID|1||112520031^^^RR|tst1584394|POWERCHART^CTRAIN||19251125|M||W|123 TESTING WAY^^PITTSBURGH^PA^15213^United States||(412)555-1212|(412)784-2222|||||112-52-0031|||||||||||N
PV1|1||10S^S1041||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058373085055|P||||||||||||||||||||||||200502241527
ORC|RE||PHS05-12^CoPathPlus||CM||||200504011446|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-12^CoPathPlus^tst9166183|PHSP^PH Surgical Pathology|||200504011446|||||||200504011446|AKA|002103||||^79^Y|-1|200504011447||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst9166183.1|AKA^Leg^L||||||F||1^1
OBX|2|TX|FIN|tst9166183|RIGHT COLON AND TERMINAL ILEUM, RIGHT HEMICOLECTOMY\.br\A.ISCHEMIC COLITIS WITH FOCAL FULL THICKNESS ISCHEMIC NECROSIS (SLIDE G), ACTIVE CHRONIC ULCERS, AND ACUTE AND ORGANIZING SEROSITIS, LARGELY LIMITED TO THE COLON (see comment).\.br\B.SMALL INTESTINE WITH VASCULAR CONGESTION AND HISTOLOGICALLY VIABLE-APPEARING MUCOSA.\.br\C.SURGICAL MARGINS OF RESECTION ARE VIABLE-APPEARING WITH FOCAL VASCULAR CONGESTION.\.br\D.TWO (2) UNREMARKABLE LYMPH NODES.\.br\E.ABSENCE OF APPENDIX.\.br\||||||F
OBX|3|CE|IMP|tst9166183|M38020^^SNO||||||||1||A
OBX|4|CE|IMP|tst9166183|M38030^^SNO||||||||1||A
OBX|5|CE|IMP|tst9166183|M42105^^SNO||||||||1||A
OBX|6|CE|IMP|tst9166183|M45000^^SNO||||||||1||A
OBX|7|CE|IMP|tst9166183|M54200^^SNO||||||||1||A
OBX|8|CE|IMP|tst9166183|P1100^^SNO||||||||1||A
OBX|9|CE|IMP|tst9166183|T50500^^SNO||||||||1||A
OBX|10|CE|IMP|tst9166183|T65520^^SNO||||||||1||A
OBX|11|CE|IMP|tst9166183|T67000^^SNO||||||||1||A
OBX|12|CE|IMP|tst9166183|T67010^^SNO||||||||1||A
OBX|13|CE|IMP|tst9166183|T67965^^SNO||||||||1||A
OBX|14|CE|IMP|tst9166183|M36100^^SNO||||||||1||A
OBX|15|CE|IMP|tst9166183|T00100^^SNO||||||||1||A
OBX|16|CE|IMP|tst9166183|T08000^^SNO||||||||1||A
OBX|17|CE|IMP|tst9166183|T40000^^SNO||||||||1||A
OBX|18|CE|IMP|tst9166183|T66000^^SNO||||||||1||A
OBX|19|CE|IMP|tst9166183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004372|P|2.3
PID|1||700000007^^^MAGEE|tst1745394|RUBBLE^BETTY||19620101|F|||||||||||700-00-0007|||||||||||N
PV1|1||MWQ||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|MWO|0001700000007|||||||||||||||||||||||||200504211525
ORC|RE||BDS05-13^CoPathPlus||CM||||200505111405|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||BDS05-13^CoPathPlus^tst7396183|^BD Histology|||200505111403|||||||200505111403|LUNL|505074||||^43^Y|-1|200505260848||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst7396183.1|LUNL^Right Upper Lobe for FS^L||||||F||1^1
OBX|2|ST|BLOCK|tst7396183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst7396183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst7396183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst7396183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst7396183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst7396183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst7396183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst7396183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst7396183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|11|CE|PROCESS|tst7396183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|12|CE|PROCESS|tst7396183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|13|CE|PROCESS|tst7396183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|14|CE|PROCESS|tst7396183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|15|CE|PROCESS|tst7396183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|16|CE|PROCESS|tst7396183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|17|CE|PROCESS|tst7396183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505131524
OBX|18|TX|GDT|tst7396183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||F
OBX|19|TX|MDT|tst7396183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Apical\.br\PROCEDURE:      Segmental\.br\TUMOR SIZE:      Maximum dimension:  1.0 cm\.br\     Ipsilateral lobe(s)\.br\TUMOR TYPE:      Atypical carcinoid, Squamous carcinoma, in situ, Mesothelioma\.br\HISTOLOGIC GRADE:      G1, Well differentiated\.br\MICROSCOPIC SATELLITES: \.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Bronchial margin, Vascular margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Mild\.br\     Number of N1 lymph nodes examined: 0\.br\     Number of N2 lymph nodes examined: 0\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      No\.br\UNDERLYING DISEASE(S):      Pneumoconiosis, NOS\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\ANCILLARY STUDIES:      Immunohistochemical stains\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.  \.br\||||||F
OBX|20|TX|FIN|tst7396183|Part 1. LUNG LOBECTOMY\.br\A.          MALIGNANT\.br\B.     INVASIVE CARCINOMA\.br\||||||F
OBX|21|CE|IMP|tst7396183|M80103^^SNO||||||||1||A
OBX|22|CE|IMP|tst7396183|P1100^^SNO||||||||1||A
OBX|23|CE|IMP|tst7396183|T28000^^SNO||||||||1||A
OBX|24|CE|IMP|tst7396183|654.63^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004373|P|2.3
PID|1||319751697^^^RR|tst2584394|POWERCHART^DTRAIN||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||319-75-1697|||||||||||N
PV1|1||10G^G1006||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058084805055|P||||||||||||||||||||||||200502241354
ORC|RE||PHS05-13^CoPathPlus||CM||||200504011448|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-13^CoPathPlus^tst0266183|PHSP^PH Surgical Pathology|||200504011448|||||||200504011448|DUBX|002103||||^31^Y|-1|200504011451||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst0266183.1|DUBX^Biopsy Duodenum^L||||||F||1^1
OBX|2|TX|GDT|tst0266183|The specimen received unfixed with patient's name, initials , and labeled "right subdural hematoma," consists of five irregular portions of soft to friable, dark red clot, 0.8 to 3.5 cm in greatest dimension, with representative tissue submitted labeled A.\.br\||||||F
OBX|3|TX|MDT|tst0266183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst0266183|BRAIN, SITE NOT SPECIFIED, HEMORRHAGE, CRANIOTOMY \.br\HEMATOMA.\.br\||||||F
OBX|5|CE|IMP|tst0266183|M37000^^SNO||||||||1||A
OBX|6|CE|IMP|tst0266183|M37100^^SNO||||||||1||A
OBX|7|CE|IMP|tst0266183|P1000^^SNO||||||||1||A
OBX|8|CE|IMP|tst0266183|TX2000^^SNO||||||||1||A
OBX|9|CE|IMP|tst0266183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004374|P|2.3
PID|1||299963636^^^RR|tpmc5596305|TEST^A^TESTAROONIE||19361017|F||W|TESTAWAY DRIVE^THIRD FLOOR^PITTSBURGH^PA^15235^United States||(412)473-6024|(412)473-6024|||||299-96-3636|||||||||||N
PV1|1||6D^D0661||||042870^TANZER^PETER||||||||||pmc6832^TANZER^PETER|I|0058801146011|||||||||||||||||1||||||||200601110629|200601121351
ORC|RE||PHS06-13^CoPathPlus||CM||||200601170717|z491^NESTLER^RICK||042870^TANZER^PETER
OBR|1||PHS06-13^CoPathPlus^tpmc5487183|PHSP^PH Surgical Pathology|||200601170717|||||||200601170717|BOBX|042870||||^69^Y|-1|200601170728||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tpmc5487183.1|BOBX^Bone^L||||||F||1^1
OBX|2|TX|GDT|tpmc5487183|Testing\.br\\.br\||||||F
OBX|3|TX|MDT|tpmc5487183|Testing\.br\||||||F
OBX|4|TX|FIN|tpmc5487183|Testing\.br\\.br\||||||F
OBX|5|CE|IMP|tpmc5487183|786.50^^ICD||||||||1
OBR|2||tpmc5487183^CoPathPlus^tpmc5487183.P1|FC^Flow Cytometry||||||||||200601170717|||||||1|200601170717||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|PIN|tpmc5487183|Testing\.br\||||||F
OBR|3||tpmc5487183^CoPathPlus^tpmc5487183.P2|CG^Cytogenetics||||||||||200601171244|||||||2|200601171244||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|PIN|tpmc5487183|Testing     \.br\||||||F
OBX|2|TX|PRC|tpmc5487183|Testing     \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004375|P|2.3
PID|1||333333334^^^WASH|tst2146394|RUBBLE^PEBBLES||19741110|F|||||||||||333-33-3334|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001333333334|||||||||||||||||||||||||200504251332
ORC|RE||BDS05-14^CoPathPlus||CM||||200505111407|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||BDS05-14^CoPathPlus^tst8396183|^BD Histology|||200505111406|||||||200505111406|LUNL|505074||||^30^Y|-1|200511031152||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst8396183.1|LUNL^Right Upper Lobe for FS^L||||||C||1^1
OBX|2|ST|BLOCK|tst8396183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst8396183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst8396183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst8396183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst8396183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst8396183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst8396183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst8396183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst8396183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|11|CE|PROCESS|tst8396183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|12|CE|PROCESS|tst8396183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|13|CE|PROCESS|tst8396183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|14|CE|PROCESS|tst8396183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|15|CE|PROCESS|tst8396183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|16|CE|PROCESS|tst8396183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|17|CE|PROCESS|tst8396183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|18|TX|GDT|tst8396183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||C
OBX|19|TX|MDT|tst8396183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Posterior\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Maximum dimension:  10.0 cm\.br\     Minor dimension: 2.1 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 3\.br\TUMOR TYPE:      Invasive adenocarcinoma\.br\HISTOLOGIC GRADE:      G1, Well differentiated\.br\MICROSCOPIC SATELLITES:      Number of microscopic satellite lesions: 0\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Tumor involves main bronchus < 2cm from carina\.br\ANGIOLYMPHATIC INVASION:      No\.br\SURGICAL MARGIN INVOLVEMENT:      Yes\.br\SURGICAL MARGIN SITE:      Parenchymal margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Severe\.br\     Number of N1 lymph nodes examined: 12\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 2L\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 10\.br\     Number of N2 lymph nodes examined: 12\.br\UNDERLYING DISEASE(S):      Bronchiectasis, Smokers bronchiolitis\.br\T STAGE, PATHOLOGIC:      pTis\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pMX\.br\ANCILLARY STUDIES:      Immunohistochemical stains, Molecular studies\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.  \.br\||||||C
OBX|20|TX|FIN|tst8396183|LUNG, RIGHT, LOBECTOMY \.br\A.          MALIGNANT.\.br\B.     INVASIVE ADENOCARCINOMA.\.br\C.     TEN LYMPH NODES POSITIVE.\.br\||||||C
OBX|21|CE|IMP|tst8396183|M81403^^SNO||||||||1||A
OBX|22|CE|IMP|tst8396183|P1100^^SNO||||||||1||A
OBX|23|CE|IMP|tst8396183|T08000^^SNO||||||||1||A
OBX|24|CE|IMP|tst8396183|T28100^^SNO||||||||1||A
OBX|25|CE|IMP|tst8396183|V70.0^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004377|P|2.3
PID|1||222115588^^^RR|tst3584394|POWERCHART^ETRAIN||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||222-11-5588|||||||||||N
PV1|1||10S^S1042||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058739245055|P||||||||||||||||||||||||200502241528
ORC|RE||PHS05-14^CoPathPlus||CM||||200504011452|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-14^CoPathPlus^tst1266183|PHSP^PH Surgical Pathology|||200504011452|||||||200504011452|EBB|002103||||^31^Y|-1|200504011454||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst1266183.1|EBB^Endobronchial Biopsy^L||||||F||1^1
OBX|2|TX|FIN|tst1266183|COLON, SIGMOID, SEGMENTAL RESECTION \.br\A.SEGMENT OF COLON WITH FOCAL EARLY (MILD) ACUTE PSEUDOMEMBRANOUS COLITIS CHARACTERIZED BY FOCAL SUPERFICIAL EROSIONS WITH OVERLYING INFLAMMATORY EXUDATE (TYPE I LESIONS).  ADJACENT COLONIC MUCOSA WITH EDEMA (see comment).\.br\B.FOCAL FUNGAL YEAST FORMS SUGGESTIVE OF CANDIDA IN LUMINAL EXUDATE (SLIDE C); NO INVASIVE FUNGAL ORGANISMS ARE SEEN.\.br\C.NO EVIDENCE OF PERFORATION.\.br\D.EARLY (MILD) PSEUDOMEMBRANOUS COLITIS IS PRESENT AT BOTH PROXIMAL AND DISTAL RESECTION MARGINS.\.br\||||||F
OBX|3|CE|IMP|tst1266183|E0004^^SNO||||||||1||A
OBX|4|CE|IMP|tst1266183|E4041^^SNO||||||||1||A
OBX|5|CE|IMP|tst1266183|E4080^^SNO||||||||1||A
OBX|6|CE|IMP|tst1266183|M36370^^SNO||||||||1||A
OBX|7|CE|IMP|tst1266183|M36500^^SNO||||||||1||A
OBX|8|CE|IMP|tst1266183|M41041^^SNO||||||||1||A
OBX|9|CE|IMP|tst1266183|M41400^^SNO||||||||1||A
OBX|10|CE|IMP|tst1266183|P1100^^SNO||||||||1||A
OBX|11|CE|IMP|tst1266183|T67000^^SNO||||||||1||A
OBX|12|CE|IMP|tst1266183|T67010^^SNO||||||||1||A
OBX|13|CE|IMP|tst1266183|T67700^^SNO||||||||1||A
OBX|14|CE|IMP|tst1266183|M40590^^SNO||||||||1||A
OBX|15|CE|IMP|tst1266183|M46300^^SNO||||||||1||A
OBX|16|CE|IMP|tst1266183|T00100^^SNO||||||||1||A
OBX|17|CE|IMP|tst1266183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004378|P|2.3
PID|1||299963636^^^RR|tpmc5596305|TEST^A^TESTAROONIE||19361017|F||W|TESTAWAY DRIVE^THIRD FLOOR^PITTSBURGH^PA^15235^United States||(412)473-6024|(412)473-6024|||||299-96-3636|||||||||||N
PV1|1||6D^D0661||||042870^TANZER^PETER||||||||||pmc6832^TANZER^PETER|I|0058801146011|||||||||||||||||1||||||||200601110629|200601121351
ORC|RE||PHS06-14^CoPathPlus||CM||||200601170728|z491^NESTLER^RICK||042870^TANZER^PETER
OBR|1||PHS06-14^CoPathPlus^tpmc6487183|PHSP^PH Surgical Pathology|||200601170728|||||||200601170728|LART|042870||||^69^Y|-1|200601170729||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tpmc6487183.1|LART^Larynx, Total Laryngectomy^L||||||F||1^1
OBX|2|TX|GDT|tpmc6487183|Testing\.br\\.br\||||||F
OBX|3|TX|MDT|tpmc6487183|Testing\.br\\.br\||||||F
OBX|4|TX|FIN|tpmc6487183|Testing\.br\\.br\||||||F
OBX|5|CE|IMP|tpmc6487183|786.50^^ICD||||||||1
OBR|2||tpmc6487183^CoPathPlus^tpmc6487183.A2|ADD^Addendum||||||||||200601170730|||||||2|200601170730||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|ADX|tpmc6487183|This is an addendum.\.br\||||||F
OBR|3||tpmc6487183^CoPathPlus^tpmc6487183.A3|ADD^Addendum||||||||||200601171248|||||||3|200601171248||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|ADX|tpmc6487183|Testing\.br\||||||F
OBR|4||tpmc6487183^CoPathPlus^tpmc6487183.P1|FC^Flow Cytometry||||||||||200601170730|||||||1|200601170730||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|PIN|tpmc6487183|Testing\.br\\.br\||||||F
OBX|2|TX|PRC|tpmc6487183|Testing\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004379|P|2.3
PID|1||000999999^^^RR|tst4584394|POWERCHART^FTRAIN||19681009|F||W|7878 BOVINE LANE^^PITTSBURGH^PA^15207^United States||(412)647-3434||||||998-85-5223|||||||||||N
PV1|1||10G^G1007||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0056575635055|P||||||||||||||||1||||||||200502241355|200601101341
ORC|RE||PHS05-15^CoPathPlus||CM||||200504011454|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-15^CoPathPlus^tst2266183|PHSP^PH Surgical Pathology|||200504011454|||||||200504011454|BMB|002103||||^36^Y|-1|200504011455||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst2266183.1|BMB^Bone Marrow Biopsy^L||||||F||1^1
OBX|2|TX|GDT|tst2266183|The specimen received unfixed, with patient's name, initials, and labeled "pancreatic debridement," consists of a 4.0 x 3.0 by 0.8 cm portion of gray, soft to friable, necrotic tissue.  A representative section is submitted labeled A.\.br\||||||F
OBX|3|TX|FIN|tst2266183|PANCREAS, DEBRIDEMENT\.br\HEMORRHAGIC TISSUE WITH EXTENSIVE LIQUIFACTION NECROSIS, SAPONIFICATION, ACUTE AND CHRONIC INFLAMMATION AND RARE CALCIFICATION (h/o of necrotizing pancreatitis).\.br\||||||F
OBX|4|CE|IMP|tst2266183|M37000^^SNO||||||||1||A
OBX|5|CE|IMP|tst2266183|M42100^^SNO||||||||1||A
OBX|6|CE|IMP|tst2266183|M43700^^SNO||||||||1||A
OBX|7|CE|IMP|tst2266183|M54000^^SNO||||||||1||A
OBX|8|CE|IMP|tst2266183|M55400^^SNO||||||||1||A
OBX|9|CE|IMP|tst2266183|P1130^^SNO||||||||1||A
OBX|10|CE|IMP|tst2266183|T59000^^SNO||||||||1||A
OBX|11|CE|IMP|tst2266183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004381|P|2.3
PID|1||299963636^^^RR|tpmc5596305|TEST^A^TESTAROONIE||19361017|F||W|TESTAWAY DRIVE^THIRD FLOOR^PITTSBURGH^PA^15235^United States||(412)473-6024|(412)473-6024|||||299-96-3636|||||||||||N
PV1|1||6D^D0661||||042870^TANZER^PETER||||||||||pmc6832^TANZER^PETER|I|0058801146011|||||||||||||||||1||||||||200601110629|200601121351
ORC|RE||PHS06-15^CoPathPlus||CM||||200601170732|z491^NESTLER^RICK||042870^TANZER^PETER
OBR|1||PHS06-15^CoPathPlus^tpmc7487183|PHSP^PH Surgical Pathology|||200601170732|||||||200601170732|ABS|042870||||^69^Y|-1|200601170733||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tpmc7487183.1|ABS^Abscess^L||||||F||1^1
OBX|2|TX|GDT|tpmc7487183|Testing\.br\\.br\||||||F
OBX|3|TX|MDT|tpmc7487183|Testing\.br\\.br\||||||F
OBX|4|TX|FIN|tpmc7487183|Testing\.br\\.br\||||||F
OBX|5|CE|IMP|tpmc7487183|786.50^^ICD||||||||1
OBR|2||tpmc7487183^CoPathPlus^tpmc7487183.A2|ADD^Addendum||||||||||200601171320|||||||2|200601171320||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|ADX|tpmc7487183|testing\.br\||||||F
OBR|3||tpmc7487183^CoPathPlus^tpmc7487183.P1|EM^Electron Microscopy||||||||||200601170733|||||||1|200601170733||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|PIN|tpmc7487183|Testing\.br\\.br\||||||F
OBX|2|TX|PRC|tpmc7487183|Testing\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004382|P|2.3
PID|1||170700439^^^RD|tst9407394|SYNOPTEST^BRADDOCK^THREE||19430703|M||B|||||||||170-70-0439|||||||||||N
PV1|1||D2W^203||||505071^PLANET^MERCURY||||||||||pmc08361^PLANET^JUPITER|I|0001170700439|||||||||||||||||||||||||200503021741
ORC|RE||BDS05-15^CoPathPlus||CM||||200505111412|^LASSIGE^KAREN||505071^PLANET^MERCURY
OBR|1||BDS05-15^CoPathPlus^tst9396183|^BD Histology|||200505111409|||||||200505111409|LUNL|505071||||^61^Y|-1|200511031153||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst9396183.1|LUNL^ Right Upper Lobe for FS^L||||||F||1^1
OBX|2|ST|BLOCK|tst9396183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst9396183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst9396183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst9396183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst9396183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst9396183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst9396183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst9396183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst9396183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|11|CE|PROCESS|tst9396183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|12|CE|PROCESS|tst9396183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|13|CE|PROCESS|tst9396183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|14|CE|PROCESS|tst9396183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|15|CE|PROCESS|tst9396183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|16|CE|PROCESS|tst9396183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|17|CE|PROCESS|tst9396183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|18|TX|GDT|tst9396183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||F
OBX|19|TX|MDT|tst9396183|Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.  \.br\||||||F
OBX|20|TX|FIN|tst9396183|PART1, LUNG, LOBECTOMY:\.br\A. MALIGNANT\.br\||||||F
OBX|21|CE|IMP|tst9396183|M80003^^SNO||||||||1||A
OBX|22|CE|IMP|tst9396183|P1100^^SNO||||||||1||A
OBX|23|CE|IMP|tst9396183|T28000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004383|P|2.3
PID|1||170700439^^^RD|tst9407394|SYNOPTEST^BRADDOCK^THREE||19430703|M||B|||||||||170-70-0439|||||||||||N
PV1|1||D2W^203||||505071^PLANET^MERCURY||||||||||pmc08361^PLANET^JUPITER|I|0001170700439|||||||||||||||||||||||||200503021741
ORC|RE||BDS05-16^CoPathPlus||CM||||200505111415|^LASSIGE^KAREN||505071^PLANET^MERCURY
OBR|1||BDS05-16^CoPathPlus^tst0496183|^BD Histology|||200505111413|||||||200505111413|LUNL|505071||||^61^Y|-1|200511031153||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst0496183.1|LUNL^ Right Upper Lobe for FS^L||||||F||1^1
OBX|2|ST|BLOCK|tst0496183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst0496183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst0496183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst0496183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst0496183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst0496183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst0496183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst0496183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst0496183.1.9|I||||||||9^I|200508311407
OBX|11|CE|PROCESS|tst0496183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505131708
OBX|12|CE|PROCESS|tst0496183.1.2.2|$hinit^Initial H&E^L||||||||6^H&E|200505131708
OBX|13|CE|PROCESS|tst0496183.1.3.3|$hinit^Initial H&E^L||||||||6^H&E|200505131708
OBX|14|CE|PROCESS|tst0496183.1.4.4|$hinit^Initial H&E^L||||||||9^H&E|200505131708
OBX|15|CE|PROCESS|tst0496183.1.5.5|$hinit^Initial H&E^L||||||||11^H&E|200505131708
OBX|16|CE|PROCESS|tst0496183.1.6.6|$hinit^Initial H&E^L||||||||13^H&E|200505131708
OBX|17|CE|PROCESS|tst0496183.1.7.7|$hinit^Initial H&E^L||||||||13^H&E|200505131708
OBX|18|CE|PROCESS|tst0496183.1.8.8|$hinit^Initial H&E^L||||||||13^H&E|200505131708
OBX|19|CE|PROCESS|tst0496183.1.9.9|$hinit^Initial H&E^L||||||||13^H&E|200508311427
OBX|20|CE|PROCESS|tst0496183.1.9.10|pmc3653^PAS Stain (Histo)^L||||||||14^PAS|200507271603
OBX|21|CE|PROCESS|tst0496183.1.1.11|pmc9033^S100 (IPEX)^L||||||||2^S100|200507291629
OBX|22|CE|PROCESS|tst0496183.1.0.12|pmc3474^ABCL6 (IPEX)^L||||||||1^ABCL6|200507291632
OBX|23|CE|PROCESS|tst0496183.1.1.13|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||3^IBNKNC|200601132341
OBX|24|CE|PROCESS|tst0496183.1.1.14|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||4^H&E Recut|200601132341
OBX|25|CE|PROCESS|tst0496183.1.3.15|pmc1433^Grocott Stain (Histo)^L||||||||7^Grocott|200507291634
OBX|26|CE|PROCESS|tst0496183.1.1.16|pmc2233^Acid Fast Stain (Histo)^L||||||||5^AcidFast|200507291641
OBX|27|CE|PROCESS|tst0496183.1.1.17|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||6^RHHE Lev ___|200507291642
OBX|28|CE|PROCESS|tst0496183.1.3.18|pmc2233^Acid Fast Stain (Histo)^L||||||||8^AcidFast|200507291641
OBX|29|CE|PROCESS|tst0496183.1.3.19|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||9^RHHE Lev ___|200507291642
OBX|30|CE|PROCESS|tst0496183.1.4.20|pmc2233^Acid Fast Stain (Histo)^L||||||||10^AcidFast|200507291641
OBX|31|CE|PROCESS|tst0496183.1.4.21|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||11^RHHE Lev ___|200507291642
OBX|32|CE|PROCESS|tst0496183.1.5.22|pmc2233^Acid Fast Stain (Histo)^L||||||||12^AcidFast|200507291641
OBX|33|CE|PROCESS|tst0496183.1.5.23|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||13^RHHE Lev ___|200507291642
OBX|34|TX|GDT|tst0496183|The specimen is identified as "right upper lobe".  Received is a 150-gram right upper lung lobectomy, 12.0 x 12.0 x 4.5 cm.  The pleural surface is soft, smooth and tan-pink to focally anthracotic.  The bronchial and vascular surgical resection margins are patent and grossly unremarkable.  On cross section, the parenchyma cut surfaces demonstrate a poorly circumscribed, 3.5 x 3.2 x 3.0 cm gray-tan focally anthracotic solid, firm mass, situated 2.5 cm from the bronchial resection margin and 1.0 cm from the closest overlying pleural surface.  A representative portion of the mass is frozen for intraoperative diagnostic evaluation and representative tissue is also taken for Oncotech Laboratory.  The pleura overlying the mass is marked with blue ink.  The remainder of the cut surfaces show tan-pink, spongy parenchyma with patent vasculature and bronchi.  The following sections are submitted:\.br\A  frozen section portion\.br\B  parabronchial lymph nodes\.br\C  bronchial resection margin\.br\D  vascular resection margin\.br\E-G  mass in relation to overlying pleura\.br\H  mass and adjacent bronchus\.br\I/J  representative remainder of lung parenchyma.\.br\\.br\||||||F
OBX|35|TX|MDT|tst0496183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Middle Lobe, Right Lower Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Upper Division, Posterior\.br\PROCEDURE:      Wedge\.br\TUMOR SIZE:      Minor dimension: 102 cm\.br\     Not applicable\.br\     Contralateral lobe(s)\.br\TUMOR TYPE:      Atypical carcinoid\.br\HISTOLOGIC GRADE:      G4, Undifferentiated\.br\     Contralateral lobe(s)\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Obstructive pneumonia or atelectasis involving entire lung\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Parietal pleural margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Mild\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 0\.br\     Number of N1 lymph nodes examined: 0\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 3A, Level 5\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 0\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      Yes\.br\UNDERLYING DISEASE(S):      Asthma\.br\T STAGE, PATHOLOGIC:      pTX\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM0\.br\ANCILLARY STUDIES:      Histochemical stains\.br\Comment:      This is the comment field\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.  Elastic stain highlights intact visceral pleura.  Mucin, PAS and PAS with diastase are positive.  Trichrome and Grocott stains are negative.  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004384|P|2.3
PID|1||265499556^^^RR|tst5584394|POWERCHART^GTRAIN||19550415|F||W|111 JENSEN STREET^APARTMENT 3B^PITTSBURGH^PA^15221^United States||(412)654-6432||||||265-49-9556|||||||||||N
PV1|1||10S^S1043||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058065265055|P||||||||||||||||||||||||200502241529
ORC|RE||PHS05-16^CoPathPlus||CM||||200504040836|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-16^CoPathPlus^tst3266183|PHSP^PH Surgical Pathology|||200504040836|||||||200504040836|CLOT|002103||||^50^Y|-1|200504040844||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst3266183.1|CLOT^Clot or Thrombus^L||||||F||1^1
OBX|2|TX|GDT|tst3266183|The specimen is received unfixed labeled with the patient's name, initials TP, and  "right femoral thrombus." It consists of two irregular portions of soft, dark, blood clot, each measuring approximately 0.8 cm in greatest dimension, and accompanying a single segment of patent , pink, blood vessel, 1.5 x 0.5 x 0.5 cm.  The specimen is entirely submitted\.br\||||||F
OBX|3|TX|MDT|tst3266183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst3266183|THROMBUS, RIGHT FEMORAL, THROMBECTOMY \.br\VASCULAR TISSUE WITH ORGANIZING THROMBUS AND BLOOD CLOT.\.br\||||||F
OBX|5|CE|IMP|tst3266183|M35000^^SNO||||||||1||A
OBX|6|CE|IMP|tst3266183|M35100^^SNO||||||||1||A
OBX|7|CE|IMP|tst3266183|M35102^^SNO||||||||1||A
OBX|8|CE|IMP|tst3266183|P1100^^SNO||||||||1||A
OBX|9|CE|IMP|tst3266183|T11710^^SNO||||||||1||A
OBX|10|CE|IMP|tst3266183|T40000^^SNO||||||||1||A
OBX|11|CE|IMP|tst3266183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004386|P|2.3
PID|1||147558857^^^RG|tst4274394|TESTFOUR^WORKLIST||19480227|F|||||||||||147-55-8857|||||||||||N
PV1|1||MWGYN||||505073^PLANET^EARTH||||||||||pmc97361^PLANET^MARS|MWD|01147558857|||||||||||||||||||||||||200503251434
ORC|RE||MWS05-17^CoPathPlus||CM||||200503251439|^SOLTESZ^BENJAMIN||505073^PLANET^EARTH
OBR|1||MWS05-17^CoPathPlus^tst7756183|MWSP^MW Pathology|||200503251438|||||||200503251438|BNBXMW|505073||||^57^Y|-1|200601041121||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst7756183.1|BNBXMW^Breast Core Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst7756183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst7756183.1.2|B||||||||2^B|200507221753
OBX|4|CE|PROCESS|tst7756183.1.1.1|pmc4115^Blank Slide (MW)^L||||||||1^BLANK|200512121428
OBX|5|CE|PROCESS|tst7756183.1.1.2|$hinit^Initial H&E^L||||||||2^H&E Lv1|200512121431
OBX|6|CE|PROCESS|tst7756183.1.1.3|pmc4115^Blank Slide (MW)^L||||||||3^BLANK|200512121428
OBX|7|CE|PROCESS|tst7756183.1.1.4|pmc5553^HH&E (HISTO)^L||||||||4^H&E Lv2|200512121431
OBX|8|CE|PROCESS|tst7756183.1.1.5|pmc4115^Blank Slide (MW)^L||||||||5^BLANK|200512121428
OBX|9|CE|PROCESS|tst7756183.1.1.6|pmc5553^HH&E (HISTO)^L||||||||6^H&E Lv3|200512121431
OBX|10|CE|PROCESS|tst7756183.1.1.7|pmc4115^Blank Slide (MW)^L||||||||7^BLANK|200512121428
OBX|11|CE|PROCESS|tst7756183.1.1.8|pmc5553^HH&E (HISTO)^L||||||||8^H&E Lv4|200512121431
OBX|12|CE|PROCESS|tst7756183.1.1.9|pmc4115^Blank Slide (MW)^L||||||||9^BLANK|200512121428
OBX|13|CE|PROCESS|tst7756183.1.1.10|$hinit^Initial H&E^L||||||||10^H&E Lv1|200512121431
OBX|14|CE|PROCESS|tst7756183.1.1.11|pmc4115^Blank Slide (MW)^L||||||||11^BLANK|200512121428
OBX|15|CE|PROCESS|tst7756183.1.1.12|pmc5553^HH&E (HISTO)^L||||||||12^H&E Lv2|200512121431
OBX|16|CE|PROCESS|tst7756183.1.1.13|pmc4115^Blank Slide (MW)^L||||||||13^BLANK|200512121428
OBX|17|CE|PROCESS|tst7756183.1.1.14|pmc5553^HH&E (HISTO)^L||||||||14^H&E Lv3|200512121431
OBX|18|CE|PROCESS|tst7756183.1.1.15|pmc4115^Blank Slide (MW)^L||||||||15^BLANK|200512121428
OBX|19|CE|PROCESS|tst7756183.1.1.16|pmc5553^HH&E (HISTO)^L||||||||16^H&E Lv4|200512121431
OBX|20|CE|PROCESS|tst7756183.1.1.17|pmc1884^Her-2/neu (IPEX)^L||||||||17^Her- 2/neu|200512121428
OBX|21|CE|PROCESS|tst7756183.1.2.18|pmc2025^19q1319p13, FISH (PHIS)^L||||||||17^19q1319p13|200504221525
OBX|22|CE|PROCESS|tst7756183.1.2.19|pmc5553^HH&E (HISTO)^L||||||||18^HHE|200512121431
OBX|23|TX|GDT|tst7756183|\.br\The specimen is received in formalin in two parts.\.br\\.br\Part 1 is labeled 3right breast at 3:004 and consists of three cylindrical segments of pale yellow, soft, lobulated tissue, the two larger measuring 3.0 cm in length and 0.2 cm in diameter.  The tissue is entirely submitted in cassette 1A.\.br\\.br\Part 2 is labeled 3right breast 3:00, non-calc.4 and consists of 12 cylindrical segments of focally hemorrhagic, pale yellow, soft, lobulated tissue aggregating 2.2 x 1.0 x 0.8 cm.  The tissue is entirely submitted in three cassettes labeled 2A-2C.\.br\VG/caa\.br\||||||F
OBX|24|TX|MDT|tst7756183|Microscopic examination substantiates the above diagnosis.\.br\SK/kmr\.br\||||||F
OBX|25|TX|FIN|tst7756183|PART 1\.br\AND 2:   BREAST, RIGHT, CORE BIOPSY AT 3 O' CLOCK, CALC AND NON-CALC, STEREOTACTIC GUIDED \.br\ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA WITH ASSOCIATED MICROCALCIFICATION.\.br\SK/kmr\.br\||||||F
OBX|26|CE|IMP|tst7756183|M55400^^SNO||||||||1||A
OBX|27|CE|IMP|tst7756183|M72175^^SNO||||||||1||A
OBX|28|CE|IMP|tst7756183|P1140^^SNO||||||||1||A
OBX|29|CE|IMP|tst7756183|T04020^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004388|P|2.3
PID|1||124586963^^^RR|tst6584394|POWERCHART^HTRAIN||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||124-58-6963|||||||||||N
PV1|1||10G^G1008||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058793105055|P||||||||||||||||1||||||||200502241355|200601101341
ORC|RE||PHS05-17^CoPathPlus||CM||||200504040852|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-17^CoPathPlus^tst4266183|PHSP^PH Surgical Pathology|||200504040852|||||||200504040852|COBX|002103||||^31^Y|-1|200504040859||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst4266183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|FIN|tst4266183|SMALL INTESTINE, ILEUM, SEGMENTAL RESECTION\.br\A.ILEAL DUPLICATION CYST WITH PARTIALLY AUTOLYZED MUCOSA AND FOCAL INFLAMMATION (LYMPHOCYTES, EOSINOPHILS, AND NEUTROPHILS) IN MUSCULARIS PROPRIA (SLIDE E).\.br\B.NO EVIDENCE OF NEOPLASIA.\.br\||||||F
OBX|3|CE|IMP|tst4266183|M22360^^SNO||||||||1||A
OBX|4|CE|IMP|tst4266183|M33400^^SNO||||||||1||A
OBX|5|CE|IMP|tst4266183|M40001^^SNO||||||||1||A
OBX|6|CE|IMP|tst4266183|M80001^^SNO||||||||1||A
OBX|7|CE|IMP|tst4266183|P1100^^SNO||||||||1||A
OBX|8|CE|IMP|tst4266183|T05230^^SNO||||||||1||A
OBX|9|CE|IMP|tst4266183|T0X160^^SNO||||||||1||A
OBX|10|CE|IMP|tst4266183|T64000^^SNO||||||||1||A
OBX|11|CE|IMP|tst4266183|T64020^^SNO||||||||1||A
OBX|12|CE|IMP|tst4266183|T64070^^SNO||||||||1||A
OBX|13|CE|IMP|tst4266183|T65200^^SNO||||||||1||A
OBX|14|CE|IMP|tst4266183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004389|P|2.3
PID|1||000000011^^^MAGEE|tst9545394|LANE^LOIS^L||19641225|F|||||||||||000-00-0011|||||||||||N
PV1|1||MCL||||^HOAG^GORDON||||||||||pmc30442^HOAG^GORDON|LRLAB|0001000000011|||||||||||||||||||||||||200504210842
ORC|RE||MWS05-18^CoPathPlus||CM||||200504210909|^LASSIGE^KAREN||^HOAG^GORDON
OBR|1||MWS05-18^CoPathPlus^tst9976183|MWSP^MW Pathology|||200504210909|||||||200504210909|UTM|||||^40^Y|-1|200506231514||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst9976183.1|UTM^Uterine Tumor / Mass^L||||||F||1^1
OBX|2|ST|BLOCK|tst9976183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst9976183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst9976183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst9976183.1.4|D||||||||4^D|200507221753
OBX|6|CE|PROCESS|tst9976183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|7|CE|PROCESS|tst9976183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|8|CE|PROCESS|tst9976183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|9|CE|PROCESS|tst9976183.1.4.4|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|10|CE|PROCESS|tst9976183.1.1.5|pmc3633^Trichrome Stain (Histo)^L||||||||2^Trichrome|200512121428
OBX|11|CE|PROCESS|tst9976183.1.2.6|pmc4324^Smooth Muscle Actin IA4 (IPEX)^L||||||||3^SMActin|200512121428
OBX|12|CE|PROCESS|tst9976183.1.4.7|pmc4324^Smooth Muscle Actin IA4 (IPEX)^L||||||||4^SMActin|200512121428
OBX|13|TX|GDT|tst9976183|The specimen is received ...\.br\||||||F
OBX|14|TX|MDT|tst9976183|See above.\.br\||||||F
OBX|15|TX|FIN|tst9976183|A.          SOME\.br\B.     DIAGNOSIS \.br\C.     HERE\.br\||||||F
OBX|16|CE|IMP|tst9976183|621.0^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004390|P|2.3
PID|1||248643232^^^RR|tst0684394|POWERCHART^LTRAIN||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||248-64-3232|||||||||||N
PV1|1||10G^G1014||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058793025055|P||||||||||||||||1||||||||200502241406|200601101341
ORC|RE||PHS05-18^CoPathPlus||CM||||200504061158|z32^PICCOLI^ANTHONY||002103^TULSKY^ASHER
OBR|1||PHS05-18^CoPathPlus^tst9466183|PHSP^PH Surgical Pathology|||200504061045|||||||200504061157|TB|002103||||^31^Y|-1|200504061230||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst9466183.1|TB^Transbronchial Biopsy, LLL^L||||||F||1^1
OBX|2|ST|BLOCK|tst9466183.1.1|A||||||||1^A|200507221753
OBX|3|CE|PROCESS|tst9466183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|4|CE|PROCESS|tst9466183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200504121005
OBX|5|CE|PROCESS|tst9466183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^HHE|200504121005
OBX|6|CE|PROCESS|tst9466183.1.1.4|pmc1433^Grocott Stain (Histo)^L||||||||4^Grocott|200504121005
OBX|7|CE|PROCESS|tst9466183.1.1.5|pmc3633^Trichrome Stain (Histo)^L||||||||5^Trichrome|200504121005
OBX|8|CE|PROCESS|tst9466183.1.1.6|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||6^HBNKNC|200504121005
OBX|9|TX|GDT|tst9466183|The specimen is received in 95% alcohol with patient's name, initials LP, and labeled "transbronchial needle biopsy."  It consists of a single core of hemorrhagic soft tissue, 0.6 x 0.1 to 0.1 cm and entirely submitted labeled A.\.br\||||||F
OBX|10|TX|MDT|tst9466183|Slides reviewed.  Microscopic examination substantiates the above diagnosis.  Grocott stain is negative for fungal organisms.  Trichrome stain shows no significant fibrosis.\.br\||||||F
OBX|11|TX|FIN|tst9466183|LYMPH NODE, SUBCARINAL, TRANSBRONCHIAL NEEDLE BIOPSY \.br\ADENOCARCINOMA WITH NECROSIS.\.br\||||||F
OBX|12|CE|IMP|tst9466183|M54000^^SNO||||||||1||A
OBX|13|CE|IMP|tst9466183|M81403^^SNO||||||||1||A
OBX|14|CE|IMP|tst9466183|P1143^^SNO||||||||1||A
OBX|15|CE|IMP|tst9466183|T08330^^SNO||||||||1||A
OBX|16|CE|IMP|tst9466183|T25201^^SNO||||||||1||A
OBX|17|CE|IMP|tst9466183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004391|P|2.3
PID|1||554844784^^^RR|tst3684394|POWERCHART^OTRAIN||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||554-84-4784|||||||||||N
PV1|1||10S^S1045||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058822735055|P||||||||||||||||||||||||200502241625
ORC|RE||PHS05-19^CoPathPlus||CM||||200504061213|z32^PICCOLI^ANTHONY||002103^TULSKY^ASHER
OBR|1||PHS05-19^CoPathPlus^tst2566183|PHSP^PH Surgical Pathology|||200504060810|||||||200504061212|ANBX|002103||||^31^Y|-1|200504061252||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst2566183.1|ANBX^Biopsy Antrum^L||||||F||1^1
OBX|2|ST|BLOCK|tst2566183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst2566183.1.2|B||||||||2^B|200507221753
OBX|4|CE|PROCESS|tst2566183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|5|CE|PROCESS|tst2566183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|6|TX|GDT|tst2566183|\.br\The specimen is received in buffered formalin identified as "bronchial cast" and is labeled with the patient' s name and initials .  Received is a 6.0 x1.0 x 0.3 cm single, irregular portion of rubbery, 3branched4, tan tissue grossly resembling a bronchial cast.  The specimen is bisected and entirely submitted labeled A and B.\.br\HAS\.br\||||||F
OBX|7|TX|MDT|tst2566183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|8|TX|FIN|tst2566183|BRONCHIAL CAST, BIOPSY  \.br\FIBRINOUS EXUDATE ASSOCIATED WITH FOAMY MACROPHAGES, DEGENERATED CELLS AND BACTERIA. SPECIAL STAINS FOR MICROORGANISMS ARE PENDING.  ADDENDUM REPORT TO FOLLOW.\.br\||||||F
OBX|9|CE|IMP|tst2566183|E1000^^SNO||||||||1||A
OBX|10|CE|IMP|tst2566183|M33010^^SNO||||||||1||A
OBX|11|CE|IMP|tst2566183|M36370^^SNO||||||||1||A
OBX|12|CE|IMP|tst2566183|M50000^^SNO||||||||1||A
OBX|13|CE|IMP|tst2566183|P1140^^SNO||||||||1||A
OBX|14|CE|IMP|tst2566183|T05128^^SNO||||||||1||A
OBX|15|CE|IMP|tst2566183|T26000^^SNO||||||||1||A
OBX|16|CE|IMP|tst2566183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004392|P|2.3
PID|1||000000011^^^MAGEE|tst9545394|LANE^LOIS^L||19641225|F|||||||||||000-00-0011|||||||||||N
PV1|1||MCL||||^HOAG^GORDON||||||||||pmc30442^HOAG^GORDON|LRLAB|0001000000011|||||||||||||||||||||||||200504210842
ORC|RE||MWS05-19^CoPathPlus||CM||||200504211325|^LASSIGE^KAREN||^HOAG^GORDON
OBR|1||MWS05-19^CoPathPlus^tst1086183|MWSP^MW Pathology|||200504211314|||||||200504211314|BRM|||||^40^Y|-1|200505101527||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst1086183.1|BRM^Breast Mass^L||||||F||1^1
OBX|2|CE|ANT|tst1086183.2|AXLNB^Axillary Lymph Node Biopsy^L||||||F||2^2
OBX|3|CE|ANT|tst1086183.3|CLNH^Lymph Node for Cytogenetics^L||||||F||3^3
OBX|4|ST|BLOCK|tst1086183.1.1|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst1086183.1.2|B||||||||2^B|200507221753
OBX|6|ST|BLOCK|tst1086183.1.3|C||||||||3^C|200507221753
OBX|7|ST|BLOCK|tst1086183.1.4|D||||||||4^D|200507221753
OBX|8|ST|BLOCK|tst1086183.1.5|E||||||||5^E|200507221753
OBX|9|ST|BLOCK|tst1086183.1.6|F||||||||6^F|200507221753
OBX|10|ST|BLOCK|tst1086183.1.7|G||||||||7^G|200507221753
OBX|11|ST|BLOCK|tst1086183.1.8|H||||||||8^H|200507221753
OBX|12|ST|BLOCK|tst1086183.1.9|I||||||||9^I|200507221753
OBX|13|ST|BLOCK|tst1086183.1.10|J||||||||10^J|200507221753
OBX|14|ST|BLOCK|tst1086183.1.11|K||||||||11^K|200507221753
OBX|15|ST|BLOCK|tst1086183.1.12|L||||||||12^L|200507221753
OBX|16|ST|BLOCK|tst1086183.1.13|M||||||||13^M|200507221753
OBX|17|ST|BLOCK|tst1086183.1.14|N||||||||14^N|200507221753
OBX|18|ST|BLOCK|tst1086183.1.15|O||||||||15^O|200507221753
OBX|19|ST|BLOCK|tst1086183.2.16|A||||||||1^A|200507221753
OBX|20|CE|PROCESS|tst1086183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|21|CE|PROCESS|tst1086183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|22|CE|PROCESS|tst1086183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|23|CE|PROCESS|tst1086183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|24|CE|PROCESS|tst1086183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|25|CE|PROCESS|tst1086183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|26|CE|PROCESS|tst1086183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|27|CE|PROCESS|tst1086183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|28|CE|PROCESS|tst1086183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|29|CE|PROCESS|tst1086183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|30|CE|PROCESS|tst1086183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|31|CE|PROCESS|tst1086183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|32|CE|PROCESS|tst1086183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|33|CE|PROCESS|tst1086183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|34|CE|PROCESS|tst1086183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|35|CE|PROCESS|tst1086183.2.16.16|$hinit^Initial H&E^L||||||||2^H&E Lvs|200512121431
OBX|36|CE|PROCESS|tst1086183.2.16.17|pmc7533^Reticulin Stain (Histo)^L||||||||1^Retic|200512121428
OBX|37|TX|MDT|tst1086183|Consistent with the final diagnosis.\.br\||||||F
OBX|38|TX|FIN|tst1086183|Part 1.  Breast Mass:  \.br\A.     Fibroadoma.\.br\B.     Lesion may be present at the medial surgical margin of resection.\.br\C.     All other surgical lines of resection are free of lesion.\.br\2.  Axillary Lymph Node Biopsy:   \.br\Negative for carcinoma\.br\\.br\\.br\||||||F
OBX|39|CE|IMP|tst1086183|V76.11^^ICD||||||||1
OBX|40|CE|IMP|tst1086183|196.9^^ICD||||||||1
OBR|2||tst1086183^CoPathPlus^tst1086183.P1|CG^Cytogenetics||||||||||200504211325|||||||1|200504211325||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|TX|PIN|tst1086183|46,XX[20]\.br\\.br\Apparently normal female lymph node chromosome analysis.  No clonal numerical or structural abnormalities were observed.  \.br\\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 20\.br\No. of Cells Karyotyped:              2\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:             2       18      \.br\\.br\Twenty trypsin-Giemsa banded metaphase cells were analyzed from 24 hour harvests of unstimulated cell cultures derived from a specimen labeled "PCL05-10005LN."  Eighteen cells had an apparently normal female chromosome complement. Two cells had hypodiploid karyotypes, likely as a result of random chromosomal loss.\.br\\.br\Average band level/haploid set:     #425\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004393|P|2.3
PID|1||600600600^^^RR|tst5684394|POWERCHART^QTRAIN||19770815|M||O|777 SEVENTH STREET^^PITTSBURGH^PA^15236^United States||(888)552-1594|(412)828-8000|||||600-60-0600|||||||||||N
PV1|1||10S^S1045||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058305325055|P||||||||||||||||||||||||200502241627
ORC|RE||PHS05-20^CoPathPlus||CM||||200504061215|z32^PICCOLI^ANTHONY||002103^TULSKY^ASHER
OBR|1||PHS05-20^CoPathPlus^tst4566183|PHSP^PH Surgical Pathology|||200504061015|||||||200504061215|SAL|002103||||^27^Y|-1|200504061256||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst4566183.1|SAL^Left Parotid Mass^L||||||F||1^1
OBX|2|ST|BLOCK|tst4566183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst4566183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst4566183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst4566183.1.4|D||||||||4^D|200507221753
OBX|6|ST|BLOCK|tst4566183.1.5|E||||||||5^E|200507221753
OBX|7|CE|PROCESS|tst4566183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|8|CE|PROCESS|tst4566183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|9|CE|PROCESS|tst4566183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|10|CE|PROCESS|tst4566183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|11|CE|PROCESS|tst4566183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|12|TX|GDT|tst4566183|The specimen is received in buffered formalin identified as "bile duct biopsy" and is labeled with the patient' s name and initials .     Received are two soft gray translucent and hemorrhagic tissue fragments each 0.2 cm in greatest dimension.  The specimen is inked with eosin and entirely submitted labeled A.\.br\||||||F
OBX|13|TX|MDT|tst4566183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|14|TX|FIN|tst4566183|BILE DUCT, ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BIOPSY \.br\A.MINUTE FRAGMENTS OF BENIGN BILIARY EPITHELIUM WITH ACUTE AND CHRONIC INFLAMMATION.\.br\B.NO EVIDENCE OF MALIGNANCY SEEN.\.br\||||||F
OBX|15|CE|IMP|tst4566183|M42100^^SNO||||||||1||A
OBX|16|CE|IMP|tst4566183|M80003^^SNO||||||||1||A
OBX|17|CE|IMP|tst4566183|P1140^^SNO||||||||1||A
OBX|18|CE|IMP|tst4566183|T58000^^SNO||||||||1||A
OBX|19|CE|IMP|tst4566183|T5Y010^^SNO||||||||1||A
OBX|20|CE|IMP|tst4566183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004394|P|2.3
PID|1||156234565^^^RR|tst8684394|POWERCHART^TTRAIN||20031120|F||W|PO BOS 44^^IRWIN^PA^15642^United States||(724)555-1254||||||156-23-4565|||||||||||N
PV1|1||10G^G1015||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058375295055|P||||||||||||||||1||||||||200502241452|200601101341
ORC|RE||PHS05-21^CoPathPlus||CM||||200504061220|z32^PICCOLI^ANTHONY||002103^TULSKY^ASHER
OBR|1||PHS05-21^CoPathPlus^tst7566183|PHSP^PH Surgical Pathology|||200504061019|||||||200504061219|LNGI|002103||||^503^D|-1|200504061300||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst7566183.1|LNGI^Left Peritoneal Lymph Node, Biopsy^L||||||F||1^1
OBX|2|CE|ANT|tst7566183.2|COLTUM^Sigmoid Colon Mass^L||||||F||2^2
OBX|3|CE|ANT|tst7566183.3|GGI^Omentum^L||||||F||3^3
OBX|4|ST|BLOCK|tst7566183.1.1|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst7566183.2.2|A||||||||1^A|200507221753
OBX|6|ST|BLOCK|tst7566183.2.3|B||||||||2^B|200507221753
OBX|7|ST|BLOCK|tst7566183.2.4|C||||||||3^C|200507221753
OBX|8|ST|BLOCK|tst7566183.2.5|D||||||||4^D|200507221753
OBX|9|ST|BLOCK|tst7566183.2.6|E||||||||5^E|200507221753
OBX|10|ST|BLOCK|tst7566183.2.7|F||||||||6^F|200507221753
OBX|11|ST|BLOCK|tst7566183.3.8|A||||||||1^A|200507221753
OBX|12|ST|BLOCK|tst7566183.3.9|B||||||||2^B|200507221753
OBX|13|CE|PROCESS|tst7566183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|14|CE|PROCESS|tst7566183.1.1.2|pmc7764^Frozen Sect Single Block (Surg)^L||||||||2^FRZ Single|200504121005
OBX|15|CE|PROCESS|tst7566183.2.2.3|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|16|CE|PROCESS|tst7566183.2.3.4|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|17|CE|PROCESS|tst7566183.2.4.5|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|18|CE|PROCESS|tst7566183.2.5.6|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|19|CE|PROCESS|tst7566183.2.6.7|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|20|CE|PROCESS|tst7566183.2.7.8|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|21|CE|PROCESS|tst7566183.3.8.9|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|22|CE|PROCESS|tst7566183.3.9.10|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|23|CE|PROCESS|tst7566183.3.9.11|pmc7984^IThyroid (PHMP)^L||||||||2^ITHYR|200504251633
OBX|24|CE|PROCESS|tst7566183.3.9.12|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||3^H&E Recut|200504261212
OBX|25|CE|PROCESS|tst7566183.3.9.13|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||4^IBNKNC|200504261212
OBX|26|TX|GDT|tst7566183|The specimen is received fresh labeled with the patient' s name, medical record number and 3cervical lymph node4.  It measures 2.6 x 2.3 x 1.1 cm.  It consists of white fleshy soft tissue with focal hemorrhage and attached adipose tissue. Touch preparations are performed. Material is snap frozen (two blocks), sent for cell suspension immunophenotypic studies (flow cytometry) and sent to the Molecular Diagnostics Laboratory with an adjacent section submitted in formalin fixative labeled A(CMB/DNA).  Additional material is sent for cytogenetic studies. The remainder of the node is submitted in cassette BB5 after B5 fixation and in block C after formalin fixation.\.br\||||||F
OBX|27|TX|MDT|tst7566183|Consists of a portion of fibroadipose tissue with a nodular lymphocytic infiltrate. These nodules are large, occasionally irregular in shape and appear back-to-back. They are mainly composed of large cells with irregular-shaped nuclei and occasional prominent nucleoli and vesicular chromatin.  Additionally, there are areas of diffuse sheets of these large cells accounting for less than 25% of total area.  \.br\||||||F
OBX|28|TX|FIN|tst7566183|LYMPH NODE, CERVICAL, BIOPSY \.br\NON-HODGKIN LYMPHOMA, FOLLICULAR LYMPHOMA (GRADE 3 OF 3) AND DIFFUSE LARGE B-CELL LYMPHOMA, (see comment).\.br\||||||F
OBX|29|CE|IMP|tst7566183|M95913^^SNO||||||||1||A
OBX|30|CE|IMP|tst7566183|MYY933^^SNO||||||||1||A
OBX|31|CE|IMP|tst7566183|MYYX43^^SNO||||||||1||A
OBX|32|CE|IMP|tst7566183|MYYX73^^SNO||||||||1||A
OBX|33|CE|IMP|tst7566183|P1140^^SNO||||||||1||A
OBX|34|CE|IMP|tst7566183|T08200^^SNO||||||||1||A
OBX|35|CE|IMP|tst7566183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004395|P|2.3
PID|1||321321321^^^WASH|tst6766394|SPRATT^MARGIE||19700623|F|||||||||||987-98-7987|||||||||||N
PV1|1||PATHOS||||099973^PATHOLOGY^OUTSIDE||||||||||pmc1622^PATHOLOGY^OUTSIDE|OSD|0001321321321|||||||||||||||||||||||||200504261538
ORC|RE||MWS05-22^CoPathPlus||CM||||200504261547|^LASSIGE^KAREN||099973^PATHOLOGY^OUTSIDE
OBR|1||MWS05-22^CoPathPlus^tst0486183|MWSP^MW Pathology|||200504261546|||||||200504261546|POV|099973||||^34^Y|-1|200505050909||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst0486183.1|POV^Vaginal Polyp^L||||||F||1^1
OBX|2|ST|BLOCK|tst0486183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst0486183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst0486183.1.3|A||||||||3^A|200507221753
OBX|5|ST|BLOCK|tst0486183.1.4|B||||||||4^B|200507221753
OBX|6|CE|PROCESS|tst0486183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|7|CE|PROCESS|tst0486183.1.2.2|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|8|CE|PROCESS|tst0486183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200512121431
OBX|9|CE|PROCESS|tst0486183.1.2.4|pmc5553^HH&E (HISTO)^L||||||||5^HHE|200512121431
OBX|10|CE|PROCESS|tst0486183.1.1.5|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|11|CE|PROCESS|tst0486183.1.2.6|$hinit^Initial H&E^L||||||||6^H&E|200512121431
OBX|12|CE|PROCESS|tst0486183.1.1.7|pmc5553^HH&E (HISTO)^L||||||||4^HHE|200512121431
OBX|13|CE|PROCESS|tst0486183.1.2.8|pmc5553^HH&E (HISTO)^L||||||||7^HHE|200512121431
OBX|14|TX|GDT|tst0486183|The specimen is received in formalin in one part labeled with the patient' s name, initials AA and "vaginal polyp".  It consists of a possible tan polyp with a papillary surface measuring 1.4 x 1.0 x 0.9 cm.  The specimen is sectioned and submitted in cassette A and cassette B.\.br\||||||F
OBX|15|TX|MDT|tst0486183|Microscopic examination supports the above diagnosis.\.br\||||||F
OBX|16|TX|FIN|tst0486183|VAGINA, POLYPECTOMY\.br\FIBROEPITHELIA POLYP.\.br\||||||F
OBX|17|CE|IMP|tst0486183|M76800^^SNO||||||||1||A
OBX|18|CE|IMP|tst0486183|P1100^^SNO||||||||1||A
OBX|19|CE|IMP|tst0486183|T81000^^SNO||||||||1||A
OBX|20|CE|IMP|tst0486183|623.7^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004396|P|2.3
PID|1||169748910^^^RR|tst2784394|POWERCHART^XTRAIN||20030920|F||W|PO BOX 22^^PITTSBURGH^PA^15222^United States||(412)555-4646||||||169-74-8910|||||||||||N
PV1|1||10G^G1019||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||002103|I|0058295345055|P||||||||||||||||1||||||||200502241458|200601101341
ORC|RE||PHS05-23^CoPathPlus||CM||||200504061224|z32^PICCOLI^ANTHONY||002103^TULSKY^ASHER
OBR|1||PHS05-23^CoPathPlus^tst2666183|PHSP^PH Surgical Pathology|||200504061050|||||||200504061224|DUBX|002103||||^564^D|-1|200504061341||SP|F|||||||987654^PATHOID^DOCTOR|z41^LOSOS^FRANK
OBX|1|CE|ANT|tst2666183.1|DUBX^Biopsy Duodenum^L||||||F||1^1
OBX|2|CE|ANT|tst2666183.2|ANBX^Biopsy Antrum^L||||||F||2^2
OBX|3|ST|BLOCK|tst2666183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst2666183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst2666183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|6|CE|PROCESS|tst2666183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|7|TX|GDT|tst2666183|The specimen is received fresh, labeled with the patient' s name and initials\.br\(IL) and identified as 3left femoral head4.  It consists of a femoral head\.br\with attached femoral neck.  The femoral head measures 1.8 cm in diameter and\.br\4.0 cm in height.  The cartilaginous surface is irregular and peeling from the\.br\bone in an area which measures 4.5 x 3.0 cm.  The cut surface of the femoral\.br\neck shows spongiotic bone with a canal and measures 4.6 cm in diameter and\.br\0.9 cm in length.  The cut surface of the femoral head shows an area of\.br\yellow, necrotic bone which measures 2.5 x 1.8 cm with underlying subchondral\.br\cyst and sclerotic spongiotic bone.  A representative cross section of bone\.br\with cartilage is submitted in cassette A for decalcification.\.br\\.br\||||||F
OBX|8|TX|MDT|tst2666183|Microscopic examination substantiates the above diagnosis.\.br\\.br\||||||F
OBX|9|TX|FIN|tst2666183|\.br\BONE, FEMORAL HEAD, LEFT, TOTAL HIP \.br\A.          DEGENERATIVE JOINT DISEASE AND OSTEONECROSIS WITH AVULSION\.br\FRACTURE.\.br\B.     NEGATIVE FOR MALIGNANCY.\.br\||||||F
OBX|10|CE|IMP|tst2666183|D3150^^SNO||||||||1||A
OBX|11|CE|IMP|tst2666183|M09450^^SNO||||||||1||A
OBX|12|CE|IMP|tst2666183|M12620^^SNO||||||||1||A
OBX|13|CE|IMP|tst2666183|M14920^^SNO||||||||1||A
OBX|14|CE|IMP|tst2666183|T11711^^SNO||||||||1||A
OBX|15|CE|IMP|tst2666183|TY1500^^SNO||||||||1||A
OBX|16|CE|IMP|tst2666183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004397|P|2.3
PID|1||000000011^^^MAGEE|tst9545394|LANE^LOIS^L||19641225|F|||||||||||000-00-0011|||||||||||N
PV1|1||MCL||||^HOAG^GORDON||||||||||pmc30442^HOAG^GORDON|LRLAB|0001000000011|||||||||||||||||||||||||200504210842
ORC|RE||BDS05-23^CoPathPlus||CM||||200505111639|^LASSIGE^KAREN||^HOAG^GORDON
OBR|1||BDS05-23^CoPathPlus^tst7496183|^BD Histology|||200505111637|||||||200505111637||||||^40^Y|-1|200505260848||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst7496183.1|^Right Breast Tissue Central Mastectomy^L||||||F||1^1
OBX|2|ST|BLOCK|tst7496183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst7496183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst7496183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst7496183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst7496183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst7496183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst7496183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst7496183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst7496183.1.9|I||||||||9^I|200508311407
OBX|11|ST|BLOCK|tst7496183.1.10|J||||||||10^J|200508311407
OBX|12|ST|BLOCK|tst7496183.1.11|K||||||||11^K|200508311407
OBX|13|ST|BLOCK|tst7496183.1.12|L||||||||12^L|200508311407
OBX|14|ST|BLOCK|tst7496183.1.13|M||||||||13^M|200508311407
OBX|15|ST|BLOCK|tst7496183.1.14|N||||||||14^N|200508311407
OBX|16|ST|BLOCK|tst7496183.1.15|O||||||||15^O|200508311407
OBX|17|CE|PROCESS|tst7496183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|18|CE|PROCESS|tst7496183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|19|CE|PROCESS|tst7496183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|20|CE|PROCESS|tst7496183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|21|CE|PROCESS|tst7496183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|22|CE|PROCESS|tst7496183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|23|CE|PROCESS|tst7496183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|24|CE|PROCESS|tst7496183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|25|CE|PROCESS|tst7496183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|26|CE|PROCESS|tst7496183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|27|CE|PROCESS|tst7496183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|28|CE|PROCESS|tst7496183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|29|CE|PROCESS|tst7496183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|30|CE|PROCESS|tst7496183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|31|CE|PROCESS|tst7496183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|32|TX|GDT|tst7496183|The specimen is received unfixed in two parts each labeled with the initials MM.\.br\\.br\Part 1 is received for intraoperative consultation labeled "right breast tissue."  It consists of a 7 x 5 x 2cm oriented portion of fibroadipose breast tissue with an attached, 5.5 x 3cm portion of skin.  The skin includes a 3 cm areola and 0.8  cm everted nipple.  The margins are inked and sections show a 1.7 x 1.3 x 0.3cm well-circumscribed, pink tan tumor found adjacent to the superior margin.  100% of the tumor and 25% of the specimen are submitted as follows:\.br\Representative sections are submitted as follows:\.br\1A -Tumor with superior margin\.br\1B - Tumor with superior margin\.br\1C - Tumor with inferior margin\.br\1D and 1E - Nipple\.br\1F and 1G - Posterior margin\.br\1H and 1I - Superior margin\.br\1J and 1K - Inferior margin\.br\1L and 1M - Lateral margin\.br\1N and 1O - Medial margin.\.br\Block 1 - Right breast tumor.\.br\Block 2 - Right breast normal.\.br\\.br\The margins are inked as follows:\.br\Posterior: Black\.br\Inferior: Green\.br\Superior: Red\.br\Lateral: Yellow\.br\Medial: Blue.\.br\||||||F
OBX|33|TX|MDT|tst7496183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Modified radical mastectomy\.br\LOCATION:      Central subareolar\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  1.7 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR AGGREGATE SIZE:      Sum of the sizes of multiple invasive tumors: 1.7 cm\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\HISTOLOGIC TYPE:      Classical\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 3\.br\     Tubule formation: 0\.br\     Mitotic activity score: 4\.br\     Total Nottingham score: 95\.br\     Nottingham grade (1, 2, 3): 2\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\DERMAL LYMPHATIC INVASION:      No\.br\CALCIFICATION:      Yes, benign zones\.br\TUMOR TYPE, IN SITU:      Solid\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      Yes, focal\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      Yes, focal\.br\PAGET'S DISEASE OF NIPPLE:      No\.br\LYMPH NODES POSITIVE:      0\.br\LYMPH NODES EXAMINED:      0\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E levels\.br\SENTINEL NODE METASTASIS:      No\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT:      Yes\.br\LYMPH NODE METASTASIS(-ES) WITH\.br\METASTASES TO IPSILATERAL INTERNAL\.br\SKIN INVOLVED (ULCERATION): \.br\NON-NEOPLASTIC BREAST TISSUE:      ADH\.br\T STAGE, PATHOLOGIC:      pT3\.br\N STAGE, PATHOLOGIC:      pN0(i+)\.br\M STAGE, PATHOLOGIC:      pM0\.br\ESTROGEN RECEPTORS:      positive\.br\PROGESTERONE RECEPTORS:      negative\.br\HER2/NEU:      zero or 1+\.br\Comment:      Cool thing!\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|34|TX|FIN|tst7496183|Breast, right, mastectomy:  INVASION DUCTAL ADENOCARCINOMA\.br\                   LATERAL AND INFERIOR MARGINS INVOLVED\.br\||||||F
OBX|35|CE|IMP|tst7496183|M85003^^SNO||||||||1||A
OBX|36|CE|IMP|tst7496183|P1100^^SNO||||||||1||A
OBX|37|CE|IMP|tst7496183|T00100^^SNO||||||||1||A
OBX|38|CE|IMP|tst7496183|T04000^^SNO||||||||1||A
OBX|39|CE|IMP|tst7496183|T04020^^SNO||||||||1||A
OBX|40|CE|IMP|tst7496183|621.0^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004399|P|2.3
PID|1||172623239^^^CMH|tst8858394|TRAINING^KARA^M||19811007|F||W|||||||||172-62-3239|||||||||||N
PV1|1||PATHOS||||^PLANET^VENUS||||||||||pmc77361^PLANET^VENUS|OSD|0002172623239|||||||||||||||||||||||||200510191442
ORC|RE||PHS06-24^CoPathPlus||CM||||200602021148|z196^DEVINE^LISA||^PLANET^VENUS
OBR|1||PHS06-24^CoPathPlus^tpmc4418183|PHSP^PH Surgical Pathology|||200602021147|||||||200602021147|SURGBX|||||^24^Y|-1|200602021400||SP|F|||||||^DJOKIC^MIROSLAV|^DJOKIC^MIROSLAV
OBX|1|CE|ANT|tpmc4418183.1|SURGBX^Nasopharynx biopsy^L||||||F||1^1
OBX|2|CE|ANT|tpmc4418183.2|ROLYM^Right Deep Cervical Node^L||||||F||2^2
OBX|3|CE|ANT|tpmc4418183.3|CLNH^Pt. 2, Right Deep Cervical Node for Cytogenetics^L||||||F||3^3
OBX|4|ST|BLOCK|tpmc4418183.1.1|A||||||||1^A|200602021148
OBX|5|ST|BLOCK|tpmc4418183.2.2|ACMB/DNA||||||||1^ACMB/DNA|200602021148
OBX|6|ST|BLOCK|tpmc4418183.2.3|BB+||||||||2^BB+|200602021148
OBX|7|ST|BLOCK|tpmc4418183.2.4|C||||||||3^C|200602021148
OBX|8|CE|PROCESS|tpmc4418183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200602021148
OBX|9|CE|PROCESS|tpmc4418183.2.2.2|$hinit^Initial H&E^L||||||||5^H&E|200602021148
OBX|10|CE|PROCESS|tpmc4418183.2.2.3|pmc5553^HH&E (HISTO)^L||||||||6^HHE|200602021148
OBX|11|CE|PROCESS|tpmc4418183.2.3.4|$hinit^Initial H&E^L||||||||6^H&E|200602021148
OBX|12|CE|PROCESS|tpmc4418183.2.4.5|$hinit^Initial H&E^L||||||||7^H&E|200602021148
OBX|13|CE|PROCESS|tpmc4418183.2.0.6|pmc0753^Touch Preparation (Surg)^L||||||||1|200602021148
OBX|14|CE|PROCESS|tpmc4418183.2.0.7|pmc4653^Tissue Banked OCT Frozen (Surg)^L||||||||2|200602021148
OBX|15|CE|PROCESS|tpmc4418183.2.0.8|pmc6553^CMB Tissue Prep (PHSP)^L||||||||3|200602021148
OBX|16|CE|PROCESS|tpmc4418183.2.0.9|pmc1273^DNA Tissue Frozen (Surg)^L||||||||4^DNAFR|200602021148
OBX|17|CE|PROCESS|tpmc4418183.2.0.10|pmc0534^Flow Cyto Tissue Prep (Surg)^L||||||||5^FLOWCY|200602021148
OBX|18|CE|PROCESS|tpmc4418183.2.3.11|tst8525^B+ Fixation (Surg)^L||||||||7^B5|200602021148
OBX|19|TX|GDT|tpmc4418183|The specimen is received fresh in two parts, both of which are identified with the patient' s name initials (CS) and medical record number.  \.br\\.br\Part 1 is labeled "nasal pharynx biopsy" and consists of tiny fragments of soft, white-tan tissue, measuring in aggregate 0.6 x 0.5 x 0.2 cm.  The entire specimen is submitted in a tea bag in cassette 1A.\.br\\.br\Part 2 is labeled "deep cervical node" and consists of a hemorrhagic, fleshy, 2.4 x 1.9 x 0.8 cm lymph node.  On cut section the node has a 0.3 cm firm, white nodule.  Touch preparations are performed.  Material is snap frozen (two blocks), sent for cell suspension immunophenotypic studies (flow cytometry), and sent to the Molecular Diagnostics Laboratory with an adjacent section submitted in formalin fixative labeled 2A (CMB/DNA).  Additional material is sent for cytogenetic studies.  The remainder (representative sections) of the lymph node is submitted in cassettes 2BB+ after B+ fixation and in Block 2C (2C has nodule) after formalin fixation.\.br\CH/ncs\.br\||||||F
OBX|20|TX|MDT|tpmc4418183|Part 1 features nasopharyngeal mucosa with a thick basement membrane and a lymphoid infiltrate that primarily consists of small, mature-appearing lymphocytes with some transformed large cells.  There are also scattered eosinophils present, as well as focal plasma cells and edema.\.br\\.br\Part 2 consists of a lymph node with hyperplastic follicles varying in size and demonstrating polarity.  Between the follicles are expanded T-zone nodules; no melanin pigment is identified.\.br\||||||F
OBX|21|TX|FIN|tpmc4418183|PART 1: SOFT TISSUE, NASOPHARYNX, ENDOSCOPIC BIOPSY\.br\NASOPHARYNGEAL MUCOSA WITH CHRONIC INFLAMMATION\.br\\.br\PART 2: LYMPH NODE, RIGHT DEEP CERVICAL, EXCISION\.br\REACTIVE LYMPHOID HYPERPLASIA, COMBINED FOLLICULAR AND PARACORTICAL TYPE (see comment).\.br\||||||F
OBX|22|CE|IMP|tpmc4418183|M43000^^SNO||||||||1||A
OBX|23|CE|IMP|tpmc4418183|P1140^^SNO||||||||1||A
OBX|24|CE|IMP|tpmc4418183|T1X000^^SNO||||||||1||A
OBX|25|CE|IMP|tpmc4418183|T23000^^SNO||||||||1||A
OBX|26|CE|IMP|tpmc4418183|T23010^^SNO||||||||1||A
OBX|27|CE|IMP|tpmc4418183|M72200^^SNO||||||||1||A
OBX|28|CE|IMP|tpmc4418183|P1100^^SNO||||||||1||A
OBX|29|CE|IMP|tpmc4418183|T08200^^SNO||||||||1||A
OBX|30|CE|IMP|tpmc4418183|V65.9^^ICD||||||||1
OBR|2||tpmc4418183^CoPathPlus^tpmc4418183.P1|CG^Cytogenetics||||||||||200602021148|||||||1|200602021148||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|PIN|tpmc4418183|This specimen was cultured and harvested, but cytogenetic analysis was not carried out due to cancellation of the test by Dr. Fiona Craig on 2/1/2006.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004400|P|2.3
PID|1||001234567^^^UDERMSHY|tst2457394|FLINTSTONE^WILMA||19560103|F|||33 Winter St^^PITTSBURGH^PA^15213^United States||4123334444||||||001-23-4567|||||||||||N
PV1|1||DRS||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0004001234567|||||||||||||||||||||||||200504270833
ORC|RE||BDS05-24^CoPathPlus||CM||||200505111640|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||BDS05-24^CoPathPlus^tst8496183|^BD Histology|||200505111640|||||||200505111640||505073||||^49^Y|-1|200512071546||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst8496183.1|^Right Breast Tissue Central Mastectomy^L||||||C||1^1
OBX|2|ST|BLOCK|tst8496183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst8496183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst8496183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst8496183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst8496183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst8496183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst8496183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst8496183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst8496183.1.9|I||||||||9^I|200508311407
OBX|11|ST|BLOCK|tst8496183.1.10|J||||||||10^J|200508311407
OBX|12|ST|BLOCK|tst8496183.1.11|K||||||||11^K|200508311407
OBX|13|ST|BLOCK|tst8496183.1.12|L||||||||12^L|200508311407
OBX|14|ST|BLOCK|tst8496183.1.13|M||||||||13^M|200508311407
OBX|15|ST|BLOCK|tst8496183.1.14|N||||||||14^N|200508311407
OBX|16|ST|BLOCK|tst8496183.1.15|O||||||||15^O|200508311407
OBX|17|CE|PROCESS|tst8496183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|18|CE|PROCESS|tst8496183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|19|CE|PROCESS|tst8496183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|20|CE|PROCESS|tst8496183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|21|CE|PROCESS|tst8496183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|22|CE|PROCESS|tst8496183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|23|CE|PROCESS|tst8496183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|24|CE|PROCESS|tst8496183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|25|CE|PROCESS|tst8496183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|26|CE|PROCESS|tst8496183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|27|CE|PROCESS|tst8496183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|28|CE|PROCESS|tst8496183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|29|CE|PROCESS|tst8496183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|30|CE|PROCESS|tst8496183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|31|CE|PROCESS|tst8496183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|32|TX|GDT|tst8496183|The specimen is received unfixed in two parts each labeled with the initials MM.\.br\\.br\Part 1 is received for intraoperative consultation labeled "right breast tissue."  It consists of a 7 x 5 x 2cm oriented portion of fibroadipose breast tissue with an attached, 5.5 x 3cm portion of skin.  The skin includes a 3 cm areola and 0.8  cm everted nipple.  The margins are inked and sections show a 1.7 x 1.3 x 0.3cm well-circumscribed, pink tan tumor found adjacent to the superior margin.  100% of the tumor and 25% of the specimen are submitted as follows:\.br\Representative sections are submitted as follows:\.br\1A -Tumor with superior margin\.br\1B - Tumor with superior margin\.br\1C - Tumor with inferior margin\.br\1D and 1E - Nipple\.br\1F and 1G - Posterior margin\.br\1H and 1I - Superior margin\.br\1J and 1K - Inferior margin\.br\1L and 1M - Lateral margin\.br\1N and 1O - Medial margin.\.br\Block 1 - Right breast tumor.\.br\Block 2 - Right breast normal.\.br\\.br\The margins are inked as follows:\.br\Posterior: Black\.br\Inferior: Green\.br\Superior: Red\.br\Lateral: Yellow\.br\Medial: Blue.\.br\||||||C
OBX|33|TX|MDT|tst8496183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Segmental\.br\LOCATION:      Central subareolar\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  1.0 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      Yes\.br\TUMOR AGGREGATE SIZE:      Sum of the sizes of multiple invasive tumors: 2.0 cm\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\HISTOLOGIC TYPE:      Solid\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 3\.br\     Tubule formation: 2\.br\     Mitotic activity score: 1\.br\     Total Nottingham score: 6\.br\     Nottingham grade (1, 2, 3): 2\.br\ANGIOLYMPHATIC INVASION:      No\.br\DERMAL LYMPHATIC INVASION:      No\.br\CALCIFICATION:      No\.br\TUMOR TYPE, IN SITU:      Cribriform\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      No\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      No\.br\PAGET'S DISEASE OF NIPPLE:      Yes\.br\LYMPH NODES POSITIVE:      0\.br\LYMPH NODES EXAMINED:      5\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E stain\.br\SENTINEL NODE METASTASIS:      No\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT:      No\.br\SIZE OF NODAL METASTASES:      Diameter of largest lymph node metastasis: 1.0 mm\.br\LYMPH NODE METASTASIS(-ES) WITH\.br\EXTRACAPSULAR EXTENSION:      No\.br\METASTASES TO IPSILATERAL INTERNAL\.br\MAMMARY LYMPH NODE (IF APPLICABLE):      No\.br\SKIN INVOLVED (ULCERATION):      No\.br\NON-NEOPLASTIC BREAST TISSUE:      Papilloma\.br\T STAGE, PATHOLOGIC:      pT1\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      negative\.br\PROGESTERONE RECEPTORS:      negative\.br\HER2/NEU:      zero or 1+\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||C
OBX|34|TX|FIN|tst8496183|BREAST, RIGHT, SEGMENTAL MASTECTOMY \.br\A.          INVASIVE DUCTAL CARCINOMA IN-SITU.\.br\B.     NUCLEAR GRADE III.\.br\||||||C
OBX|35|CE|IMP|tst8496183|M85002^^SNO||||||||1||A
OBX|36|CE|IMP|tst8496183|M85003^^SNO||||||||1||A
OBX|37|CE|IMP|tst8496183|P1100^^SNO||||||||1||A
OBX|38|CE|IMP|tst8496183|T04000^^SNO||||||||1||A
OBX|39|CE|IMP|tst8496183|T04020^^SNO||||||||1||A
OBX|40|CE|IMP|tst8496183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004401|P|2.3
PID|1||183680000^^^RR|tst4573394|TRAINING^ANN||19720811|F||W|81 SUNNY LANE^^MARS^PA^16046^United States||(724)555-1212|(724)555-7777|||||183-68-0000|||||||||||N
PV1|1||9N^N0975||||020450^KRIFCHER^EMANUEL||||||||||pmc4102^KRIFCHER^EMANUEL|I|0057757362206|M||||||||||||||||||||||||200207251039
ORC|RE||PHS06-25^CoPathPlus||CM||||200602021154|z196^DEVINE^LISA||020450^KRIFCHER^EMANUEL
OBR|1||PHS06-25^CoPathPlus^tpmc7418183|PHSP^PH Surgical Pathology|||200602021153|||||||200602021153|SURGBX|020450||||^33^Y|-1|200602021400||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tpmc7418183.1|SURGBX^Nasopharynx biopsy^L||||||F||1^1
OBX|2|CE|ANT|tpmc7418183.2|ROLYM^Right Deep Cervical Node^L||||||F||2^2
OBX|3|CE|ANT|tpmc7418183.3|CLNH^Pt. 2, Right Deep Cervical Node for Cytogenetics^L||||||F||3^3
OBX|4|ST|BLOCK|tpmc7418183.1.1|A||||||||1^A|200602021154
OBX|5|ST|BLOCK|tpmc7418183.2.2|ACMB/DNA||||||||1^ACMB/DNA|200602021154
OBX|6|ST|BLOCK|tpmc7418183.2.3|BB+||||||||2^BB+|200602021154
OBX|7|ST|BLOCK|tpmc7418183.2.4|C||||||||3^C|200602021154
OBX|8|CE|PROCESS|tpmc7418183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200602021154
OBX|9|CE|PROCESS|tpmc7418183.2.2.2|$hinit^Initial H&E^L||||||||5^H&E|200602021154
OBX|10|CE|PROCESS|tpmc7418183.2.2.3|pmc5553^HH&E (HISTO)^L||||||||6^HHE|200602021154
OBX|11|CE|PROCESS|tpmc7418183.2.3.4|$hinit^Initial H&E^L||||||||6^H&E|200602021154
OBX|12|CE|PROCESS|tpmc7418183.2.4.5|$hinit^Initial H&E^L||||||||7^H&E|200602021154
OBX|13|CE|PROCESS|tpmc7418183.2.0.6|pmc0753^Touch Preparation (Surg)^L||||||||1|200602021154
OBX|14|CE|PROCESS|tpmc7418183.2.0.7|pmc4653^Tissue Banked OCT Frozen (Surg)^L||||||||2|200602021154
OBX|15|CE|PROCESS|tpmc7418183.2.0.8|pmc6553^CMB Tissue Prep (PHSP)^L||||||||3|200602021154
OBX|16|CE|PROCESS|tpmc7418183.2.0.9|pmc1273^DNA Tissue Frozen (Surg)^L||||||||4^DNAFR|200602021154
OBX|17|CE|PROCESS|tpmc7418183.2.0.10|pmc0534^Flow Cyto Tissue Prep (Surg)^L||||||||5^FLOWCY|200602021154
OBX|18|CE|PROCESS|tpmc7418183.2.3.11|tst8525^B+ Fixation (Surg)^L||||||||7^B5|200602021154
OBX|19|TX|GDT|tpmc7418183|The specimen is received fresh in two parts, both of which are identified with the patient' s name initials (CS) and medical record number.  \.br\\.br\Part 1 is labeled "nasal pharynx biopsy" and consists of tiny fragments of soft, white-tan tissue, measuring in aggregate 0.6 x 0.5 x 0.2 cm.  The entire specimen is submitted in a tea bag in cassette 1A.\.br\\.br\Part 2 is labeled "deep cervical node" and consists of a hemorrhagic, fleshy, 2.4 x 1.9 x 0.8 cm lymph node.  On cut section the node has a 0.3 cm firm, white nodule.  Touch preparations are performed.  Material is snap frozen (two blocks), sent for cell suspension immunophenotypic studies (flow cytometry), and sent to the Molecular Diagnostics Laboratory with an adjacent section submitted in formalin fixative labeled 2A (CMB/DNA).  Additional material is sent for cytogenetic studies.  The remainder (representative sections) of the lymph node is submitted in cassettes 2BB+ after B+ fixation and in Block 2C (2C has nodule) after formalin fixation.\.br\CH/ncs\.br\||||||F
OBX|20|TX|MDT|tpmc7418183|Part 1 features nasopharyngeal mucosa with a thick basement membrane and a lymphoid infiltrate that primarily consists of small, mature-appearing lymphocytes with some transformed large cells.  There are also scattered eosinophils present, as well as focal plasma cells and edema.\.br\\.br\Part 2 consists of a lymph node with hyperplastic follicles varying in size and demonstrating polarity.  Between the follicles are expanded T-zone nodules; no melanin pigment is identified.\.br\||||||F
OBX|21|TX|FIN|tpmc7418183|PART 1: SOFT TISSUE, NASOPHARYNX, ENDOSCOPIC BIOPSY\.br\NASOPHARYNGEAL MUCOSA WITH CHRONIC INFLAMMATION\.br\\.br\PART 2: LYMPH NODE, RIGHT DEEP CERVICAL, EXCISION\.br\REACTIVE LYMPHOID HYPERPLASIA, COMBINED FOLLICULAR AND PARACORTICAL TYPE (see comment).\.br\||||||F
OBX|22|CE|IMP|tpmc7418183|M43000^^SNO||||||||1||A
OBX|23|CE|IMP|tpmc7418183|P1140^^SNO||||||||1||A
OBX|24|CE|IMP|tpmc7418183|T1X000^^SNO||||||||1||A
OBX|25|CE|IMP|tpmc7418183|T23000^^SNO||||||||1||A
OBX|26|CE|IMP|tpmc7418183|T23010^^SNO||||||||1||A
OBX|27|CE|IMP|tpmc7418183|M72200^^SNO||||||||1||A
OBX|28|CE|IMP|tpmc7418183|P1100^^SNO||||||||1||A
OBX|29|CE|IMP|tpmc7418183|T08200^^SNO||||||||1||A
OBX|30|CE|IMP|tpmc7418183|822.0^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004402|P|2.3
PID|1||114616166^^^RR|tst1005394|POWERCHART^PETER||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||114-61-6166|||||||||||N
PV1|1||10D^D1022||||002103^TULSKY^ASHER|002103^TULSKY^ASHER|||||||||pmc83981^TULSKY^ASHER|I|0058943955095|P||||||||||||||||||||||||200504050921
ORC|RE||PHS05-25^CoPathPlus||CM||||200504070914|z491^NESTLER^RICK||002103^TULSKY^ASHER
OBR|1||PHS05-25^CoPathPlus^tst2176183|PHSP^PH Surgical Pathology|||200504070914|||||||200504070914|STONES|002103||||^31^Y|-1|200504070915||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst2176183.1|STONES^Gallstones^L||||||F||1^1
OBX|2|TX|GDT|tst2176183|Cerner Testing\.br\||||||F
OBX|3|TX|MDT|tst2176183|Cerner Testing\.br\||||||F
OBX|4|TX|FIN|tst2176183|Cerner Testing\.br\||||||F
OBX|5|CE|IMP|tst2176183|786.50^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004403|P|2.3
PID|1||999555111^^^WASH|tst4507394|MANZINI^KITTY||19500403|F|||||||||||999-55-5111|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001999555111|||||||||||||||||||||||||200505121615
ORC|RE||MWS05-26^CoPathPlus||CM||||200505121636|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||MWS05-26^CoPathPlus^tst0696183|MWSP^MW Pathology|||200505121619|||||||200505121619|BRM|505074||||^55^Y|-1|200512210856||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst0696183.1|BRM^Right Breast Mass^L||||||F||1^1
OBX|2|TX|GDT|tst0696183|The specimen is received in formalin labeled with the patient' s name, initials LP and "right breast mass, unoriented, six o' clock".  It consists of pink-yellow lobulated rubbery tissue, 2.0 cm in diameter.  It is entirely inked black and serially sectioned.  Cut surfaces are homogeneous pink-white.  Tissue entirely submitted in four cassettes labeled A-D.\.br\||||||F
OBX|3|TX|MDT|tst0696183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Segmental\.br\LOCATION:      Upper outer quadrant\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  2.3 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR TYPE (invasive component):      Mucinous adenocarcinoma\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 2\.br\     Tubule formation: 3\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\DERMAL LYMPHATIC INVASION:      Not applicable\.br\CALCIFICATION:      No\.br\TUMOR TYPE, IN SITU:      DCIS admixed with invasive carcinoma, Ductal carcinoma in situ, multifocal\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      No\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      No\.br\LYMPH NODES POSITIVE:      0\.br\LYMPH NODES EXAMINED:      0\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E stain, H/E levels\.br\METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE): \.br\     No\.br\NON-NEOPLASTIC BREAST TISSUE:      ALH, Other: other non-neoplastic process\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      previously performed\.br\PROGESTERONE RECEPTORS:      unknown\.br\HER2/NEU:      unknown\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|4|TX|FIN|tst0696183|Right Breast Mass:   \.br\TEST SO TO QA\.br\\.br\||||||F
OBX|5|CE|IMP|tst0696183|M03000^^SNO||||||||1||A
OBX|6|CE|IMP|tst0696183|T04020^^SNO||||||||1||A
OBX|7|CE|IMP|tst0696183|611.72^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004405|P|2.3
PID|1||999999998|tst8046394|MOUSE^MORTIMER^M||19300415|M|||||||||||999-99-9998|||||||||||N
PV1|1||RSDY||||999002231^PARK^ANDREW||||||||||pmc30122^PARK^ANDREW|SY2|0002999999998|||||||||||||||||||||||||200504260847
ORC|RE||BDS05-28^CoPathPlus||CM||||200505111710|^LASSIGE^KAREN||999002231^PARK^ANDREW
OBR|1||BDS05-28^CoPathPlus^tst2596183|^BD Histology|||200505111709|||||||200505111709|TURP|999002231||||^75^Y|-1|200505260848||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst2596183.1|TURP^Prostate, Radical Prostatectomy^L||||||F||1^1
OBX|2|ST|BLOCK|tst2596183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst2596183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst2596183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst2596183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst2596183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst2596183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst2596183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst2596183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst2596183.1.9|I||||||||9^I|200508311407
OBX|11|ST|BLOCK|tst2596183.1.10|J||||||||10^J|200508311407
OBX|12|ST|BLOCK|tst2596183.1.11|K||||||||11^K|200508311407
OBX|13|ST|BLOCK|tst2596183.1.12|L||||||||12^L|200508311407
OBX|14|ST|BLOCK|tst2596183.1.13|M||||||||13^M|200508311407
OBX|15|ST|BLOCK|tst2596183.1.14|N||||||||14^N|200508311407
OBX|16|ST|BLOCK|tst2596183.1.15|O||||||||15^O|200508311407
OBX|17|ST|BLOCK|tst2596183.1.16|P||||||||16^P|200508311407
OBX|18|ST|BLOCK|tst2596183.1.17|Q||||||||17^Q|200508311407
OBX|19|ST|BLOCK|tst2596183.1.18|R||||||||18^R|200508311407
OBX|20|CE|PROCESS|tst2596183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|21|CE|PROCESS|tst2596183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|22|CE|PROCESS|tst2596183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|23|CE|PROCESS|tst2596183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|24|CE|PROCESS|tst2596183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|25|CE|PROCESS|tst2596183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|26|CE|PROCESS|tst2596183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|27|CE|PROCESS|tst2596183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|28|CE|PROCESS|tst2596183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|29|CE|PROCESS|tst2596183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|30|CE|PROCESS|tst2596183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|31|CE|PROCESS|tst2596183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|32|CE|PROCESS|tst2596183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|33|CE|PROCESS|tst2596183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|34|CE|PROCESS|tst2596183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|35|CE|PROCESS|tst2596183.1.16.16|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|36|CE|PROCESS|tst2596183.1.17.17|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|37|CE|PROCESS|tst2596183.1.18.18|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|38|TX|GDT|tst2596183|The specimen is labeled with the patient' s name and "prostate".  It is received in formalin.  It consists of a slightly irregular prostate gland with attached bilateral seminal vesicles and short vasa deferentia.  The seminal vesicles are removed.  The prostate measures 4.4 x 4.0 x 3.5 cm and weighs 28.0 grams.  The external surface is pink to tan, irregular with fibrous adhesions.  Margins are stained as follows:  Bladder neck yellow dye, anterior wall blue dye, apex red dye, urethral margin red dye, posterior wall black dye, right lateral green dye, left lateral orange dye.  The prostate is serially sectioned.  Sections show a mottled yellowish-gray cut surface firm in the left lobe.  The seminal vesicles are lobulated, pink to tan, moderately firm, the right measuring 3.0 x 1.4 x 1.0 cm and the left 2.5 x 1.5 x 0.8 cm.  The vasa deferentia with attached clamps measure 0.5 cm in length x 0.4 cm in diameter.  Representative sections are submitted as follows:\.br\A x two  right bladder neck\.br\B  x two  left bladder neck\.br\C  x one  right anterior wall\.br\D  x one  left anterior wall\.br\E  x two  right apex\.br\F  x two  left apex\.br\G  urethral margin\.br\H  x two  right posterior wall\.br\I  x two  left posterior wall\.br\J  x two  right lateral\.br\K  x two  left lateral\.br\L  M x two  right lobe\.br\N - O  x two  left lobe\.br\P  x two - right seminal base\.br\Q  x two  left seminal vesicle base.\.br\BM/ncs\.br\||||||F
OBX|39|TX|MDT|tst2596183|     Large tumor\.br\SYNOPTIC DATA - PRIMARY PROSTATE TUMORS\.br\CLINICAL DATA:      PSA value: 28\.br\INVASIVE CA IDENTIFIED?:      Yes\.br\TUMOR HISTOLOGY:      Adenocarcinoma NOS\.br\PRIMARY GLEASON GRADE:      0\.br\SECONDARY GLEASON GRADE:      0\.br\GLEASON SUM SCORE:      0\.br\GLEASON 4/5 PERCENTAGE:      1%\.br\WEIGHT OF PROSTATE:      89gm\.br\TUMOR SIZE:      Maximum dimension:  2 cm\.br\LOBE LATERALITY:      Right Lobe\.br\PERCENT OF SPECIMEN INVOLVED BY TUMOR:      < 5% of specimen involved by invasive tumor\.br\MULTIFOCAL DISEASE:      Yes\.br\HIGH GRADE PIN:      Yes - NOS\.br\EXTRAPROSTATIC EXTENSION:      Yes - Multifocal\.br\PERINEURAL INVASION:      No\.br\ANGIOLYMPHATIC INVASION:      No\.br\SEMINAL VESICLE INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      All surgical margins free of tumor\.br\LYMPH NODES EXAMINED:      0\.br\LYMPH NODES POSITIVE:      0\.br\EXTRANODAL EXTENSION:      Yes\.br\SIZE OF NODAL METASTASIS:      0mm\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM1\.br\HISTOLOGIC GRADE:      GX, Grade cannot be assessed\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|40|TX|FIN|tst2596183|Part #1 Prostate Gland\.br\||||||F
OBX|41|CE|IMP|tst2596183|T77100^^SNO||||||||1||A
OBX|42|CE|IMP|tst2596183|196.3^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004406|P|2.3
PID|1||101010111^^^WASH|tst9046394|PARKER^PETER||19600713|M|||||||||||101-01-0111||||||||||20050425|Y
PV1|1||PATHOS||||^BOEHME^KEVIN||||||||||pmc58923^BOEHME^KEVIN|OSD|0001101010111|||||||||||||||||||||||||200504251256
ORC|RE||BDS05-29^CoPathPlus||CM||||200505111711|^LASSIGE^KAREN||^BOEHME^KEVIN
OBR|1||BDS05-29^CoPathPlus^tst3596183|^BD Histology|||200505111711|||||||200505111711|PROST|||||^44^Y|-1|200505121349||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst3596183.1|PROST^Prostate, Radical Prostatectomy^L||||||F||1^1
OBX|2|ST|BLOCK|tst3596183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst3596183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst3596183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst3596183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst3596183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst3596183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst3596183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst3596183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst3596183.1.9|I||||||||9^I|200508311407
OBX|11|ST|BLOCK|tst3596183.1.10|J||||||||10^J|200508311407
OBX|12|ST|BLOCK|tst3596183.1.11|K||||||||11^K|200508311407
OBX|13|ST|BLOCK|tst3596183.1.12|L||||||||12^L|200508311407
OBX|14|ST|BLOCK|tst3596183.1.13|M||||||||13^M|200508311407
OBX|15|ST|BLOCK|tst3596183.1.14|N||||||||14^N|200508311407
OBX|16|ST|BLOCK|tst3596183.1.15|O||||||||15^O|200508311407
OBX|17|ST|BLOCK|tst3596183.1.16|P||||||||16^P|200508311407
OBX|18|ST|BLOCK|tst3596183.1.17|Q||||||||17^Q|200508311407
OBX|19|ST|BLOCK|tst3596183.1.18|R||||||||18^R|200508311407
OBX|20|CE|PROCESS|tst3596183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|21|CE|PROCESS|tst3596183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|22|CE|PROCESS|tst3596183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|23|CE|PROCESS|tst3596183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|24|CE|PROCESS|tst3596183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|25|CE|PROCESS|tst3596183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|26|CE|PROCESS|tst3596183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|27|CE|PROCESS|tst3596183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|28|CE|PROCESS|tst3596183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|29|CE|PROCESS|tst3596183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|30|CE|PROCESS|tst3596183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|31|CE|PROCESS|tst3596183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|32|CE|PROCESS|tst3596183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|33|CE|PROCESS|tst3596183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|34|CE|PROCESS|tst3596183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|35|CE|PROCESS|tst3596183.1.16.16|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|36|CE|PROCESS|tst3596183.1.17.17|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|37|CE|PROCESS|tst3596183.1.18.18|$hinit^Initial H&E^L||||||||1^H&E|200508311427
OBX|38|TX|GDT|tst3596183|The specimen is labeled with the patient' s name and "prostate".  It is received in formalin.  It consists of a slightly irregular prostate gland with attached bilateral seminal vesicles and short vasa deferentia.  The seminal vesicles are removed.  The prostate measures 4.4 x 4.0 x 3.5 cm and weighs 28.0 grams.  The external surface is pink to tan, irregular with fibrous adhesions.  Margins are stained as follows:  Bladder neck yellow dye, anterior wall blue dye, apex red dye, urethral margin red dye, posterior wall black dye, right lateral green dye, left lateral orange dye.  The prostate is serially sectioned.  Sections show a mottled yellowish-gray cut surface firm in the left lobe.  The seminal vesicles are lobulated, pink to tan, moderately firm, the right measuring 3.0 x 1.4 x 1.0 cm and the left 2.5 x 1.5 x 0.8 cm.  The vasa deferentia with attached clamps measure 0.5 cm in length x 0.4 cm in diameter.  Representative sections are submitted as follows:\.br\A x two  right bladder neck\.br\B  x two  left bladder neck\.br\C  x one  right anterior wall\.br\D  x one  left anterior wall\.br\E  x two  right apex\.br\F  x two  left apex\.br\G  urethral margin\.br\H  x two  right posterior wall\.br\I  x two  left posterior wall\.br\J  x two  right lateral\.br\K  x two  left lateral\.br\L  M x two  right lobe\.br\N - O  x two  left lobe\.br\P  x two - right seminal base\.br\Q  x two  left seminal vesicle base.\.br\BM/ncs\.br\||||||F
OBX|39|TX|MDT|tst3596183|     SYNOPTIC DATA - PRIMARY PROSTATE TUMORS\.br\CLINICAL DATA:      PSA value: 12.6\.br\INVASIVE CA IDENTIFIED?:      Yes\.br\TUMOR HISTOLOGY:      Adenocarcinoma NOS\.br\PRIMARY GLEASON GRADE:      6\.br\SECONDARY GLEASON GRADE:      Unknown\.br\GLEASON SUM SCORE:      Unknown\.br\GLEASON 4/5 PERCENTAGE:      25%\.br\WEIGHT OF PROSTATE:      28gm\.br\TUMOR SIZE:      Maximum dimension:  3.1 cm\.br\LOBE LATERALITY:      Right and Left Lobes\.br\PERCENT OF SPECIMEN INVOLVED BY TUMOR:      > 25%\.br\MULTIFOCAL DISEASE:      Yes\.br\HIGH GRADE PIN:      Yes - multifocal\.br\EXTRAPROSTATIC EXTENSION:      Yes - Established (> 0.8mm)\.br\PERINEURAL INVASION:      Yes\.br\ANGIOLYMPHATIC INVASION:      No\.br\SEMINAL VESICLE INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      All surgical margins free of tumor\.br\LYMPH NODES EXAMINED:      12\.br\LYMPH NODES POSITIVE:      12\.br\EXTRANODAL EXTENSION:      Yes\.br\SIZE OF NODAL METASTASIS:      0.2mm\.br\T STAGE, PATHOLOGIC:      pT1b\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pMX\.br\HISTOLOGIC GRADE:      G1, Well differentiated\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|40|TX|FIN|tst3596183|PROSTATE, TOTAL PROSTATECTOMY:\.br\A.          MODERATELY DIFFERENTIATED ADENOCARCINOMA OF PROSTATE GLAND, INVOLVING BOTH LOBES, MEASURING  3.1 CM.\.br\B.     NO ANGIOLYMPHATIC INVASION NOTED.\.br\C.     TWELVE (12) LYMPH NODES SHOWING ADENOCARCINOMA.\.br\||||||F
OBX|41|CE|IMP|tst3596183|M814032^^SNO||||||||1||A
OBX|42|CE|IMP|tst3596183|P1100^^SNO||||||||1||A
OBX|43|CE|IMP|tst3596183|T08000^^SNO||||||||1||A
OBX|44|CE|IMP|tst3596183|T77100^^SNO||||||||1||A
OBX|45|CE|IMP|tst3596183|798.9^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004408|P|2.3
PID|1||310000000^^^SYSPATH|tst4464394|Patient^31||19330115|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3100000000000|||||||||||||||||||||||||200503231055
ORC|RE||PVS05-31^CoPathPlus||CM||||200504061439|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-31^CoPathPlus^tst1966183|PVAP^PV Pathology|||200504061436|||||||200504061436|BLBT|999002814||||^72^Y|-1|200505091513||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst1966183.1|BLBT^Urinary bladder tumor, site not otherwise specified, transurethral resection^L||||||F||1^1
OBX|2|ST|BLOCK|tst1966183.1.1|A||||||||1^A|200510251135
OBX|3|CE|PROCESS|tst1966183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|4|TX|GDT|tst1966183|The specimen is received fresh, properly identified with the patient' s name Robert Pugliese and "bladder tumor #1".  It consists of multiple pieces of cauterized softened tan-pink tissue, which measures in aggregate 2.2 x 0.7 x 0.2 cm.  The specimen is totally submitted in cassette A.\.br\||||||F
OBX|5|TX|MDT|tst1966183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|6|TX|FIN|tst1966183|BLADDER, URINARY, TURBT\.br\A.          INVASIVE HIGH GRADE PAPILLARY UROTHELIAL CARCINOMA (WHO/ISUP, 2004).\.br\B.     THE CARCINOMA INVADES LAMINA PROPRIA.\.br\C.     MUSCULARIS PROPRIA (DETRUSOR MUSCLE) IS PRESENT BUT NOT INVOLVED BY TUMOR.  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004410|P|2.3
PID|1||310000000^^^SYSPATH|tst4464394|Patient^31||19330115|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3100000000000|||||||||||||||||||||||||200503231055
ORC|RE||PHS05-31^CoPathPlus||CM||||200504061201|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-31^CoPathPlus^tst4466183|PHSP^PH Surgical Pathology|||200504061135|||||||200504061135|BLBT|999002814||||^72^Y|-1|200505131137||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst4466183.1|BLBT^Urinary bladder tumor, site not otherwise specified, transurethral resection^L||||||F||1^1
OBX|2|ST|BLOCK|tst4466183.1.1|A||||||||1^A|200507221753
OBX|3|CE|PROCESS|tst4466183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|4|TX|GDT|tst4466183|The specimen is received fresh, properly identified with the patient' s name Robert Pugliese and "bladder tumor #1".  It consists of multiple pieces of cauterized softened tan-pink tissue, which measures in aggregate 2.2 x 0.7 x 0.2 cm.  The specimen is totally submitted in cassette A.\.br\||||||F
OBX|5|TX|FIN|tst4466183|URINARY BLADDER, BLADDER TUMOR #1, TRANSURETHRAL RESECTION:\.br\A.          INVASIVE HIGH GRADE  (WHO) UROTHELIAL CARCINOMA, ASH GRADE 3/4\.br\B.     TUMOR INVADES LAMINA PROPRIA\.br\C.     DETRUSOR MUSCLE FRAGMENTS FREE OF TUMOR \.br\D.     ANGIOINVASION IS NOT IDENTIFIED\.br\||||||F
OBX|6|CE|IMP|tst4466183|M80103^^SNO||||||||1||A
OBX|7|CE|IMP|tst4466183|P1100^^SNO||||||||1||A
OBX|8|CE|IMP|tst4466183|T13001^^SNO||||||||1||A
OBX|9|CE|IMP|tst4466183|T70130^^SNO||||||||1||A
OBX|10|CE|IMP|tst4466183|T74000^^SNO||||||||1||A
OBX|11|CE|IMP|tst4466183|T74020^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004411|P|2.3
PID|1||222222223^^^CITIZN|tst8996394|BLUE^SKY||19700330|F||||||||||||||||||||||N
PV1|1||PATHOS||||505071^PLANET^MERCURY||||||||||pmc07361^PLANET^MERCURY|OSD|0002222222223|||||||||||||||||||||||||200505241457
ORC|RE||MWS05-32^CoPathPlus||CM||||200505241526|^LASSIGE^KAREN||505071^PLANET^MERCURY
OBR|1||MWS05-32^CoPathPlus^tst7207183|MWSP^MW Pathology|||200505241525|||||||200505241525||505071||||^35^Y|-1|200505310825||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst7207183.1|^Biopsy Colon^L||||||F||1^1
OBX|2|ST|BLOCK|tst7207183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst7207183.1.2|A||||||||2^A|200508311407
OBX|4|CE|PROCESS|tst7207183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|5|CE|PROCESS|tst7207183.1.1.2|pmc2233^Acid Fast Stain (Histo)^L||||||||2^AcidFast|200512121428
OBX|6|TX|GDT|tst7207183|The specimen is received in formalin labeled with the patient' s name, initials JF and "colon biopsy".  It consists of 3 pieces measuring in aggregate 1.0 x 0.75 x 0.75 cm. \.br\The specimen is submitted entirely as Cassette A.\.br\||||||F
OBX|7|TX|FIN|tst7207183|PART 1: COLON BIOPSY, ENDOSCOPIC BIOPSY\.br\A.          COLONIC MUCOSA WITH NO SIGNIFICANT ABNORMALITY.\.br\B.          NEGATIVE FOR DYSPLASIA.\.br\||||||F
OBX|8|CE|IMP|tst7207183|M00100^^SNO||||||||1||A
OBX|9|CE|IMP|tst7207183|P1140^^SNO||||||||1||A
OBX|10|CE|IMP|tst7207183|T67000^^SNO||||||||1||A
OBX|11|CE|IMP|tst7207183|T67010^^SNO||||||||1||A
OBX|12|CE|IMP|tst7207183|564.1^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004413|P|2.3
PID|1||000111222^^^WASH|tst4896394|RABBIT^JESSICA||19660516|F|||||||||||000-11-1222|||||||||||N
PV1|1||PATHOS||||505071^PLANET^MERCURY||||||||||pmc07361^PLANET^MERCURY|OSD|0002000111222|||||||||||||||||||||||||200506030924
ORC|RE||MWS05-33^CoPathPlus||CM||||200506231427|^LASSIGE^KAREN||505071^PLANET^MERCURY
OBR|1||MWS05-33^CoPathPlus^tst9607183|MWSP^MW Pathology|||200506231427|||||||200506231427|AXLNB|505071||||^39^Y|-1|200506231442||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst9607183.1|AXLNB^Axillary Lymph Node Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst9607183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst9607183.1.2|A||||||||2^A|200508311407
OBX|4|CE|PROCESS|tst9607183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|5|CE|PROCESS|tst9607183.1.1.2|$hinit^Initial H&E^L||||||||2^H&E Lvs|200512121431
OBX|6|TX|GDT|tst9607183|The specimen is received unfixed labeled with the patient' s name, initial KM and "axillary dissesction".\.br\\.br\\.br\||||||F
OBX|7|TX|MDT|tst9607183|Same as above.\.br\||||||F
OBX|8|TX|FIN|tst9607183|A.          INSERT YOUR DIAGNOSIS HERE\.br\B.     WHATEVER THAT MAY BE\.br\     \.br\||||||F
OBX|9|CE|IMP|tst9607183|V70.0^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004414|P|2.3
PID|1||330000000^^^SYSPATH|tst9864394|Patient^33||19510710|F||LR1||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3300000000000|||||||||||||||||||||||||200503250842
ORC|RE||PHS05-33^CoPathPlus||CM||||200504061330|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-33^CoPathPlus^tst4666183|PHSP^PH Surgical Pathology|||200504061330|||||||200504061330|BLADD|999002814||||^53^Y|-1|200505061314||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst4666183.1|BLADD^Donor Bladder^L||||||F||1^1
OBX|2|ST|BLOCK|tst4666183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst4666183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst4666183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst4666183.1.4|D||||||||4^D|200507221753
OBX|6|CE|PROCESS|tst4666183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|7|CE|PROCESS|tst4666183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|8|CE|PROCESS|tst4666183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|9|CE|PROCESS|tst4666183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|10|TX|GDT|tst4666183|The specimen is received unfixed identified as 3donor urinary cystectomy4 and consists of a partial urinary bladder with attached soft yellow-pink adipose tissue and peritoneum, 13.0 x 12.0 x 2.0 cm, 130 grams.  The bladder stripped of fat consists of the dome and body.  No trigone is identified.  The portion of bladder measures 5.5 cm in length x 8.5 cm in open circumference and weighs 30.66 grams.  The mucosal surface is smooth, rubbery, glistening and tan-pink with focal petechial hemorrhage on the posterior aspect of the body.  Grossly, no mucosal lesions are identified.  On cross section, the wall thickness ranges 0.5 to 0.6 cm.  Representative tissue is frozen in OCT and bulk as follows:  dome x 1, body x 3 and trigone x 1.  Also three portions of bladder body weighing 10.26 grams are submitted in media and bulk frozen.  In addition, received with the specimen are two purple-topped vials of blood which are spun down and divided into their appropriate blood products and bulk frozen as follows:  plasma x 3, buffy coat x 1 and red cells x 2.  Representative sections are submitted as per the following key:\.br\A  -  bladder dome\.br\B-D  -  bladder body.\.br\||||||F
OBX|11|TX|MDT|tst4666183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|12|TX|FIN|tst4666183|URINARY BLADDER, POSTMORTEM DONOR CYSTOPROSTATECTOMY -\.br\UROTHELIUM LINED BLADDER TISSUE WITH MILD CHRONIC CYSTITIS.\.br\NO EVIDENCE OF UROTHELIAL CARCINOMA IN SITU (CIS) NOR INVASIVE UROTHELIAL CARCINOMA SEEN.\.br\\.br\\.br\\.br\||||||F
OBX|13|CE|IMP|tst4666183|M09450^^SNO||||||||1||A
OBX|14|CE|IMP|tst4666183|M43000^^SNO||||||||1||A
OBX|15|CE|IMP|tst4666183|P1100^^SNO||||||||1||A
OBX|16|CE|IMP|tst4666183|T74000^^SNO||||||||1||A
OBX|17|CE|IMP|tst4666183|T74015^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004415|P|2.3
PID|1||330000000^^^SYSPATH|tst9864394|Patient^33||19510710|F||LR1||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3300000000000|||||||||||||||||||||||||200503250842
ORC|RE||PVS05-33^CoPathPlus||CM||||200504061442|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-33^CoPathPlus^tst3966183|PVAP^PV Pathology|||200504061442|||||||200504061442|UBLADRES|999002814||||^53^Y|-1|200505142253||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst3966183.1|UBLADRES^Donor Bladder^L||||||F||1^1
OBX|2|TX|GDT|tst3966183|The specimen is received unfixed identified as 3donor urinary cystectomy4 and consists of a partial urinary bladder with attached soft yellow-pink adipose tissue and peritoneum, 13.0 x 12.0 x 2.0 cm, 130 grams.  The bladder stripped of fat consists of the dome and body.  No trigone is identified.  The portion of bladder measures 5.5 cm in length x 8.5 cm in open circumference and weighs 30.66 grams.  The mucosal surface is smooth, rubbery, glistening and tan-pink with focal petechial hemorrhage on the posterior aspect of the body.  Grossly, no mucosal lesions are identified.  On cross section, the wall thickness ranges 0.5 to 0.6 cm.  Representative tissue is frozen in OCT and bulk as follows:  dome x 1, body x 3 and trigone x 1.  Also three portions of bladder body weighing 10.26 grams are submitted in media and bulk frozen.  In addition, received with the specimen are two purple-topped vials of blood which are spun down and divided into their appropriate blood products and bulk frozen as follows:  plasma x 3, buffy coat x 1 and red cells x 2.  Representative sections are submitted as per the following key:\.br\A  -  bladder dome\.br\B-D  -  bladder body.\.br\||||||F
OBX|3|TX|MDT|tst3966183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst3966183|\.br\URINARY BLADDER (donor), CYSTECTOMY \.br\A.  BENIGN BLADDER TISSUE.\.br\B.  NO EVIDENCE OF UROTHELIAL CARCINOMA IN SITU (CIS) NOR INVASIVE UROTHELIAL CARCINOMA SEEN.\.br\\.br\\.br\  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004416|P|2.3
PID|1||008348893^^^RD|tst4114394|TESTING^BUSTER||19660612|M||W|111 DOGGIE HOUSE^^CORAOPOLIS^PA^15108^United States||(412)255-5555|(724)342-1019|||||299-38-8399|||||||||||N
PV1|1||UNEU||||||||||||||pmc97361^PLANET^MARS|SV|0058718595067|||||||||||||||||||||||||200503011200
ORC|RE||BDS05-33^CoPathPlus||CM||||200506231503|z41^LOSOS^FRANK||505073^PLANET^EARTH
OBR|1||BDS05-33^CoPathPlus^tst3707183|^BD Histology|||200506231503|||||||200506231503||505073||||^39^Y|-1|200511031154||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst3707183.1|^Biopsy Colon^L||||||F||1^1
OBX|2|TX|FIN|tst3707183|\.br\\E\BRONKIAL PNOOMONIA This report has been amended in light of a communication the Molecular Diagnostics laboratory has received from the reference laboratory, Quest Diagnostics Nichols Institute. \.br\\.br\Hepatitis B viral DNA Result is INVALIDATED.\.br\\.br\The manufacturer of the instrument used in this test has determined  that there was a problem with the instrument at the time when this specimen was tested. A false positive or over-reported result cannot be ruled out. The specimen is not available for retesting. The charge for the test is being removed and the result has been invalidated. \.br\ADENOMA and breast discharge that is MALIGNANT      EDEMATOUS AND \.br\||||||F
OBX|3|CE|IMP|tst3707183|D05200^^SNO||||||||1||A
OBX|4|CE|IMP|tst3707183|M36500^^SNO||||||||1||A
OBX|5|CE|IMP|tst3707183|M81403^^SNO||||||||1||A
OBX|6|CE|IMP|tst3707183|P1160^^SNO||||||||1||A
OBX|7|CE|IMP|tst3707183|T04000^^SNO||||||||1||A
OBX|8|CE|IMP|tst3707183|T04040^^SNO||||||||1||A
OBX|9|CE|IMP|tst3707183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004417|P|2.3
PID|1||30006669^^^RG|tst7645394|DUCK^DAISY||19750410|F|||||||||||300-00-0003|||||||||||N
PV1|1||PATHOS||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|OSD|000130006669|||||||||||||||||||||||||200506150000
ORC|RE||MWS05-34^CoPathPlus||CM||||200506231453|^LASSIGE^KAREN||505075^PLANET^JUPITER
OBR|1||MWS05-34^CoPathPlus^tst0707183|MWSP^MW Pathology|||200506231452|||||||200506231452|BRE|505075||||^30^Y|-1|200506270955||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst0707183.1|BRE^Breast, Excisional Biopsy^L||||||F||1^1
OBX|2|CE|ANT|tst0707183.6|BCTP^Breast Core Bx w/Touch Prep (Surg)^L||||||F||2^2
OBX|3|ST|BLOCK|tst0707183.1.1|A||||||||1^A|200508311407
OBX|4|ST|BLOCK|tst0707183.1.2|A||||||||2^A|200508311407
OBX|5|CE|PROCESS|tst0707183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|6|CE|PROCESS|tst0707183.1.1.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|7|TX|GDT|tst0707183|The specimen is received in formalin and labeled with the patient' s name, initials JJ and "Breast Biopsy".  The specimen was submitted in its entirety as "A".\.br\||||||F
OBX|8|TX|MDT|tst0707183|Something here.\.br\||||||F
OBX|9|TX|FIN|tst0707183|A.          SOMETHING\.br\B.     SOMETHING ELSE\.br\C.     EVEN MORE THINGS TO SAY\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004418|P|2.3
PID|1||350000000^^^SYSPATH|tst1964394|Patient^35||19520329|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3500000000000|||||||||||||||||||||||||200503250908
ORC|RE||PHS05-35^CoPathPlus||CM||||200504061334|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-35^CoPathPlus^tst6666183|PHSP^PH Surgical Pathology|||200504061334|||||||200504061334|VAS|999002814||||^53^Y|-1|200505021248||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst6666183.1|VAS^Vas Left and right-Right clip on right^L||||||F||1^1
OBX|2|ST|BLOCK|tst6666183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst6666183.1.2|B||||||||2^B|200507221753
OBX|4|CE|PROCESS|tst6666183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|5|CE|PROCESS|tst6666183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121005
OBX|6|TX|GDT|tst6666183|The specimen is received in formalin identified with the patient' s name and initials E. M. S. and labeled as "vas left and right".  It consists of two segments of vas deferens (right designated with clip).  The left measures 0.8 cm in length and 0.3 cm in diameter and the right measures 0.6 cm in length and 0.2 cm in diameter.  The external surfaces are inked and the specimens are entirely submitted as follows:\.br\1A  -  right vas deferens\.br\1B  -  left vas deferens.\.br\||||||F
OBX|7|TX|MDT|tst6666183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|8|TX|FIN|tst6666183|RIGHT VAS DEFERENS: COMPLETE CROSS SECTION OBTAINED\.br\\.br\LEFT VAS DEFERENS: COMPLETE CROSS SECTION OBTAINED\.br\||||||F
OBX|9|CE|IMP|tst6666183|M814032^^SNO||||||||1||A
OBX|10|CE|IMP|tst6666183|P1143^^SNO||||||||1||A
OBX|11|CE|IMP|tst6666183|T77100^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004419|P|2.3
PID|1||350000000^^^SYSPATH|tst1964394|Patient^35||19520329|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3500000000000|||||||||||||||||||||||||200503250908
ORC|RE||PVS05-35^CoPathPlus||CM||||200504061445|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-35^CoPathPlus^tst5966183|PVAP^PV Pathology|||200504061445|||||||200504061445|VASS|999002814||||^53^Y|-1|200505091518||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst5966183.1|VASS^Vas Left and right-Right clip on right^L||||||F||1^1
OBX|2|TX|GDT|tst5966183|The specimen is received in formalin identified with the patient' s name and initials E. M. S. and labeled as "vas left and right".  It consists of two segments of vas deferens (right designated with clip).  The left measures 0.8 cm in length and 0.3 cm in diameter and the right measures 0.6 cm in length and 0.2 cm in diameter.  The external surfaces are inked and the specimens are entirely submitted as follows:\.br\1A  -  right vas deferens\.br\1B  -  left vas deferens.\.br\||||||F
OBX|3|TX|MDT|tst5966183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst5966183|  \.br\\.br\VAS DEFERENS, "RIGHT AND LEFT", BILATERAL VASECTOMY \.br\SEGMENTS OF VAS DEFERENS, COMPLETELY TRANSECTED, CLINICALLY LABELED RIGHT AND LEFT.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004421|P|2.3
PID|1||700000007^^^MAGEE|tst1745394|RUBBLE^BETTY||19620101|F|||||||||||700-00-0007|||||||||||N
PV1|1||MWQ||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|MWO|0001700000007|||||||||||||||||||||||||200504211525
ORC|RE||MWS05-35^CoPathPlus||CM||||200506240842|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||MWS05-35^CoPathPlus^tst4707183|MWSP^MW Pathology|||200506240839|||||||200506240839|BRM|505074||||^43^Y|-1|200512290855||SP|C|||||||987654^PATHOID^DOCTOR|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst4707183.1|BRM^Breast Mass (right)^L||||||C||1^1
OBX|2|ST|BLOCK|tst4707183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst4707183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst4707183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst4707183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst4707183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst4707183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst4707183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst4707183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst4707183.1.9|I||||||||9^I|200508311407
OBX|11|ST|BLOCK|tst4707183.1.10|J||||||||10^J|200508311407
OBX|12|ST|BLOCK|tst4707183.1.11|K||||||||11^K|200508311407
OBX|13|ST|BLOCK|tst4707183.1.12|L||||||||12^L|200508311407
OBX|14|ST|BLOCK|tst4707183.1.13|M||||||||13^M|200508311407
OBX|15|ST|BLOCK|tst4707183.1.14|N||||||||14^N|200508311407
OBX|16|ST|BLOCK|tst4707183.1.15|O||||||||15^O|200508311407
OBX|17|ST|BLOCK|tst4707183.1.16|A||||||||16^A|200508311407
OBX|18|ST|BLOCK|tst4707183.1.17|B||||||||17^B|200508311407
OBX|19|ST|BLOCK|tst4707183.1.18|C||||||||18^C|200508311407
OBX|20|ST|BLOCK|tst4707183.1.19|D||||||||19^D|200508311407
OBX|21|ST|BLOCK|tst4707183.1.20|E||||||||20^E|200508311407
OBX|22|ST|BLOCK|tst4707183.1.21|F||||||||21^F|200508311407
OBX|23|ST|BLOCK|tst4707183.1.22|G||||||||22^G|200508311407
OBX|24|ST|BLOCK|tst4707183.1.23|H||||||||23^H|200508311407
OBX|25|ST|BLOCK|tst4707183.1.24|I||||||||24^I|200508311407
OBX|26|ST|BLOCK|tst4707183.1.25|J||||||||25^J|200508311407
OBX|27|ST|BLOCK|tst4707183.1.26|K||||||||26^K|200508311407
OBX|28|ST|BLOCK|tst4707183.1.27|L||||||||27^L|200508311407
OBX|29|ST|BLOCK|tst4707183.1.28|M||||||||28^M|200508311407
OBX|30|ST|BLOCK|tst4707183.1.29|N||||||||29^N|200508311407
OBX|31|ST|BLOCK|tst4707183.1.30|O||||||||30^O|200508311407
OBX|32|CE|PROCESS|tst4707183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|33|CE|PROCESS|tst4707183.1.2.2|$hinit^Initial H&E^L||||||||8^H&E|200512121431
OBX|34|CE|PROCESS|tst4707183.1.3.3|$hinit^Initial H&E^L||||||||9^H&E|200512121431
OBX|35|CE|PROCESS|tst4707183.1.4.4|$hinit^Initial H&E^L||||||||10^H&E|200512121431
OBX|36|CE|PROCESS|tst4707183.1.5.5|$hinit^Initial H&E^L||||||||11^H&E|200512121431
OBX|37|CE|PROCESS|tst4707183.1.6.6|$hinit^Initial H&E^L||||||||12^H&E|200512121431
OBX|38|CE|PROCESS|tst4707183.1.7.7|$hinit^Initial H&E^L||||||||13^H&E|200512121431
OBX|39|CE|PROCESS|tst4707183.1.8.8|$hinit^Initial H&E^L||||||||14^H&E|200512121431
OBX|40|CE|PROCESS|tst4707183.1.9.9|$hinit^Initial H&E^L||||||||15^H&E|200512121431
OBX|41|CE|PROCESS|tst4707183.1.10.10|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|42|CE|PROCESS|tst4707183.1.11.11|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|43|CE|PROCESS|tst4707183.1.12.12|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|44|CE|PROCESS|tst4707183.1.13.13|$hinit^Initial H&E^L||||||||5^H&E|200512121431
OBX|45|CE|PROCESS|tst4707183.1.14.14|$hinit^Initial H&E^L||||||||6^H&E|200512121431
OBX|46|CE|PROCESS|tst4707183.1.15.15|$hinit^Initial H&E^L||||||||7^H&E|200512121431
OBX|47|CE|PROCESS|tst4707183.1.1.16|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|48|CE|PROCESS|tst4707183.1.2.17|$hinit^Initial H&E^L||||||||9^H&E|200512121431
OBX|49|CE|PROCESS|tst4707183.1.3.18|$hinit^Initial H&E^L||||||||10^H&E|200512121431
OBX|50|CE|PROCESS|tst4707183.1.4.19|$hinit^Initial H&E^L||||||||11^H&E|200512121431
OBX|51|CE|PROCESS|tst4707183.1.5.20|$hinit^Initial H&E^L||||||||12^H&E|200512121431
OBX|52|CE|PROCESS|tst4707183.1.6.21|$hinit^Initial H&E^L||||||||13^H&E|200512121431
OBX|53|CE|PROCESS|tst4707183.1.7.22|$hinit^Initial H&E^L||||||||14^H&E|200512121431
OBX|54|CE|PROCESS|tst4707183.1.8.23|$hinit^Initial H&E^L||||||||15^H&E|200512121431
OBX|55|CE|PROCESS|tst4707183.1.9.24|$hinit^Initial H&E^L||||||||16^H&E|200512121431
OBX|56|CE|PROCESS|tst4707183.1.10.25|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|57|CE|PROCESS|tst4707183.1.11.26|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|58|CE|PROCESS|tst4707183.1.12.27|$hinit^Initial H&E^L||||||||5^H&E|200512121431
OBX|59|CE|PROCESS|tst4707183.1.13.28|$hinit^Initial H&E^L||||||||6^H&E|200512121431
OBX|60|CE|PROCESS|tst4707183.1.14.29|$hinit^Initial H&E^L||||||||7^H&E|200512121431
OBX|61|CE|PROCESS|tst4707183.1.15.30|$hinit^Initial H&E^L||||||||8^H&E|200512121431
OBX|62|TX|GDT|tst4707183|This specimen is received fresh labeled with the patient' s name, initials RJ and "Breast Mass (right)".  The specimen consisted of a 3.0 x 3.5 x. 3.5 cm portion of tan-yellow fibroadipose tissue. Grossly, no lesions are identified.  The specimen is serially sectioned from medial to lateral, inked and is totally submitted as follows:\.br\\.br\A  medial margin\.br\B  one slice\.br\C-E  one slice\.br\F-H  one slice\.br\I-K  one slice\.br\L/M  one slice\.br\N/O  lateral margin.\.br\\.br\Inking key:\.br\Red = superior\.br\Green = inferior\.br\Blue = medial\.br\Yellow = lateral\.br\Orange = anterior\.br\Black = posterior.\.br\||||||C
OBX|63|TX|MDT|tst4707183|Microscopic examination substantiates the above diagnosis.\.br\||||||C
OBX|64|TX|FIN|tst4707183|BREAST MASS, RIGHT \.br\A.DUCTAL HYPERPLASIA, USUAL AND COLUMNAR CELL TYPE WITHOUT ATYPIA.\.br\B.PSEUDOANGIOMATOUS STROMAL HYPERPLASIA.\.br\C.FIBROCYSTIC CHANGES.\.br\D.FOCAL PREVIOUS BIOPSY SITE CHANGES.\.br\E.MICROCALCIFICATIONS ASSOCIATED WITH BENIGN DUCTS.\.br\||||||C
OBX|65|CE|IMP|tst4707183|M72000^^SNO||||||||1||A
OBX|66|CE|IMP|tst4707183|M72430^^SNO||||||||1||A
OBX|67|CE|IMP|tst4707183|M80001^^SNO||||||||1||A
OBX|68|CE|IMP|tst4707183|P1140^^SNO||||||||1||A
OBX|69|CE|IMP|tst4707183|T04020^^SNO||||||||1||A
OBX|70|CE|IMP|tst4707183|654.63^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004422|P|2.3
PID|1||360000000^^^SYSPATH|tst2964394|Patient^36||19690818|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3600000000000|||||||||||||||||||||||||200503250917
ORC|RE||PHS05-36^CoPathPlus||CM||||200504061335|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-36^CoPathPlus^tst7666183|PHSP^PH Surgical Pathology|||200504061335|||||||200504061335|VAS|999002814||||^35^Y|-1|200505181027||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst7666183.1|VAS^Bilateral vas deferens^L||||||F||1^1
OBX|2|ST|BLOCK|tst7666183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst7666183.1.2|B||||||||2^B|200507221753
OBX|4|CE|PROCESS|tst7666183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041053
OBX|5|CE|PROCESS|tst7666183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041053
OBX|6|CE|PROCESS|tst7666183.1.2.3|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||2^H&E Recut|200505240647
OBX|7|TX|GDT|tst7666183|The specimen is received in formalin identified as "Richard Baur" and labeled as "bilateral vas deferens".  It consists of two segments of vas deferens (right oriented with a clip).  The left consists of a pale tan, firm segment of vas deferens which measures 0.6 cm in length and 0.3 cm in diameter and the right measures 1.0 cm in length and 0.5 cm in diameter.  The specimens are inked and entirely submitted as follows:\.br\1A  -  right\.br\1B  -  left\.br\||||||F
OBX|8|TX|MDT|tst7666183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|9|TX|FIN|tst7666183|BILATERAL VAS DEFERENS, EXCISION, COMPLETE CROSS SECTIONS OBTAINED\.br\  \.br\||||||F
OBX|10|CE|IMP|tst7666183|P1100^^SNO||||||||1||A
OBX|11|CE|IMP|tst7666183|T79200^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004423|P|2.3
PID|1||360000000^^^SYSPATH|tst2964394|Patient^36||19690818|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3600000000000|||||||||||||||||||||||||200503250917
ORC|RE||PVS05-36^CoPathPlus||CM||||200504061446|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-36^CoPathPlus^tst6966183|PVAP^PV Pathology|||200504061446|||||||200504061446|VASS|999002814||||^35^Y|-1|200505142241||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst6966183.1|VASS^Bilateral vas deferens^L||||||F||1^1
OBX|2|ST|BLOCK|tst6966183.1.1|A||||||||1^A|200510251135
OBX|3|CE|PROCESS|tst6966183.1.1.1|$hinit^Initial H&E^L||||||||2^H&E|200504121014
OBX|4|CE|PROCESS|tst6966183.1.1.2|$hinit^Initial H&E^L||||||||1^H&E|200512191445
OBX|5|TX|GDT|tst6966183|The specimen is received in formalin identified as "Richard Baur" and labeled as "bilateral vas deferens".  It consists of two segments of vas deferens (right oriented with a clip).  The left consists of a pale tan, firm segment of vas deferens which measures 0.6 cm in length and 0.3 cm in diameter and the right measures 1.0 cm in length and 0.5 cm in diameter.  The specimens are inked and entirely submitted as follows:\.br\1A  -  right\.br\1B  -  left\.br\||||||F
OBX|6|TX|MDT|tst6966183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|7|TX|FIN|tst6966183|VAS DEFERENS, BILATERAL:\.br\COMPLETE CROSS-SECTION OF VAS DEFERENS, CLINICALLY LABELLED AS "RIGHT" (CLIP) AND "LEFT".  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004425|P|2.3
PID|1||987654320^^^WASH|tst0345394|LASSIGE^KAREN^M||19710204|F|||||||||||987-65-4320|||||||||||N
PV1|1||PATHOS||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0003987654320|||||||||||||||||||||||||200507131429
ORC|RE||MWS05-36^CoPathPlus||CM||||200507201519|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||MWS05-36^CoPathPlus^tst4617183|MWSP^MW Pathology|||200507210000|||||||200507210938|BCTP|505073||||^34^Y|-1|200510271633||SP|C|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst4617183.3|BCTP^Breast Core Bx w/Touch Prep (Surg)^L||||||C||1^1
OBX|2|CE|ANT|tst4617183.4|POCP^Cervical Polyp^L||||||C||2^2
OBX|3|CE|ANT|tst4617183.5|^Endocervical Cone Biopsy^L||||||C||3^3
OBX|4|TX|GDT|tst4617183|Part 1 SOME TEXT HERE\.br\Part 2 SOME MORE TEXT HERE\.br\Part 3 Testing the amendment  by adding the part.\.br\||||||C
OBX|5|TX|MDT|tst4617183|     SYNOPTIC - BREAST NEOADJUVANT TREATMENT\.br\MAXIMUM PREADJUVANT TUMOR SIZE:      Maximum dimension invasive component: 1 cm\.br\TUMOR VOLUME REDUCTION:      Tumor volume reduction appears symmetrical\.br\STROMAL ELASTOSIS/FIBROSIS:      No\.br\HORMONAL THERAPY EFFECT**:      No, adjacent non-neoplastic breast tissue doesn't show chemotherapy effect\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||C
OBX|6|TX|FIN|tst4617183|PART 1\.br\PART 2\.br\PART 3  TESTING THE AMENDMENT\.br\||||||C
OBX|7|CE|IMP|tst4617183|787.1^^ICD||||||||1
OBX|8|CE|IMP|tst4617183|789.07^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004426|P|2.3
PID|1||370000000^^^SYSPATH|tst3964394|Patient^37||19260313|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3700000000000|||||||||||||||||||||||||200503250925
ORC|RE||PVS05-37^CoPathPlus||CM||||200504061448|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-37^CoPathPlus^tst7966183|PVAP^PV Pathology|||200504061447|||||||200504061447|BLADBIO|999002814||||^79^Y|-1|200505021210||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst7966183.1|BLADBIO^Bladder tumor^L||||||F||1^1
OBX|2|ST|BLOCK|tst7966183.1.1|A||||||||1^A|200510251135
OBX|3|CE|PROCESS|tst7966183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|4|TX|GDT|tst7966183|The specimen is received fresh labeled with the patient' s name with initials PMK and designated as 3bladder tumor4.  It consists of two tan, soft to irregular tissue biopsies measuring 0.1 and 0.4 cm in greatest dimension.  Submitted in its entirety in cassette labeled A.\.br\||||||F
OBX|5|TX|MDT|tst7966183|  \.br\||||||F
OBX|6|TX|FIN|tst7966183|PART 1: BLADDER, "TUMOR" , TRANSURETHRAL RESECTION:\.br\A.          SUPERFICIAL FRAGMENTS OF NON-INVASIVE PAPILLARY HIGH GRADE UROTHELIAL CARCINOMA.\.br\B.     THERE IS NO EVIDENCE OF LAMINA PROPRIA INVASION.\.br\C.     MUSCULARIS PROPRIA (DETRUSOR MUSCLE) IS NOT PRESENT.  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004428|P|2.3
PID|1||370000000^^^SYSPATH|tst3964394|Patient^37||19260313|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3700000000000|||||||||||||||||||||||||200503250925
ORC|RE||PHS05-37^CoPathPlus||CM||||200504061337|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-37^CoPathPlus^tst8666183|PHSP^PH Surgical Pathology|||200504061337|||||||200504061337|BLBX|999002814||||^79^Y|-1|200504281421||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst8666183.1|BLBX^Bladder tumor^L||||||F||1^1
OBX|2|TX|GDT|tst8666183|The specimen is received fresh labeled with the patient' s name with initials PMK and designated as 3bladder tumor4.  It consists of two tan, soft to irregular tissue biopsies measuring 0.1 and 0.4 cm in greatest dimension.  Submitted in its entirety in cassette labeled A.\.br\||||||F
OBX|3|TX|FIN|tst8666183|Bladder tumor, transurethral resection:\.br\A.  PAPILLARY UROTHELIAL CARCINOMA, HIGH GRADE. (WHO)  \.br\\.br\B.  NO INVASION OF LAMINA PROPRIA\.br\\.br\C.  DETRUSOR MUSCLE IS NOT PRESENT IN THESE SECTIONS\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004429|P|2.3
PID|1||380000000^^^SYSPATH|tst1074394|patient^38||19551208|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3800000000000|||||||||||||||||||||||||200503251119
ORC|RE||PVS05-38^CoPathPlus||CM||||200504061451|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-38^CoPathPlus^tst8966183|PVAP^PV Pathology|||200504061451|||||||200504061451|YBLDR|999002814||||^49^Y|-1|200505162318||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst8966183.1|YBLDR^Trigone^L||||||F||1^1
OBX|2|CE|ANT|tst8966183.2|YBLDR^Posterior wall^L||||||F||2^2
OBX|3|ST|BLOCK|tst8966183.1.1|A||||||||1^A|200510251135
OBX|4|ST|BLOCK|tst8966183.1.2|B||||||||2^B|200510251135
OBX|5|ST|BLOCK|tst8966183.1.3|C||||||||3^C|200510251135
OBX|6|ST|BLOCK|tst8966183.1.4|D||||||||4^D|200510251135
OBX|7|ST|BLOCK|tst8966183.1.5|E||||||||5^E|200510251135
OBX|8|ST|BLOCK|tst8966183.1.6|F||||||||6^F|200510251135
OBX|9|ST|BLOCK|tst8966183.1.7|G||||||||7^G|200510251135
OBX|10|ST|BLOCK|tst8966183.1.8|H||||||||8^H|200510251135
OBX|11|ST|BLOCK|tst8966183.1.9|I||||||||9^I|200510251135
OBX|12|ST|BLOCK|tst8966183.1.10|J||||||||10^J|200510251135
OBX|13|ST|BLOCK|tst8966183.1.11|K||||||||11^K|200510251135
OBX|14|ST|BLOCK|tst8966183.1.12|L||||||||12^L|200510251135
OBX|15|ST|BLOCK|tst8966183.2.13|A||||||||1^A|200510251135
OBX|16|ST|BLOCK|tst8966183.2.14|B||||||||2^B|200510251135
OBX|17|ST|BLOCK|tst8966183.2.15|C||||||||3^C|200510251135
OBX|18|ST|BLOCK|tst8966183.2.16|D||||||||4^D|200510251135
OBX|19|ST|BLOCK|tst8966183.2.17|E||||||||5^E|200510251135
OBX|20|ST|BLOCK|tst8966183.2.18|F||||||||6^F|200510251135
OBX|21|ST|BLOCK|tst8966183.2.19|G||||||||7^G|200510251135
OBX|22|ST|BLOCK|tst8966183.2.20|H||||||||8^H|200510251135
OBX|23|ST|BLOCK|tst8966183.2.21|I||||||||9^I|200510251135
OBX|24|ST|BLOCK|tst8966183.2.22|J||||||||10^J|200510251135
OBX|25|ST|BLOCK|tst8966183.2.23|K||||||||11^K|200510251135
OBX|26|ST|BLOCK|tst8966183.2.24|L||||||||12^L|200510251135
OBX|27|CE|PROCESS|tst8966183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|28|CE|PROCESS|tst8966183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|29|CE|PROCESS|tst8966183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|30|CE|PROCESS|tst8966183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|31|CE|PROCESS|tst8966183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|32|CE|PROCESS|tst8966183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|33|CE|PROCESS|tst8966183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|34|CE|PROCESS|tst8966183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|35|CE|PROCESS|tst8966183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|36|CE|PROCESS|tst8966183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|37|CE|PROCESS|tst8966183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|38|CE|PROCESS|tst8966183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|39|CE|PROCESS|tst8966183.2.13.13|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|40|CE|PROCESS|tst8966183.2.14.14|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|41|CE|PROCESS|tst8966183.2.15.15|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|42|CE|PROCESS|tst8966183.2.16.16|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|43|CE|PROCESS|tst8966183.2.17.17|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|44|CE|PROCESS|tst8966183.2.18.18|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|45|CE|PROCESS|tst8966183.2.19.19|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|46|CE|PROCESS|tst8966183.2.20.20|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|47|CE|PROCESS|tst8966183.2.21.21|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|48|CE|PROCESS|tst8966183.2.22.22|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|49|CE|PROCESS|tst8966183.2.23.23|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|50|CE|PROCESS|tst8966183.2.24.24|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|51|TX|GDT|tst8966183|Specimens received in two parts.\.br\\.br\Part 1 is received in formalin, identified the patient's name with initials RH, and designated as "trigone".  It consists of a single pale tan soft fragment, which measures 0.3 cm in diameter.  The specimen is entirely submitted in cassette 1A.\.br\\.br\Part 2 is received in formalin, identified with patient's name with the initials RH, and designated as "posterior wall".  It consists of two pale tan soft fragments, which measure 0.1 and 0.2 cm in diameter. Specimens are entirely submitted in cassette 2A.\.br\||||||F
OBX|52|TX|MDT|tst8966183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|53|TX|FIN|tst8966183|PART 1: URINARY BLADDER, TRIGONE, BIOPSY\.br\A.          BENIGN BLADDER TISSUE WITH CYSTITIS CYSTICA, CHRONIC INFLAMMATION AND REACTI VE CHANGES.\.br\B.     FOCAL GRANULOMATOUS INFLAMMATION.\.br\\.br\PART 2: URINARY BLADDER, POSTERIOR WALL, BIOPSY\.br\A.          BENIGN BLADDER TISSUE WITH CYSTITIS CYSTICA, CHRONIC INFLAMMATION AND REACTI VE CHANGES.\.br\B.     FOCAL GRANULOMATOUS INFLAMMATION (See Comment).\.br\     \.br\  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004430|P|2.3
PID|1||380000000^^^SYSPATH|tst1074394|patient^38||19551208|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3800000000000|||||||||||||||||||||||||200503251119
ORC|RE||PHS05-38^CoPathPlus||CM||||200504061341|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-38^CoPathPlus^tst9666183|PHSP^PH Surgical Pathology|||200504061340|||||||200504061340|YBLDR|999002814||||^49^Y|-1|200505062018||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst9666183.1|YBLDR^Trigone^L||||||F||1^1
OBX|2|CE|ANT|tst9666183.2|YBLDR^Posterior wall^L||||||F||2^2
OBX|3|ST|BLOCK|tst9666183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst9666183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst9666183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041054
OBX|6|CE|PROCESS|tst9666183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041054
OBX|7|TX|GDT|tst9666183|Specimens received in two parts.\.br\\.br\Part 1 is received in formalin, identified the patient's name with initials RH, and designated as "trigone".  It consists of a single pale tan soft fragment, which measures 0.3 cm in diameter.  The specimen is entirely submitted in cassette 1A.\.br\\.br\Part 2 is received in formalin, identified with patient's name with the initials RH, and designated as "posterior wall".  It consists of two pale tan soft fragments, which measure 0.1 and 0.2 cm in diameter. Specimens are entirely submitted in cassette 2A.\.br\||||||F
OBX|8|TX|MDT|tst9666183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|9|TX|FIN|tst9666183| PART 1\.br\A.          URINARY BLADDER, LABELED TRIGONE, BIOPSY: BENIGN UROTHELIUM WITH MILD CHRONIC CYSTITIS.  NO EVIDENCE OF MALIGNANCY.\.br\PART 2\.br\A. URINARY BLADDER, LABELED POSTERIOR WALL, BIOPSY: CYSTITIS CYSTICA. NO EVIDENCE OF MALIGNANCY.\.br\||||||F
OBX|10|CE|IMP|tst9666183|M09450^^SNO||||||||1||A
OBX|11|CE|IMP|tst9666183|M43000^^SNO||||||||1||A
OBX|12|CE|IMP|tst9666183|M73370^^SNO||||||||1||A
OBX|13|CE|IMP|tst9666183|P1140^^SNO||||||||1||A
OBX|14|CE|IMP|tst9666183|T70130^^SNO||||||||1||A
OBX|15|CE|IMP|tst9666183|T74062^^SNO||||||||1||A
OBX|16|CE|IMP|tst9666183|T74310^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004432|P|2.3
PID|1||390000000^^^SYSPATH|tst2074394|Patient^39||19170111|M||B||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3900000000000|||||||||||||||||||||||||200503251126
ORC|RE||PVS05-39^CoPathPlus||CM||||200504061452|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-39^CoPathPlus^tst9966183|PVAP^PV Pathology|||200504061452|||||||200504061452|YBLDR|999002814||||^88^Y|-1|200505170957||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst9966183.1|YBLDR^BLADDER BIOPSY^L||||||F||1^1
OBX|2|ST|BLOCK|tst9966183.1.1|A||||||||1^A|200510251135
OBX|3|CE|PROCESS|tst9966183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|4|TX|GDT|tst9966183|The specimen is received fresh, properly identified with the patient' s name, George Brown and site given as 3bladder biopsy4.  It consists of multiple pieces of irregular shaped soft and cauterized resilient tissue which measures in aggregate of 1.7 x 1.5 x 0.2 cm.  The specimen is totally submitted in cassette A.\.br\||||||F
OBX|5|TX|MDT|tst9966183|  \.br\||||||F
OBX|6|TX|FIN|tst9966183|URINARY BLADDER, TURBT-\.br\A.          INVASIVE HIGH GRADE UROTHELIAL CARCINOMA (WHO/ISUP, 2004)\.br\B.     THE CARCINOMA INVADES INTO DETRUSOR MUSCLE.  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004434|P|2.3
PID|1||390000000^^^SYSPATH|tst2074394|Patient^39||19170111|M||B||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|3900000000000|||||||||||||||||||||||||200503251126
ORC|RE||PHS05-39^CoPathPlus||CM||||200504061342|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-39^CoPathPlus^tst0766183|PHSP^PH Surgical Pathology|||200504061342|||||||200504061342|YBLDR|999002814||||^88^Y|-1|200505121357||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst0766183.1|YBLDR^BLADDER BIOPSY^L||||||F||1^1
OBX|2|TX|GDT|tst0766183|The specimen is received fresh, properly identified with the patient' s name, George Brown and site given as 3bladder biopsy4.  It consists of multiple pieces of irregular shaped soft and cauterized resilient tissue which measures in aggregate of 1.7 x 1.5 x 0.2 cm.  The specimen is totally submitted in cassette A.\.br\||||||F
OBX|3|TX|MDT|tst0766183|SYNOPTIC PRIMARY URINARY BLADDER/URETHRA TUMORS\.br\\.br\\.br\A.     Location of primary tumor:   not specified\.br\1.  Dome               4.  Right wall          7.  Ureter     10.  No residual tumor\.br\2.  Anterior wall          5.  Left wall          8.  Urethra\.br\3.  Posterior wall           6.  Trigone          9.  Multicentric\.br\B.     Procedure: 4\.br\1.  Partial cystectomy          3.  Cystoprostatectomy          \.br\2.  Total cystectomy          4.  Other\.br\C.    Size (if multicentric, maximum dimension of the most deeply invasive or largest tumor): unk cm\.br\C1:  Tumor configuration:  2\.br\        1.  Papillary           4.  Ulcerated.\.br\        2.  Solid/nodular     5.  Cystic\.br\        3.  Flat\.br\D.     Non-invasive neoplastic lesions:  # / # / # / #\.br\1.  Papilloma                    4.  Flat CIS\.br\     2.  Inverted papilloma               5.  Other\.br\3.  Papillary TCCa\.br\E.     Invasive neoplasia:  1\.br\1.  Urothelial (Transitional cell) carcinoma                     7. Small cell/neuroendocrine carcinoma \.br\2.  Urothelial carcinoma with squamous differentiation  8 Mixed urothelial carcinoma\.br\3.  Urothelial carcinoma with glandular differentiation    9. Lymphoma/leukemia\.br\4.  Squamous carcinoma                      10. Sarcoma\.br\5.  Adenocarcinoma                                     11. Metastasis/direct extension from a \.br\6.  Sarcmatoid carcinoma                                                    contiguous primary\.br\                                                                                  12. Other\.br\F.     Grade:  3 (Ash for TCCa grades 1-4) /  # (WHO for TCCa grades 1-3)/3 (WHO / ISUP (LMP, LG, HG)\.br\G.     Non-neoplastic and other conditions:  # / # / # / # / #\.br\1.  Von Brunn' s nests, cystitis cystica/glandularis, intestinal metaplasia\.br\2    Nephrogenic metaplasia/ adenoma\.br\3.   Granulomatous cystitis\.br\4.   Interstitial cystitis     \.br\5.   Inflammatory pseudotumors\.br\6.   Carbuncle\.br\7.   Malakoplakia\.br\8.   Other\.br\H.     Margins of resection:  1               1.  Positive               2.   Negative\.br\I.      Angiolymphatic invasion:  #2               1.  Yes                   2.   No\.br\J.     Perineural invasion:  2                1.  Yes                              2.  No\.br\K.     Mitotic activity:  # per 10 high power fields\.br\L.     Flat dysplasia in background:  #           1.  Yes                    2.   No\.br\M.   Number of positive lymph nodes:   0\.br\N.   Total number of lymph nodes examined:   0 \.br\O.   Extracapsular spread of lymph node metastases:   0           1.  Yes          2.  No\.br\P.     Prostate/seminal vesicles (if cystoprostatectomy)\.br\P1.  Involved by bladder neoplasm:  #2                    1.  Yes            2 .  No\.br\P2.  Concurrent primary invasive prostatic neoplasm:  2           1.  Yes            2.   No\.br\P3.  High grade PIN:  2                          1.  Yes            2.   No\.br\Q.   Additional findings:  #\.br\1.  Urothelial dysplasia     2.  Therapy associated changes\.br\R.   TNM stage: T 2NOS      N X      M X\.br\||||||F
OBX|4|TX|FIN|tst0766183| URINARY BLADDER, SITE UNSPECIFIED, BIOPSY: \.br\A.          INVASIVE UROTHELIAL CARCINOMA, HIGH GRADE (WHO), GRADE 3 OF 4 (ASH)\.br\B.     TUMOR INVADES DETRUSOR MUSCLE\.br\C.     NO EVIDENCE OF ANGIOLYMPHATIC INVASION\.br\D.     SEE ATTACHED STAGING SHEET  \.br\||||||F
OBX|5|CE|IMP|tst0766183|M80103^^SNO||||||||1||A
OBX|6|CE|IMP|tst0766183|P1140^^SNO||||||||1||A
OBX|7|CE|IMP|tst0766183|T13001^^SNO||||||||1||A
OBX|8|CE|IMP|tst0766183|T70130^^SNO||||||||1||A
OBX|9|CE|IMP|tst0766183|T74000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004435|P|2.3
PID|1||400000000^^^SYSPATH|tst3074394|patient^40||19481013|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4000000000000|||||||||||||||||||||||||200503251130
ORC|RE||PVS05-40^CoPathPlus||CM||||200504061454|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-40^CoPathPlus^tst0076183|PVAP^PV Pathology|||200504061454|||||||200504061454|YBLDR|999002814||||^56^Y|-1|200505251250||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst0076183.1|YBLDR^BLADDER BIOPSY^L||||||F||1^1
OBX|2|ST|BLOCK|tst0076183.1.1|A||||||||1^A|200510251135
OBX|3|ST|BLOCK|tst0076183.1.2|B||||||||2^B|200510251135
OBX|4|ST|BLOCK|tst0076183.1.3|C||||||||3^C|200510251135
OBX|5|ST|BLOCK|tst0076183.1.4|D||||||||4^D|200510251135
OBX|6|ST|BLOCK|tst0076183.1.5|E||||||||5^E|200510251135
OBX|7|ST|BLOCK|tst0076183.1.6|F||||||||6^F|200510251135
OBX|8|ST|BLOCK|tst0076183.1.7|G||||||||7^G|200510251135
OBX|9|ST|BLOCK|tst0076183.1.8|H||||||||8^H|200510251135
OBX|10|ST|BLOCK|tst0076183.1.9|I||||||||9^I|200510251135
OBX|11|ST|BLOCK|tst0076183.1.10|J||||||||10^J|200510251135
OBX|12|ST|BLOCK|tst0076183.1.11|K||||||||11^K|200510251135
OBX|13|ST|BLOCK|tst0076183.1.12|L||||||||12^L|200510251135
OBX|14|CE|PROCESS|tst0076183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|15|CE|PROCESS|tst0076183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|16|CE|PROCESS|tst0076183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|17|CE|PROCESS|tst0076183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|18|CE|PROCESS|tst0076183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|19|CE|PROCESS|tst0076183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|20|CE|PROCESS|tst0076183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|21|CE|PROCESS|tst0076183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|22|CE|PROCESS|tst0076183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|23|CE|PROCESS|tst0076183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|24|CE|PROCESS|tst0076183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|25|CE|PROCESS|tst0076183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|26|TX|GDT|tst0076183|The specimen is received in formalin identified with the patient' s name initials "RDB" and labeled as "bladder biopsies".  It consists of a single soft, pale tan fragment which measures 0.3 cm in greatest dimension.  The specimen is entirely submitted in cassette 1A.\.br\||||||F
OBX|27|TX|MDT|tst0076183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|28|TX|FIN|tst0076183|PART1: URINARY BLADDER, BIOPSY-\.br\A.          NON-INVASIVE LOW GRADE PAPILLARY UROTHELIAL CARCINOMA (WHO/ISUP, 2003)\.br\B.     NO DEFINITE INVASION IS IDENTIFIED.\.br\C.     DETRUSOR MUSCLE IS NOT PRESENT.\.br\  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004437|P|2.3
PID|1||400000000^^^SYSPATH|tst3074394|patient^40||19481013|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4000000000000|||||||||||||||||||||||||200503251130
ORC|RE||PHS05-40^CoPathPlus||CM||||200504061346|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-40^CoPathPlus^tst1766183|PHSP^PH Surgical Pathology|||200504060000|||||||200504061346|YBLDR|999002814||||^56^Y|-1|200505131148||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst1766183.1|YBLDR^BLADDER BIOPSY^L||||||F||1^1
OBX|2|ST|BLOCK|tst1766183.1.1|A||||||||1^A|200508311407
OBX|3|TX|GDT|tst1766183|The specimen is received in formalin identified with the patient' s name initials "RDB" and labeled as "bladder biopsies".  It consists of a single soft, pale tan fragment which measures 0.3 cm in greatest dimension.  The specimen is entirely submitted in cassette 1A.\.br\||||||F
OBX|4|TX|MDT|tst1766183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|5|TX|FIN|tst1766183|URINARY BLADDER, BIOPSY:\.br\\.br\A. SUPERFICIALLY INVASIVE HIGH GRADE (WHO) PAPILLARY UROTHELIAL CARCINOMA, GRADE 3 OF 4 (ASH)\.br\\.br\B. INVADES LAMINA PROPRIA\.br\\.br\C. DETRUSOR MUSCLE IS NOT IDENTIFIED IN THESE FRAGMENTS\.br\||||||F
OBX|6|CE|IMP|tst1766183|P1140^^SNO||||||||1||A
OBX|7|CE|IMP|tst1766183|T74000^^SNO||||||||1||A
OBX|8|CE|IMP|tst1766183|M80503^^SNO||||||||1||A
OBX|9|CE|IMP|tst1766183|T70130^^SNO||||||||1||A
OBX|10|CE|IMP|tst1766183|T13001^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004439|P|2.3
PID|1||420000000^^^SYSPATH|tst7074394|Patient^42||19400621|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4200000000000|||||||||||||||||||||||||200503251236
ORC|RE||PVS05-42^CoPathPlus||CM||||200504061457|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-42^CoPathPlus^tst2076183|PVAP^PV Pathology|||200504061457|||||||200504061457|KIDPTN|999002814||||^64^Y|-1|200505201428||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst2076183.1|KIDPTN^Right kidney^L||||||F||1^1
OBX|2|ST|BLOCK|tst2076183.1.1|A||||||||1^A|200510251135
OBX|3|ST|BLOCK|tst2076183.1.2|B||||||||2^B|200510251135
OBX|4|ST|BLOCK|tst2076183.1.3|C||||||||3^C|200510251135
OBX|5|ST|BLOCK|tst2076183.1.4|D||||||||4^D|200510251135
OBX|6|ST|BLOCK|tst2076183.1.5|E||||||||5^E|200510251135
OBX|7|ST|BLOCK|tst2076183.1.6|F||||||||6^F|200510251135
OBX|8|ST|BLOCK|tst2076183.1.7|G||||||||7^G|200510251135
OBX|9|ST|BLOCK|tst2076183.1.8|H||||||||8^H|200510251135
OBX|10|ST|BLOCK|tst2076183.1.9|I||||||||9^I|200510251135
OBX|11|ST|BLOCK|tst2076183.1.10|J||||||||10^J|200510251135
OBX|12|CE|PROCESS|tst2076183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|13|CE|PROCESS|tst2076183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|14|CE|PROCESS|tst2076183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|15|CE|PROCESS|tst2076183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|16|CE|PROCESS|tst2076183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|17|CE|PROCESS|tst2076183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|18|CE|PROCESS|tst2076183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|19|CE|PROCESS|tst2076183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|20|CE|PROCESS|tst2076183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|21|CE|PROCESS|tst2076183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|22|TX|GDT|tst2076183|The specimen is received fresh labeled "Robert Salmons" and "right kidney".  The specimen was received the morning after the procedure, therefore tissue was not obtained for banking.  It consists of a nephrectomy specimen with kidney (11.0 x 7.9 x 4.5 cm) and perirenal adipose tissue, ranging in thickness from 1.0 to 2.8 cm.  The specimen has been previously opened revealing a yellow-gold, well-circumscribed, irregular tumor (5.4 x 5.0 x 5.0 cm) with a subtle lobular architecture in the center of the kidney with the gross epicenter located at the cortical medullary junction. The lesion grossly infiltrates the renal pelvis and focally appears more solid and white.  The mass is seen bulging from the renal capsule, however, there is a thin rim of parenchyma seen between the lesion and the renal capsule. There is no gross extension into perirenal fat.  The deep soft tissue margin is inked in black.  The specimen is submitted as follows:\.br\\.br\1AMargins.\.br\1B-1DTumor in relation to deep soft tissue margin.\.br\1E-1GRepresentative sections of tumor.\.br\1HRepresentative section of uninvolved kidney.\.br\||||||F
OBX|23|TX|FIN|tst2076183|A.          RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR) CELL TYPE\.br\B.          FUHRMAN' S NUCLEAR GRADE IS III OF IV.\.br\C.          RENAL CELL CARCINOMA GROWS IN ACINAR AND TUBULAR/ SOLID PATTERN OF GROWTH.\.br\D.          THE GREATEST DIAMETER OF THE NEOPLASM IS 5.4 CM.\.br\E.          THE NEOPLASM  EXTENDS INTO THE RENAL PELVIS.\.br\F.          NO INVASION OF THE RENAL VEIN IS IDENTIFIED.\.br\G.          NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED.\.br\H.          ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM\.br\I.          THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE.\.br\J.          THE ADRENAL GLAND IS NOT SUBMITTED.\.br\K.          TNM STAGE: PT1b N0 MX.\.br\     \.br\     \.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004440|P|2.3
PID|1||420000000^^^SYSPATH|tst7074394|Patient^42||19400621|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4200000000000|||||||||||||||||||||||||200503251236
ORC|RE||PHS05-42^CoPathPlus||CM||||200504061349|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-42^CoPathPlus^tst3766183|PHSP^PH Surgical Pathology|||200504061349|||||||200504061349|KIDO|999002814||||^64^Y|-1|200505121643||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst3766183.1|KIDO^Right kidney^L||||||F||1^1
OBX|2|ST|BLOCK|tst3766183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst3766183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst3766183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst3766183.1.4|D||||||||4^D|200507221753
OBX|6|ST|BLOCK|tst3766183.1.5|E||||||||5^E|200507221753
OBX|7|ST|BLOCK|tst3766183.1.6|F||||||||6^F|200507221753
OBX|8|ST|BLOCK|tst3766183.1.7|G||||||||7^G|200507221753
OBX|9|ST|BLOCK|tst3766183.1.8|H||||||||8^H|200507221753
OBX|10|TX|GDT|tst3766183|The specimen is received fresh labeled "Robert Salmons" and "right kidney".  The specimen was received the morning after the procedure, therefore tissue was not obtained for banking.  It consists of a nephrectomy specimen with kidney (11.0 x 7.9 x 4.5 cm) and perirenal adipose tissue, ranging in thickness from 1.0 to 2.8 cm.  The specimen has been previously opened revealing a yellow-gold, well-circumscribed, irregular tumor (5.4 x 5.0 x 5.0 cm) with a subtle lobular architecture in the center of the kidney with the gross epicenter located at the cortical medullary junction. The lesion grossly infiltrates the renal pelvis and focally appears more solid and white.  The mass is seen bulging from the renal capsule, however, there is a thin rim of parenchyma seen between the lesion and the renal capsule. There is no gross extension into perirenal fat.  The deep soft tissue margin is inked in black.  The specimen is submitted as follows:\.br\\.br\1AMargins.\.br\1B-1DTumor in relation to deep soft tissue margin.\.br\1E-1GRepresentative sections of tumor.\.br\1HRepresentative section of uninvolved kidney.\.br\||||||F
OBX|11|TX|MDT|tst3766183|SYNOPTIC -  PRIMARY Kidney/Renal Pelvis/Ureter TUMORS\.br\\.br\\.br\A.    Side: 1                         1.  Right                                    2.  Left\.br\B.    Location:  1\.br\1.  Kidney (parenchyma - cortex/medulla)                            3.   Ureter\.br\2.  Kidney (pelvis)                                                                 4.   Kidney and ureter\.br\C.     Procedure:  2\.br\1.  Partial nephrectomy                                                         4.   Ureterectomy\.br\2.  Simple nephrectomy                                                         5.   Other\.br\3.  Radical nephrectomy\.br\D.     Size of neoplasm (maximum dimension; if multicentric, size of largest mass):      5.4 cm\.br\E.     Type of malignant neoplasm:  1\.br\1.   Renal cell carcinoma, clear cell type                                  11.   Urothelial carcinoma, small cell/neuroendocrine \.br\       (includes non-papillary granular cell RCC)                             carcinoma\.br\2.   Renal cell carcinoma, chromophil cell type                     12.   Urothelial carcinoma, mixed\.br\         (papillary RCC, no clear cell component)\.br\3.   Renal cell carcinoma, chromophobe cell type                    13.   Juxtaglomerular cell tumor \.br\4.   Renal cell carcinoma, oncocytic                                      14.   Wilms' tumor\.br\5.     Renal cell carcinoma, sarcomatoid                                  15.   Rhabdoid tumor\.br\6.     Collecting duct carcinoma                                                16.   Clear cell sarcoma\.br\7.     Urothelial carcinoma, TCCa                                             17.   Congenital mesoblastic nephroma\.br\         (non-invasive)\.br\8.     Urothelial carcinoma, TCCa                                             18.   Sarcoma (non-clear cell)\.br\          (invasive 1 in-situ)\.br\9.     Urothelial carcinoma, squamous carcinoma                    19.   Lymphoma/leukemia\.br\10.     Urothelial carcinoma, adenocarcinoma                            20.   Other\.br\F.     Histologic grade\.br\F1.  Fuhrman grade (for RCC; grades 1-4):  2\.br\F2.  Ash grade (grade 1-4):  #\.br\F3.  WHO grade (grade 1-3):  # (for TCCa)\.br\F4.  1998 WHO/ISUP Classification:   # \.br\     1.  LMP          2.  LG          3.  HG\.br\F5.  Other malignant neoplasms (grades 1-3):  #\.br\G.     Non-neoplastic and other conditions:  2 / # / # / #\.br\1.  Glomerulopathy\.br\2.  Interstitial nephritis\.br\3.  Pyelonephritis\.br\4.  Nephrolithiasis\.br\5.  Papillary necrosis\.br\6.  Chronic parenchymal disease\.br\7.  Other\.br\H.     Margins of resection: 2                                                          1.   Positive                        2.   Negative\.br\I.     Mitotic activity: # per 10 high power fields\.br\J.     Angiolymphatic invasion\.br\J1.  Macroscopic (e.g., renal vein thrombus):  2                    1.   Positive                        2.   Negative\.br\J2.  Microscopic: 1                                                                 1.   Positive                        2.   Negative\.br\K.     Number of positive lymph nodes:   0 \.br\L.     Total number of lymph nodes examined:   0 \.br\M.     Extracapsular spread of lymph node metastases:   2\.br\     1.  Yes          2.  No\.br\N.     Adrenal gland:\.br\N1.  Present   2                    1.   Yes                 2.    No\.br\N2.  Involvement by renal neoplasm:  2                 1.   Yes                 2.    No                 3.   Not Applicable\.br\N3.  Other adrenal pathology: 2                             1.   Yes                 2.    No                 3.   Not applicable\.br\O.   TNM stage:      T 1b      N x      M x\.br\||||||F
OBX|12|TX|FIN|tst3766183| RIGHT KIDNEY, LAPAROSCOPIC NEPHRECTOMY\.br\A.          RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE \.br\B.     FUHRMAN NUCLEAR GRADE 2/4\.br\C.     LYMPHATIC INVASION IS IDENTIFIED\.br\D.     VASCULAR INVASION IS NOT IDENTIFIED\.br\E.          RESECTED MARGINS FREE OF TUMOR\.br\       F.    UNINVOLVED KIDNEY WITH MILD INTERSTITIAL NEPHRITIS\.br\||||||F
OBX|13|CE|IMP|tst3766183|M09400^^SNO||||||||1||A
OBX|14|CE|IMP|tst3766183|M83103^^SNO||||||||1||A
OBX|15|CE|IMP|tst3766183|M83123^^SNO||||||||1||A
OBX|16|CE|IMP|tst3766183|P1100^^SNO||||||||1||A
OBX|17|CE|IMP|tst3766183|T09010^^SNO||||||||1||A
OBX|18|CE|IMP|tst3766183|T40000^^SNO||||||||1||A
OBX|19|CE|IMP|tst3766183|T71010^^SNO||||||||1||A
OBX|20|CE|IMP|tst3766183|M40000^^SNO||||||||1||A
OBX|21|CE|IMP|tst3766183|T1X007^^SNO||||||||1||A
OBX|22|CE|IMP|tst3766183|T71000^^SNO||||||||1||A
OBR|2||tst3766183^CoPathPlus^tst3766183.A1|ADD^Addendum||||||||||200506031435|||||||1|200506031435||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|TX|ADX|tst3766183|This addendum is to provide further synoptic information regarding staging.\.br\KIDNEY, RIGHT, SIMPLE NEPHRECTOMY:\.br\RENAL CELL CARCINOMA,  CONVENTIONAL (CLEAR) CELL TYPE\.br\FUHRMAN' S NUCLEAR GRADE IS 2 OF 4\.br\THE GREATEST DIAMETER OF THE NEOPLASM IS 5.4 CM.\.br\THE NEOPLASM IS CONFINED WITHIN THE RENAL CAPSULE \.br\NO INVASION OF THE RENAL VEIN IS IDENTIFIED \.br\THERE IS EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED.\.br\ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM THE NON-NEOPLASTIC KIDNEY REVEALS MILD INTERSTITIAL NEPHRITIS\.br\THE ADRENAL GLAND IS NOT SUBMITTED \.br\THE LYMPH NODE STATUS IS AS FOLLOWS: NODES WERE NOT RECEIVED\.br\TNM STAGE: T1bNX MX.\.br\TNM HISTOLOGIC GRADE = G2.\.br\\.br\SYNOPTIC -  PRIMARY Kidney/Renal Pelvis/Ureter TUMORS\.br\A.    Side: 1                         1.  Right                                    2.  Left\.br\B.    Location:  1\.br\1.  Kidney (parenchyma - cortex/medulla)                            3.   Ureter\.br\2.  Kidney (pelvis)                                                                 4.   Kidney and ureter\.br\C.     Procedure:  2\.br\1.  Partial nephrectomy                                                         4.   Ureterectomy\.br\2.  Simple nephrectomy                                                         5.   Other\.br\3.  Radical nephrectomy\.br\D.     Size of neoplasm (maximum dimension; if multicentric, size of largest mass):      5.4 cm\.br\E.     Type of malignant neoplasm:  1\.br\1.   Renal cell carcinoma, clear cell type                                  11.   Urothelial carcinoma, small cell/neuroendocrine \.br\       (includes non-papillary granular cell RCC)                             carcinoma\.br\2.   Renal cell carcinoma, chromophil cell type                     12.   Urothelial carcinoma, mixed\.br\         (papillary RCC, no clear cell component)\.br\3.   Renal cell carcinoma, chromophobe cell type                    13.   Juxtaglomerular cell tumor \.br\4.   Renal cell carcinoma, oncocytic                                      14.   Wilms' tumor\.br\5.     Renal cell carcinoma, sarcomatoid                                  15.   Rhabdoid tumor\.br\6.     Collecting duct carcinoma                                                16.   Clear cell sarcoma\.br\7.     Urothelial carcinoma, TCCa                                             17.   Congenital mesoblastic nephroma\.br\         (non-invasive)\.br\8.     Urothelial carcinoma, TCCa                                             18.   Sarcoma (non-clear cell)\.br\          (invasive 1 in-situ)\.br\9.     Urothelial carcinoma, squamous carcinoma                    19.   Lymphoma/leukemia\.br\10.     Urothelial carcinoma, adenocarcinoma                            20.   Other\.br\F.     Histologic grade\.br\F1.  Fuhrman grade (for RCC; grades 1-4):  2\.br\F2.  Ash grade (grade 1-4):  #\.br\F3.  WHO grade (grade 1-3):  # (for TCCa)\.br\F4.  1998 WHO/ISUP Classification:   # \.br\     1.  LMP          2.  LG          3.  HG\.br\F5.  Other malignant neoplasms (grades 1-3):  #\.br\G.     Non-neoplastic and other conditions:  2 / # / # / #\.br\1.  Glomerulopathy\.br\2.  Interstitial nephritis\.br\3.  Pyelonephritis\.br\4.  Nephrolithiasis\.br\5.  Papillary necrosis\.br\6.  Chronic parenchymal disease\.br\7.  Other\.br\H.     Margins of resection: 2                                                          1.   Positive                        2.   Negative\.br\I.     Mitotic activity: 1 per 10 high power fields\.br\J.     Angiolymphatic invasion\.br\J1.  Macroscopic (e.g., renal vein thrombus):  2                    1.   Positive                        2.   Negative\.br\J2.  Microscopic: 1                                                                 1.   Positive                        2.   Negative\.br\K.     Number of positive lymph nodes:   0 \.br\L.     Total number of lymph nodes examined:   0 \.br\M.     Extracapsular spread of lymph node metastases:   # \.br\     1.  Yes          2.  No\.br\N.     Adrenal gland:\.br\N1.  Present   2                    1.   Yes                 2.    No\.br\N2.  Involvement by renal neoplasm:  #                 1.   Yes                 2.    No                 3.   Not Applicable\.br\N3.  Other adrenal pathology: #                             1.   Yes                 2.    No                 3.   Not applicable\.br\O.   TNM stage:      T 1b      N #      M #\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004441|P|2.3
PID|1||430000000^^^SYSPATH|tst8074394|Patient^43||19440506|F||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4300000000000|||||||||||||||||||||||||200503251243
ORC|RE||PVS05-43^CoPathPlus||CM||||200504061458|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-43^CoPathPlus^tst3076183|PVAP^PV Pathology|||200504061458|||||||200504061458|BLBT|999002814||||^60^Y|-1|200505201621||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst3076183.1|BLBT^Bladder^L||||||F||1^1
OBX|2|ST|BLOCK|tst3076183.1.1|A||||||||1^A|200510251135
OBX|3|CE|PROCESS|tst3076183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200504121014
OBX|4|CE|PROCESS|tst3076183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200504121014
OBX|5|CE|PROCESS|tst3076183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200504121014
OBX|6|TX|GDT|tst3076183|The specimen is received in formalin, properly identified and labeled as "bladder".  It consists of a firm piece of pink-tan tissue with cautery which measures 2.5 x 1.5 x 1.0 cm.  The specimen is inked and serially sectioned.  It is entirely submitted in cassettes 1A and 1B.\.br\||||||F
OBX|7|TX|MDT|tst3076183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|8|TX|FIN|tst3076183|URINARY BLADDER ---\.br\MOSTLY DENUDED, BENIGN BALDDER TISSUE WITH FOCAL GIANT CELL REACTION.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004442|P|2.3
PID|1||430000000^^^SYSPATH|tst8074394|Patient^43||19440506|F||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4300000000000|||||||||||||||||||||||||200503251243
ORC|RE||PHS05-43^CoPathPlus||CM||||200504061351|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-43^CoPathPlus^tst4766183|PHSP^PH Surgical Pathology|||200504061351|||||||200504061351|BLBT|999002814||||^60^Y|-1|200505181112||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst4766183.1|BLBT^Bladder^L||||||F||1^1
OBX|2|TX|GDT|tst4766183|The specimen is received in formalin, properly identified and labeled as "bladder".  It consists of a firm piece of pink-tan tissue with cautery which measures 2.5 x 1.5 x 1.0 cm.  The specimen is inked and serially sectioned.  It is entirely submitted in cassettes 1A and 1B.\.br\||||||F
OBX|3|TX|MDT|tst4766183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst4766183|URINARY BLADDER, EXCISIONAL BIOPSY: DENUDED UROTHELIUM WITH MILD CHRONIC CYSTITIS AND STROMAL GIANT CELL REACTION.  NO EVIDENCE OF UROTHELIAL ATYPIA OR NEOPLASIA. (See comment)   \.br\||||||F
OBX|5|CE|IMP|tst4766183|M09450^^SNO||||||||1||A
OBX|6|CE|IMP|tst4766183|M43000^^SNO||||||||1||A
OBX|7|CE|IMP|tst4766183|M44140^^SNO||||||||1||A
OBX|8|CE|IMP|tst4766183|P1141^^SNO||||||||1||A
OBX|9|CE|IMP|tst4766183|T70130^^SNO||||||||1||A
OBX|10|CE|IMP|tst4766183|T74000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004444|P|2.3
PID|1||000669105^^^CHPADT|tpmc1298394|TESTVTWOFIVE^BILLING^FELICIA||19491020|F|||||||||||173-44-3373|||||||||||N
PV1|1||CH5SDS^5400||||505074^PLANET^MARS||||||||||pmc87361^PLANET^EARTH|CHY|1025913748|||||||||||||||||||||||||200511160559
ORC|RE||CHS05-44^CoPathPlus||CM||||200512061014|^SOLTESZ^BENJAMIN||505074^PLANET^MARS
OBR|1||CHS05-44^CoPathPlus^tpmc7367183|^CHP Histology|||200512060000|||||||200512061013|CCNSL|505074||||^56^Y|-1|200512061449||SP|F|||||||C006429^JAFFE^RONALD|^SOLTESZ^BENJAMIN
OBX|1|CE|ANT|tpmc7367183.1|CCNSL^Consult slides^L||||||F||1^1
OBX|2|TX|GDT|tpmc7367183|Received 3 slides labeled S04-5022 from CHLA, Los Angeles, CA and identifying surgical pathology report.  The slides are  retained.\.br\||||||F
OBX|3|TX|MDT|tpmc7367183|Parotid gland contains a multilocular cystic lesion.  Some of the smaller cysts are filled with mucoid debris.  The cystic lesion is embedded in a dense, collagenous pseudo-capsular reaction with entrapped smaller cysts within the dense collagen.  There is extensive inflammation around the smaller peripheral cysts, and in places there is follicular lymphoid tissue around the larger cystic areas.  The lining varies.  Most of the larger cysts are lined by a mucoid layer rich in goblet cells that are very large and often ballooned with concretions.  There are cuboidal and squamous areas admixed with oncocytic foci.  In some areas, the lining is proliferative, and there are multiple layers that appear disorganized.  The collagenous reaction that encompasses squamoid hyalines approaches within one high-power field of the inked margin of resection.  The surrounding gland is locally atrophic, with a chronic periductal inflammatory component.  \.br\||||||F
OBX|4|TX|FIN|tpmc7367183|Consult from CHLA, Los Angeles, CA:\.br\\.br\S04-5022 (12/28/04)):\.br\Left parotid gland, resection:\.br\MUCOEPIDERMOID CARCINOMA, LOW GRADE (SEE NOTE).\.br\||||||F
OBX|5|CE|IMP|tpmc7367183|M84303^^SNO||||||||1||A
OBX|6|CE|IMP|tpmc7367183|P1100^^SNO||||||||1||A
OBX|7|CE|IMP|tpmc7367183|T55120^^SNO||||||||1||A
OBR|2||tpmc7367183^CoPathPlus^tpmc7367183.A1|ADD^Addendum||||||||||200512061517|||||||1|200512061517||SP|F||||||||^SOLTESZ^BENJAMIN
OBX|1|TX|ADX|tpmc7367183|(Accessioned #/#/#;Sections submitted #/#/#;Slides received #/#/#)\.br\||||||F
OBR|3||tpmc7367183^CoPathPlus^tpmc7367183.P2|EM^Electron Microscopy||||||||||200512061520|||||||2|200512061520||SP|F||||||||^SOLTESZ^BENJAMIN
OBX|1|TX|PIN|tpmc7367183|\.br\PROFORMA FOR HEAD AND NECK HISTOPATHOLOGY\.br\\.br\Histological Diagnosis: _________________________________________\.br\\.br\Histological grade: _____________________________________________\.br\\.br\Perineural invasion (Major nerves) No   Yes\.br\\.br\Perineural invasion (Minor nerves) No   Yes\.br\Vascular invasion                  No   Yes\.br\Lymphatic invasion                 No   Yes\.br\Margins clear                      No   Yes  Uncertain\.br\If margins clear                   <mm  1-2mm     >2mm\.br\\.br\Laryngeal tumors\.br\Thyroid /cricoid cartilage invasion     No   Into Through\.br\Extralaryngeal soft tissue invasion     No   Yes\.br\Thyroid gland invasion                  No   Yes\.br\Subglottic (>1cm below edge of VC)      Yes  No\.br\\.br\               Left neck dissection     Right neck dissection\.br\Metastases      YES  NO  \F\  YES  NO     YES  NO  \F\     YES  NO   \.br\Number of mets  1  2  3  \F\  4  5  >5    1  2  3  \F\     4  5  >5\.br\\.br\Zones dissected 1  2  3  \F\  4  5  >5    1  2  3  \F\     4  5  >5  \.br\Zones with mets 1  2  3  \F\  4  5  >5    1  2  3  \F\     4  5  >5\.br\ECS               YES    \F\  NO            YES          NO\.br\\.br\Additional comments:  ___________________________________________\.br\\.br\_________________________________________________________________\.br\\.br\Tissue available for additional studies Yes  No\.br\\.br\Permanent Block     Electron Microscopy Tissue Bank _____________\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004446|P|2.3
PID|1||440000000^^^SYSPATH|tst9074394|Patient^44||19301110|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4400000000000|||||||||||||||||||||||||200503251247
ORC|RE||PHS05-44^CoPathPlus||CM||||200504061352|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-44^CoPathPlus^tst5766183|PHSP^PH Surgical Pathology|||200504061352|||||||200504061352|TURP|999002814||||^74^Y|-1|200505061520||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst5766183.1|TURP^Prostatic Tissue^L||||||F||1^1
OBX|2|ST|BLOCK|tst5766183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst5766183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst5766183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst5766183.1.4|D||||||||4^D|200507221753
OBX|6|CE|PROCESS|tst5766183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041115
OBX|7|CE|PROCESS|tst5766183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041115
OBX|8|CE|PROCESS|tst5766183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505041115
OBX|9|CE|PROCESS|tst5766183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505041115
OBX|10|TX|GDT|tst5766183|The specimen is received fresh identified with the patient' s name, initials DMS and labeled as "prostate tissue".  It consists of multiple pink-tan, firm chips which weigh 27.0 grams and measures 4.5 x 4.0 x 2.5 cm in aggregate.  Representative sections are submitted in cassettes 1A through 1L.\.br\||||||F
OBX|11|TX|MDT|tst5766183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|12|TX|FIN|tst5766183|PROSTATE, TRANSURETHRAL RESECTION: BENIGN PROSTATIC PARENCHYMA\.br\||||||F
OBX|13|CE|IMP|tst5766183|P1100^^SNO||||||||1||A
OBX|14|CE|IMP|tst5766183|T77100^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004447|P|2.3
PID|1||440000000^^^SYSPATH|tst9074394|Patient^44||19301110|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4400000000000|||||||||||||||||||||||||200503251247
ORC|RE||PVS05-44^CoPathPlus||CM||||200504061500|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-44^CoPathPlus^tst4076183|PVAP^PV Pathology|||200504061500|||||||200504061500|PROSTUR|999002814||||^74^Y|-1|200506131804||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst4076183.1|PROSTUR^Prostatic Tissue^L||||||F||1^1
OBX|2|ST|BLOCK|tst4076183.1.1|A||||||||1^A|200510251135
OBX|3|ST|BLOCK|tst4076183.1.2|B||||||||2^B|200510251135
OBX|4|ST|BLOCK|tst4076183.1.3|C||||||||3^C|200510251135
OBX|5|ST|BLOCK|tst4076183.1.4|D||||||||4^D|200510251135
OBX|6|ST|BLOCK|tst4076183.1.5|K||||||||5^K|200510251135
OBX|7|CE|PROCESS|tst4076183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|8|CE|PROCESS|tst4076183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|9|CE|PROCESS|tst4076183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|10|CE|PROCESS|tst4076183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|11|CE|PROCESS|tst4076183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512191445
OBX|12|CE|PROCESS|tst4076183.1.5.6|pmc4905^P504S (IPEX)^L||||||||2^AP504S|200506011406
OBX|13|CE|PROCESS|tst4076183.1.5.7|pmc9715^34BE12 (HMW) (PVHS)^L||||||||3^34BE12|200506011406
OBX|14|TX|GDT|tst4076183|The specimen is received fresh identified with the patient' s name, initials DMS and labeled as "prostate tissue".  It consists of multiple pink-tan, firm chips which weigh 27.0 grams and measures 4.5 x 4.0 x 2.5 cm in aggregate.  Representative sections are submitted in cassettes 1A through 1L.\.br\||||||F
OBX|15|TX|MDT|tst4076183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|16|TX|FIN|tst4076183|BENIGN PROSTATIC HYPERPLASIA WITH FOCI OF ADENOSIS (See Comment)\.br\\.br\Comment: Admixed with foci of benign prostatic hyperplasia are areas of crowded glands with a nodular configuration of growth. While I favor that these foci represent adenosis, special stains to confirm the benign nature of these foci were non-contributory. This case will be reviewed in our WSI consensus conference and an addendum will be issued with the results of this consensus.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004449|P|2.3
PID|1||450000000^^^SYSPATH|tst0174394|Patient^45||19291216|M||W||||||||||||||||||||N
PV1|1||ILAB||||^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4500000000000|||||||||||||||||||||||||200503251251
ORC|RE||PHS05-45^CoPathPlus||CM||||200504061353|^KISTLER^MICHAEL||^JUKIC^DRAZEN
OBR|1||PHS05-45^CoPathPlus^tst6766183|PHSP^PH Surgical Pathology|||200504061353|||||||200504061353|BLBT|||||^75^Y|-1|200505131210||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst6766183.1|BLBT^Old clot and bladder tumor^L||||||F||1^1
OBX|2|ST|BLOCK|tst6766183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst6766183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst6766183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst6766183.1.4|D||||||||4^D|200507221753
OBX|6|ST|BLOCK|tst6766183.1.5|E||||||||5^E|200507221753
OBX|7|ST|BLOCK|tst6766183.1.6|F||||||||6^F|200507221753
OBX|8|ST|BLOCK|tst6766183.1.7|G||||||||7^G|200507221753
OBX|9|ST|BLOCK|tst6766183.1.8|H||||||||8^H|200507221753
OBX|10|ST|BLOCK|tst6766183.1.9|I||||||||9^I|200507221753
OBX|11|CE|PROCESS|tst6766183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|12|CE|PROCESS|tst6766183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|13|CE|PROCESS|tst6766183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|14|CE|PROCESS|tst6766183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|15|CE|PROCESS|tst6766183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|16|CE|PROCESS|tst6766183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|17|CE|PROCESS|tst6766183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|18|CE|PROCESS|tst6766183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|19|CE|PROCESS|tst6766183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200505041144
OBX|20|TX|GDT|tst6766183|The specimen is received fresh, properly identified with the patient' s name "Anthony Sciullo" and site given as "old clot and bladder tumor".  It consists of multiple pieces of hemorrhagic, soft resilient, pink-tan tissue which measures in aggregate as 7.2 x 6.3 x 2.0 cm.  Intermixed with the tissue there are multiple clotted pieces of blood.  The specimens are totally submitted in cassettes A through I.\.br\||||||F
OBX|21|TX|MDT|tst6766183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|22|TX|FIN|tst6766183|OLD CLOT AND BLADDER TUMOR, TRANSURETHRAL RESECTION: \.br\A.          INVASIVE, PAPILLARY HIGH GRADE (WHO) UROTHELIAL CARCINOMA, GRADE 3 OF 4 (ASH)\.br\B.     TUMOR INVADES LAMINA PROPRIA\.br\C.     NO EVIDENCE OF ANGIOLYMPHATIC INVASION\.br\D.     DETRUSOR MUSCLE FRAGMENTS FREE OF TUMOR\.br\E.     FRAGMENTS OF BLOOD CLOT  \.br\||||||F
OBX|23|CE|IMP|tst6766183|M80103^^SNO||||||||1||A
OBX|24|CE|IMP|tst6766183|M80503^^SNO||||||||1||A
OBX|25|CE|IMP|tst6766183|P1100^^SNO||||||||1||A
OBX|26|CE|IMP|tst6766183|T13001^^SNO||||||||1||A
OBX|27|CE|IMP|tst6766183|T70130^^SNO||||||||1||A
OBX|28|CE|IMP|tst6766183|T74000^^SNO||||||||1||A
OBX|29|CE|IMP|tst6766183|T74020^^SNO||||||||1||A
OBX|30|CE|IMP|tst6766183|M35000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004450|P|2.3
PID|1||450000000^^^SYSPATH|tst0174394|Patient^45||19291216|M||W||||||||||||||||||||N
PV1|1||ILAB||||^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|4500000000000|||||||||||||||||||||||||200503251251
ORC|RE||PVS05-45^CoPathPlus||CM||||200504061502|^KISTLER^MICHAEL||^JUKIC^DRAZEN
OBR|1||PVS05-45^CoPathPlus^tst5076183|PVAP^PV Pathology|||200504061502|||||||200504061502|BLBT|||||^75^Y|-1|200505230808||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst5076183.1|BLBT^Old clot and bladder tumor^L||||||F||1^1
OBX|2|TX|GDT|tst5076183|The specimen is received fresh, properly identified with the patient' s name "Anthony Sciullo" and site given as "old clot and bladder tumor".  It consists of multiple pieces of hemorrhagic, soft resilient, pink-tan tissue which measures in aggregate as 7.2 x 6.3 x 2.0 cm.  Intermixed with the tissue there are multiple clotted pieces of blood.  The specimens are totally submitted in cassettes A through I.\.br\||||||F
OBX|3|TX|MDT|tst5076183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst5076183|URINARY BLADDER, TURBT \.br\A.          INVASIVE HIGH GRADE UROTHELIAL CARCINOMA WITH EXENSIVE NECROSIS AND FOCAL RHABDOID DIFFERENTIATION.\.br\B.     FOCI SUSPICIOUS FOR MUSCULARIS PROPRIA INVASION ARE IDENTIFIED (see comment).\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004451|P|2.3
PID|1||000222222^^^CHPADT|tpmc6670494|TESTVTWOFIVE^CH TWO||19940405|F||W|||||||||123-22-3232|||||||||||N
PV1|1||CHSDSH||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|CHS|1023232323|||||||||||||||||||||||||200511210753
ORC|RE||CHS05-45^CoPathPlus||CM||||200512070914|^SOLTESZ^BENJAMIN||505079^PLANET^PLUTO
OBR|1||CHS05-45^CoPathPlus^tpmc2467183|^CHP Histology|||200512070000|||||||200512070914|CDOBX|505079||||^11^Y|-1|200512091123||SP|F|||||||031969^GALAMBOS^CSABA|^SOLTESZ^BENJAMIN
OBX|1|CE|ANT|tpmc2467183.1|CDOBX^Duodenal biopsy^L||||||F||1^1
OBX|2|CE|ANT|tpmc2467183.2|CATBX^Gastric antral biopsy^L||||||F||2^2
OBX|3|CE|ANT|tpmc2467183.3|CESBX^Esophageal biopsy^L||||||F||3^3
OBX|4|TX|GDT|tpmc2467183|The specimen is received in three parts.\.br\\.br\Part 1 is received in formalin, labeled with patient's name, and is designated "duodenal biopsy."  It consists of four pieces of pink tan mucosa, which measure 0.3 cm in diameter.  The specimen is entirely submitted in cassette 1A.\.br\\.br\Part 2 is received in formalin, labeled with the patient's name, and is designated "antral/stomach biopsy."  It consists of four pieces of pink tan mucosa, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 2A.\.br\\.br\Part 3 is received in formalin, labeled with the patient's name, and is designated "esophageal biopsy."  It consists of three pieces of pink tan mucosa, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 3A.  Part 2\.br\||||||F
OBX|5|TX|MDT|tpmc2467183|There is one fragment of esophageal mucosa.  There are no proliferative or inflammatory changes.\.br\||||||F
OBX|6|TX|FIN|tpmc2467183|Esophageal biopsy:  UNREMARKABLE ESOPHAGEAL EPITHELIUM.\.br\\.br\My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation.\.br\||||||F
OBX|7|CE|IMP|tpmc2467183|M00100^^SNO||||||||1||A
OBX|8|CE|IMP|tpmc2467183|P1140^^SNO||||||||1||A
OBX|9|CE|IMP|tpmc2467183|T62000^^SNO||||||||1||A
OBR|2||tpmc2467183^CoPathPlus^tpmc2467183.A1|ADD^Addendum||||||||||200512091125|||||||1|200512091125||SP|F|||||||MW019935^JONES^MIRKA (Miroslawa)|^SOLTESZ^BENJAMIN
OBX|1|TX|ADX|tpmc2467183|This is an Addendum report and reflects a change to the demographic component of the report.  All previous copies of this report should be destroyed.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004453|P|2.3
PID|1||000659874^^^CHPADT|tpmc5840205|TESTVTWOFIVE^CH FIVE||19840810|F||LR1|||||||||890-85-4611|||||||||||N
PV1|1||CHSDSH^7661||||SDMDA-12323^MILLER^SUSAN||||||||||pmc1583^MILLER^SUSAN|CHJ|1026069672|||||||||||||||||||||||||200512161327
ORC|RE||CHS05-48^CoPathPlus||CM||||200512161355|z40^KOKAL^ELLEN||SDMDA-12323^MILLER^SUSAN
OBR|1||CHS05-48^CoPathPlus^tpmc0077183|^CHP Histology|||200512160000|||||||200512161354|CECBXCH|SDMDA-12323||||^21^Y|-1|200601040848||SP|F|||||||C21501^RANGANATHAN^SARANGARAJAN|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tpmc0077183.1|CECBXCH^Endomyocardial biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc0077183.1.1|A||||||||1^A|200512201105
OBX|3|ST|BLOCK|tpmc0077183.1.2|B||||||||2^B|200601031316
OBX|4|CE|PROCESS|tpmc0077183.1.1.1|pmc3154^Blank Slide (CHP)^L||||||||3^Blank|200601131529
OBX|5|CE|PROCESS|tpmc0077183.1.1.2|pmc2154^H&E (CHP)^L||||||||4^Lvl 3/5|200601131529
OBX|6|CE|PROCESS|tpmc0077183.1.1.3|pmc2154^H&E (CHP)^L||||||||5^Lvl 7/9|200601131529
OBX|7|CE|PROCESS|tpmc0077183.1.0.4|$hinit^Initial H&E^L||||||||1^H&E|200601131529
OBX|8|CE|PROCESS|tpmc0077183.1.0.5|pmc3354^PAS (CHP)^L||||||||2^PAS|200601131530
OBX|9|CE|PROCESS|tpmc0077183.1.0.6|pmc1433^Grocott Stain (Histo)^L||||||||3^Grocott|200601131530
OBX|10|CE|PROCESS|tpmc0077183.1.2.7|$hinit^Initial H&E^L||||||||5^H&E|200601131529
OBX|11|CE|PROCESS|tpmc0077183.1.2.8|pmc1354^Oil Red O (CHP)^L||||||||6^OilRedO|200601131530
OBX|12|CE|PROCESS|tpmc0077183.1.2.9|pmc3323^CD3 T Lymphocytes (IPEX)^L||||||||7^CD3|200601132341
OBX|13|CE|PROCESS|tpmc0077183.1.2.10|pmc8623^L26 B lymphocyte (IPEX)^L||||||||8^L26|200601132341
OBX|14|CE|PROCESS|tpmc0077183.1.2.11|pmc6604^CD5 T/some B Lymphocytes (IPEX)^L||||||||9^ACD5|200601132341
OBX|15|CE|PROCESS|tpmc0077183.1.2.12|pmc8624^CD10 CALLA paraffin (IPEX)^L||||||||10^ACD10|200601132341
OBX|16|CE|PROCESS|tpmc0077183.1.2.13|pmc6323^CD43 L60 T Lymphocytes (IPEX)^L||||||||11^CD43|200601132341
OBX|17|CE|PROCESS|tpmc0077183.1.2.14|pmc8733^Bcl-2 Oncoprotein (IPEX)^L||||||||12^Bcl-2|200601132341
OBX|18|CE|PROCESS|tpmc0077183.1.2.15|pmc8405^CD56, ERIC-1(CHP)^L||||||||13^CD56,ERIC1|200601132341
OBX|19|CE|PROCESS|tpmc0077183.1.2.16|pmc6324^cyclin D1 Bcl-1 (IPEX)^L||||||||14^ACYCLD1|200601132341
OBX|20|TX|GDT|tpmc0077183|The specimen is received in formalin, labeled with the patient' s name and designated "endomyocardial biopsy."  It consists of # pieces of #, soft tissue.  They measure # cm in aggregate.  The largest piece measures # cm in greatest dimension.  The specimen is totally submitted in a single cassette labeled 1A.  \.br\||||||F
OBX|21|TX|MDT|tpmc0077183|This case was discussed by telephone with Dr. Jones at 3:05pm, 12/30/2005. \.br\||||||F
OBX|22|TX|FIN|tpmc0077183|Endomyocardial biopsy:  \.br\MYOCARDITIS WITHOUT FIBROSIS (DALLAS CRITERIA).\.br\POLYMERASE CHAIN REACTION TESTING FOR VIRUSES IS PENDING.\.br\\.br\My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation.\.br\||||||F
OBX|23|CE|IMP|tpmc0077183|M40000^^SNO||||||||1||A
OBX|24|CE|IMP|tpmc0077183|P1140^^SNO||||||||1||A
OBX|25|CE|IMP|tpmc0077183|T33010^^SNO||||||||1||A
OBX|26|CE|IMP|tpmc0077183|T34000^^SNO||||||||1||A
OBR|2||tpmc0077183^CoPathPlus^tpmc0077183.P1|^CHP Flow Cytometry||||||||||200601031334|||||||1|200601031334||SP|F|||||||000023^SWERDLOW^STEVEN|z40^KOKAL^ELLEN
OBX|1|TX|PIN|tpmc0077183|A report is received from the Central Laboratory Services Inc., Department of Pathology, UPMC Health System, Pittsburgh, PA.  The reference laboratory number is PHS05-36823.\.br\ \.br\Flow cytometry studies performed on the adenoid demonstrate polyclonal B-cells, including a population of CD20+/CD10+ cells which could reflect germinal center cells, along with heterogeneous T-cells with an increased T-helper to T-suppressor cell ratio. \.br\A very small population of Tdt positive cells is identified (\R\1.9% of cells), the significance of which is uncertain. These results should be correlated with the corresponding histologic findings and were discussed with Dr. Beth Clark, 12/21/2005.\.br\\.br\See patient chart for original report.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004454|P|2.3
PID|1||001202116^^^CHPADT|tst3948394|TEST^HEATHER||19950102|F||W|123 ADDRESS^^PITTSBURGH^PA^15220^United States||2342342343||||||234-23-4233|||||||||||N
PV1|1||CHIICU^IICU||||||||||||||pmc79212^NECHES^WILLIAM|CHI|1021257439|||||||||||||||||||||||||200511221023|200601271219
ORC|RE||CHS05-49^CoPathPlus||CM||||200512161356|DAG^GALVIS^DAN||C001990^NECHES^WILLIAM
OBR|1||CHS05-49^CoPathPlus^tpmc1077183|^CHP Histology|||200512161200|||||||200512161355|CLTBX|C001990||||^10^Y|-1|200512271326||SP|F|||||||031969^GALAMBOS^CSABA|031969^GALAMBOS^CSABA
OBX|1|CE|ANT|tpmc1077183.1|CLTBX^Allograft transbronchial biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc1077183.1.1|A||||||||1^A|200512201105
OBX|3|CE|PROCESS|tpmc1077183.1.1.1|pmc3154^Blank Slide (CHP)^L||||||||1^Blank|200512211520
OBX|4|CE|PROCESS|tpmc1077183.1.1.2|pmc2154^H&E (CHP)^L||||||||2^2|200512211520
OBX|5|CE|PROCESS|tpmc1077183.1.1.3|pmc2154^H&E (CHP)^L||||||||3^4/9|200512211520
OBX|6|CE|PROCESS|tpmc1077183.1.1.4|pmc5533^PAS w/Diastase (Histo)^L||||||||4^6 PASD|200512211520
OBX|7|CE|PROCESS|tpmc1077183.1.1.5|pmc1433^Grocott Stain (Histo)^L||||||||5^7 GMS|200512211520
OBX|8|CE|PROCESS|tpmc1077183.1.1.6|pmc6734^Elastic Trichrome^L||||||||6^8 ElsTri|200512211520
OBX|9|TX|GDT|tpmc1077183|The specimen is received in formalin, labeled with the patient's name, and is designated "allograft transbronchial biopsy."  It consists of multiple small pieces of pink-tan soft tissue, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 1A.\.br\||||||F
OBX|10|TX|MDT|tpmc1077183|There are five fragments of alveolated pulmonary parenchyma. A fragment of large airway without significant inflammation is seen. No perivascular lymphocytic infiltrate is noted. Small airways are present without obstructive changes. Elastic trichrome and PAS stains highlight thin alveolar basement membrane. A Grocott stain is negative for fungus and for Pneumocystis. No viral inclusions are present.     \.br\||||||F
OBX|11|TX|FIN|tpmc1077183|Allograft lung transbronchial biopsy (1 year, 2 months, 5 days):\.br\     NO ACUTE CELLULAR REJECTION (A0).\.br\     NO AIRWAY INFLAMMATION (B0).\.br\     NO BRONCHIOLITIS OBLITERANS (C0).\.br\     NO FUNGUS, PNEUMOCYSTIS OR VIRAL INCLUSIONS.\.br\     \.br\||||||F
OBX|12|CE|IMP|tpmc1077183|E0004^^SNO||||||||1||A
OBX|13|CE|IMP|tpmc1077183|E3000^^SNO||||||||1||A
OBX|14|CE|IMP|tpmc1077183|M00100^^SNO||||||||1||A
OBX|15|CE|IMP|tpmc1077183|P1140^^SNO||||||||1||A
OBX|16|CE|IMP|tpmc1077183|T26000^^SNO||||||||1||A
OBX|17|CE|IMP|tpmc1077183|T28000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004455|P|2.3
PID|1||200000022^^^RR|tpmc7690494|TESTVTWOFIVE^PH ONE||19500729|F||W|||||||||200-00-0022|||||||||||N
PV1|1||CCAR||||505079^PLANET^PLUTO|505073^PLANET^EARTH|||||||||pmc48361^PLANET^PLUTO|S|0202449191919|||||||||||||||||||||||||200511210835
ORC|RE||PHS06-50^CoPathPlus||CM||||200601101306|z32^PICCOLI^ANTHONY||505079^PLANET^PLUTO
OBR|1||PHS06-50^CoPathPlus^tpmc9187183|PHSP^PH Surgical Pathology|||200511300000|||||||200601101303|RIB|505079||||^55^Y|-1|200601111405||SP|F|||||||002065^DACIC^SANJA|002065^DACIC^SANJA
OBX|1|CE|ANT|tpmc9187183.1|RIB^Right 6th rib^L||||||F||1^1
OBX|2|CE|ANT|tpmc9187183.2|LNTH^Pericardial fat pad lymph node^L||||||F||2^2
OBX|3|CE|ANT|tpmc9187183.3|LNTH^Level 11 lymph node^L||||||F||3^3
OBX|4|CE|ANT|tpmc9187183.4|LNTH^Lymph node near fissure^L||||||F||4^4
OBX|5|CE|ANT|tpmc9187183.5|LUNL^Right upper lobe lung^L||||||F||5^5
OBX|6|ST|BLOCK|tpmc9187183.1.1|A||||||||1^A|200601101305
OBX|7|ST|BLOCK|tpmc9187183.2.2|A||||||||1^A|200601101305
OBX|8|ST|BLOCK|tpmc9187183.3.3|A||||||||1^A|200601101305
OBX|9|ST|BLOCK|tpmc9187183.4.4|A||||||||1^A|200601101305
OBX|10|ST|BLOCK|tpmc9187183.5.5|A||||||||1^A|200601101305
OBX|11|ST|BLOCK|tpmc9187183.5.6|B||||||||2^B|200601101305
OBX|12|ST|BLOCK|tpmc9187183.5.7|C||||||||3^C|200601101305
OBX|13|ST|BLOCK|tpmc9187183.5.8|D||||||||4^D|200601101305
OBX|14|ST|BLOCK|tpmc9187183.5.9|E||||||||5^E|200601101305
OBX|15|ST|BLOCK|tpmc9187183.5.10|F||||||||6^F|200601101305
OBX|16|ST|BLOCK|tpmc9187183.5.11|G||||||||7^G|200601101305
OBX|17|ST|BLOCK|tpmc9187183.5.12|H||||||||8^H|200601101305
OBX|18|CE|PROCESS|tpmc9187183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|19|CE|PROCESS|tpmc9187183.1.1.2|pmc7453^Decal Routine (Surg)^L||||||||2^Decal|200601101305
OBX|20|CE|PROCESS|tpmc9187183.2.2.3|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|21|CE|PROCESS|tpmc9187183.3.3.4|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|22|CE|PROCESS|tpmc9187183.4.4.5|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|23|CE|PROCESS|tpmc9187183.5.5.6|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|24|CE|PROCESS|tpmc9187183.5.6.7|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|25|CE|PROCESS|tpmc9187183.5.7.8|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|26|CE|PROCESS|tpmc9187183.5.8.9|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|27|CE|PROCESS|tpmc9187183.5.9.10|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|28|CE|PROCESS|tpmc9187183.5.10.11|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|29|CE|PROCESS|tpmc9187183.5.11.12|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|30|CE|PROCESS|tpmc9187183.5.12.13|$hinit^Initial H&E^L||||||||1^H&E|200601101305
OBX|31|TX|GDT|tpmc9187183|The specimen is received unfixed in five parts.\.br\\.br\Part 1 is received unfixed, labeled with the patient's name, initials,  and "right sixth rib".  It consists of a solitary irregular, focally hemorrhagic, bony fragment that is 2.0 x 1.5 x 0.8 cm.  A representative section is submitted following   decalcification in 1A.\.br\\.br\Part 2 is received unfixed, for intraoperative consultation, labeled with the patient's name, initials, and "paracardial fat pad lymph node".  The specimen consists of an aggregate of focally hemorrhagic fibrofatty tissue with accompanying lymph node that is 1.0 x 1.0 x 0.4 cm in aggregate.  The specimen is entirely submitted following intraoperative consultation in 2AFS. \.br\\.br\Part 3 is received unfixed, labeled with the patient's name, initials, and "level 2 lymph node".  The specimen consists of a 1.5 x 1.0 x 0.3 cm aggregate of fibrofatty tissue and lymph nodes. The specimen is totally submitted in cassette 3A.\.br\\.br\Part 4 is received unfixed, labeled with the patient's name, initials, and "lymph node near fissure".  The specimen consists of a 0.6 x 0.3 x 0.3 cm anthracotic lymph node that is totally submitted in cassette 4A.\.br\\.br\Part 5 is received unfixed for intraoperative consultation, labeled with the patient's name, initials, and "right upper lobe".  The specimen consists of a 200 gram lobectomy specimen of lung, 13.5 x 10.0 x 2.5 cm. In the mid portion of the specimen there is puckering of the pleural surface.  Serial sectioning of the lung demonstrates a 5.1 x 3.0 x 2.7 cm pleural base lesion that is firm, tan and poorly circumscribed.  This lesion extends to and surrounds adjacent airways at the hilum of the lobectomy specimen.  The lesion is highly suspicious for pleural invasion.  There is also possible invasion in adjacent lymph nodes.  There is no obvious invasion of the segmental bronchi.  No other masses or nodules occur within the lung parenchyma.  The remaining lung parenchyma shows changes of centra-acinar emphysema.  Representative sections are submitted as follows:\.br\5A  bronchial margin \.br\5B  vascular margin \.br\5C  5D  hilar lymph node \.br\5E  5F  area suspicious for pleural invasion\.br\5G  hilar lymph node \.br\5H  airway with surrounding tumor \.br\5I  N1 lymph node \.br\5J  tumor in transition to normal parenchyma\.br\5K representative section of tumor \.br\5L  lymph node \.br\5M  emphysematous non-neoplastic lung.\.br\||||||F
OBX|32|TX|MDT|tpmc9187183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Maximum dimension:  5.1 cm\.br\     Minor dimension: 2.7 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 0\.br\TUMOR TYPE:      Invasive adenocarcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES:      Number of microscopic satellite lesions: 0\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Mild\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 2\.br\     Number of N1 lymph nodes examined: 20\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 2\.br\UNDERLYING DISEASE(S):      Emphysema, Parenchymal scar\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pMX\.br\ANCILLARY STUDIES:      Histochemical stains, FISH studies, Molecular studies\.br\--------------------------------------------------------\.br\Mucicarmine, PAS with diastase and PAS are negative.  Elastic stain highlights intact visceral pleura.\.br\Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|33|TX|FIN|tpmc9187183|Summary Statement\.br\The right upper lobe demonstrates a 5.1 cm invasive moderately differentiated adenocarcinoma arising in a scar.  There is no evidence of visceral pleural invasion.  Metastatic adenocarcinoma is present in two (2) N1 lymph nodes.  Surgical resection margins are free of tumor.  Pathologic stage is ypT2N1MxR2.\.br\\.br\PART 1: BONE, RIGHT 6TH RIB, RESECTION \.br\PENDING DECALCIFICATION.  ADDENDUM REPORT TO FOLLOW.\.br\\.br\PART 2: LYMPH NODE, PERICARDIAL FAT PAD, BIOPSY \.br\ONE (1) LYMPH NODE WITH ANTHRACOTIC PIGMENT.\.br\\.br\PART 3: LYMPH NODE, LEVEL 11, BIOPSY \.br\EIGHT (8) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT.\.br\\.br\PART 4: LYMPH NODE, NEAR FISSURE, BIOPSY \.br\ONE (1) LYMPH NODE WITH ANTHRACOTIC PIGMENT.\.br\\.br\PART 5: LUNG, RIGHT UPPER LOBE, LOBECTOMY \.br\A.INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA (5.1 CM IN DIAMETER) ARISING IN A SCAR.  NO EVIDENCE OF VISCERAL PLEURAL INVASION.  MILD LYMPHOCYTIC HOST RESPONSE.  METASTATIC ADENOCARCINOMA PRESENT IN TWO (2) OF NINE (9) FRAGMENTS OF N1 LYMPH NODES.  PATHOLOGIC STAGE:  T2N1MX.\.br\B.THE SURGICAL RESECTION MARGINS ARE FREE OF TUMOR.\.br\C.BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE.\.br\||||||F
OBX|34|CE|IMP|tpmc9187183|M09400^^SNO||||||||1||A
OBX|35|CE|IMP|tpmc9187183|M49060^^SNO||||||||1||A
OBX|36|CE|IMP|tpmc9187183|M814032^^SNO||||||||1||A
OBX|37|CE|IMP|tpmc9187183|T08000^^SNO||||||||1||A
OBX|38|CE|IMP|tpmc9187183|P1100^^SNO||||||||1||A
OBX|39|CE|IMP|tpmc9187183|T10350^^SNO||||||||1||A
OBX|40|CE|IMP|tpmc9187183|P1140^^SNO||||||||1||A
OBX|41|CE|IMP|tpmc9187183|T08000^^SNO||||||||1||A
OBX|42|CE|IMP|tpmc9187183|T31040^^SNO||||||||1||A
OBX|43|CE|IMP|tpmc9187183|P1140^^SNO||||||||1||A
OBX|44|CE|IMP|tpmc9187183|T08000^^SNO||||||||1||A
OBX|45|CE|IMP|tpmc9187183|M46360^^SNO||||||||1||A
OBX|46|CE|IMP|tpmc9187183|P1140^^SNO||||||||1||A
OBX|47|CE|IMP|tpmc9187183|T08000^^SNO||||||||1||A
OBX|48|CE|IMP|tpmc9187183|M09400^^SNO||||||||1||A
OBX|49|CE|IMP|tpmc9187183|M49060^^SNO||||||||1||A
OBX|50|CE|IMP|tpmc9187183|M814032^^SNO||||||||1||A
OBX|51|CE|IMP|tpmc9187183|P1100^^SNO||||||||1||A
OBX|52|CE|IMP|tpmc9187183|T08000^^SNO||||||||1||A
OBX|53|CE|IMP|tpmc9187183|T28200^^SNO||||||||1||A
OBX|54|CE|IMP|tpmc9187183|M32800^^SNO||||||||1||A
OBX|55|CE|IMP|tpmc9187183|T28000^^SNO||||||||1||A
OBX|56|CE|IMP|tpmc9187183|V42.1^^ICD||||||||1
OBR|2||tpmc9187183^CoPathPlus^tpmc9187183.P1|MICGEN^Microdissection Genotyping||||||||||200512211314|||||||1|200512211314||SP|F|||||||002065^DACIC^SANJA|002065^DACIC^SANJA
OBX|1|TX|PIN|tpmc9187183|Molecular Anatomic Pathology testing:  \.br\A.KRAS Exon 1 mutation not identified. \.br\B.EGFR Exon 19 mutation not identified. \.br\C.EGFR Exon 21 mutation not identified. \.br\\.br\Note:  \.br\EGFR mutations are present in up to 40% of lung cancers overall and are not thought to occur in high prevalence in other types of tumors (3,4,7).  KRAS mutations are also found in approximately 30% lung carcinomas, but not in combination with EGFR mutations, which implies different pathogenic mechanisms (2,3).  The presence of these mutations may have prognostic and or therapeutic implications (1,5,6).\.br\||||||F
OBX|2|TX|PRC|tpmc9187183|Sample Preparation\.br\For cytology samples, extraction of DNA was performed from the fluid or sample provided.  For surgical specimens, microdissection was performed to include neoplastic tissue and normal adjacent tissue.  Optical density readings were obtained.   \.br\\.br\Gene Sequencing\.br\PCR was performed using primers that flank exon 1 in the KRAS gene and exon 19 and 21 of the EGFR gene.  Analysis of the PCR products was first performed for the EGFR 19 to detect aberrant length PCR product.  A sequencing analysis, using the BigDye Terminator Kit (Applied Biosystems, Inc.) was then performed. The known hotspots were analyzed for the presence of mutations.  Both forward and the reverse sequencing was performed.  \.br\\.br\\.br\1.Grossi F, Loprevite M, Chiaramondia M et al. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. European Journal of Cancer. 2003;39:1242-50.\.br\2.Kim DH, Kim JS, Park JH et al. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer. Cancer Research. 2003;63:6206-11.\.br\3.Kosaka T, Yatabe Y, Endoh H et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Research. 2004;64:8919-23.\.br\4.Lee JW, Soung YH, Kim SY et al. Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. International Journal of Cancer. 2005;113:510-1.\.br\5.Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.[see comment]. New England Journal of Medicine. 2004;350:2129-39.\.br\6.Paez JG, Janne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.[see comment]. Science. 2004;304:1497-500.\.br\7.Pao W, Miller V, Zakowski M et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:13306-11.\.br\||||||F
OBR|3||tpmc9187183^CoPathPlus^tpmc9187183.P2|MICGEN2^Microdissection Genotyping #2||||||||||200601101320|||||||2|200601101320||SP|F|||||||002065^DACIC^SANJA|002065^DACIC^SANJA
OBX|1|TX|PIN|tpmc9187183|This is interpretation text for second Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for second Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for second Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for second Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for second Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for second Microdissection Genotyping procedure on this test specimen ------\.br\||||||F
OBX|2|TX|PRC|tpmc9187183|This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------ This is results text for second Microdissection Genotyping procedure on this test specimen ------\.br\||||||F
OBR|4||tpmc9187183^CoPathPlus^tpmc9187183.P3|MICGEN3^Microdissection Genotyping #3||||||||||200601101324|||||||3|200601101324||SP|F|||||||002065^DACIC^SANJA|002065^DACIC^SANJA
OBX|1|TX|PIN|tpmc9187183|This is interpretation text for third Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for third Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for third Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for third Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for third Microdissection Genotyping procedure on this test specimen ------ This is interpretation text for third Microdissection Genotyping procedure on this test specimen ------\.br\||||||F
OBX|2|TX|PRC|tpmc9187183|This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------ This is results text for third Microdissection Genotyping procedure on this test specimen ------\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004456|P|2.3
PID|1||000222222^^^CHPADT|tpmc6670494|TESTVTWOFIVE^CH TWO||19940405|F||W|||||||||123-22-3232|||||||||||N
PV1|1||CHSDSH||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|CHS|1023232323|||||||||||||||||||||||||200511210753
ORC|RE||CHS05-50^CoPathPlus||CM||||200512201035|z40^KOKAL^ELLEN||505079^PLANET^PLUTO
OBR|1||CHS05-50^CoPathPlus^tpmc2277183|^CHP Histology|||200512200000|||||||200512201034||505079||||^11^Y|-1|200601040856||SP|F|||||||C006429^JAFFE^RONALD|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tpmc2277183.1|^Consult block^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc2277183.1.1|A||||||||1^A|200512291149
OBX|3|CE|PROCESS|tpmc2277183.1.1.1|pmc3354^PAS (CHP)^L||||||||1^PAS|200601131530
OBX|4|CE|PROCESS|tpmc2277183.1.1.2|pmc1433^Grocott Stain (Histo)^L||||||||2^Grocott|200601131530
OBX|5|CE|PROCESS|tpmc2277183.1.1.3|pmc5733^Adenovirus Probe (PHIS)^L||||||||3^Adeno probe|200601131530
OBX|6|TX|GDT|tpmc2277183|Received are 5 slides labeled S05-1200 from Childrens Hospital Seattle and identifying surgical pathology reports.  The slides are returned.\.br\||||||F
OBX|7|TX|FIN|tpmc2277183|\.br\Consult from Childrens Hospital\.br\\.br\Rectum, suction biopsy at 1cm (#1):  HIRSCHSPRUNG' S DISEASE.\.br\\.br\Rectum, suction biopsy at 2cm (#2):  HIRSCHSPRUNG' S DISEASE.\.br\\.br\Rectum, suction biopsy at 3cm (#3):  HIRSCHSPRUNG' S DISEASE.\.br\\.br\My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation.\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004457|P|2.3
PID|1||001023456^^^CHPADT|tpmc5262005|TESTVTWOFIVE^CH THREE||19900901|M||LR1|||||||||300-25-5319|||||||||||N
PV1|1||CHSDSS||||C020115^CLAVELL^MARIA||||||||||pmc39142^CLAVELL^MARIA|CHV|3002353195|||||||||||||||||||||||||200512090956
ORC|RE||CHS05-51^CoPathPlus||CM||||200512231033|z40^KOKAL^ELLEN||C020115^CLAVELL^MARIA
OBR|1||CHS05-51^CoPathPlus^tpmc6677183|^CHP Histology|||200512230000|||||||200512231031|CCNTS|C020115||||^15^Y|-1|200601040927||SP|F|||||||031969^GALAMBOS^CSABA|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tpmc6677183.1|CCNTS^Rectal biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc6677183.1.1|A||||||||1^A|200512231031
OBX|3|CE|PROCESS|tpmc6677183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200601131529
OBX|4|CE|PROCESS|tpmc6677183.1.1.2|pmc9354^Acetylcholinesterase (CHP)^L||||||||2^AChE|200601131530
OBX|5|CE|PROCESS|tpmc6677183.1.1.3|pmc0454^Acetylcholinesterase (CHP) WLO^L||||||||3^AChE|200601131530
OBX|6|TX|GDT|tpmc6677183|The specimen is received frozen in OCT, labeled with the patient's name and outside accession number S05-2910, and is designated "rectal biopsy."  The specimen is thawed in RPMI media, and to determine adequacy the specimen is viewed under the dissecting microscope.  It consists of an irregular piece of pink-tan and glistening mucosa, which measures 0.3 cm in diameter.  The adequate biopsy shows abundant pale white and fluffy submucosal tissue and an overlying mucosal layer.  The biopsy is divided and entirely frozen in OCT for acetylcholinesterase staining, labeled 1A.\.br\||||||F
OBX|7|TX|MDT|tpmc6677183|The specimen consists of four pieces of rectal mucosa; all showing similar histologic features.  There is a dense lymphocytic infiltrate throughout the lamina propria with scattered neutrophils.  Crypts are disrupted and contain neutrophils within the crypt epithelium.  Crypt abscesses are identified.  The surface epithelium shows marked reactive change and ulceration.  Large reactive endothelial cells are present.  No granulomas are present.   No organisms or viral inclusions are identified.  \.br\||||||F
OBX|8|TX|FIN|tpmc6677183|Rectal biopsy:  MILD ACTIVE COLITIS AND LYMPHOID HYPERPLASIA (SEE NOTE).\.br\||||||F
OBX|9|CE|IMP|tpmc6677183|M40005^^SNO||||||||1||A
OBX|10|CE|IMP|tpmc6677183|M72200^^SNO||||||||1||A
OBX|11|CE|IMP|tpmc6677183|P1140^^SNO||||||||1||A
OBX|12|CE|IMP|tpmc6677183|T68000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004460|P|2.3
PID|1||560000000^^^SYSPATH|tst5005394|Patient^56||19350508|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|5600000000000|||||||||||||||||||||||||200504061108
ORC|RE||PHS05-56^CoPathPlus||CM||||200504061425|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-56^CoPathPlus^tst8866183|PHSP^PH Surgical Pathology|||200504061425|||||||200504061425|PNB|999002814||||^69^Y|-1|200505101622||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst8866183.1|PNB^Left prostate needle core biopsy^L||||||F||1^1
OBX|2|CE|ANT|tst8866183.2|PNB^Right porstate needle core biopsy^L||||||F||2^2
OBX|3|ST|BLOCK|tst8866183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst8866183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst8866183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041146
OBX|6|CE|PROCESS|tst8866183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041146
OBX|7|CE|PROCESS|tst8866183.1.1.3|pmc3633^Trichrome Stain (Histo)^L||||||||2^Trichrome|200512191038
OBX|8|CE|PROCESS|tst8866183.1.1.4|pmc2233^Acid Fast Stain (Histo)^L||||||||3^AcidFast|200512191038
OBX|9|TX|GDT|tst8866183|The specimen is received in buffered formalin in two parts, each part labeled with the patient's name, initials 3ROR4.\.br\\.br\Part 1 is designated as 3left4.  It consists of five light tan, rubbery, cylindrical core biopsies, each 0.05 cm in diameter and ranging from 0.4 to 2.1 cm in length.  The specimen is totally submitted in cassettes labeled 1A through 1C.\.br\\.br\Part 2 is designated as 3Right4.  It consists of six, light tan, rubbery, cylindrical core biopsies, each 0.05 cm in diameter and ranging in length from 0.3 to 1.7 cm. The specimen is totally submitted in cassettes labeled 2A through 2C. The specimens are stained with Erythrosin.\.br\||||||F
OBX|10|TX|MDT|tst8866183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|11|TX|FIN|tst8866183|1.  LEFT PROSTATE NEEDLE CORE BIOPSY:   BENIGN PROSTATIC PARENCHYMA.  NO EVIDENCE OF MALIGNANCY\.br\2.  RIGHT PROSTATE NEEDLE CORE BIOPSY:  BENIGN PROSTATIC PARENCHYMA.  NO EVIDENCE OF MALIGNANCY \.br\||||||F
OBX|12|CE|IMP|tst8866183|M09450^^SNO||||||||1||A
OBX|13|CE|IMP|tst8866183|P1143^^SNO||||||||1||A
OBX|14|CE|IMP|tst8866183|T77100^^SNO||||||||1||A
OBX|15|CE|IMP|tst8866183|T77230^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004461|P|2.3
PID|1||560000000^^^SYSPATH|tst5005394|Patient^56||19350508|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|5600000000000|||||||||||||||||||||||||200504061108
ORC|RE||PVS05-56^CoPathPlus||CM||||200504071034|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-56^CoPathPlus^tst5276183|PVAP^PV Pathology|||200504071032|||||||200504071032|HPNB|999002814||||^69^Y|-1|200505230832||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst5276183.1|HPNB^Left prostate needle core biopsy^L||||||F||1^1
OBX|2|CE|ANT|tst5276183.2|HPNB^Right porstate needle core biopsy^L||||||F||2^2
OBX|3|ST|BLOCK|tst5276183.1.1|A||||||||1^A|200510251135
OBX|4|ST|BLOCK|tst5276183.2.2|A||||||||1^A|200510251135
OBX|5|CE|PROCESS|tst5276183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200504121014
OBX|6|CE|PROCESS|tst5276183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200504121014
OBX|7|CE|PROCESS|tst5276183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200504121014
OBX|8|CE|PROCESS|tst5276183.2.2.4|$hinit^Initial H&E^L||||||||1^H&E L1|200504121014
OBX|9|CE|PROCESS|tst5276183.2.2.5|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200504121014
OBX|10|CE|PROCESS|tst5276183.2.2.6|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200504121014
OBX|11|TX|GDT|tst5276183|The specimen is received in buffered formalin in two parts, each part labeled with the patient's name, initials 3ROR4.\.br\\.br\Part 1 is designated as 3left4.  It consists of five light tan, rubbery, cylindrical core biopsies, each 0.05 cm in diameter and ranging from 0.4 to 2.1 cm in length.  The specimen is totally submitted in cassettes labeled 1A through 1C.\.br\\.br\Part 2 is designated as 3Right4.  It consists of six, light tan, rubbery, cylindrical core biopsies, each 0.05 cm in diameter and ranging in length from 0.3 to 1.7 cm. The specimen is totally submitted in cassettes labeled 2A through 2C. The specimens are stained with Erythrosin.\.br\||||||F
OBX|12|TX|MDT|tst5276183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|13|TX|FIN|tst5276183|PART 1: \.br\PROSTATE, LEFT, BIOPSY\.br\A.          FOCAL HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN).\.br\     \.br\PART 2: \.br\PROSTATE, RIGHT, BIOPSY\.br\A.           FOCAL HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN).\.br\     \.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004462|P|2.3
PID|1||570000000^^^SYSPATH|tst7005394|Patient^57||19150130|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|5700000000000|||||||||||||||||||||||||200504061115
ORC|RE||PVS05-57^CoPathPlus||CM||||200504071039|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-57^CoPathPlus^tst6276183|PVAP^PV Pathology|||200504071037|||||||200504071037|PROSTUR|999002814||||^90^Y|-1|200505131547||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst6276183.1|PROSTUR^right prostate trus bx^L||||||F||1^1
OBX|2|CE|ANT|tst6276183.2|PROSTUR^left prostate trus bx^L||||||F||2^2
OBX|3|ST|BLOCK|tst6276183.1.1|A||||||||1^A|200510251135
OBX|4|ST|BLOCK|tst6276183.1.2|B||||||||2^B|200510251135
OBX|5|ST|BLOCK|tst6276183.1.3|C||||||||3^C|200510251135
OBX|6|ST|BLOCK|tst6276183.1.4|D||||||||4^D|200510251135
OBX|7|ST|BLOCK|tst6276183.2.5|A||||||||1^A|200510251135
OBX|8|ST|BLOCK|tst6276183.2.6|B||||||||2^B|200510251135
OBX|9|ST|BLOCK|tst6276183.2.7|C||||||||3^C|200510251135
OBX|10|ST|BLOCK|tst6276183.2.8|D||||||||4^D|200510251135
OBX|11|CE|PROCESS|tst6276183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|12|CE|PROCESS|tst6276183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|13|CE|PROCESS|tst6276183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|14|CE|PROCESS|tst6276183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|15|CE|PROCESS|tst6276183.2.5.5|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|16|CE|PROCESS|tst6276183.2.6.6|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|17|CE|PROCESS|tst6276183.2.7.7|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|18|CE|PROCESS|tst6276183.2.8.8|$hinit^Initial H&E^L||||||||1^H&E|200504121014
OBX|19|TX|GDT|tst6276183|The specimen is received in formalin in two parts.\.br\\.br\Part 1 is labeled with "right prostate biopsy" and it consists of five cores of white-tan needle biopsy specimen, measuring less than 0.1 cm. in diameter and up to 2.5 cm. in length.  The specimen is entirely submitted as: 1A three cores, 1B two cores.\.br\\.br\Part 2 is labeled with "left prostate biopsy" and it consists of six white-tan soft needle biopsy specimens, measuring less than 0.1 cm. in diameter and 1.8 cm. to 2.5 cm. in length.  The specimen is entirely submitted as follows: 2A three cores, 2B three cores.\.br\||||||F
OBX|20|TX|FIN|tst6276183|PART 1: PROSTATE TISSUE, RIGHT, NEEDLE BIOPSY-\.br\     A.  PROSTATIC ADENOCARCINOMA, GLEASON SCORE 4+3=7, INVOLVING 1 OF 5 CORES AND \.br\          APPROXIMATELY 40% OF THE TISSUE.\.br\     B. PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3+3=6, INVOLVING AN ADDITIONAL 2 OF 5 CORES AND \.br\          APPROXIMATELY 30% OF THE TISSUE\.br\     B.  TOTAL LINEAR EXTENT IS 1.0 CM  (DISCONTINUOUSLY).\.br\     C. NO PERINEURAL INVASION IS IDENTIFIED\.br\\.br\PART 2: PROSTATE TISSUE LEF, NEEDLE BIOPSY-\.br\     A. PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3+3=6, INVOLVING 1 OF 6 CORES AND \.br\          APPROXIMATELY 20% OF THE CORE.\.br\     B. SEPARATE SMALL FOCUS OF ATYPICAL GLANDS.\.br\     B. TOTAL LINEAR EXTENT IS 0.5 CM\.br\     C. NO PERINEURAL INVASION IS IDENTIFIED\.br\\.br\\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004464|P|2.3
PID|1||570000000^^^SYSPATH|tst7005394|Patient^57||19150130|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|5700000000000|||||||||||||||||||||||||200504061115
ORC|RE||PHS05-57^CoPathPlus||CM||||200504061428|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-57^CoPathPlus^tst9866183|PHSP^PH Surgical Pathology|||200504061428|||||||200504061428|PNB|999002814||||^90^Y|-1|200506131626||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst9866183.1|PNB^right prostate trus bx^L||||||F||1^1
OBX|2|CE|ANT|tst9866183.2|PNB^left prostate trus bx^L||||||F||2^2
OBX|3|ST|BLOCK|tst9866183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst9866183.1.2|B||||||||2^B|200507221753
OBX|5|ST|BLOCK|tst9866183.1.3|C||||||||3^C|200507221753
OBX|6|ST|BLOCK|tst9866183.1.4|D||||||||4^D|200507221753
OBX|7|ST|BLOCK|tst9866183.2.5|A||||||||1^A|200507221753
OBX|8|ST|BLOCK|tst9866183.2.6|B||||||||2^B|200507221753
OBX|9|ST|BLOCK|tst9866183.2.7|C||||||||3^C|200507221753
OBX|10|ST|BLOCK|tst9866183.2.8|D||||||||4^D|200507221753
OBX|11|CE|PROCESS|tst9866183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041147
OBX|12|CE|PROCESS|tst9866183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041147
OBX|13|CE|PROCESS|tst9866183.1.3.3|$hinit^Initial H&E^L||||||||4^H&E|200505041147
OBX|14|CE|PROCESS|tst9866183.1.4.4|$hinit^Initial H&E^L||||||||4^H&E|200505041147
OBX|15|CE|PROCESS|tst9866183.2.5.5|$hinit^Initial H&E^L||||||||1^H&E|200505041147
OBX|16|CE|PROCESS|tst9866183.2.6.6|$hinit^Initial H&E^L||||||||1^H&E|200505041147
OBX|17|CE|PROCESS|tst9866183.2.7.7|$hinit^Initial H&E^L||||||||4^H&E|200505041147
OBX|18|CE|PROCESS|tst9866183.2.8.8|$hinit^Initial H&E^L||||||||4^H&E|200505041147
OBX|19|CE|PROCESS|tst9866183.1.2.9|pmc8923^34BE12 (CK 1 2 10 14/15 5) (IPEX)^L||||||||2^AP903|200506011408
OBX|20|CE|PROCESS|tst9866183.1.2.10|pmc5194^P63 Tumor Suppressor Protein (IPEX)^L||||||||3^P63|200506011408
OBX|21|CE|PROCESS|tst9866183.1.2.11|pmc4905^P504S (IPEX)^L||||||||4^AP504S|200506011408
OBX|22|CE|PROCESS|tst9866183.2.6.12|pmc8923^34BE12 (CK 1 2 10 14/15 5) (IPEX)^L||||||||2^AP903|200506011408
OBX|23|CE|PROCESS|tst9866183.2.6.13|pmc5194^P63 Tumor Suppressor Protein (IPEX)^L||||||||3^P63|200506011408
OBX|24|CE|PROCESS|tst9866183.2.6.14|pmc4905^P504S (IPEX)^L||||||||4^AP504S|200506011408
OBX|25|TX|GDT|tst9866183|The specimen is received in formalin in two parts.\.br\\.br\Part 1 is labeled with "right prostate biopsy" and it consists of five cores of white-tan needle biopsy specimen, measuring less than 0.1 cm. in diameter and up to 2.5 cm. in length.  The specimen is entirely submitted as: 1A three cores, 1B two cores.\.br\\.br\Part 2 is labeled with "left prostate biopsy" and it consists of six white-tan soft needle biopsy specimens, measuring less than 0.1 cm. in diameter and 1.8 cm. to 2.5 cm. in length.  The specimen is entirely submitted as follows: 2A three cores, 2B three cores.\.br\||||||F
OBX|26|TX|FIN|tst9866183|PART 1\.br\LEFT PROSTATE, CORE BIOPSY:\.br\A.      MODERATELY DIFFERENTIATED PROSTATIC ADENOCARCINOMA (GLEASON' S GRADE 3+4=7)\.br\B.     HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA\.br\C.     NO EVIDENCE OF ANGIOLYMPHATIC INVASION\.br\D.     NO EVIDENCE OF PERINEURAL INVASION\.br\\.br\PART 2\.br\RIGHT PROSTATE, BIOPSY: \.br\A.     ATYPICAL GLANDS SUSPICIOUS FOR ADENOCARCINOMA (see comment)\.br\||||||F
OBX|27|CE|IMP|tst9866183|M74000^^SNO||||||||1||A
OBX|28|CE|IMP|tst9866183|M814032^^SNO||||||||1||A
OBX|29|CE|IMP|tst9866183|P1140^^SNO||||||||1||A
OBX|30|CE|IMP|tst9866183|T77230^^SNO||||||||1||A
OBX|31|CE|IMP|tst9866183|M69760^^SNO||||||||1||A
OBX|32|CE|IMP|tst9866183|P1140^^SNO||||||||1||A
OBX|33|CE|IMP|tst9866183|T77220^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004466|P|2.3
PID|1||580000000^^^SYSPATH|tst8005394|Patient^58||19301016|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|5800000000000|||||||||||||||||||||||||200504061122
ORC|RE||PVS05-58^CoPathPlus||CM||||200504071042|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PVS05-58^CoPathPlus^tst7276183|PVAP^PV Pathology|||200504071040|||||||200504071040|HPNB|999002814||||^74^Y|-1|200505171259||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tst7276183.1|HPNB^PROSTATE, CORE NEEDLE BIOPSY (SHY), RT LOBE PROSTATE BX^L||||||F||1^1
OBX|2|CE|ANT|tst7276183.2|HPNB^PROSTATE, CORE NEEDLE BIOPSY (SHY), LT LOBE PROSTATE BX^L||||||F||2^2
OBX|3|ST|BLOCK|tst7276183.1.1|A||||||||1^A|200510251135
OBX|4|ST|BLOCK|tst7276183.2.2|A||||||||1^A|200510251135
OBX|5|CE|PROCESS|tst7276183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200504121014
OBX|6|CE|PROCESS|tst7276183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200504121014
OBX|7|CE|PROCESS|tst7276183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200504121014
OBX|8|CE|PROCESS|tst7276183.2.2.4|$hinit^Initial H&E^L||||||||1^H&E L1|200504121014
OBX|9|CE|PROCESS|tst7276183.2.2.5|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200504121014
OBX|10|CE|PROCESS|tst7276183.2.2.6|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200504121014
OBX|11|TX|GDT|tst7276183|The specimen is submitted in two parts. \.br\\.br\Part 1 is identified by name and designated "#1 prostate biopsy,\.br\right lobe." Received in Bouin's are four yellow-stained soft\.br\tissue cores, 0.1 cm. in diameter and of length ranging from 0.8\.br\to 1.5 cm. The entire specimen is submitted in four cassettes.  \.br\\.br\Part 2 is identified by name and designated "#2 prostate biopsy,\.br\left lobe." Received in Bouin's are four cores of yellow-stained\.br\soft tissue of diameter less than 0.1 cm. and length ranging from\.br\0.6 to 1.3 cm. The entire specimen is submitted in four\.br\cassettes.\.br\||||||F
OBX|12|TX|FIN|tst7276183|PART 1: PROSTATE TISSUE, RIGHT LOBE, NEEDLE BIOPSY-\.br\     A. PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3+3=6, INVOLVING 4 OF 4 CORES (80%, 5%, 30% and 30%).\.br\     B. NO PERINEURAL INVASION IS IDENTIFIED.\.br\\.br\PART 2: PROSTATE TISSUE, LEFT LOBE, NEEDLE BIOPSY-\.br\     A. PROSTATIC ADENOCARCINOMA, GLEASON SCORE 3+3=6, INVOLVING 1 OF 4 CORES (20% of the core).\.br\     B. NO PERINEURAL INVASION IS IDENTIFIED.\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004467|P|2.3
PID|1||580000000^^^SYSPATH|tst8005394|Patient^58||19301016|M||W||||||||||||||||||||N
PV1|1||ILAB||||999002814^JUKIC^DRAZEN||||||||||pmc31062^JUKIC^DRAZEN|SY2|5800000000000|||||||||||||||||||||||||200504061122
ORC|RE||PHS05-58^CoPathPlus||CM||||200504061430|^KISTLER^MICHAEL||999002814^JUKIC^DRAZEN
OBR|1||PHS05-58^CoPathPlus^tst0966183|PHSP^PH Surgical Pathology|||200504061430|||||||200504061430|PNB|999002814||||^74^Y|-1|200505131133||SP|F|||||||^HO^JONHAN|^HO^JONHAN
OBX|1|CE|ANT|tst0966183.1|PNB^PROSTATE, CORE NEEDLE BIOPSY (SHY), RT LOBE PROSTATE BX^L||||||F||1^1
OBX|2|CE|ANT|tst0966183.2|PNB^PROSTATE, CORE NEEDLE BIOPSY (SHY), LT LOBE PROSTATE BX^L||||||F||2^2
OBX|3|ST|BLOCK|tst0966183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst0966183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst0966183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200505041148
OBX|6|CE|PROCESS|tst0966183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200505041148
OBX|7|TX|GDT|tst0966183|The specimen is submitted in two parts. \.br\\.br\Part 1 is identified by name and designated "#1 prostate biopsy,\.br\right lobe." Received in Bouin's are four yellow-stained soft\.br\tissue cores, 0.1 cm. in diameter and of length ranging from 0.8\.br\to 1.5 cm. The entire specimen is submitted in four cassettes.  \.br\\.br\Part 2 is identified by name and designated "#2 prostate biopsy,\.br\left lobe." Received in Bouin's are four cores of yellow-stained\.br\soft tissue of diameter less than 0.1 cm. and length ranging from\.br\0.6 to 1.3 cm. The entire specimen is submitted in four\.br\cassettes.  \.br\||||||F
OBX|8|TX|FIN|tst0966183|1.  PROSTATE, CORE NEEDLE BIOPSY (SHY), RT LOBE PROSTATE BX:  \.br\     A.     MODERATELY DIFFERENTIATED  PROSTATIC ADENOCARCINOMA, GLEASON' S GRADE 3+3=6 INVOLVING 40% OF 4 CORES\.br\     B.     ANGIOLYMPHATIC INVASION IS NOT IDENTIFIED\.br\C.      PERNINEURAL INVASION IS NOT IDENTIFIED\.br\     \.br\2.          PROSTATE, CORE NEEDLE BIOPSY (SHY), LT LOBE PROSTATE BX:\.br\     A.     MODERATELY DIFFERENTIATED  PROSTATIC ADENOCARCINOMA, GLEASON' S GRADE 3+3=6 INVOLVING 10% OF 1 OF 4 CORES\.br\B.     ANGIOLYMPHATIC INVASION IS NOT IDENTIFIED\.br\     C.      PERNINEURAL INVASION IS NOT IDENTIFIED\.br\     \.br\        \.br\||||||F
OBX|9|CE|IMP|tst0966183|M814032^^SNO||||||||1||A
OBX|10|CE|IMP|tst0966183|P1140^^SNO||||||||1||A
OBX|11|CE|IMP|tst0966183|P1143^^SNO||||||||1||A
OBX|12|CE|IMP|tst0966183|T77100^^SNO||||||||1||A
OBX|13|CE|IMP|tst0966183|T77220^^SNO||||||||1||A
OBX|14|CE|IMP|tst0966183|M814032^^SNO||||||||1||A
OBX|15|CE|IMP|tst0966183|P1140^^SNO||||||||1||A
OBX|16|CE|IMP|tst0966183|P1143^^SNO||||||||1||A
OBX|17|CE|IMP|tst0966183|T77100^^SNO||||||||1||A
OBX|18|CE|IMP|tst0966183|T77230^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004468|P|2.3
PID|1||999999998|tst8046394|MOUSE^MORTIMER^M||19300415|M|||||||||||999-99-9998|||||||||||N
PV1|1||RSDY||||999002231^PARK^ANDREW||||||||||pmc30122^PARK^ANDREW|SY2|0002999999998|||||||||||||||||||||||||200504260847
ORC|RE||PHS05-59^CoPathPlus||CM||||200504260900|^LASSIGE^KAREN||999002231^PARK^ANDREW
OBR|1||PHS05-59^CoPathPlus^tst0386183|PHSP^PH Surgical Pathology|||200504260858|||||||200504260858|CLNH|999002231||||^75^Y|-1|200511031150||SP|C|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst0386183.1|CLNH^Lymph Node for Cytogenetics^L||||||C||1^1
OBX|2|CE|ANT|tst0386183.2|LNTX^Lymph Node, Biopsy or Excision, Transplant^L||||||C||2^2
OBX|3|ST|BLOCK|tst0386183.2.1|A||||||||1^A|200507221753
OBX|4|CE|PROCESS|tst0386183.2.1.1|$hinit^Initial H&E^L||||||||1^H&E|200504261212
OBX|5|CE|PROCESS|tst0386183.2.1.2|pmc9033^S100 (IPEX)^L||||||||2^S100|200504261212
OBX|6|CE|PROCESS|tst0386183.2.1.3|pmc7523^HMB45 Melanoma (IPEX)^L||||||||3^HMB45|200504261212
OBX|7|CE|PROCESS|tst0386183.2.1.4|pmc0674^Melan A/Melanoma (IPEX)^L||||||||4^Melan A|200504261212
OBX|8|CE|PROCESS|tst0386183.2.1.5|pmc0105^Tyrosinase^L||||||||5^ATYROS|200504261212
OBX|9|CE|PROCESS|tst0386183.2.1.6|pmc5973^KI67 Proliferating Cells (IPEX)^L||||||||6^KI67|200504261212
OBX|10|CE|PROCESS|tst0386183.2.1.7|pmc4283^Immuno Blanks Recut (IPEX)^L||||||||7^ABNKNC|200504261212
OBX|11|CE|PROCESS|tst0386183.2.1.8|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||8^H&E Recut|200504261212
OBX|12|CE|PROCESS|tst0386183.2.1.9|pmc7533^Reticulin Stain (Histo)^L||||||||9^Retic|200504261212
OBX|13|TX|GDT|tst0386183|Received fresh labeled Mortimer Mouse Lymph Node is a 1.25 x 2 x 2 cm  lymph node.    Touch preparations are performed including some sent to the DNA cytometry laboratory.  Material is snap frozen ( 1 block), sent for cell suspension immunophenotypic studies and sent to the Molecular Diagnostics and the DNA Cytometry Laboratory with an adjacent section submitted in formalin fixative labeled A(CMB/DNA).  Additional material is sent for Cytogenetic studies.  (The frozen section is submitted after formalin fixation in cassette A FS.)  \.br\||||||C
OBX|14|TX|FIN|tst0386183|DIAGNOSIS:  Malignant B-cell lymphoma \.br\\.br\SPECIMEN: Lymph Node\.br\\.br\PATHOLOGY: \.br\\.br\SURGICAL PATHOLOGY DIAGNOSIS:\.br\\.br\TESTS:    Immunoglobulin heavy chain rearrangement\.br\\.br\          T-cell receptor beat-chain gene rearrangement\.br\          Bcl-2 gene rearrangement\.br\          DNA purification\.br\\.br\RESULTS:  The heavy chain gene shows _2__ bands of gene\.br\rearrangement.  The T-cell beta chain gene is germline.  The Bcl-\.br\2 gene rearranged at the ___32.1__________ locus.\.br\\.br\COMMENTS:  The lesion probably contains a single clone of\.br\neoplastic B-cells.\.br\||||||C
OBX|15|CE|IMP|tst0386183|MYY933^^SNO||||||||1||A
OBX|16|CE|IMP|tst0386183|T08000^^SNO||||||||1||A
OBX|17|CE|IMP|tst0386183|F47500^^SNO||||||||1||A
OBX|18|CE|IMP|tst0386183|M80001^^SNO||||||||1||A
OBX|19|CE|IMP|tst0386183|196.3^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004469|P|2.3
PID|1||724746906^^^CITIZN|tst0766394|DUCK^HUEY||19550515|M|||||||||||724-74-6906|||||||||||N
PV1|1||PATHOS||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0001724746906|||||||||||||||||||||||||200504261325
ORC|RE||PHS05-60^CoPathPlus||CM||||200504261337|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||PHS05-60^CoPathPlus^tst2386183|PHSP^PH Surgical Pathology|||200504261332|||||||200504261332|ROLYM|505073||||^49^Y|-1|200505191408||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2386183.1|ROLYM^Lymph Node^L||||||F||1^1
OBX|2|CE|ANT|tst2386183.2|LNBS^Lymph Node, Biopsy or Excision, B/S^L||||||F||2^2
OBX|3|ST|BLOCK|tst2386183.1.1|ACMB/DNA||||||||1^ACMB/DNA|200507221753
OBX|4|ST|BLOCK|tst2386183.1.2|BB5||||||||2^BB5|200507221753
OBX|5|ST|BLOCK|tst2386183.1.3|C||||||||3^C|200507221753
OBX|6|ST|BLOCK|tst2386183.2.4|A||||||||1^A|200507221753
OBX|7|CE|PROCESS|tst2386183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|8|CE|PROCESS|tst2386183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200508180859
OBX|9|CE|PROCESS|tst2386183.1.2.3|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|10|CE|PROCESS|tst2386183.1.3.4|$hinit^Initial H&E^L||||||||3^H&E|200508180859
OBX|11|CE|PROCESS|tst2386183.1.3.5|pmc0753^Touch Preparation (Surg)^L||||||||4|200504261332
OBX|12|CE|PROCESS|tst2386183.1.3.6|pmc4653^Tissue Banked OCT Frozen (Surg)^L||||||||5|200504261332
OBX|13|CE|PROCESS|tst2386183.1.3.7|pmc6553^CMB Tissue Prep (PHSP)^L||||||||6|200504261332
OBX|14|CE|PROCESS|tst2386183.1.3.8|pmc1273^DNA Tissue Frozen (Surg)^L||||||||7^DNAFR|200504261332
OBX|15|CE|PROCESS|tst2386183.1.3.9|pmc0534^Flow Cyto Tissue Prep (Surg)^L||||||||8^FLOWCY|200504261332
OBX|16|CE|PROCESS|tst2386183.1.2.10|pmc9453^B5 Fixation (Surg)^L||||||||3^B5|200504261332
OBX|17|TX|GDT|tst2386183|The specimen is received fresh I two parts labeled with the patient' s name, initials BK.  Part 1 was labeled right axillary nodule.  Part 2 was labeled inguinal node biopsy.\.br\\.br\Part 1 consisted of a rubbery 2.0 x 1.4 x 1.2 cm gray-white tissue.  The tissue is divided into three sections and submitted in cassettes:\.br\ACMB/DNA\.br\BB5\.br\C\.br\\.br\Part 2 consisted of a biopsy 0.4 x 04. x 0.2 cm.  Part is submitted in cassette A.\.br\||||||F
OBX|18|TX|MDT|tst2386183|Agrees with the above diagnosis\.br\||||||F
OBX|19|TX|FIN|tst2386183|SOME DIAGNOSIS\.br\||||||F
OBX|20|CE|IMP|tst2386183|202.80^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004471|P|2.3
PID|1||111222333^^^WASH|tst6796394|JAMES^JESSIE||19540706|F|||||||||||111-22-2333|||||||||||N
PV1|1||PATHOS||||099973^PATHOLOGY^OUTSIDE||||||||||pmc1622^PATHOLOGY^OUTSIDE|OSD|0001111222333|||||||||||||||||||||||||200504270842
ORC|RE||PHS05-63^CoPathPlus||CM||||200504270851|^LASSIGE^KAREN||099973^PATHOLOGY^OUTSIDE
OBR|1||PHS05-63^CoPathPlus^tst5486183|PHSP^PH Surgical Pathology|||200504270846|||||||200504270846|LNBS|099973||||^50^Y|-1|200505191446||SP|C|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst5486183.1|LNBS^Lymph Node, Biopsy or Excision, AXILLARY^L||||||C||1^1
OBX|2|CE|ANT|tst5486183.2|LNBS^Lymph Node, Biopsy or Excision, INGUINAL^L||||||C||2^2
OBX|3|CE|ANT|tst5486183.3|LNTH^Lymph Node, Biopsy or Excision, Thoracic^L||||||C||3^3
OBX|4|ST|BLOCK|tst5486183.1.1|AFS||||||||1^AFS|200507221753
OBX|5|ST|BLOCK|tst5486183.1.2|BFS||||||||2^BFS|200507221753
OBX|6|ST|BLOCK|tst5486183.2.3|AFS||||||||1^AFS|200507221753
OBX|7|ST|BLOCK|tst5486183.2.4|BFS||||||||2^BFS|200507221753
OBX|8|ST|BLOCK|tst5486183.3.5|ACMB/DNA||||||||1^ACMB/DNA|200507221753
OBX|9|ST|BLOCK|tst5486183.3.6|BB5||||||||2^BB5|200507221753
OBX|10|ST|BLOCK|tst5486183.3.7|C||||||||3^C|200507221753
OBX|11|CE|PROCESS|tst5486183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|12|CE|PROCESS|tst5486183.1.1.2|pmc7764^Frozen Sect Single Block (Surg)^L||||||||2^FRZ Single|200508180859
OBX|13|CE|PROCESS|tst5486183.1.2.3|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|14|CE|PROCESS|tst5486183.1.2.4|pmc9764^Frozen Sect Add'l Block (Surg)^L||||||||3^FRZ Addit|200508180859
OBX|15|CE|PROCESS|tst5486183.2.3.5|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|16|CE|PROCESS|tst5486183.2.3.6|pmc7764^Frozen Sect Single Block (Surg)^L||||||||2^FRZ Single|200508180859
OBX|17|CE|PROCESS|tst5486183.2.4.7|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|18|CE|PROCESS|tst5486183.2.4.8|pmc9764^Frozen Sect Add'l Block (Surg)^L||||||||3^FRZ Addit|200508180859
OBX|19|CE|PROCESS|tst5486183.3.5.9|$hinit^Initial H&E^L||||||||5^H&E|200508180859
OBX|20|CE|PROCESS|tst5486183.3.5.10|pmc5553^HH&E (HISTO)^L||||||||6^HHE|200508180859
OBX|21|CE|PROCESS|tst5486183.3.6.11|$hinit^Initial H&E^L||||||||6^H&E|200508180859
OBX|22|CE|PROCESS|tst5486183.3.7.12|$hinit^Initial H&E^L||||||||7^H&E|200508180859
OBX|23|CE|PROCESS|tst5486183.3.0.13|pmc0753^Touch Preparation (Surg)^L||||||||1|200504270910
OBX|24|CE|PROCESS|tst5486183.3.0.14|pmc4653^Tissue Banked OCT Frozen (Surg)^L||||||||2|200504270910
OBX|25|CE|PROCESS|tst5486183.3.0.15|pmc6553^CMB Tissue Prep (PHSP)^L||||||||3|200504270910
OBX|26|CE|PROCESS|tst5486183.3.0.16|pmc1273^DNA Tissue Frozen (Surg)^L||||||||4^DNAFR|200504270910
OBX|27|CE|PROCESS|tst5486183.3.0.17|pmc0534^Flow Cyto Tissue Prep (Surg)^L||||||||5^FLOWCY|200504270910
OBX|28|CE|PROCESS|tst5486183.3.6.18|pmc9453^B5 Fixation (Surg)^L||||||||7^B5|200504270910
OBX|29|TX|GDT|tst5486183|The specimen is received in three parts.\.br\\.br\Part 1 is received fresh with patient' s name, initials PA, and labeled "axillary nodule".  It consists of a single, soft, lymph node, 1.0 x 1.5 x 2.0 cm.  The node was bisected and submitted following frozen section evaluation labeled 1A and 1B.\.br\\.br\Part 2 is received fresh with patient' s name, initials PA, and labeled "axillary nodule".  It consists of a single, soft, lymph node, 1.0 x 1.0 x 2.0 cm.  The node was bisected and submitted following frozen section evaluation labeled 2A and 2B.\.br\\.br\Part 3 is received fresh with patient' s name, initials PA, and labeled "axillary nodule".  It consists of a single, soft, lymph node, 1.1 x 1.2 x 2.3 cm.  The node was dissected and following submission for special procedures labeled 3ACNB/DNA and 3BB5 and 3C.\.br\\.br\||||||C
OBX|30|TX|FIN|tst5486183|Part 1\.br\No evidence of carcinoma.\.br\Part 2\.br\No evidence of carcinoma.\.br\Part 3\.br\No evidence of carcinoma.\.br\\.br\||||||C
OBX|31|CE|IMP|tst5486183|M09450^^SNO||||||||1||A
OBX|32|CE|IMP|tst5486183|200.88^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004472|P|2.3
PID|1||N0000085^^^RV|tpmc3531494|TESTVTWOFIVE^PASSAVANT^PAUL||19300520|M||PVW|888 STREET^^PITTSBURGH^PA^15237^United States||412-367-6100|724-625-3184|||||888-55-2223|||||||||||N
PV1|1||PVLAB||||ABU.KA^ABU-HAMAD^GHASSAN|||||||||||PVSDC|N00000001370|PVBC||||||||||||||||||||||||200511210857
ORC|RE||PVS05-65^CoPathPlus||CM||||200511301732|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PVS05-65^CoPathPlus^tpmc0067183|PVAP^PV Pathology|||200511301731|||||||200511301731|COLONBIO|505074||||^75^Y|-1|200511301735||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc0067183.1|COLONBIO^Colon Biopsy/Polyp^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc0067183.1.1|A||||||||1^A|200511301731
OBX|3|CE|PROCESS|tpmc0067183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200512191445
OBX|4|CE|PROCESS|tpmc0067183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512191445
OBX|5|CE|PROCESS|tpmc0067183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512191445
OBX|6|TX|GDT|tpmc0067183|THIS IS THE GROSS DESCRIPTION\.br\||||||F
OBX|7|TX|MDT|tpmc0067183|This is the microscopic desdription\.br\||||||F
OBX|8|TX|FIN|tpmc0067183|THIS IS THE FINAL DIAGNOSIS\.br\||||||F
OBR|2||tpmc0067183^CoPathPlus^tpmc0067183.A1|ADD^Addendum||||||||||200511301735|||||||1|200511301735||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc0067183|THIS IS AN ADDENDUM ADDED TO PVS05-65\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004473|P|2.3
PID|1||N0000085^^^RV|tpmc3531494|TESTVTWOFIVE^PASSAVANT^PAUL||19300520|M||PVW|888 STREET^^PITTSBURGH^PA^15237^United States||412-367-6100|724-625-3184|||||888-55-2223|||||||||||N
PV1|1||PVLAB||||ABU.KA^ABU-HAMAD^GHASSAN|||||||||||PVSDC|N00000001370|PVBC||||||||||||||||||||||||200511210857
ORC|RE||PVS05-66^CoPathPlus||CM||||200512011339|987654^PATHOID^DOCTOR||505074^PLANET^MARS
OBR|1||PVS05-66^CoPathPlus^tpmc1167183|PVAP^PV Pathology|||200512011338|||||||200512011338|COM|505074||||^75^Y|-1|200512011851||SP|C|||||||987654^PATHOID^DOCTOR|z41^LOSOS^FRANK
OBX|1|CE|ANT|tpmc1167183.1|COM^Consult Material^L||||||C||1^1
OBX|2|TX|MDT|tpmc1167183|The microscopic findings substantiate the diagnosis.\.br\||||||C
OBX|3|TX|FIN|tpmc1167183|PART 1: PROSTATE GLAND, RIGHT, NEEDLE BIOPSIES \.br\               A. MODERATELY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 6 (3+3) INVOLVING TWO OF \.br\                    FOUR (2/4) CORES SUBMITTED. \.br\               B. ONLY SMALL MICROSCOPIC FOCI OF TUMOR TISSUE ARE SEEN IN EACH CORE WHICH OCCUPY LESS\.br\                    THAN 5% OF THE TISSUE EXAMINED MICROSCOPICALLY.\.br\               C. NO PERINEURAL SHEATH INVASION IS SEEN. \.br\\.br\PART 2: PROSTATE GLAND, LEFT, NEEDLE BIOPSIES \.br\               A. MODERATELY DIFFERENTIATED ADENOCARCINOMA, GLEASON SCORE 6 (3+3) INVOLVING THREE OF \.br\                   FOUR CORES SUBMITTED (3/4).\.br\               B. TUMOR TISSUE OCCUPIES APPROXIMATELY 20% OF THE TISSUE EXAMINED MICROSCOPICALLY.\.br\               C. NO PERINEURAL SHEATH INVASION IS SEEN.\.br\||||||C
OBR|2||tpmc1167183^CoPathPlus^tpmc1167183.A1|ADD^Addendum||||||||||200512011846|||||||1|200512011846||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc1167183|This is an addendum to PVS05-66 to test OBX:11 flag.   Should display as "Corrected"\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004474|P|2.3
PID|1||N0000085^^^RV|tpmc3531494|TESTVTWOFIVE^PASSAVANT^PAUL||19300520|M||PVW|888 STREET^^PITTSBURGH^PA^15237^United States||412-367-6100|724-625-3184|||||888-55-2223|||||||||||N
PV1|1||PVLAB||||ABU.KA^ABU-HAMAD^GHASSAN|||||||||||PVSDC|N00000001370|PVBC||||||||||||||||||||||||200511210857
ORC|RE||PVS05-67^CoPathPlus||CM||||200512011347|987654^PATHOID^DOCTOR||505071^PLANET^MERCURY
OBR|1||PVS05-67^CoPathPlus^tpmc2167183|PVAP^PV Pathology|||200512011346|||||||200512011346|BREASTBIO|505071||||^75^Y|-1|200512011349||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc2167183.1|BREASTBIO^Breast Biopsy^L||||||C||1^1
OBX|2|ST|BLOCK|tpmc2167183.1.1|A||||||||1^A|200512011346
OBX|3|CE|PROCESS|tpmc2167183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200512191445
OBX|4|CE|PROCESS|tpmc2167183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512191445
OBX|5|CE|PROCESS|tpmc2167183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512191445
OBX|6|CE|PROCESS|tpmc2167183.1.1.4|pmc7904^Alcian Blue pH 1.0 (Histo)^L||||||||4^AlBlue1.0|200512191445
OBX|7|CE|PROCESS|tpmc2167183.1.1.5|pmc9333^Giemsa Stain (Histo)^L||||||||5^Giemsa|200512191445
OBX|8|CE|PROCESS|tpmc2167183.1.1.6|pmc2233^Acid Fast Stain (Histo)^L||||||||6^AcidFast|200512191445
OBX|9|CE|PROCESS|tpmc2167183.1.1.7|pmc8733^Bcl-2 Oncoprotein (IPEX)^L||||||||7^Bcl-2|200512191445
OBX|10|CE|PROCESS|tpmc2167183.1.1.8|pmc4014^Bielschowsky Stain (Histo)^L||||||||8^Biels|200512191445
OBX|11|TX|GDT|tpmc2167183|The specimen is received in formalin labeled with the patient' s name, initials RHS and "left breast 3:00 2B".  It consists of multiple cores of soft yellow tissue ranging from 1.4 to 1.7 cm. in length with the diameters ranging from 0.3 to 0.4 cm.  The specimen is totally submitted in one cassette labeled 1A.\.br\1A x multiple, totally submitted\.br\||||||C
OBX|12|TX|MDT|tpmc2167183|The microscopic findings substantiate the diagnosis.\.br\||||||C
OBX|13|TX|FIN|tpmc2167183|\.br\LEFT BREAST, TISSUE AT 3:00 O' CLOCK 2B AREA, ULTRASOUND GUIDED MAMMOTOME BIOPSY-\.br\A.  FIBROCYSTIC CHANGES WITH EXTENSIVE APOCRINE METAPLASIA, CYST, PAPILLOMATOSIS \.br\     AND FOCAL ADENOSIS.  \.br\B.  FOCAL MICROCALCIFICATIONS.\.br\C.  FOCAL DUCT EPITHELIAL HYPERPLASIA.\.br\D.  NO MALIGNANCY.\.br\||||||C
OBX|14|CE|IMP|tpmc2167183|M33400^^SNO||||||||1||A
OBX|15|CE|IMP|tpmc2167183|M55401^^SNO||||||||1||A
OBX|16|CE|IMP|tpmc2167183|M72171^^SNO||||||||1||A
OBX|17|CE|IMP|tpmc2167183|M73310^^SNO||||||||1||A
OBX|18|CE|IMP|tpmc2167183|M74201^^SNO||||||||1||A
OBX|19|CE|IMP|tpmc2167183|M74320^^SNO||||||||1||A
OBX|20|CE|IMP|tpmc2167183|M80600^^SNO||||||||1||A
OBX|21|CE|IMP|tpmc2167183|T04060^^SNO||||||||1||A
OBX|22|CE|IMP|tpmc2167183|M09450^^SNO||||||||1||A
OBR|2||tpmc2167183^CoPathPlus^tpmc2167183.A1|ADD^Addendum||||||||||200512011855|||||||1|200512011855||SP|F|||||||987654^PATHOID^DOCTOR|z41^LOSOS^FRANK
OBX|1|TX|ADX|tpmc2167183|This is an Addendum on PVS05-67 to test the OBX:11 flag\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004475|P|2.3
PID|1||580141-00^^^RG|tpmc2298394|TESTVTWOFIVE^BILLING^DOUGLAS||19301103|M|||||||||||198-26-1576|||||||||||N
PV1|1||MWBRI||||505073^PLANET^EARTH||||||||||pmc97361^PLANET^MARS|MWO|38029013|||||||||||||||||||||||||200511161000
ORC|RE||PVS05-68^CoPathPlus||CM||||200512191437|^SOLTESZ^BENJAMIN||505073^PLANET^EARTH
OBR|1||PVS05-68^CoPathPlus^tpmc9077183|PVAP^PV Pathology|||200512191436|||||||200512191436|ANTRUMBIO|505073||||^75^Y|-1|200512191640||SP|C|||||||MD.AMIN.RA^AMIN^RAJNIKANT|^SOLTESZ^BENJAMIN
OBX|1|CE|ANT|tpmc9077183.1|ANTRUMBIO^Antrum, Biopsy^L||||||C||1^1
OBX|2|ST|BLOCK|tpmc9077183.1.1|A||||||||1^A|200512191436
OBX|3|CE|PROCESS|tpmc9077183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200512191445
OBX|4|CE|PROCESS|tpmc9077183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512191445
OBX|5|CE|PROCESS|tpmc9077183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512191445
OBX|6|CE|PROCESS|tpmc9077183.1.1.4|pmc8133^UCHL1 CD45RO (IPEX)^L||||||||4^UCHL1|200512191448
OBX|7|TX|GDT|tpmc9077183|The specimen is received in formalin labeled with the patient' s name and "gastric antrum biopsy".  It consists of one fragment of soft, tan tissue measuring 0.2 cm in greatest dimension.  The specimen is wrapped in lens paper and totally submitted in one cassette labeled 1A.\.br\1A  x1, totally submitted\.br\RK/kmr\.br\||||||C
OBX|8|TX|MDT|tpmc9077183|Microscopic examination substantiates the above diagnosis.\.br\BR/ncs\.br\||||||C
OBX|9|TX|FIN|tpmc9077183|STOMACH, ANTRUM, BIOPSY \.br\A.UNREMARKABLE GASTRIC FUNDUS MUCOSA.\.br\B.GIEMSA STAIN IS NEGATIVE FOR HELICOBACTER PYLORI.\.br\BR/ncs\.br\||||||C
OBX|10|CE|IMP|tpmc9077183|E0004^^SNO||||||||1||A
OBX|11|CE|IMP|tpmc9077183|P1140^^SNO||||||||1||A
OBX|12|CE|IMP|tpmc9077183|T63010^^SNO||||||||1||A
OBX|13|CE|IMP|tpmc9077183|T63400^^SNO||||||||1||A
OBX|14|CE|IMP|tpmc9077183|T63600^^SNO||||||||1||A
OBR|2||tpmc9077183^CoPathPlus^tpmc9077183.P1|DNA^DNA||||||||||200512191635|||||||1|200512191635||SP|F||||||||^SOLTESZ^BENJAMIN
OBX|1|TX|PIN|tpmc9077183|Immunohistochemical stains have been ordered to classify this neoplasm. Results will be reported in an addendum. \.br\||||||C
OBX|2|TX|PRC|tpmc9077183|\.br\A.          ONYCHOMYCOSIS.\.br\B.          INTERPRETATION OF PAS-D STAIN CONFIRMS PRESENCE OF HYPHAE AND SPORES.\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004476|P|2.3
PID|1||000444888^^^WASH|tst9896394|TAYLOR^OPIE||19421212|M|||||||||||000-44-4888|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001000444888|||||||||||||||||||||||||200504281622
ORC|RE||PHS05-68^CoPathPlus||CM||||200504281625|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||PHS05-68^CoPathPlus^tst1686183|PHSP^PH Surgical Pathology|||200504281625|||||||200504281625|SPLT|505074||||^62^Y|-1|200511031151||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst1686183.1|SPLT^Spleen^L||||||F||1^1
OBX|2|ST|BLOCK|tst1686183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst1686183.1.2|B||||||||2^B|200507221753
OBX|4|CE|PROCESS|tst1686183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|5|CE|PROCESS|tst1686183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|TX|GDT|tst1686183|This specimen is received in formalin and labeled with the patient' s name, initials LM and "spleen".  It consists of two pieces of tissues dark red in color one measuring 0.6 x 0.75 x 1.5 cm and the other measuring 0.5 x 0.8 x 0.9 cm.  Each is place in a separate cassette and submitted as A and B.\.br\\.br\||||||F
OBX|7|TX|MDT|tst1686183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|8|TX|FIN|tst1686183|SPLEEN, SPLENECTOMY-\.br\A.    SPLEEN SHOWING NON-NECROTIZING GRANULOMAS AND RECENT HEMORRHAGE.\.br\B.    SPECIAL STAINS FOR FUNGAL ORGANISMS (GROCOTT STAIN), ACID FAST BACILLI (AFB STAIN) AND WHIPPLE'S DISEASE (PAS WITH DIASTASE STAIN) ARE NEGATIVE.\.br\C.    NEGATIVE FOR NEOPLASM.\.br\||||||F
OBX|9|CE|IMP|tst1686183|D0840^^SNO||||||||1||A
OBX|10|CE|IMP|tst1686183|E2000^^SNO||||||||1||A
OBX|11|CE|IMP|tst1686183|E4000^^SNO||||||||1||A
OBX|12|CE|IMP|tst1686183|M09450^^SNO||||||||1||A
OBX|13|CE|IMP|tst1686183|M37000^^SNO||||||||1||A
OBX|14|CE|IMP|tst1686183|M44200^^SNO||||||||1||A
OBX|15|CE|IMP|tst1686183|T07000^^SNO||||||||1||A
OBX|16|CE|IMP|tst1686183|789.2^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004477|P|2.3
PID|1||N0095685^^^RV|tpmc2242405|TESTVTWOFIVE^PVMARY^V||19290517|F||PVW|||||||||194-22-2676|||||||||||N
PV1|1||PVGI||||RAVI.JA^JANARDHANAN^RAVI||||||||||pmc27833^JANARDHANAN^RAVI|PVCLI|N00024558272|||||||||||||||||||||||||200512291138
ORC|RE||PVS05-69^CoPathPlus||CM||||200512291142|z40^KOKAL^ELLEN||RAVI.JA^JANARDHANAN^RAVI
OBR|1||PVS05-69^CoPathPlus^tpmc7877183|PVAP^PV Pathology|||200512291141|||||||200512291141|COLONBIO|RAVI.JA||||^76^Y|-1|200601040815||SP|F|||||||MD.MYER.RI^MYEROWITZ^RICHARD|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tpmc7877183.1|COLONBIO^Rectal sigmoid polyp^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc7877183.1.1|A||||||||1^A|200512291142
OBX|3|CE|PROCESS|tpmc7877183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200512291142
OBX|4|CE|PROCESS|tpmc7877183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512291142
OBX|5|CE|PROCESS|tpmc7877183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512291142
OBX|6|TX|GDT|tpmc7877183|The specimen is received in formalin, labeled with the patient' s name, initials MMG and "rectal sigmoid polyp".  It consists of two fragments of tan, soft tissue measuring 0.2 x 0.1 x 0.1 cm.  The specimen is stained with hematoxylin, wrapped in lens paper, and totally submitted in one cassette labeled 1A\.br\1A x 2, totally submitted.  \.br\||||||F
OBX|7|TX|MDT|tpmc7877183|The microscopic findings substantiate the diagnosis.\.br\||||||F
OBX|8|TX|FIN|tpmc7877183|RECTUM, POLYP, BIOPSY-\.br\COLONIC MUCOSA WITH FOCAL ADENOMATOUS CHANGE AND LYMPHOID AGGREGATE.\.br\||||||F
OBX|9|CE|IMP|tpmc7877183|569.0^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004478|P|2.3
PID|1||444333222^^^WASH|tst4996394|RABBIT^ROGER||19550416|M|||||||||||444-33-3222|||||||||||N
PV1|1||PATHOS||||505077^PLANET^NEPTUNE||||||||||pmc28361^PLANET^NEPTUNE|OSD|0001444333222|||||||||||||||||||||||||200505041035
ORC|RE||PHS05-70^CoPathPlus||CM||||200505041050|^LASSIGE^KAREN||505077^PLANET^NEPTUNE
OBR|1||PHS05-70^CoPathPlus^tst1786183|PHSP^PH Surgical Pathology|||200505041049|||||||200505041049|LNBS|505077||||^50^Y|-1|200505110944||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst1786183.1|LNBS^Left axillary Lymph Node^L||||||F||1^1
OBX|2|ST|BLOCK|tst1786183.1.1|A||||||||1^A|200505041533
OBX|3|ST|BLOCK|tst1786183.1.2|B||||||||2^B|200505041533
OBX|4|CE|PROCESS|tst1786183.1.1.1|pmc7533^Reticulin Stain (Histo)^L||||||||1^Retic|200506011408
OBX|5|CE|PROCESS|tst1786183.1.1.2|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|6|CE|PROCESS|tst1786183.1.2.3|$hinit^Initial H&E^L||||||||3^H&E|200508180859
OBX|7|CE|PROCESS|tst1786183.1.2.4|pmc7533^Reticulin Stain (Histo)^L||||||||4^Retic|200506011408
OBX|8|CE|PROCESS|tst1786183.1.1.5|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||3^HBNKNC|200505240648
OBX|9|CE|PROCESS|tst1786183.1.2.6|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||5^HBNKNC|200505240648
OBX|10|TX|GDT|tst1786183|The specimen is received fresh and labeled with the patient' s name, initials AD, medical record number and "left axillary node".  The node has areas of yellow adipose tissue.  It measures 1.2 x 1.6 x 1.6 cm.  The specimen is cut and formalin fixed and submitted in cassettes A and B.\.br\||||||F
OBX|11|TX|FIN|tst1786183|Left axillary Lymph Node:  \.br\NEGATIVE FOR CARCINOMA\.br\||||||F
OBX|12|CE|IMP|tst1786183|M09450^^SNO||||||||1||A
OBX|13|CE|IMP|tst1786183|T08710^^SNO||||||||1||A
OBX|14|CE|IMP|tst1786183|TY8120^^SNO||||||||1||A
OBX|15|CE|IMP|tst1786183|202.04^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004479|P|2.3
PID|1||322388000^^^WASH|tst5996394|PIPER^PETER||19621221|M|||||||||||322-38-8000|||||||||||N
PV1|1||PATHOS||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|OSD|0001322388000|||||||||||||||||||||||||200505041635
ORC|RE||PHS05-71^CoPathPlus||CM||||200505041643|^LASSIGE^KAREN||505079^PLANET^PLUTO
OBR|1||PHS05-71^CoPathPlus^tst2786183|PHSP^PH Surgical Pathology|||200505041642|||||||200505041642|TRBX|505079||||^42^Y|-1|200506231420||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2786183.1|TRBX^Biopsy Transverse Colon^L||||||F||1^1
OBX|2|ST|BLOCK|tst2786183.1.1|A||||||||1^A|200507221753
OBX|3|CE|PROCESS|tst2786183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|4|TX|GDT|tst2786183|The specimen is received in formalin labeled with the patient' s name, initials FN and "transverse colon biopsy".  It consists of four soft, pink-tan portions of tissue measuring in aggregate 0.5 x 0.3 x 0.1 cm.  Entirely submitted in one block.  \.br\||||||F
OBX|5|TX|FIN|tst2786183|TRANSVERSE COLON BIOPSY\.br\A.          AJGAF\.br\B.     KGJ;AJREI\.br\C.     LSKRKIE\.br\     \.br\||||||F
OBX|6|CE|IMP|tst2786183|P1140^^SNO||||||||1||A
OBX|7|CE|IMP|tst2786183|T67400^^SNO||||||||1||A
OBX|8|CE|IMP|tst2786183|789.00^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004480|P|2.3
PID|1||222000222^^^WASH|tst1996394|RICH^RICHIE||19600415|M|||||||||||222-00-0222|||||||||||N
PV1|1||PATHOS||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0002222000222|||||||||||||||||||||||||200505050955
ORC|RE||PHS05-72^CoPathPlus||CM||||200505051415|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||PHS05-72^CoPathPlus^tst3786183|PHSP^PH Surgical Pathology|||200505051414|||||||200505051414|COBX|505073||||^45^Y|-1|200505181421||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst3786183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|CE|ANT|tst3786183.2|REBX^Biopsy Rectum^L||||||F||2^2
OBX|3|TX|GDT|tst3786183|This specimen is received in formalin in two parts.\.br\\.br\Part 1 is labeled with the patient' s name, initials VJ and "colon biopsy".  Received are five irregular, soft, tan tissue fragments ranging in size from 0.1 to 0.25 cm in greatest dimension.  The specimen is entirely submitted in cassette 1A. \.br\\.br\Part 2 is labeled with the patient' s name, initials VJ and "Rectum biopsy".  Received are six irregular, soft, tan tissue fragments ranging in size from 0.2 to 0.25 cm in greatest dimension.  The specimen is entirely submitted in cassette 2A. \.br\\.br\||||||F
OBX|4|TX|FIN|tst3786183|PART 1: COLON BIOPSY, ENDOSCOPIC BIOPSY\.br\A.          COLONIC MUCOSA WITH NO SIGNIFICANT ABNORMALITY.\.br\B.     NEGATIVE FOR DYSPLASIA.\.br\\.br\PART 2: RECTUM, ENDOSCOPIC BIOPSY\.br\A.          COLONIC MUCOSA WITH FOCAL HYPERPLASTIC CHANGES, OTHERWISE NO ACTIVE INFLAMATION.\.br\B.          NEGATIVE FOR DYSPLASIA.\.br\||||||F
OBX|5|CE|IMP|tst3786183|M00100^^SNO||||||||1||A
OBX|6|CE|IMP|tst3786183|P1140^^SNO||||||||1||A
OBX|7|CE|IMP|tst3786183|T67000^^SNO||||||||1||A
OBX|8|CE|IMP|tst3786183|T67010^^SNO||||||||1||A
OBX|9|CE|IMP|tst3786183|M72001^^SNO||||||||1||A
OBX|10|CE|IMP|tst3786183|P1140^^SNO||||||||1||A
OBX|11|CE|IMP|tst3786183|T67010^^SNO||||||||1||A
OBX|12|CE|IMP|tst3786183|T68000^^SNO||||||||1||A
OBX|13|CE|IMP|tst3786183|787.91^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004481|P|2.3
PID|1||N0100666^^^RV|tst6005394|PASSAVANT^PATTIE||19880214|F|||||||||||169-12-6666|||||||||||N
PV1|1||PVC.CT||||VUCH.TH^VUCHINICH^THEODORE||||||||||pmc83043^VUCHINICH^THEODORE|PVREF|N00021696666|||||||||||||||||||||||||200504061057
ORC|RE||PHS05-74^CoPathPlus||CM||||200505051544|z41^LOSOS^FRANK||VUCH.TH^VUCHINICH^THEODORE
OBR|1||PHS05-74^CoPathPlus^tst2886183|PHSP^PH Surgical Pathology|||200505051544|||||||200505051544|COBX|VUCH.TH||||^17^Y|-1|200601261247||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst2886183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|FIN|tst2886183|This is a test per saving recorded dictation in which I'm going to respond yes to the message to save the recorded dictation.\.br\||||||F
OBX|3|CE|IMP|tst2886183|E883.2^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004482|P|2.3
PID|1||222222222^^^RR|tst0704394|FLINTSTONE^FRED^F||19560102|M|||||||||||222-22-2222|||||||||||N
PV1|1||D1022^102-2||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|I|1234222222222|||||||||||||||||||||||||200503151511
ORC|RE||PHS05-75^CoPathPlus||CM||||200505060831|z196^DEVINE^LISA||505073^PLANET^EARTH
OBR|1||PHS05-75^CoPathPlus^tst6886183|PHSP^PH Surgical Pathology|||200505060831|||||||200505060831|EBB|505073||||^49^Y|-1|200601261248||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst6886183.1|EBB^Endobronchial Biopsy^L||||||F||1^1
OBX|2|CE|ANT|tst6886183.2|EBB^Endobronchial Biopsy^L||||||F||2^2
OBX|3|CE|ANT|tst6886183.3|TB^Transbronchial Biopsy^L||||||F||3^3
OBX|4|ST|BLOCK|tst6886183.1.1|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst6886183.2.2|A||||||||1^A|200511181345
OBX|6|ST|BLOCK|tst6886183.3.3|A||||||||1^A|200601061423
OBX|7|CE|PROCESS|tst6886183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512200954
OBX|8|CE|PROCESS|tst6886183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200512200954
OBX|9|CE|PROCESS|tst6886183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^HHE|200512200954
OBX|10|CE|PROCESS|tst6886183.1.1.4|pmc1433^Grocott Stain (Histo)^L||||||||4^Grocott|200506011408
OBX|11|CE|PROCESS|tst6886183.1.1.5|pmc3653^PAS Stain (Histo)^L||||||||5^PAS|200512191038
OBX|12|CE|PROCESS|tst6886183.1.1.6|pmc5533^PAS w/Diastase (Histo)^L||||||||6^PASD|200512191038
OBX|13|CE|PROCESS|tst6886183.1.1.7|pmc6933^HPV Probe Panel (PHIS)^L||||||||7^IHPV|200508241642
OBX|14|CE|PROCESS|tst6886183.1.1.8|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||8^IBNKNC|200601132341
OBX|15|CE|PROCESS|tst6886183.2.2.9|$hinit^Initial H&E^L||||||||1^H&E|200511181407
OBX|16|CE|PROCESS|tst6886183.2.2.10|pmc1433^Grocott Stain (Histo)^L||||||||2^Grocott|200512191038
OBX|17|CE|PROCESS|tst6886183.3.3.11|$hinit^Initial H&E^L||||||||1^H&E|200512201002
OBX|18|CE|PROCESS|tst6886183.1.1.12|pmc3653^PAS Stain (Histo)^L||||||||9^PAS|200601132341
OBX|19|TX|GDT|tst6886183|It is to be noted that the patient' s name on the container is Barney Rubble while on the requisition it is Fred Flintstone. The specimen, submitted as "biopsy of right middle lobe", consists of approximately ten small fragments of soft tissue alternating between white and dark red.  They measure between less than 0.1 and 0.5 x 0.2 cm.  They are totally embedded.\.br\||||||F
OBX|20|TX|MDT|tst6886183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Lower Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Superior\.br\PROCEDURE:      Bilobectomy\.br\TUMOR SIZE:      Not applicable\.br\     Ipsilateral lobe(s)\.br\TUMOR TYPE:      Giant cell carcinoma, Lymphoepithelioma-like carcinoma\.br\HISTOLOGIC GRADE:      G3, Poorly differentiated\.br\     Ipsilateral lobe(s)\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Pericardium\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      > 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Bronchial margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Severe\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 2\.br\     Number of N1 lymph nodes examined: 2\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 3A, Level 9L\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 2\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      No\.br\UNDERLYING DISEASE(S):      Atypical alveolar hyperplasia, Pneumoconiosis, NOS\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pM0\.br\ANCILLARY STUDIES:      Immunohistochemical stains\.br\     --------------------------------------------------------\.br\testing\.br\\.br\||||||F
OBX|21|TX|FIN|tst6886183|Blah blah blah tthoulkdjLKJKLJIOU KLHFIOHIKLJ\.br\This is a test of the Dragon property save recorded dictation.  In this testing I'm going to respond yes to saving the recorded dictation.\.br\||||||F
OBX|22|CE|IMP|tst6886183|285.9^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004483|P|2.3
PID|1||222222222^^^RR|tst0704394|FLINTSTONE^FRED^F||19560102|M|||||||||||222-22-2222|||||||||||N
PV1|1||D1022^102-2||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|I|1234222222222|||||||||||||||||||||||||200503151511
ORC|RE||PHS05-76^CoPathPlus||CM||||200505060832|z196^DEVINE^LISA||505073^PLANET^EARTH
OBR|1||PHS05-76^CoPathPlus^tst7886183|PHSP^PH Surgical Pathology|||200505060832|||||||200505060832|EBB|505073||||^49^Y|-1|200601181638||SP|F|||||||987654^PATHOID^DOCTOR|^MOHANTY^SAMBIT
OBX|1|CE|ANT|tst7886183.1|EBB^Endobronchial Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst7886183.1.1|A||||||||1^A|200507221753
OBX|3|CE|PROCESS|tst7886183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|4|CE|PROCESS|tst7886183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200508180859
OBX|5|CE|PROCESS|tst7886183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^HHE|200508180859
OBX|6|CE|PROCESS|tst7886183.1.1.4|pmc1433^Grocott Stain (Histo)^L||||||||4^Grocott|200506011408
OBX|7|CE|PROCESS|tst7886183.1.1.5|pmc3653^PAS Stain (Histo)^L||||||||5^PAS|200512191038
OBX|8|CE|PROCESS|tst7886183.1.1.6|pmc5533^PAS w/Diastase (Histo)^L||||||||6^PASD|200512191038
OBX|9|CE|PROCESS|tst7886183.1.1.7|pmc8323^CEA polyclonal (IPEX)^L||||||||7^ACEA|200601132341
OBX|10|CE|PROCESS|tst7886183.1.1.8|pmc9323^CEA monoclonal (IPEX)^L||||||||8^ACEAM|200601132341
OBX|11|CE|PROCESS|tst7886183.1.1.9|pmc2823^Leu M1 CD15 (IPEX)^L||||||||9^LeuM1|200601132341
OBX|12|CE|PROCESS|tst7886183.1.1.10|pmc3133^B72.3 Tumor Glycoprotein (IPEX)^L||||||||10^ATAG|200601132341
OBX|13|CE|PROCESS|tst7886183.1.1.11|pmc3144^Cytokeratin 5/6 (IPEX)^L||||||||11^ACK5/6|200601132341
OBX|14|CE|PROCESS|tst7886183.1.1.12|pmc2144^Calretinin (IPEX)^L||||||||12^ACALRET|200601132341
OBX|15|CE|PROCESS|tst7886183.1.1.13|pmc5544^BerEP4 (IPEX)^L||||||||13^ABEREP4|200601132341
OBX|16|CE|PROCESS|tst7886183.1.1.14|pmc3653^PAS Stain (Histo)^L||||||||14^PAS|200512191038
OBX|17|CE|PROCESS|tst7886183.1.1.15|pmc5533^PAS w/Diastase (Histo)^L||||||||15^PASD|200512191038
OBX|18|TX|GDT|tst7886183|It is to be noted that the patient' s name on the container is Barney Rubble while on the requisition it is Fred Flintstone. The specimen, submitted as "biopsy of right middle lobe", consists of approximately ten small fragments of soft tissue alternating between white and dark red.  They measure between less than 0.1 and 0.5 x 0.2 cm.  They are totally embedded.\.br\||||||F
OBX|19|TX|MDT|tst7886183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Upper Division\.br\PROCEDURE:      Segmental\.br\TUMOR SIZE:      Maximum dimension:  4 cm\.br\     Minor dimension: 1 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 2\.br\TUMOR TYPE:      Invasive squamous carcinoma, Carcinosarcoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES:      Number of microscopic satellite lesions: 3\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      Yes\.br\SURGICAL MARGIN SITE:      Bronchial margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Moderate\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 4\.br\     Number of N1 lymph nodes examined: 8\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      Yes\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 2R\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 4\.br\     Number of N2 lymph nodes examined: 8\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      Yes\.br\UNDERLYING DISEASE(S):      Asthma\.br\T STAGE, PATHOLOGIC:      pTX\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pMX\.br\ANCILLARY STUDIES:      Histochemical stains\.br\--------------------------------------------------------\.br\test \.br\\.br\||||||F
OBX|20|TX|FIN|tst7886183|LUNG, LEFT LOBECTOMY\.br\\.br\No Evidence of Lymph Node infiltration\.br\Test\.br\||||||F
OBX|21|CE|IMP|tst7886183|P1100^^SNO||||||||1||A
OBX|22|CE|IMP|tst7886183|T28500^^SNO||||||||1||A
OBX|23|CE|IMP|tst7886183|285.9^^ICD||||||||1
OBR|2||tst7886183^CoPathPlus^tst7886183.P1|MICGEN^Microdissection Genotyping||||||||||200506301131|||||||1|200506301131||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|PIN|tst7886183|Loss Of heterozygosity was found in klhjgfioahjgiorui out of kjgioejrtu markers.\.br\||||||F
OBX|2|TX|PRC|tst7886183|Loss if heterozygosity was found in # out of thaioujasdklo  markers.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004484|P|2.3
PID|1||222222222^^^RR|tst0704394|FLINTSTONE^FRED^F||19560102|M|||||||||||222-22-2222|||||||||||N
PV1|1||D1022^102-2||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|I|1234222222222|||||||||||||||||||||||||200503151511
ORC|RE||PHS05-77^CoPathPlus||CM||||200505060833|z196^DEVINE^LISA||505073^PLANET^EARTH
OBR|1||PHS05-77^CoPathPlus^tst8886183|PHSP^PH Surgical Pathology|||200505060833|||||||200505060833|EBB|505073||||^49^Y|-1|200601181631||SP|F|||||||^MOHANTY^SAMBIT|^MOHANTY^SAMBIT
OBX|1|CE|ANT|tst8886183.1|EBB^Endobronchial Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst8886183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst8886183.1.2|B||||||||2^B|200508311407
OBX|4|CE|PROCESS|tst8886183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|5|CE|PROCESS|tst8886183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200508180859
OBX|6|CE|PROCESS|tst8886183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^HHE|200508180859
OBX|7|CE|PROCESS|tst8886183.1.1.4|pmc1433^Grocott Stain (Histo)^L||||||||4^Grocott|200506011408
OBX|8|CE|PROCESS|tst8886183.1.1.5|pmc3653^PAS Stain (Histo)^L||||||||5^PAS|200512191038
OBX|9|CE|PROCESS|tst8886183.1.1.6|pmc5533^PAS w/Diastase (Histo)^L||||||||6^PASD|200512191038
OBX|10|CE|PROCESS|tst8886183.1.1.7|pmc9873^Amyloid A (IPEX)^L||||||||7^AAMY|200601132341
OBX|11|CE|PROCESS|tst8886183.1.1.8|pmc0383^Amyloid P (IPEX)^L||||||||8^AAMP|200601132341
OBX|12|CE|PROCESS|tst8886183.1.1.9|pmc0973^amyloid transthyretin prealbumin(IPEX)^L||||||||9^APREA|200601132341
OBX|13|CE|PROCESS|tst8886183.1.1.10|pmc3834^Kappa amyloid (IPEX)^L||||||||10^AKAPY|200601132341
OBX|14|CE|PROCESS|tst8886183.1.1.11|pmc9724^Amyloid lambda (IPEX)^L||||||||11^ALAMY|200601132341
OBX|15|CE|PROCESS|tst8886183.1.1.12|pmc1333^Congo Red Stain (Histo)^L||||||||12^CongoRed|200512191038
OBX|16|CE|PROCESS|tst8886183.1.1.13|pmc9333^Giemsa Stain (Histo)^L||||||||13^Giemsa|200512191038
OBX|17|CE|PROCESS|tst8886183.1.2.14|$hinit^Initial H&E^L||||||||13^H&E|200508311427
OBX|18|CE|PROCESS|tst8886183.1.2.15|pmc9033^S100 (IPEX)^L||||||||14^S100|200601132341
OBX|19|TX|GDT|tst8886183|It is to be noted that the patient' s name on the container is Barney Rubble while on the requisition it is Fred Flintstone. The specimen, submitted as "biopsy of right middle lobe", consists of approximately ten small fragments of soft tissue alternating between white and dark red.  They measure between less than 0.1 and 0.5 x 0.2 cm.  They are totally embedded.\.br\||||||F
OBX|20|TX|MDT|tst8886183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe, Right Middle Lobe, Left Lower Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Apical, Superior\.br\PROCEDURE:      Wedge\.br\TUMOR SIZE:      Maximum dimension:  7 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 2\.br\     Ipsilateral lobe(s)\.br\     TUMOR TYPE:      Invasive squamous carcinoma, Clear cell carcinoma, Blastoma, Other Type(s): testing\.br\     HISTOLOGIC GRADE:      G1, Well differentiated\.br\MICROSCOPIC SATELLITES: \.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Chest wall (into skeletal muscle or soft tissue)\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      Yes\.br\SURGICAL MARGIN SITE:      Distance of invasive tumor to closest margin: 7 mm, Bronchial margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Severe\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 5\.br\     Number of N1 lymph nodes examined: 4\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      Yes\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 2R\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 5\.br\     Number of N2 lymph nodes examined: 4\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      Yes\.br\UNDERLYING DISEASE(S):      Atypical alveolar hyperplasia\.br\T STAGE, PATHOLOGIC:      pT0\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pMX\.br\ANCILLARY STUDIES:      FISH studies\.br\Comment:      COMMENT:\.br\     --------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|21|TX|FIN|tst8886183|Liver Right and Left Lobes:  Fragments of liver parenchyma with sinusoidal dilation, congestion and focal fibrosis.  (See Microscopic Description.)\.br\||||||F
OBX|22|CE|IMP|tst8886183|M32100^^SNO||||||||1||A
OBX|23|CE|IMP|tst8886183|M36100^^SNO||||||||1||A
OBX|24|CE|IMP|tst8886183|M49001^^SNO||||||||1||A
OBX|25|CE|IMP|tst8886183|T56010^^SNO||||||||1||A
OBX|26|CE|IMP|tst8886183|T56020^^SNO||||||||1||A
OBX|27|CE|IMP|tst8886183|T56240^^SNO||||||||1||A
OBX|28|CE|IMP|tst8886183|285.9^^ICD||||||||1
OBR|2||tst8886183^CoPathPlus^tst8886183.A2|ADD^Addendum||||||||||200601191343|||||||2|200601191343||SP|F||||||||z491^NESTLER^RICK
OBX|1|TX|ADX|tst8886183|CaBIG testing, this is the addendum text.\.br\||||||F
OBR|3||tst8886183^CoPathPlus^tst8886183.P1|MICGEN^Microdissection Genotyping||||||||||200506301130|||||||1|200506301130||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|PIN|tst8886183|This is a test of the Dragon property for saving recorded dictation.  In this test I'm going to say yes to saving the recorded dictation.\.br\Loss Of heterozygosity was found in # out of # markers.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004485|P|2.3
PID|1||800000008^^^UDERMSHY|tst2745394|JETSON^GEORGE^ELROY||19310826|M|||||||||||800-00-0008||||||||||20050824|Y
PV1|1||DRS||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|OSD|0002800000008|||||||||||||||||||||||||200504270857
ORC|RE||PHS05-78^CoPathPlus||CM||||200505061001|z196^DEVINE^LISA||505079^PLANET^PLUTO
OBR|1||PHS05-78^CoPathPlus^tst9886183|PHSP^PH Surgical Pathology|||200505061000|||||||200505061000|PROST|505079||||^73^Y|-1|200601261250||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst9886183.1|PROST^Prostate and Seminal Vesicles^L||||||F||1^1
OBX|2|TX|FIN|tst9886183|This is a test of the Dragon property to save recorded dictation.  In this test I'm going to say yes to saving the recorded dictation.\.br\||||||F
OBX|3|CE|IMP|tst9886183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004486|P|2.3
PID|1||800000008^^^UDERMSHY|tst2745394|JETSON^GEORGE^ELROY||19310826|M|||||||||||800-00-0008||||||||||20050824|Y
PV1|1||DRS||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|OSD|0002800000008|||||||||||||||||||||||||200504270857
ORC|RE||PHS05-79^CoPathPlus||CM||||200505061000|^BILEC^SUSAN||505079^PLANET^PLUTO
OBR|1||PHS05-79^CoPathPlus^tst0986183|PHSP^PH Surgical Pathology|||200505061000|||||||200505061000|PROST|505079||||^73^Y|-1|200601261251||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst0986183.1|PROST^Prostate and Seminal Vesicles^L||||||F||1^1
OBX|2|TX|FIN|tst0986183|This is a test of the Dragon property to save recorded dictation.  In this test I going to say yes to saving the recorded dictation.\.br\||||||F
OBX|3|CE|IMP|tst0986183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004487|P|2.3
PID|1||222333444^^^CITIZN|tst7796394|JORDAN^BAILEY||19630303|F|||||||||||222-33-3444|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001800000000|||||||||||||||||||||||||200505061505
ORC|RE||MWS05-86^CoPathPlus||CM||||200510031728|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||MWS05-86^CoPathPlus^tst2637183|MWSP^MW Pathology|||200510031712|||||||200510031712|BCTP|505074||||^42^Y|-1|200510031740||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2637183.1|BCTP^Breast Core Bx w/Touch Prep (Surg)^L||||||F||1^1
OBX|2|ST|BLOCK|tst2637183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst2637183.1.2|A||||||||2^A|200512121425
OBX|4|CE|PROCESS|tst2637183.1.1.1|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||2^TP|200512121431
OBX|5|CE|PROCESS|tst2637183.1.1.2|pmc6963^Gross Intraop Consult (Surg)^L||||||||3^GR|200512121428
OBX|6|CE|PROCESS|tst2637183.1.1.3|pmc4115^Blank Slide (MW)^L||||||||4^BLANK|200512121428
OBX|7|CE|PROCESS|tst2637183.1.1.4|$hinit^Initial H&E^L||||||||5^H&E Lv1|200512121431
OBX|8|CE|PROCESS|tst2637183.1.1.5|pmc4115^Blank Slide (MW)^L||||||||6^BLANK|200512121428
OBX|9|CE|PROCESS|tst2637183.1.1.6|pmc5553^HH&E (HISTO)^L||||||||7^H&E Lv2|200512121431
OBX|10|CE|PROCESS|tst2637183.1.1.7|pmc4115^Blank Slide (MW)^L||||||||8^BLANK|200512121428
OBX|11|CE|PROCESS|tst2637183.1.1.8|pmc5553^HH&E (HISTO)^L||||||||9^H&E Lv3|200512121431
OBX|12|CE|PROCESS|tst2637183.1.1.9|pmc4115^Blank Slide (MW)^L||||||||10^BLANK|200512121428
OBX|13|CE|PROCESS|tst2637183.1.1.10|pmc5553^HH&E (HISTO)^L||||||||11^H&E Lv4|200512121431
OBX|14|CE|PROCESS|tst2637183.1.1.11|pmc4115^Blank Slide (MW)^L||||||||12^BLANK|200512121428
OBX|15|CE|PROCESS|tst2637183.1.1.12|pmc5553^HH&E (HISTO)^L||||||||13^H&E Lv5|200512121431
OBX|16|CE|PROCESS|tst2637183.1.1.13|pmc5553^HH&E (HISTO)^L||||||||14^HHE|200512121431
OBX|17|CE|PROCESS|tst2637183.1.0.14|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||1^TP|200512121431
OBX|18|CE|PROCESS|tst2637183.1.0.15|pmc6963^Gross Intraop Consult (Surg)^L||||||||2^GR|200512121428
OBX|19|CE|PROCESS|tst2637183.1.1.16|pmc4115^Blank Slide (MW)^L||||||||15^BLANK|200512121428
OBX|20|CE|PROCESS|tst2637183.1.1.17|$hinit^Initial H&E^L||||||||16^H&E Lv1|200512121431
OBX|21|CE|PROCESS|tst2637183.1.1.18|pmc4115^Blank Slide (MW)^L||||||||17^BLANK|200512121428
OBX|22|CE|PROCESS|tst2637183.1.1.19|pmc5553^HH&E (HISTO)^L||||||||18^H&E Lv2|200512121431
OBX|23|CE|PROCESS|tst2637183.1.1.20|pmc4115^Blank Slide (MW)^L||||||||19^BLANK|200512121428
OBX|24|CE|PROCESS|tst2637183.1.1.21|pmc5553^HH&E (HISTO)^L||||||||20^H&E Lv3|200512121431
OBX|25|CE|PROCESS|tst2637183.1.1.22|pmc4115^Blank Slide (MW)^L||||||||21^BLANK|200512121428
OBX|26|CE|PROCESS|tst2637183.1.1.23|pmc5553^HH&E (HISTO)^L||||||||22^H&E Lv4|200512121431
OBX|27|CE|PROCESS|tst2637183.1.1.24|pmc4115^Blank Slide (MW)^L||||||||23^BLANK|200512121428
OBX|28|CE|PROCESS|tst2637183.1.1.25|pmc5553^HH&E (HISTO)^L||||||||24^H&E Lv5|200512121431
OBX|29|CE|PROCESS|tst2637183.1.1.26|pmc5553^HH&E (HISTO)^L||||||||25^HHE|200512121431
OBX|30|CE|PROCESS|tst2637183.1.1.27|pmc6305^FISH Order (MWSP)^L||||||||26^Magee FISH|200512121428
OBX|31|TX|GDT|tst2637183|The specimen is received in formalin in one part labeled with the patient's name, initials RL and "left breast".  It consists of three cylindrical off-white/tan rubbery cores measuring 1.2 to 1.6 cm in length and 0.15 cm in diameter.  The specimen is submitted entirely in cassette A.\.br\||||||F
OBX|32|TX|MDT|tst2637183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|33|TX|FIN|tst2637183|PART 1: Breast Core Bx\.br\\.br\A.INFILTRATING CARCINOMA WITH APOCRINE FEATURES, NUCLEAR GRADE 3.   \.br\||||||F
OBX|34|CE|IMP|tst2637183|P1140^^SNO||||||||1||A
OBX|35|CE|IMP|tst2637183|T04010^^SNO||||||||1||A
OBX|36|CE|IMP|tst2637183|M80103^^SNO||||||||1||A
OBX|37|CE|IMP|tst2637183|285.9^^ICD||||||||1
OBR|2||tst2637183^CoPathPlus^tst2637183.P1|FISH^FISH (PCL)||||||||||200510031736|||||||1|200510031736||SP|F|||||||987654^PATHOID^DOCTOR|^LASSIGE^KAREN
OBX|1|TX|PIN|tst2637183|Amplification of the HER-2/NEU gene was identified by interphase FISH analysis.\.br\\.br\RESULTS:\.br\\.br\Fluorescence in situ hybridization (FISH) analysis was performed on MWH Surgical  #MWS05-18803, Block 1A (Breast Cancer) using the DNA probe for the HER-2/NEU gene (Vysis, Inc., lot #61093).  The ratio of HER-2/NEU signals to chromosome 17 centromere signals was determined to be 3.36.  A ratio of 2.0 or greater is considered to be amplified; therefore, this specimen is amplified.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004488|P|2.3
PID|1||154565433^^^RR|tst3407394|PRESBY^PENELOPE||19580602|F||||||||||||||||||||||N
PV1|1||5E||||505074^PLANET^MARS||||||||||pmc87361^PLANET^EARTH|I|0238928985128|||||||||||||||||||||||||200505081530
ORC|RE||PHS05-89^CoPathPlus||CM||||200505101750|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PHS05-89^CoPathPlus^tst1196183|PHSP^PH Surgical Pathology|||200505101750|||||||200505101750|COBX|505074||||^46^Y|-1|200505251346||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst1196183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|GDT|tst1196183|The specimen is recieved in B5 fixative labeled "bone marrow biopsy" and consists of a single core of tan, cancellous bone measuring # cm x # cm.\.br\||||||F
OBX|3|TX|MDT|tst1196183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Middle Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Anterior\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Minor dimension: 3 cm\.br\GROSS SATELLITES: \.br\TUMOR TYPE:      Invasive adenocarcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES: \.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Vascular margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Severe\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 0\.br\     Number of N1 lymph nodes examined: 3\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 2R\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 3\.br\T STAGE, PATHOLOGIC:      pTis\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM0\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|4|TX|FIN|tst1196183|MUCINOUS ADENOCARCINOMA\.br\||||||F
OBX|5|CE|IMP|tst1196183|M84803^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004489|P|2.3
PID|1||205588348^^^RR|tst2407394|PRESBY^PETER||19760720|M|||||||||||205-58-8348|||||||||||N
PV1|1||6D^D0658||||505074^PLANET^MARS||||||||||pmc87361^PLANET^EARTH|I|0061859405128|||||||||||||||||||||||||200505080217
ORC|RE||PHS05-90^CoPathPlus||CM||||200505101751|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PHS05-90^CoPathPlus^tst2196183|PHSP^PH Surgical Pathology|||200505101751|||||||200505101751|COBX|505074||||^28^Y|-1|200505251345||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst2196183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|GDT|tst2196183|The specimen is recieved in B5 fixative labeled "bone marrow biopsy" and consists of a single core of tan, cancellous bone measuring # cm x # cm.\.br\||||||F
OBX|3|TX|MDT|tst2196183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Left Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Superior\.br\PROCEDURE:      Bilobectomy\.br\TUMOR SIZE:      Minor dimension: 4 cm\.br\     Ipsilateral lobe(s)\.br\TUMOR TYPE:      Basaloid squamous carcinoma, Carcinosarcoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\     Ipsilateral lobe(s)\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Diaphragm\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      > 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Chest wall margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Moderate\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 5\.br\     Number of N1 lymph nodes examined: 5\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      Yes\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 4R, Level 10L\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 5\.br\     Number of N2 lymph nodes examined: 0\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      Yes\.br\UNDERLYING DISEASE(S):      Atypical alveolar hyperplasia\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM0\.br\ANCILLARY STUDIES:      FISH studies\.br\--------------------------------------------------------\.br\\.br\||||||F
OBX|4|TX|FIN|tst2196183|ADENOCARCINOMA\.br\||||||F
OBX|5|CE|IMP|tst2196183|M81403^^SNO||||||||1||A
OBR|2||tst2196183^CoPathPlus^tst2196183.P1|EM^Electron Microscopy||||||||||200505251328|||||||1|200505251328||SP|F|||||||002624^BECICH^MICHAEL|987654^PATHOID^DOCTOR
OBX|1|TX|PIN|tst2196183|adenocarcinoma\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004490|P|2.3
PID|1||888444222^^^MCPH|tst8147394|MARTIAN^MARVIN||19620808|M|||||||||||888-44-4222|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001888444222|||||||||||||||||||||||||200505130856
ORC|RE||PHS05-91^CoPathPlus||CM||||200505130904|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||PHS05-91^CoPathPlus^tst1696183|PHSP^PH Surgical Pathology|||200505130901|||||||200505130901|PROST|505074||||^42^Y|-1|200506231414||SP|C|||||||987654^PATHOID^DOCTOR|^LASSIGE^KAREN
OBX|1|CE|ANT|tst1696183.1|PROST^Prostate and Seminal Vesicles^L||||||C||1^1
OBX|2|ST|BLOCK|tst1696183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst1696183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst1696183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst1696183.1.4|D||||||||4^D|200507221753
OBX|6|ST|BLOCK|tst1696183.1.5|E||||||||5^E|200507221753
OBX|7|ST|BLOCK|tst1696183.1.6|F||||||||6^F|200507221753
OBX|8|ST|BLOCK|tst1696183.1.7|G||||||||7^G|200507221753
OBX|9|ST|BLOCK|tst1696183.1.8|H||||||||8^H|200507221753
OBX|10|CE|PROCESS|tst1696183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|11|CE|PROCESS|tst1696183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|12|CE|PROCESS|tst1696183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|13|CE|PROCESS|tst1696183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|14|CE|PROCESS|tst1696183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|15|CE|PROCESS|tst1696183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|16|CE|PROCESS|tst1696183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|17|CE|PROCESS|tst1696183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|18|TX|GDT|tst1696183|The specimen is received in buffered formalin labeled "      " and consists of _____________  of pink, soft tissue, _________ cm in greatest dimension.  Specimen is submitted labeled A- H.\.br\FF\.br\||||||C
OBX|19|TX|MDT|tst1696183|     SYNOPTIC DATA - PRIMARY PROSTATE TUMORS\.br\CLINICAL DATA:      PSA value: 5\.br\INVASIVE CA IDENTIFIED?:      Yes\.br\TUMOR HISTOLOGY:      Adenocarcinoma NOS\.br\     Ductal adenocarcinoma\.br\PRIMARY GLEASON GRADE:      Not primary tumor\.br\SECONDARY GLEASON GRADE:      Unknown\.br\GLEASON SUM SCORE:      Unknown\.br\GLEASON 4/5 PERCENTAGE:      5%\.br\WEIGHT OF PROSTATE:      55gm\.br\TUMOR SIZE:      Maximum dimension:  5.0 cm\.br\LOBE LATERALITY:      Left Lobe\.br\PERCENT OF SPECIMEN INVOLVED BY TUMOR:      5 - 25%\.br\MULTIFOCAL DISEASE:      Yes\.br\HIGH GRADE PIN:      Yes - NOS\.br\EXTRAPROSTATIC EXTENSION:      Yes - Multifocal\.br\PERINEURAL INVASION:      Yes\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\SEMINAL VESICLE INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      All surgical margins free of tumor\.br\LYMPH NODES EXAMINED:      0\.br\LYMPH NODES POSITIVE:      0\.br\EXTRANODAL EXTENSION:      No\.br\T STAGE, PATHOLOGIC:      pT1c\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM1\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\--------------------------------------------------------\.br\\.br\||||||C
OBX|20|TX|FIN|tst1696183|PROSTATE CANCER\.br\||||||C
OBX|21|CE|IMP|tst1696183|M80003^^SNO||||||||1||A
OBX|22|CE|IMP|tst1696183|T77100^^SNO||||||||1||A
OBX|23|CE|IMP|tst1696183|602.8^^ICD||||||||1
OBR|2||tst1696183^CoPathPlus^tst1696183.P1|CG^Cytogenetics||||||||||200505251329|||||||1|200505251329||SP|F|||||||SHEKHTER-PCL^SHEKHTER-LEVIN^SOFIA|^LASSIGE^KAREN
OBX|1|TX|PIN|tst1696183|46,XY,del(6)(q21q22)[16]/46,XY[4]\.br\\.br\Mosaic abnormal male  chromosome analysis with an apparently normal cell line and one that has an interstitial deletion of the long arm of one chromosome 6.  Deletions of the long arm of chromosome 6 have been found in a variety of B cell neoplasms, mostly in combination with other chromosome changes accumulated during disease progression [Merup M et al. (1998) Blood 91:3397-3400; Offit K et al. (1993) Blood 82:2157-2162; Brigaudeau C, Bilhou-Nabera C. del(6q) abnormalities in lymphoid malignancies. Atlas Genet Cytogenet Oncol Haematol. December 1998. URL : http://www.infobiogen.fr/services/chromcancer /Anomalies/del6qID1148.html].  Three regions of minimal critical deletions were delineated and the existence of a tumor suppressor gene(s) on 6q, involved in the pathogenesis of lymphoma, was proposed [Zhang Y et al. (2000) Genes Chromosomes Cancer 27:52-58; Menasce LP et al. (1994) Idem 10:286-288; Guan XY et al. (1996) Blood 88:1418-1422].\.br\\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 20\.br\No. of Cells Karyotyped:              4\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:                    20      \.br\\.br\Twenty trypsin-Giemsa banded metaphase cells were analyzed from direct and 24hr  hour harvests of unstimulated tumor cell cultures.  Four cells had an apparently normal male chromosome complement.    Sixteen cells had a 46,XY,del(6)(q21q22) chromosome pattern.  \.br\\.br\Average band level/haploid set:     425\.br\\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004491|P|2.3
PID|1||100013559^^^RG|tst8868394|CIDTWO^PATIENT||19680425|F||MWW|200 OAKLAND AVE^^PITTSBURGH^PA^15213^United States||(412)641-7897|||||||||||||||||N
PV1|1||MWSPC||||MW234027383^CHESIN^CAROLE||||||||||tst27363^CHESIN^CAROLE|MWO|71397657|MWR||||||||||||||||||||||||200511011200
ORC|RE|00003|MWS05-91^CoPathPlus||CM||||200511011258|^LASSIGE^KAREN||MW234027383^CHESIN^CAROLE
OBR|1|00003|MWS05-91^CoPathPlus^tst4747183|MWSP^MW Pathology|||200511011253|||||||200511011253||MW234027383||||^37^Y|-1|200511011353||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst4747183.2|^Endometrial Curettings^L||||||F||1^1
OBX|2|ST|BLOCK|tst4747183.1.1|A||||||||1^A|200511011252
OBX|3|ST|BLOCK|tst4747183.1.2|B||||||||2^B|200511011252
OBX|4|ST|BLOCK|tst4747183.1.3|C||||||||3^C|200511011252
OBX|5|ST|BLOCK|tst4747183.1.4|D||||||||4^D|200511011252
OBX|6|ST|BLOCK|tst4747183.1.5|E||||||||5^E|200511011252
OBX|7|ST|BLOCK|tst4747183.1.6|F||||||||6^F|200511011252
OBX|8|ST|BLOCK|tst4747183.1.7|G||||||||7^G|200511011252
OBX|9|ST|BLOCK|tst4747183.1.8|H||||||||8^H|200511011252
OBX|10|ST|BLOCK|tst4747183.1.9|I||||||||9^I|200511011252
OBX|11|ST|BLOCK|tst4747183.1.10|J||||||||10^J|200511011252
OBX|12|ST|BLOCK|tst4747183.1.11|K||||||||11^K|200511011252
OBX|13|ST|BLOCK|tst4747183.1.12|L||||||||12^L|200511011252
OBX|14|ST|BLOCK|tst4747183.1.13|M||||||||13^M|200511011252
OBX|15|ST|BLOCK|tst4747183.1.14|N||||||||14^N|200511011252
OBX|16|ST|BLOCK|tst4747183.1.15|O||||||||15^O|200511011252
OBX|17|CE|PROCESS|tst4747183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|18|CE|PROCESS|tst4747183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|19|CE|PROCESS|tst4747183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|20|CE|PROCESS|tst4747183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|21|CE|PROCESS|tst4747183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|22|CE|PROCESS|tst4747183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|23|CE|PROCESS|tst4747183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|24|CE|PROCESS|tst4747183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|25|CE|PROCESS|tst4747183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|26|CE|PROCESS|tst4747183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|27|CE|PROCESS|tst4747183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|28|CE|PROCESS|tst4747183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|29|CE|PROCESS|tst4747183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|30|CE|PROCESS|tst4747183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|31|CE|PROCESS|tst4747183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|32|TX|GDT|tst4747183|The specimen is received in formalin labeled with the patient' s name with initials AA and "endometrial curettings".  Specimen consists of a 2.3 x 2.0 x 0.3 cm admixture of multiple soft, tan-gray friable tissue fragments and blood stained mucus.  The specimen is totally submitted in cassette labeled A.\.br\||||||F
OBX|33|TX|MDT|tst4747183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|34|TX|FIN|tst4747183|A.     HYPERPLASTIC AND ADENOMYOMATOUS ENDOMETRIAL POLYP.\.br\B.     PROLIFERATIVE ENDOMETRIUM.\.br\||||||F
OBX|35|CE|IMP|tst4747183|M72440^^SNO||||||||1||A
OBX|36|CE|IMP|tst4747183|M76800^^SNO||||||||1||A
OBX|37|CE|IMP|tst4747183|M79310^^SNO||||||||1||A
OBX|38|CE|IMP|tst4747183|T84000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004492|P|2.3
PID|1||100013561^^^RG|tst0968394|CIDTHREE^PATIENT||19760210|F||MWW|300 CRAIG STREET^^PITTSBURGH^PA^15213^United States||(412)457-8754|||||||||||||||||N
PV1|1||MW3700^3195||||MW240017616^JEYABALAN^ARUNDHATH/PRS||||||||||tst38363^JEYABALAN^ARUNDHATH/PRS|MWL|71397673|MWI||||||||||||||||||||||||200511011400|200512010700
ORC|RE|00003|MWS05-92^CoPathPlus||CM||||200511011436|^LASSIGE^KAREN||MW240017616^JEYABALAN^ARUNDHATH/PRS
OBR|1|00003|MWS05-92^CoPathPlus^tst5747183|MWSP^MW Pathology|||200511011433|||||||200511011433|PLAC|MW240017616||||^29^Y|-1|200511011455||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst5747183.1|PLAC^Placenta 40 weeks^L||||||F||1^1
OBX|2|ST|BLOCK|tst5747183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst5747183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tst5747183.1.3|C||||||||3^C|200512121425
OBX|5|ST|BLOCK|tst5747183.1.4|A||||||||4^A|200512121425
OBX|6|ST|BLOCK|tst5747183.1.5|B||||||||5^B|200512121425
OBX|7|ST|BLOCK|tst5747183.1.6|C||||||||6^C|200512121425
OBX|8|CE|PROCESS|tst5747183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|9|CE|PROCESS|tst5747183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|10|CE|PROCESS|tst5747183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|11|CE|PROCESS|tst5747183.1.1.4|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|12|CE|PROCESS|tst5747183.1.2.5|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|13|CE|PROCESS|tst5747183.1.3.6|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|14|TX|GDT|tst5747183|Received fresh labeled with the patient's name initials "AA" is a single-lobed placenta with membranes and umbilical cord. The 3-vessel, tan-white cord inserts eccentrically, 6.0 cm from the nearest margin, is 56.0 cm in length and 1.2 cm in diameter. The cord shows two areas of possible flattening.  The first measures 10.0 cm in length and is located approximately 11.0 cm from the placental insertion site and the second is on a separately received, un-oriented portion of cord and measures approximately 16.0 cm. in length.  The membranes show partial circummarginate insertion, do not appear complete, are partially torn from the disc and the point of rupture cannot be assessed.  The amnion is partially separated from the chorion.   No subchorionic fibrin plaques are noted.  The fetal surface is minimally dull with normal distribution of vessels. The placental disc is ovoid, 21.0 x 15.5 x 2.1 cm, and weighs 600 grams, greater than the 90th percentile (normal placental weight for this gestational age is 453 +/- 75 gms). The maternal surface is intact with minimal calcification. On cut section, the parenchymal color and consistency are unremarkable.  No discrete lesions are noted grossly. Representative sections are submitted labeled as follows:\.br\A - full thickness adjacent to cord insertion B - full thickness of periphery C - rolled membranes and cord, includes flattened areas.\.br\\.br\||||||F
OBX|15|TX|FIN|tst5747183|PLACENTA, TERM (40 WEEKS) \.br\A.600 GRAMS (>90TH PERCENTILE FOR 40 WEEKS).\.br\B.APPROPRIATE VILLOUS MATURATION FOR GESTATIONAL AGE.\.br\C.MECONIUM CONTAINING MACROPHAGES IN CHORIONIC PLATE, STRIPPED REACTIVE AMNION, AND EXTRAPLACENTAL MEMBRANES.\.br\D.MINIMAL TO MILD ACUTE CHORIOAMNIONITIS (STAGE 1) INVOLVING CHORIONIC PLATE.\.br\E.FOCALLY REACTIVE CHORIONIC PLATE AMNION.\.br\F.PARTIAL CIRCUMMARGINATE INSERTION OF EXTRAPLACENTAL MEMBRANES.\.br\G.THREE-VESSEL UMBILICAL CORD (TOTAL LENGTH OF SEGMENTS RECEIVED 56 CM WITH TWO FLATTENED AREAS 10 AND 16 CM. IN LENGTH, RESPECTIVELY); MILD EDEMA OF WHARTON' S JELLY.\.br\\.br\||||||F
OBX|16|CE|IMP|tst5747183|M41000^^SNO||||||||1||A
OBX|17|CE|IMP|tst5747183|T05128^^SNO||||||||1||A
OBX|18|CE|IMP|tst5747183|T88100^^SNO||||||||1||A
OBX|19|CE|IMP|tst5747183|M36500^^SNO||||||||1||A
OBX|20|CE|IMP|tst5747183|T88210^^SNO||||||||1||A
OBX|21|CE|IMP|tst5747183|T88300^^SNO||||||||1||A
OBX|22|CE|IMP|tst5747183|T88800^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004493|P|2.3
PID|1||100013569^^^RG|tst0278394|CIDFIVE^PATIENT||19800522|F||MWW|5000 BLUE STREET^^PITTSBURGH^PA^15222^United States||(412)457-8787|||||||||||||||||N
PV1|1||MW5300^5306||||MW017616^JEYABALAN^ARUNDHATH||||||||||pmc42203^JEYABALAN^ARUNDHATH|MWH|71397764|MWI||||||||||||||||||||||||200511010800
ORC|RE|00003|MWS05-93^CoPathPlus||CM||||200511011553|^LASSIGE^KAREN||MW017616^JEYABALAN^ARUNDHATH
OBR|1|00003|MWS05-93^CoPathPlus^tst6747183|MWSP^MW Pathology|||200511011553|||||||200511011553|BCTP|MW017616||||^25^Y|-1|200511011633||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst6747183.1|BCTP^Breast Core Bx w/Touch Prep (Surg)^L||||||F||1^1
OBX|2|ST|BLOCK|tst6747183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst6747183.1.2|A||||||||2^A|200512121425
OBX|4|CE|PROCESS|tst6747183.1.1.1|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||2^TP|200512121431
OBX|5|CE|PROCESS|tst6747183.1.1.2|pmc6963^Gross Intraop Consult (Surg)^L||||||||3^GR|200512121428
OBX|6|CE|PROCESS|tst6747183.1.1.3|pmc4115^Blank Slide (MW)^L||||||||4^BLANK|200512121428
OBX|7|CE|PROCESS|tst6747183.1.1.4|$hinit^Initial H&E^L||||||||5^H&E Lv1|200512121431
OBX|8|CE|PROCESS|tst6747183.1.1.5|pmc4115^Blank Slide (MW)^L||||||||6^BLANK|200512121428
OBX|9|CE|PROCESS|tst6747183.1.1.6|pmc5553^HH&E (HISTO)^L||||||||7^H&E Lv2|200512121431
OBX|10|CE|PROCESS|tst6747183.1.1.7|pmc4115^Blank Slide (MW)^L||||||||8^BLANK|200512121428
OBX|11|CE|PROCESS|tst6747183.1.1.8|pmc5553^HH&E (HISTO)^L||||||||9^H&E Lv3|200512121431
OBX|12|CE|PROCESS|tst6747183.1.1.9|pmc4115^Blank Slide (MW)^L||||||||10^BLANK|200512121428
OBX|13|CE|PROCESS|tst6747183.1.1.10|pmc5553^HH&E (HISTO)^L||||||||11^H&E Lv4|200512121431
OBX|14|CE|PROCESS|tst6747183.1.1.11|pmc4115^Blank Slide (MW)^L||||||||12^BLANK|200512121428
OBX|15|CE|PROCESS|tst6747183.1.1.12|pmc5553^HH&E (HISTO)^L||||||||13^H&E Lv5|200512121431
OBX|16|CE|PROCESS|tst6747183.1.1.13|pmc5553^HH&E (HISTO)^L||||||||14^HHE|200512121431
OBX|17|CE|PROCESS|tst6747183.1.0.14|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||1^TP|200512121431
OBX|18|CE|PROCESS|tst6747183.1.0.15|pmc6963^Gross Intraop Consult (Surg)^L||||||||2^GR|200512121428
OBX|19|CE|PROCESS|tst6747183.1.1.16|pmc4115^Blank Slide (MW)^L||||||||15^BLANK|200512121428
OBX|20|CE|PROCESS|tst6747183.1.1.17|$hinit^Initial H&E^L||||||||16^H&E Lv1|200512121431
OBX|21|CE|PROCESS|tst6747183.1.1.18|pmc4115^Blank Slide (MW)^L||||||||17^BLANK|200512121428
OBX|22|CE|PROCESS|tst6747183.1.1.19|pmc5553^HH&E (HISTO)^L||||||||18^H&E Lv2|200512121431
OBX|23|CE|PROCESS|tst6747183.1.1.20|pmc4115^Blank Slide (MW)^L||||||||19^BLANK|200512121428
OBX|24|CE|PROCESS|tst6747183.1.1.21|pmc5553^HH&E (HISTO)^L||||||||20^H&E Lv3|200512121431
OBX|25|CE|PROCESS|tst6747183.1.1.22|pmc4115^Blank Slide (MW)^L||||||||21^BLANK|200512121428
OBX|26|CE|PROCESS|tst6747183.1.1.23|pmc5553^HH&E (HISTO)^L||||||||22^H&E Lv4|200512121431
OBX|27|CE|PROCESS|tst6747183.1.1.24|pmc4115^Blank Slide (MW)^L||||||||23^BLANK|200512121428
OBX|28|CE|PROCESS|tst6747183.1.1.25|pmc5553^HH&E (HISTO)^L||||||||24^H&E Lv5|200512121431
OBX|29|CE|PROCESS|tst6747183.1.1.26|pmc5553^HH&E (HISTO)^L||||||||25^HHE|200512121431
OBX|30|TX|GDT|tst6747183|The specimen is received in formalin in one part labeled with the patient's name, initials AB and "right breast at 10 o'clock".  It consists of a 0.8 x 0.3 x 0.2 cm aggregate of rubbery/firm white/tan to yellow fibroadipose tissue fragments.  The specimen is submitted entirely in cassette A.\.br\\.br\\.br\||||||F
OBX|31|TX|MDT|tst6747183|Microscopic examination substantiates the above diagnosis.\.br\\.br\\.br\||||||F
OBX|32|TX|FIN|tst6747183|BREAST, RIGHT, 10:00, CORE BIOPSY \.br\INVASIVE DUCTAL CARCINOMA, NUCLEAR GRADE 1\.br\||||||F
OBX|33|CE|IMP|tst6747183|M85003^^SNO||||||||1||A
OBX|34|CE|IMP|tst6747183|P1140^^SNO||||||||1||A
OBX|35|CE|IMP|tst6747183|T04020^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004494|P|2.3
PID|1||100013570^^^RG|tst1278394|CIDSIX^PATIENT||19790215|F||MWU|660 MAIN STREET^^PITTSBURGH^PA^15213^United States||(412)555-7874|||||||||||||||||N
PV1|1||MWSPC||||MW001107^MCINTYRE-SELTMAN^KATHLEEN||||||||||pmc58662^MCINTYRE-SELTMAN^KATHLEEN|MWO|71397780|MWI||||||||||||||||||||||||200511011400
ORC|RE|00003|MWS05-94^CoPathPlus||CM||||200511011644|^LASSIGE^KAREN||MW001107^MCINTYRE-SELTMAN^KATHLEEN
OBR|1|00003|MWS05-94^CoPathPlus^tst7747183|MWSP^MW Pathology|||200511011644|||||||200511011644||MW001107||||^26^Y|-1|200511011650||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst7747183.1|^Cervix Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst7747183.1.1|A||||||||1^A|200512121425
OBX|3|CE|PROCESS|tst7747183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|4|TX|GDT|tst7747183|The specimen is received in formalin in one part labeled with the patient's name, initials AB and "3 o'clock cervix biopsy".  It consists of a rubbery gray tissue fragment measuring 0.5 x 0.2 x 0.1 cm.  The specimen is entirely submitted in cassette A.\.br\\.br\||||||F
OBX|5|TX|MDT|tst7747183|Microscopic examination substantiates the above diagnosis\.br\\.br\\.br\||||||F
OBX|6|TX|FIN|tst7747183|CERVIX, 3 O'CLOCK, COLPOSCOPIC BIOPSY \.br\A. CERVICAL INTRAEPITHELIAL NEOPLASIA 1 (CIN 1).\.br\B. CHRONIC CERVICITIS.\.br\\.br\||||||F
OBX|7|CE|IMP|tst7747183|M43000^^SNO||||||||1||A
OBX|8|CE|IMP|tst7747183|M74000^^SNO||||||||1||A
OBX|9|CE|IMP|tst7747183|P1140^^SNO||||||||1||A
OBX|10|CE|IMP|tst7747183|T83000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004495|P|2.3
PID|1||100013609^^^RG|tst8088394|CIDEIGHT^PATIENT||19790219|F||MWW|200 MAIN RD^^PITTSBURGH^PA^15213^United States||(412)457-8288|||||||||||||||||N
PV1|1||MW3700^3204||||MW240020586^SIMHAN^HYAGRIV||||||||||tst87363^SIMHAN^HYAGRIV|MWL|71398226|MWI||||||||||||||||||||||||200511091349|200512010800
ORC|RE|00001|MWS05-96^CoPathPlus||CM||||200511091357|^LASSIGE^KAREN||MW240017616^JEYABALAN^ARUNDHATH/PRS
OBR|1|00001|MWS05-96^CoPathPlus^tst1947183|MWSP^MW Pathology|||200511091356|||||||200511091356|PLAC|MW240017616||||^26^Y|-1|200511091420||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst1947183.1|PLAC^Placenta - 39+weeks^L||||||F||1^1
OBX|2|ST|BLOCK|tst1947183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst1947183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tst1947183.1.3|C||||||||3^C|200512121425
OBX|5|ST|BLOCK|tst1947183.1.4|A||||||||4^A|200512121425
OBX|6|ST|BLOCK|tst1947183.1.5|B||||||||5^B|200512121425
OBX|7|ST|BLOCK|tst1947183.1.6|C||||||||6^C|200512121425
OBX|8|CE|PROCESS|tst1947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|9|CE|PROCESS|tst1947183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|10|CE|PROCESS|tst1947183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|11|CE|PROCESS|tst1947183.1.1.4|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|12|CE|PROCESS|tst1947183.1.2.5|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|13|CE|PROCESS|tst1947183.1.3.6|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|14|TX|GDT|tst1947183|Received fresh labeled with the patient's name with the initials PM is a single-lobed placenta with membranes and umbilical cord. The 3-vessel, yellow-tan cord inserts eccentrically, 3.5 cm from the nearest margin, is 18.0 cm in length and 1.0 cm in diameter. The membranes insert marginally, are complete and the point of rupture is 2.0 cm from the nearest margin.  Minimal subchorionic fibrin plaques are noted.  The fetal surface is green-yellow with normal distribution of vessels. The placental disc is ovoid, 16.0 x 15.0 x 1.0 cm and weighs 350 grams, less than 10th percentile (normal placental weight for this gestational age is 451 +/- 76 gms). There is an accessory lobe measuring 6.2 x 4.5 x 1.2 cm separated from the main placental disc with a membrane distance of 1.5 cm.  The maternal surface is intact with minimal calcification. On cut section, two small marginal white lesions, up to 1.7 cm in maximum dimension are identified.  The parenchymal color and consistency are unremarkable. Representative sections are submitted labeled as follows:\.br\A - full thickness adjacent to cord insertion B - full thickness of periphery C - rolled membranes and cord.\.br\\.br\||||||F
OBX|15|TX|MDT|tst1947183|Microscopic examination substantiates the above diagnosis.\.br\\.br\||||||F
OBX|16|TX|FIN|tst1947183|PLACENTA, POST DATES (41 1/7 WEEKS) \.br\A.350 GRAMS (LESS THAN 10TH PERCENTILE FOR 41 WEEKS).\.br\B.TERM VILLOUS MATURATION WITH HYPERMATURE FEATURES INCLUDING INCREASED SYNCYTIAL KNOTS.\.br\C.ACCESSORY LOBE (6.2 X 4.5 X 1.2 CM IN DIMENSION).\.br\D.MECONIUM CONTAINING MACROPHAGES IN CHORIONIC PLATE AND EXTRAPLACENTAL MEMBRANES.\.br\E.MARGINAL INFARCT (TWO; UP TO 1.7 CM IN MAXIMUM DIMENSION).\.br\F.FOCAL ACUTE FETAL ENDOVASCULITIS INVOLVING AT LEAST ONE CHORIONIC PLATE VESSEL, PATCHY AMNION EPITHELIAL NECROSIS.\.br\G.THREE VESSEL UMBILICAL CORD WITH SMALL AMNION EPITHELIAL INCLUSION "CYSTS" AND RARE NEUTROPHILS IN MEDIA OF UMBILICAL VEIN.\.br\\.br\||||||F
OBX|17|CE|IMP|tst1947183|T05128^^SNO||||||||1||A
OBX|18|CE|IMP|tst1947183|T88100^^SNO||||||||1||A
OBX|19|CE|IMP|tst1947183|M29720^^SNO||||||||1||A
OBX|20|CE|IMP|tst1947183|M33410^^SNO||||||||1||A
OBX|21|CE|IMP|tst1947183|M41000^^SNO||||||||1||A
OBX|22|CE|IMP|tst1947183|M54000^^SNO||||||||1||A
OBX|23|CE|IMP|tst1947183|M54700^^SNO||||||||1||A
OBX|24|CE|IMP|tst1947183|T0X160^^SNO||||||||1||A
OBX|25|CE|IMP|tst1947183|T48000^^SNO||||||||1||A
OBX|26|CE|IMP|tst1947183|T88210^^SNO||||||||1||A
OBX|27|CE|IMP|tst1947183|T88300^^SNO||||||||1||A
OBX|28|CE|IMP|tst1947183|T88800^^SNO||||||||1||A
OBX|29|CE|IMP|tst1947183|T89000^^SNO||||||||1||A
OBX|30|CE|IMP|tst1947183|TY4230^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004496|P|2.3
PID|1||100013611^^^RG|tst0188394|CIDTEN^PATIENT||19881015|F||MWU|200 MAIN^^PITTSBURGH^PA^15213^United States||(412)457-8454|||||||||||||||||N
PV1|1||MWSPC||||MW320001107^MCINTYRE-SELTMAN^KATHLEEN||||||||||tst28363^MCINTYRE-SELTMAN^KATHLEEN|MWO|71398242|MWI||||||||||||||||||||||||200511091000
ORC|RE|00002|MWS05-97^CoPathPlus||CM||||200511091454|^LASSIGE^KAREN||MW001107^MCINTYRE-SELTMAN^KATHLEEN
OBR|1|00002|MWS05-97^CoPathPlus^tst2947183|MWSP^MW Pathology|||200511091452|||||||200511091452||MW001107||||^17^Y|-1|200511091510||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2947183.1|^Vulvar Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst2947183.1.1|A||||||||1^A|200512121425
OBX|3|CE|PROCESS|tst2947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|4|TX|GDT|tst2947183|The specimen is received in formalin in one part labeled with the patient's name, initials BH and "vulvar tissue".  It consists of two rubbery/firm brown tissue fragments measuring up to 0.4 x 0.3 x 0.1 cm.  The specimen is submitted entirely in cassette A.\.br\\.br\||||||F
OBX|5|TX|MDT|tst2947183|Microscopic examination substantiates the above diagnosis.\.br\\.br\||||||F
OBX|6|TX|FIN|tst2947183|VULVA, BIOPSY \.br\VULVAR INTRAEPITHELIAL NEOPLASIA 1 (VIN 1).\.br\\.br\||||||F
OBX|7|CE|IMP|tst2947183|M80002^^SNO||||||||1||A
OBX|8|CE|IMP|tst2947183|P1140^^SNO||||||||1||A
OBX|9|CE|IMP|tst2947183|T80100^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004497|P|2.3
PID|1||100013618^^^RG|tst0288394|CIDSIXTEEN^PATIENT||20051110|F||MWW|12111 GREENLEAF AVENUE^^BETHEL PARK^PA^15102^United States||(412)555-1212|||||||||||||||||N
PV1|1||MWLDR^LD01||||MW075887^HUGO^MARY ANN||||||||||pmc48162^HUGO^MARY ANN|MWL|71398341|MWI||||||||||||||||||||||||200511101414|200511101429
ORC|RE|00002|MWS05-98^CoPathPlus||CM||||200511101422|^LASSIGE^KAREN||MW075887^HUGO^MARY ANN
OBR|1|00002|MWS05-98^CoPathPlus^tst6947183|MWSP^MW Pathology|||200511101421|||||||200511101421|PLAC|MW075887||||^0^D|-1|200511101426||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst6947183.1|PLAC^Placenta - 40 weeks^L||||||F||1^1
OBX|2|ST|BLOCK|tst6947183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst6947183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tst6947183.1.3|C||||||||3^C|200512121425
OBX|5|CE|PROCESS|tst6947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|6|CE|PROCESS|tst6947183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|7|CE|PROCESS|tst6947183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|8|TX|GDT|tst6947183|Received fresh labeled with the patient's name initials "AA" is a single-lobed placenta with membranes and umbilical cord. The 3-vessel, tan-white cord inserts eccentrically, 6.0 cm from the nearest margin, is 56.0 cm in length and 1.2 cm in diameter. The cord shows two areas of possible flattening.  The first measures 10.0 cm in length and is located approximately 11.0 cm from the placental insertion site and the second is on a separately received, un-oriented portion of cord and measures approximately 16.0 cm. in length.  The membranes show partial circummarginate insertion, do not appear complete, are partially torn from the disc and the point of rupture cannot be assessed.  The amnion is partially separated from the chorion.   No subchorionic fibrin plaques are noted.  The fetal surface is minimally dull with normal distribution of vessels. The placental disc is ovoid, 21.0 x 15.5 x 2.1 cm, and weighs 600 grams, greater than the 90th percentile (normal placental weight for this gestational age is 453 +/- 75 gms). The maternal surface is intact with minimal calcification. On cut section, the parenchymal color and consistency are unremarkable.  No discrete lesions are noted grossly. Representative sections are submitted labeled as follows:\.br\A - full thickness adjacent to cord insertion B - full thickness of periphery C - rolled membranes and cord, includes flattened areas.\.br\\.br\||||||F
OBX|9|TX|FIN|tst6947183|PLACENTA, TERM (40 WEEKS) \.br\A.600 GRAMS (>90TH PERCENTILE FOR 40 WEEKS).\.br\B.APPROPRIATE VILLOUS MATURATION FOR GESTATIONAL AGE.\.br\C.MECONIUM CONTAINING MACROPHAGES IN CHORIONIC PLATE, STRIPPED REACTIVE AMNION, AND EXTRAPLACENTAL MEMBRANES.\.br\D.MINIMAL TO MILD ACUTE CHORIOAMNIONITIS (STAGE 1) INVOLVING CHORIONIC PLATE.\.br\E.FOCALLY REACTIVE CHORIONIC PLATE AMNION.\.br\F.PARTIAL CIRCUMMARGINATE INSERTION OF EXTRAPLACENTAL MEMBRANES.\.br\G.THREE-VESSEL UMBILICAL CORD (TOTAL LENGTH OF SEGMENTS RECEIVED 56 CM WITH TWO FLATTENED AREAS 10 AND 16 CM. IN LENGTH, RESPECTIVELY); MILD EDEMA OF WHARTON' S JELLY.\.br\\.br\||||||F
OBX|10|CE|IMP|tst6947183|M41000^^SNO||||||||1||A
OBX|11|CE|IMP|tst6947183|T05128^^SNO||||||||1||A
OBX|12|CE|IMP|tst6947183|T88100^^SNO||||||||1||A
OBX|13|CE|IMP|tst6947183|M36500^^SNO||||||||1||A
OBX|14|CE|IMP|tst6947183|T88210^^SNO||||||||1||A
OBX|15|CE|IMP|tst6947183|T88300^^SNO||||||||1||A
OBX|16|CE|IMP|tst6947183|T88800^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004498|P|2.3
PID|1||100013617^^^RG|tst8188394|CIDFIFTEEN^PATIENT||19551110|F||MWU|3112 GREENLEAF AVENUE^^BETHEL PARK^PA^15102^United States||(412)555-1212|||||||||||||||||N
PV1|1||MWSPC||||MW012922^BRUFSKY^ADAM||||||||||pmc13362^BRUFSKY^ADAM|MWO|71398325|MWI||||||||||||||||||||||||200511101358
ORC|RE|00003|MWS05-99^CoPathPlus||CM||||200511101624|^LASSIGE^KAREN||MW012922^BRUFSKY^ADAM
OBR|1|00003|MWS05-99^CoPathPlus^tst7947183|MWSP^MW Pathology|||200511101623|||||||200511101623||MW012922||||^50^Y|-1|200511110803||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst7947183.1|^Endocervical Curettings^L||||||F||1^1
OBX|2|ST|BLOCK|tst7947183.1.1|A||||||||1^A|200512121425
OBX|3|CE|PROCESS|tst7947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|4|TX|GDT|tst7947183|The specimen is received in formalin in one part labeled with the patient's name, initials AA and "Endocervical currettings".  It consists of a 0.6 x 0.4 x 0.2 cm aggregate of tan mucoid material.  The specimen is submitted entirely in cassette A.\.br\||||||F
OBX|5|TX|MDT|tst7947183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|6|TX|FIN|tst7947183|ENDOCERVIX, ENDOCERVICAL CURETTINGS \.br\A.BENIGN ENDOCERVICAL TISSUE.\.br\B.MUCUS AND DESQUAMATED SQUAMOUS CELLS (see comment).\.br\||||||F
OBX|7|CE|IMP|tst7947183|P1154^^SNO||||||||1||A
OBX|8|CE|IMP|tst7947183|T83300^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004700|P|2.3
PID|1||580141-00^^^RG|tpmc2298394|TESTVTWOFIVE^BILLING^DOUGLAS||19301103|M|||||||||||198-26-1576|||||||||||N
PV1|1||MWBRI||||505073^PLANET^EARTH||||||||||pmc97361^PLANET^MARS|MWO|38029013|||||||||||||||||||||||||200511161000
ORC|RE||PVS05-68^CoPathPlus||CM||||200512191437|^SOLTESZ^BENJAMIN||505073^PLANET^EARTH
OBR|1||PVS05-68^CoPathPlus^tpmc9077183|PVAP^PV Pathology|||200512191436|||||||200512191436|ANTRUMBIO|505073||||^75^Y|-1|200512191640||SP|C|||||||MD.AMIN.RA^AMIN^RAJNIKANT|^SOLTESZ^BENJAMIN
OBX|1|CE|ANT|tpmc9077183.1|ANTRUMBIO^Antrum, Biopsy^L||||||C||1^1
OBX|2|ST|BLOCK|tpmc9077183.1.1|A||||||||1^A|200512191436
OBX|3|CE|PROCESS|tpmc9077183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E L1|200512191445
OBX|4|CE|PROCESS|tpmc9077183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^H&E L2|200512191445
OBX|5|CE|PROCESS|tpmc9077183.1.1.3|pmc5553^HH&E (HISTO)^L||||||||3^H&E L3|200512191445
OBX|6|CE|PROCESS|tpmc9077183.1.1.4|pmc8133^UCHL1 CD45RO (IPEX)^L||||||||4^UCHL1|200512191448
OBX|7|TX|GDT|tpmc9077183|The specimen is received in formalin labeled with the patient' s name and "gastric antrum biopsy".  It consists of one fragment of soft, tan tissue measuring 0.2 cm in greatest dimension.  The specimen is wrapped in lens paper and totally submitted in one cassette labeled 1A.\.br\1A  x1, totally submitted\.br\RK/kmr\.br\||||||C
OBX|8|TX|MDT|tpmc9077183|Microscopic examination substantiates the above diagnosis.\.br\BR/ncs\.br\||||||C
OBX|9|TX|FIN|tpmc9077183|STOMACH, ANTRUM, BIOPSY \.br\A.UNREMARKABLE GASTRIC FUNDUS MUCOSA.\.br\B.GIEMSA STAIN IS NEGATIVE FOR HELICOBACTER PYLORI.\.br\BR/ncs\.br\||||||C
OBX|10|CE|IMP|tpmc9077183|E0004^^SNO||||||||1||A
OBX|11|CE|IMP|tpmc9077183|P1140^^SNO||||||||1||A
OBX|12|CE|IMP|tpmc9077183|T63010^^SNO||||||||1||A
OBX|13|CE|IMP|tpmc9077183|T63400^^SNO||||||||1||A
OBX|14|CE|IMP|tpmc9077183|T63600^^SNO||||||||1||A
OBR|2||tpmc9077183^CoPathPlus^tpmc9077183.P1|DNA^DNA||||||||||200512191635|||||||1|200512191635||SP|F||||||||^SOLTESZ^BENJAMIN
OBX|1|TX|PIN|tpmc9077183|Immunohistochemical stains have been ordered to classify this neoplasm. Results will be reported in an addendum. \.br\||||||C
OBX|2|TX|PRC|tpmc9077183|\.br\A.          ONYCHOMYCOSIS.\.br\B.          INTERPRETATION OF PAS-D STAIN CONFIRMS PRESENCE OF HYPHAE AND SPORES.\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004701|P|2.3
PID|1||444333222^^^WASH|tst4996394|RABBIT^ROGER||19550416|M|||||||||||444-33-3222|||||||||||N
PV1|1||PATHOS||||505077^PLANET^NEPTUNE||||||||||pmc28361^PLANET^NEPTUNE|OSD|0001444333222|||||||||||||||||||||||||200505041035
ORC|RE||PHS05-70^CoPathPlus||CM||||200505041050|^LASSIGE^KAREN||505077^PLANET^NEPTUNE
OBR|1||PHS05-70^CoPathPlus^tst1786183|PHSP^PH Surgical Pathology|||200505041049|||||||200505041049|LNBS|505077||||^50^Y|-1|200505110944||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst1786183.1|LNBS^Left axillary Lymph Node^L||||||F||1^1
OBX|2|ST|BLOCK|tst1786183.1.1|A||||||||1^A|200505041533
OBX|3|ST|BLOCK|tst1786183.1.2|B||||||||2^B|200505041533
OBX|4|CE|PROCESS|tst1786183.1.1.1|pmc7533^Reticulin Stain (Histo)^L||||||||1^Retic|200506011408
OBX|5|CE|PROCESS|tst1786183.1.1.2|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|6|CE|PROCESS|tst1786183.1.2.3|$hinit^Initial H&E^L||||||||3^H&E|200508180859
OBX|7|CE|PROCESS|tst1786183.1.2.4|pmc7533^Reticulin Stain (Histo)^L||||||||4^Retic|200506011408
OBX|8|CE|PROCESS|tst1786183.1.1.5|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||3^HBNKNC|200505240648
OBX|9|CE|PROCESS|tst1786183.1.2.6|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||5^HBNKNC|200505240648
OBX|10|TX|GDT|tst1786183|The specimen is received fresh and labeled with the patient' s name, initials AD, medical record number and "left axillary node".  The node has areas of yellow adipose tissue.  It measures 1.2 x 1.6 x 1.6 cm.  The specimen is cut and formalin fixed and submitted in cassettes A and B.\.br\||||||F
OBX|11|TX|FIN|tst1786183|Left axillary Lymph Node:  \.br\NEGATIVE FOR CARCINOMA\.br\||||||F
OBX|12|CE|IMP|tst1786183|M09450^^SNO||||||||1||A
OBX|13|CE|IMP|tst1786183|T08710^^SNO||||||||1||A
OBX|14|CE|IMP|tst1786183|TY8120^^SNO||||||||1||A
OBX|15|CE|IMP|tst1786183|202.04^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004702|P|2.3
PID|1||322388000^^^WASH|tst5996394|PIPER^PETER||19621221|M|||||||||||322-38-8000|||||||||||N
PV1|1||PATHOS||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|OSD|0001322388000|||||||||||||||||||||||||200505041635
ORC|RE||PHS05-71^CoPathPlus||CM||||200505041643|^LASSIGE^KAREN||505079^PLANET^PLUTO
OBR|1||PHS05-71^CoPathPlus^tst2786183|PHSP^PH Surgical Pathology|||200505041642|||||||200505041642|TRBX|505079||||^42^Y|-1|200506231420||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2786183.1|TRBX^Biopsy Transverse Colon^L||||||F||1^1
OBX|2|ST|BLOCK|tst2786183.1.1|A||||||||1^A|200507221753
OBX|3|CE|PROCESS|tst2786183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|4|TX|GDT|tst2786183|The specimen is received in formalin labeled with the patient' s name, initials FN and "transverse colon biopsy".  It consists of four soft, pink-tan portions of tissue measuring in aggregate 0.5 x 0.3 x 0.1 cm.  Entirely submitted in one block.  \.br\||||||F
OBX|5|TX|FIN|tst2786183|TRANSVERSE COLON BIOPSY\.br\A.          AJGAF\.br\B.     KGJ;AJREI\.br\C.     LSKRKIE\.br\     \.br\||||||F
OBX|6|CE|IMP|tst2786183|P1140^^SNO||||||||1||A
OBX|7|CE|IMP|tst2786183|T67400^^SNO||||||||1||A
OBX|8|CE|IMP|tst2786183|789.00^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004703|P|2.3
PID|1||222000222^^^WASH|tst1996394|RICH^RICHIE||19600415|M|||||||||||222-00-0222|||||||||||N
PV1|1||PATHOS||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0002222000222|||||||||||||||||||||||||200505050955
ORC|RE||PHS05-72^CoPathPlus||CM||||200505051415|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||PHS05-72^CoPathPlus^tst3786183|PHSP^PH Surgical Pathology|||200505051414|||||||200505051414|COBX|505073||||^45^Y|-1|200505181421||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst3786183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|CE|ANT|tst3786183.2|REBX^Biopsy Rectum^L||||||F||2^2
OBX|3|TX|GDT|tst3786183|This specimen is received in formalin in two parts.\.br\\.br\Part 1 is labeled with the patient' s name, initials VJ and "colon biopsy".  Received are five irregular, soft, tan tissue fragments ranging in size from 0.1 to 0.25 cm in greatest dimension.  The specimen is entirely submitted in cassette 1A. \.br\\.br\Part 2 is labeled with the patient' s name, initials VJ and "Rectum biopsy".  Received are six irregular, soft, tan tissue fragments ranging in size from 0.2 to 0.25 cm in greatest dimension.  The specimen is entirely submitted in cassette 2A. \.br\\.br\||||||F
OBX|4|TX|FIN|tst3786183|PART 1: COLON BIOPSY, ENDOSCOPIC BIOPSY\.br\A.          COLONIC MUCOSA WITH NO SIGNIFICANT ABNORMALITY.\.br\B.     NEGATIVE FOR DYSPLASIA.\.br\\.br\PART 2: RECTUM, ENDOSCOPIC BIOPSY\.br\A.          COLONIC MUCOSA WITH FOCAL HYPERPLASTIC CHANGES, OTHERWISE NO ACTIVE INFLAMATION.\.br\B.          NEGATIVE FOR DYSPLASIA.\.br\||||||F
OBX|5|CE|IMP|tst3786183|M00100^^SNO||||||||1||A
OBX|6|CE|IMP|tst3786183|P1140^^SNO||||||||1||A
OBX|7|CE|IMP|tst3786183|T67000^^SNO||||||||1||A
OBX|8|CE|IMP|tst3786183|T67010^^SNO||||||||1||A
OBX|9|CE|IMP|tst3786183|M72001^^SNO||||||||1||A
OBX|10|CE|IMP|tst3786183|P1140^^SNO||||||||1||A
OBX|11|CE|IMP|tst3786183|T67010^^SNO||||||||1||A
OBX|12|CE|IMP|tst3786183|T68000^^SNO||||||||1||A
OBX|13|CE|IMP|tst3786183|787.91^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004704|P|2.3
PID|1||222333444^^^CITIZN|tst7796394|JORDAN^BAILEY||19630303|F|||||||||||222-33-3444|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001800000000|||||||||||||||||||||||||200505061505
ORC|RE||MWS05-86^CoPathPlus||CM||||200510031728|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||MWS05-86^CoPathPlus^tst2637183|MWSP^MW Pathology|||200510031712|||||||200510031712|BCTP|505074||||^42^Y|-1|200510031740||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2637183.1|BCTP^Breast Core Bx w/Touch Prep (Surg)^L||||||F||1^1
OBX|2|ST|BLOCK|tst2637183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst2637183.1.2|A||||||||2^A|200512121425
OBX|4|CE|PROCESS|tst2637183.1.1.1|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||2^TP|200512121431
OBX|5|CE|PROCESS|tst2637183.1.1.2|pmc6963^Gross Intraop Consult (Surg)^L||||||||3^GR|200512121428
OBX|6|CE|PROCESS|tst2637183.1.1.3|pmc4115^Blank Slide (MW)^L||||||||4^BLANK|200512121428
OBX|7|CE|PROCESS|tst2637183.1.1.4|$hinit^Initial H&E^L||||||||5^H&E Lv1|200512121431
OBX|8|CE|PROCESS|tst2637183.1.1.5|pmc4115^Blank Slide (MW)^L||||||||6^BLANK|200512121428
OBX|9|CE|PROCESS|tst2637183.1.1.6|pmc5553^HH&E (HISTO)^L||||||||7^H&E Lv2|200512121431
OBX|10|CE|PROCESS|tst2637183.1.1.7|pmc4115^Blank Slide (MW)^L||||||||8^BLANK|200512121428
OBX|11|CE|PROCESS|tst2637183.1.1.8|pmc5553^HH&E (HISTO)^L||||||||9^H&E Lv3|200512121431
OBX|12|CE|PROCESS|tst2637183.1.1.9|pmc4115^Blank Slide (MW)^L||||||||10^BLANK|200512121428
OBX|13|CE|PROCESS|tst2637183.1.1.10|pmc5553^HH&E (HISTO)^L||||||||11^H&E Lv4|200512121431
OBX|14|CE|PROCESS|tst2637183.1.1.11|pmc4115^Blank Slide (MW)^L||||||||12^BLANK|200512121428
OBX|15|CE|PROCESS|tst2637183.1.1.12|pmc5553^HH&E (HISTO)^L||||||||13^H&E Lv5|200512121431
OBX|16|CE|PROCESS|tst2637183.1.1.13|pmc5553^HH&E (HISTO)^L||||||||14^HHE|200512121431
OBX|17|CE|PROCESS|tst2637183.1.0.14|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||1^TP|200512121431
OBX|18|CE|PROCESS|tst2637183.1.0.15|pmc6963^Gross Intraop Consult (Surg)^L||||||||2^GR|200512121428
OBX|19|CE|PROCESS|tst2637183.1.1.16|pmc4115^Blank Slide (MW)^L||||||||15^BLANK|200512121428
OBX|20|CE|PROCESS|tst2637183.1.1.17|$hinit^Initial H&E^L||||||||16^H&E Lv1|200512121431
OBX|21|CE|PROCESS|tst2637183.1.1.18|pmc4115^Blank Slide (MW)^L||||||||17^BLANK|200512121428
OBX|22|CE|PROCESS|tst2637183.1.1.19|pmc5553^HH&E (HISTO)^L||||||||18^H&E Lv2|200512121431
OBX|23|CE|PROCESS|tst2637183.1.1.20|pmc4115^Blank Slide (MW)^L||||||||19^BLANK|200512121428
OBX|24|CE|PROCESS|tst2637183.1.1.21|pmc5553^HH&E (HISTO)^L||||||||20^H&E Lv3|200512121431
OBX|25|CE|PROCESS|tst2637183.1.1.22|pmc4115^Blank Slide (MW)^L||||||||21^BLANK|200512121428
OBX|26|CE|PROCESS|tst2637183.1.1.23|pmc5553^HH&E (HISTO)^L||||||||22^H&E Lv4|200512121431
OBX|27|CE|PROCESS|tst2637183.1.1.24|pmc4115^Blank Slide (MW)^L||||||||23^BLANK|200512121428
OBX|28|CE|PROCESS|tst2637183.1.1.25|pmc5553^HH&E (HISTO)^L||||||||24^H&E Lv5|200512121431
OBX|29|CE|PROCESS|tst2637183.1.1.26|pmc5553^HH&E (HISTO)^L||||||||25^HHE|200512121431
OBX|30|CE|PROCESS|tst2637183.1.1.27|pmc6305^FISH Order (MWSP)^L||||||||26^Magee FISH|200512121428
OBX|31|TX|GDT|tst2637183|The specimen is received in formalin in one part labeled with the patient's name, initials RL and "left breast".  It consists of three cylindrical off-white/tan rubbery cores measuring 1.2 to 1.6 cm in length and 0.15 cm in diameter.  The specimen is submitted entirely in cassette A.\.br\||||||F
OBX|32|TX|MDT|tst2637183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|33|TX|FIN|tst2637183|PART 1: Breast Core Bx\.br\\.br\A.INFILTRATING CARCINOMA WITH APOCRINE FEATURES, NUCLEAR GRADE 3.   \.br\||||||F
OBX|34|CE|IMP|tst2637183|P1140^^SNO||||||||1||A
OBX|35|CE|IMP|tst2637183|T04010^^SNO||||||||1||A
OBX|36|CE|IMP|tst2637183|M80103^^SNO||||||||1||A
OBX|37|CE|IMP|tst2637183|285.9^^ICD||||||||1
OBR|2||tst2637183^CoPathPlus^tst2637183.P1|FISH^FISH (PCL)||||||||||200510031736|||||||1|200510031736||SP|F|||||||987654^PATHOID^DOCTOR|^LASSIGE^KAREN
OBX|1|TX|PIN|tst2637183|Amplification of the HER-2/NEU gene was identified by interphase FISH analysis.\.br\\.br\RESULTS:\.br\\.br\Fluorescence in situ hybridization (FISH) analysis was performed on MWH Surgical  #MWS05-18803, Block 1A (Breast Cancer) using the DNA probe for the HER-2/NEU gene (Vysis, Inc., lot #61093).  The ratio of HER-2/NEU signals to chromosome 17 centromere signals was determined to be 3.36.  A ratio of 2.0 or greater is considered to be amplified; therefore, this specimen is amplified.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004705|P|2.3
PID|1||154565433^^^RR|tst3407394|PRESBY^PENELOPE||19580602|F||||||||||||||||||||||N
PV1|1||5E||||505074^PLANET^MARS||||||||||pmc87361^PLANET^EARTH|I|0238928985128|||||||||||||||||||||||||200505081530
ORC|RE||PHS05-89^CoPathPlus||CM||||200505101750|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PHS05-89^CoPathPlus^tst1196183|PHSP^PH Surgical Pathology|||200505101750|||||||200505101750|COBX|505074||||^46^Y|-1|200505251346||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst1196183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|GDT|tst1196183|The specimen is recieved in B5 fixative labeled "bone marrow biopsy" and consists of a single core of tan, cancellous bone measuring # cm x # cm.\.br\||||||F
OBX|3|TX|MDT|tst1196183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Middle Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Anterior\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Minor dimension: 3 cm\.br\GROSS SATELLITES: \.br\TUMOR TYPE:      Invasive adenocarcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES: \.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Vascular margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Severe\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 0\.br\     Number of N1 lymph nodes examined: 3\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 2R\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 3\.br\T STAGE, PATHOLOGIC:      pTis\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM0\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|4|TX|FIN|tst1196183|MUCINOUS ADENOCARCINOMA\.br\||||||F
OBX|5|CE|IMP|tst1196183|M84803^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004706|P|2.3
PID|1||205588348^^^RR|tst2407394|PRESBY^PETER||19760720|M|||||||||||205-58-8348|||||||||||N
PV1|1||6D^D0658||||505074^PLANET^MARS||||||||||pmc87361^PLANET^EARTH|I|0061859405128|||||||||||||||||||||||||200505080217
ORC|RE||PHS05-90^CoPathPlus||CM||||200505101751|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PHS05-90^CoPathPlus^tst2196183|PHSP^PH Surgical Pathology|||200505101751|||||||200505101751|COBX|505074||||^28^Y|-1|200505251345||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst2196183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|GDT|tst2196183|The specimen is recieved in B5 fixative labeled "bone marrow biopsy" and consists of a single core of tan, cancellous bone measuring # cm x # cm.\.br\||||||F
OBX|3|TX|MDT|tst2196183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Left Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Superior\.br\PROCEDURE:      Bilobectomy\.br\TUMOR SIZE:      Minor dimension: 4 cm\.br\     Ipsilateral lobe(s)\.br\TUMOR TYPE:      Basaloid squamous carcinoma, Carcinosarcoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\     Ipsilateral lobe(s)\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      Diaphragm\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      > 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Chest wall margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Moderate\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 5\.br\     Number of N1 lymph nodes examined: 5\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      Yes\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 4R, Level 10L\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 5\.br\     Number of N2 lymph nodes examined: 0\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      Yes\.br\UNDERLYING DISEASE(S):      Atypical alveolar hyperplasia\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM0\.br\ANCILLARY STUDIES:      FISH studies\.br\--------------------------------------------------------\.br\\.br\||||||F
OBX|4|TX|FIN|tst2196183|ADENOCARCINOMA\.br\||||||F
OBX|5|CE|IMP|tst2196183|M81403^^SNO||||||||1||A
OBR|2||tst2196183^CoPathPlus^tst2196183.P1|EM^Electron Microscopy||||||||||200505251328|||||||1|200505251328||SP|F|||||||002624^BECICH^MICHAEL|987654^PATHOID^DOCTOR
OBX|1|TX|PIN|tst2196183|adenocarcinoma\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004707|P|2.3
PID|1||100013559^^^RG|tst8868394|CIDTWO^PATIENT||19680425|F||MWW|200 OAKLAND AVE^^PITTSBURGH^PA^15213^United States||(412)641-7897|||||||||||||||||N
PV1|1||MWSPC||||MW234027383^CHESIN^CAROLE||||||||||tst27363^CHESIN^CAROLE|MWO|71397657|MWR||||||||||||||||||||||||200511011200
ORC|RE|00003|MWS05-91^CoPathPlus||CM||||200511011258|^LASSIGE^KAREN||MW234027383^CHESIN^CAROLE
OBR|1|00003|MWS05-91^CoPathPlus^tst4747183|MWSP^MW Pathology|||200511011253|||||||200511011253||MW234027383||||^37^Y|-1|200511011353||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst4747183.2|^Endometrial Curettings^L||||||F||1^1
OBX|2|ST|BLOCK|tst4747183.1.1|A||||||||1^A|200511011252
OBX|3|ST|BLOCK|tst4747183.1.2|B||||||||2^B|200511011252
OBX|4|ST|BLOCK|tst4747183.1.3|C||||||||3^C|200511011252
OBX|5|ST|BLOCK|tst4747183.1.4|D||||||||4^D|200511011252
OBX|6|ST|BLOCK|tst4747183.1.5|E||||||||5^E|200511011252
OBX|7|ST|BLOCK|tst4747183.1.6|F||||||||6^F|200511011252
OBX|8|ST|BLOCK|tst4747183.1.7|G||||||||7^G|200511011252
OBX|9|ST|BLOCK|tst4747183.1.8|H||||||||8^H|200511011252
OBX|10|ST|BLOCK|tst4747183.1.9|I||||||||9^I|200511011252
OBX|11|ST|BLOCK|tst4747183.1.10|J||||||||10^J|200511011252
OBX|12|ST|BLOCK|tst4747183.1.11|K||||||||11^K|200511011252
OBX|13|ST|BLOCK|tst4747183.1.12|L||||||||12^L|200511011252
OBX|14|ST|BLOCK|tst4747183.1.13|M||||||||13^M|200511011252
OBX|15|ST|BLOCK|tst4747183.1.14|N||||||||14^N|200511011252
OBX|16|ST|BLOCK|tst4747183.1.15|O||||||||15^O|200511011252
OBX|17|CE|PROCESS|tst4747183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|18|CE|PROCESS|tst4747183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|19|CE|PROCESS|tst4747183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|20|CE|PROCESS|tst4747183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|21|CE|PROCESS|tst4747183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|22|CE|PROCESS|tst4747183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|23|CE|PROCESS|tst4747183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|24|CE|PROCESS|tst4747183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|25|CE|PROCESS|tst4747183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|26|CE|PROCESS|tst4747183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|27|CE|PROCESS|tst4747183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|28|CE|PROCESS|tst4747183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|29|CE|PROCESS|tst4747183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|30|CE|PROCESS|tst4747183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|31|CE|PROCESS|tst4747183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200511011252
OBX|32|TX|GDT|tst4747183|The specimen is received in formalin labeled with the patient' s name with initials AA and "endometrial curettings".  Specimen consists of a 2.3 x 2.0 x 0.3 cm admixture of multiple soft, tan-gray friable tissue fragments and blood stained mucus.  The specimen is totally submitted in cassette labeled A.\.br\||||||F
OBX|33|TX|MDT|tst4747183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|34|TX|FIN|tst4747183|A.     HYPERPLASTIC AND ADENOMYOMATOUS ENDOMETRIAL POLYP.\.br\B.     PROLIFERATIVE ENDOMETRIUM.\.br\||||||F
OBX|35|CE|IMP|tst4747183|M72440^^SNO||||||||1||A
OBX|36|CE|IMP|tst4747183|M76800^^SNO||||||||1||A
OBX|37|CE|IMP|tst4747183|M79310^^SNO||||||||1||A
OBX|38|CE|IMP|tst4747183|T84000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004708|P|2.3
PID|1||888444222^^^MCPH|tst8147394|MARTIAN^MARVIN||19620808|M|||||||||||888-44-4222|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0001888444222|||||||||||||||||||||||||200505130856
ORC|RE||PHS05-91^CoPathPlus||CM||||200505130904|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||PHS05-91^CoPathPlus^tst1696183|PHSP^PH Surgical Pathology|||200505130901|||||||200505130901|PROST|505074||||^42^Y|-1|200506231414||SP|C|||||||987654^PATHOID^DOCTOR|^LASSIGE^KAREN
OBX|1|CE|ANT|tst1696183.1|PROST^Prostate and Seminal Vesicles^L||||||C||1^1
OBX|2|ST|BLOCK|tst1696183.1.1|A||||||||1^A|200507221753
OBX|3|ST|BLOCK|tst1696183.1.2|B||||||||2^B|200507221753
OBX|4|ST|BLOCK|tst1696183.1.3|C||||||||3^C|200507221753
OBX|5|ST|BLOCK|tst1696183.1.4|D||||||||4^D|200507221753
OBX|6|ST|BLOCK|tst1696183.1.5|E||||||||5^E|200507221753
OBX|7|ST|BLOCK|tst1696183.1.6|F||||||||6^F|200507221753
OBX|8|ST|BLOCK|tst1696183.1.7|G||||||||7^G|200507221753
OBX|9|ST|BLOCK|tst1696183.1.8|H||||||||8^H|200507221753
OBX|10|CE|PROCESS|tst1696183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|11|CE|PROCESS|tst1696183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|12|CE|PROCESS|tst1696183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|13|CE|PROCESS|tst1696183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|14|CE|PROCESS|tst1696183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|15|CE|PROCESS|tst1696183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|16|CE|PROCESS|tst1696183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|17|CE|PROCESS|tst1696183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|18|TX|GDT|tst1696183|The specimen is received in buffered formalin labeled "      " and consists of _____________  of pink, soft tissue, _________ cm in greatest dimension.  Specimen is submitted labeled A- H.\.br\FF\.br\||||||C
OBX|19|TX|MDT|tst1696183|     SYNOPTIC DATA - PRIMARY PROSTATE TUMORS\.br\CLINICAL DATA:      PSA value: 5\.br\INVASIVE CA IDENTIFIED?:      Yes\.br\TUMOR HISTOLOGY:      Adenocarcinoma NOS\.br\     Ductal adenocarcinoma\.br\PRIMARY GLEASON GRADE:      Not primary tumor\.br\SECONDARY GLEASON GRADE:      Unknown\.br\GLEASON SUM SCORE:      Unknown\.br\GLEASON 4/5 PERCENTAGE:      5%\.br\WEIGHT OF PROSTATE:      55gm\.br\TUMOR SIZE:      Maximum dimension:  5.0 cm\.br\LOBE LATERALITY:      Left Lobe\.br\PERCENT OF SPECIMEN INVOLVED BY TUMOR:      5 - 25%\.br\MULTIFOCAL DISEASE:      Yes\.br\HIGH GRADE PIN:      Yes - NOS\.br\EXTRAPROSTATIC EXTENSION:      Yes - Multifocal\.br\PERINEURAL INVASION:      Yes\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\SEMINAL VESICLE INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      All surgical margins free of tumor\.br\LYMPH NODES EXAMINED:      0\.br\LYMPH NODES POSITIVE:      0\.br\EXTRANODAL EXTENSION:      No\.br\T STAGE, PATHOLOGIC:      pT1c\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM1\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\--------------------------------------------------------\.br\\.br\||||||C
OBX|20|TX|FIN|tst1696183|PROSTATE CANCER\.br\||||||C
OBX|21|CE|IMP|tst1696183|M80003^^SNO||||||||1||A
OBX|22|CE|IMP|tst1696183|T77100^^SNO||||||||1||A
OBX|23|CE|IMP|tst1696183|602.8^^ICD||||||||1
OBR|2||tst1696183^CoPathPlus^tst1696183.P1|CG^Cytogenetics||||||||||200505251329|||||||1|200505251329||SP|F|||||||SHEKHTER-PCL^SHEKHTER-LEVIN^SOFIA|^LASSIGE^KAREN
OBX|1|TX|PIN|tst1696183|46,XY,del(6)(q21q22)[16]/46,XY[4]\.br\\.br\Mosaic abnormal male  chromosome analysis with an apparently normal cell line and one that has an interstitial deletion of the long arm of one chromosome 6.  Deletions of the long arm of chromosome 6 have been found in a variety of B cell neoplasms, mostly in combination with other chromosome changes accumulated during disease progression [Merup M et al. (1998) Blood 91:3397-3400; Offit K et al. (1993) Blood 82:2157-2162; Brigaudeau C, Bilhou-Nabera C. del(6q) abnormalities in lymphoid malignancies. Atlas Genet Cytogenet Oncol Haematol. December 1998. URL : http://www.infobiogen.fr/services/chromcancer /Anomalies/del6qID1148.html].  Three regions of minimal critical deletions were delineated and the existence of a tumor suppressor gene(s) on 6q, involved in the pathogenesis of lymphoma, was proposed [Zhang Y et al. (2000) Genes Chromosomes Cancer 27:52-58; Menasce LP et al. (1994) Idem 10:286-288; Guan XY et al. (1996) Blood 88:1418-1422].\.br\\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 20\.br\No. of Cells Karyotyped:              4\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:                    20      \.br\\.br\Twenty trypsin-Giemsa banded metaphase cells were analyzed from direct and 24hr  hour harvests of unstimulated tumor cell cultures.  Four cells had an apparently normal male chromosome complement.    Sixteen cells had a 46,XY,del(6)(q21q22) chromosome pattern.  \.br\\.br\Average band level/haploid set:     425\.br\\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004709|P|2.3
PID|1||100013561^^^RG|tst0968394|CIDTHREE^PATIENT||19760210|F||MWW|300 CRAIG STREET^^PITTSBURGH^PA^15213^United States||(412)457-8754|||||||||||||||||N
PV1|1||MW3700^3195||||MW240017616^JEYABALAN^ARUNDHATH/PRS||||||||||tst38363^JEYABALAN^ARUNDHATH/PRS|MWL|71397673|MWI||||||||||||||||||||||||200511011400|200512010700
ORC|RE|00003|MWS05-92^CoPathPlus||CM||||200511011436|^LASSIGE^KAREN||MW240017616^JEYABALAN^ARUNDHATH/PRS
OBR|1|00003|MWS05-92^CoPathPlus^tst5747183|MWSP^MW Pathology|||200511011433|||||||200511011433|PLAC|MW240017616||||^29^Y|-1|200511011455||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst5747183.1|PLAC^Placenta 40 weeks^L||||||F||1^1
OBX|2|ST|BLOCK|tst5747183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst5747183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tst5747183.1.3|C||||||||3^C|200512121425
OBX|5|ST|BLOCK|tst5747183.1.4|A||||||||4^A|200512121425
OBX|6|ST|BLOCK|tst5747183.1.5|B||||||||5^B|200512121425
OBX|7|ST|BLOCK|tst5747183.1.6|C||||||||6^C|200512121425
OBX|8|CE|PROCESS|tst5747183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|9|CE|PROCESS|tst5747183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|10|CE|PROCESS|tst5747183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|11|CE|PROCESS|tst5747183.1.1.4|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|12|CE|PROCESS|tst5747183.1.2.5|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|13|CE|PROCESS|tst5747183.1.3.6|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|14|TX|GDT|tst5747183|Received fresh labeled with the patient's name initials "AA" is a single-lobed placenta with membranes and umbilical cord. The 3-vessel, tan-white cord inserts eccentrically, 6.0 cm from the nearest margin, is 56.0 cm in length and 1.2 cm in diameter. The cord shows two areas of possible flattening.  The first measures 10.0 cm in length and is located approximately 11.0 cm from the placental insertion site and the second is on a separately received, un-oriented portion of cord and measures approximately 16.0 cm. in length.  The membranes show partial circummarginate insertion, do not appear complete, are partially torn from the disc and the point of rupture cannot be assessed.  The amnion is partially separated from the chorion.   No subchorionic fibrin plaques are noted.  The fetal surface is minimally dull with normal distribution of vessels. The placental disc is ovoid, 21.0 x 15.5 x 2.1 cm, and weighs 600 grams, greater than the 90th percentile (normal placental weight for this gestational age is 453 +/- 75 gms). The maternal surface is intact with minimal calcification. On cut section, the parenchymal color and consistency are unremarkable.  No discrete lesions are noted grossly. Representative sections are submitted labeled as follows:\.br\A - full thickness adjacent to cord insertion B - full thickness of periphery C - rolled membranes and cord, includes flattened areas.\.br\\.br\||||||F
OBX|15|TX|FIN|tst5747183|PLACENTA, TERM (40 WEEKS) \.br\A.600 GRAMS (>90TH PERCENTILE FOR 40 WEEKS).\.br\B.APPROPRIATE VILLOUS MATURATION FOR GESTATIONAL AGE.\.br\C.MECONIUM CONTAINING MACROPHAGES IN CHORIONIC PLATE, STRIPPED REACTIVE AMNION, AND EXTRAPLACENTAL MEMBRANES.\.br\D.MINIMAL TO MILD ACUTE CHORIOAMNIONITIS (STAGE 1) INVOLVING CHORIONIC PLATE.\.br\E.FOCALLY REACTIVE CHORIONIC PLATE AMNION.\.br\F.PARTIAL CIRCUMMARGINATE INSERTION OF EXTRAPLACENTAL MEMBRANES.\.br\G.THREE-VESSEL UMBILICAL CORD (TOTAL LENGTH OF SEGMENTS RECEIVED 56 CM WITH TWO FLATTENED AREAS 10 AND 16 CM. IN LENGTH, RESPECTIVELY); MILD EDEMA OF WHARTON' S JELLY.\.br\\.br\||||||F
OBX|16|CE|IMP|tst5747183|M41000^^SNO||||||||1||A
OBX|17|CE|IMP|tst5747183|T05128^^SNO||||||||1||A
OBX|18|CE|IMP|tst5747183|T88100^^SNO||||||||1||A
OBX|19|CE|IMP|tst5747183|M36500^^SNO||||||||1||A
OBX|20|CE|IMP|tst5747183|T88210^^SNO||||||||1||A
OBX|21|CE|IMP|tst5747183|T88300^^SNO||||||||1||A
OBX|22|CE|IMP|tst5747183|T88800^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004710|P|2.3
PID|1||100013569^^^RG|tst0278394|CIDFIVE^PATIENT||19800522|F||MWW|5000 BLUE STREET^^PITTSBURGH^PA^15222^United States||(412)457-8787|||||||||||||||||N
PV1|1||MW5300^5306||||MW017616^JEYABALAN^ARUNDHATH||||||||||pmc42203^JEYABALAN^ARUNDHATH|MWH|71397764|MWI||||||||||||||||||||||||200511010800
ORC|RE|00003|MWS05-93^CoPathPlus||CM||||200511011553|^LASSIGE^KAREN||MW017616^JEYABALAN^ARUNDHATH
OBR|1|00003|MWS05-93^CoPathPlus^tst6747183|MWSP^MW Pathology|||200511011553|||||||200511011553|BCTP|MW017616||||^25^Y|-1|200511011633||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst6747183.1|BCTP^Breast Core Bx w/Touch Prep (Surg)^L||||||F||1^1
OBX|2|ST|BLOCK|tst6747183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst6747183.1.2|A||||||||2^A|200512121425
OBX|4|CE|PROCESS|tst6747183.1.1.1|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||2^TP|200512121431
OBX|5|CE|PROCESS|tst6747183.1.1.2|pmc6963^Gross Intraop Consult (Surg)^L||||||||3^GR|200512121428
OBX|6|CE|PROCESS|tst6747183.1.1.3|pmc4115^Blank Slide (MW)^L||||||||4^BLANK|200512121428
OBX|7|CE|PROCESS|tst6747183.1.1.4|$hinit^Initial H&E^L||||||||5^H&E Lv1|200512121431
OBX|8|CE|PROCESS|tst6747183.1.1.5|pmc4115^Blank Slide (MW)^L||||||||6^BLANK|200512121428
OBX|9|CE|PROCESS|tst6747183.1.1.6|pmc5553^HH&E (HISTO)^L||||||||7^H&E Lv2|200512121431
OBX|10|CE|PROCESS|tst6747183.1.1.7|pmc4115^Blank Slide (MW)^L||||||||8^BLANK|200512121428
OBX|11|CE|PROCESS|tst6747183.1.1.8|pmc5553^HH&E (HISTO)^L||||||||9^H&E Lv3|200512121431
OBX|12|CE|PROCESS|tst6747183.1.1.9|pmc4115^Blank Slide (MW)^L||||||||10^BLANK|200512121428
OBX|13|CE|PROCESS|tst6747183.1.1.10|pmc5553^HH&E (HISTO)^L||||||||11^H&E Lv4|200512121431
OBX|14|CE|PROCESS|tst6747183.1.1.11|pmc4115^Blank Slide (MW)^L||||||||12^BLANK|200512121428
OBX|15|CE|PROCESS|tst6747183.1.1.12|pmc5553^HH&E (HISTO)^L||||||||13^H&E Lv5|200512121431
OBX|16|CE|PROCESS|tst6747183.1.1.13|pmc5553^HH&E (HISTO)^L||||||||14^HHE|200512121431
OBX|17|CE|PROCESS|tst6747183.1.0.14|pmc0394^Touch Preparation, Initial (MWSP)^L||||||||1^TP|200512121431
OBX|18|CE|PROCESS|tst6747183.1.0.15|pmc6963^Gross Intraop Consult (Surg)^L||||||||2^GR|200512121428
OBX|19|CE|PROCESS|tst6747183.1.1.16|pmc4115^Blank Slide (MW)^L||||||||15^BLANK|200512121428
OBX|20|CE|PROCESS|tst6747183.1.1.17|$hinit^Initial H&E^L||||||||16^H&E Lv1|200512121431
OBX|21|CE|PROCESS|tst6747183.1.1.18|pmc4115^Blank Slide (MW)^L||||||||17^BLANK|200512121428
OBX|22|CE|PROCESS|tst6747183.1.1.19|pmc5553^HH&E (HISTO)^L||||||||18^H&E Lv2|200512121431
OBX|23|CE|PROCESS|tst6747183.1.1.20|pmc4115^Blank Slide (MW)^L||||||||19^BLANK|200512121428
OBX|24|CE|PROCESS|tst6747183.1.1.21|pmc5553^HH&E (HISTO)^L||||||||20^H&E Lv3|200512121431
OBX|25|CE|PROCESS|tst6747183.1.1.22|pmc4115^Blank Slide (MW)^L||||||||21^BLANK|200512121428
OBX|26|CE|PROCESS|tst6747183.1.1.23|pmc5553^HH&E (HISTO)^L||||||||22^H&E Lv4|200512121431
OBX|27|CE|PROCESS|tst6747183.1.1.24|pmc4115^Blank Slide (MW)^L||||||||23^BLANK|200512121428
OBX|28|CE|PROCESS|tst6747183.1.1.25|pmc5553^HH&E (HISTO)^L||||||||24^H&E Lv5|200512121431
OBX|29|CE|PROCESS|tst6747183.1.1.26|pmc5553^HH&E (HISTO)^L||||||||25^HHE|200512121431
OBX|30|TX|GDT|tst6747183|The specimen is received in formalin in one part labeled with the patient's name, initials AB and "right breast at 10 o'clock".  It consists of a 0.8 x 0.3 x 0.2 cm aggregate of rubbery/firm white/tan to yellow fibroadipose tissue fragments.  The specimen is submitted entirely in cassette A.\.br\\.br\\.br\||||||F
OBX|31|TX|MDT|tst6747183|Microscopic examination substantiates the above diagnosis.\.br\\.br\\.br\||||||F
OBX|32|TX|FIN|tst6747183|BREAST, RIGHT, 10:00, CORE BIOPSY \.br\INVASIVE DUCTAL CARCINOMA, NUCLEAR GRADE 1\.br\||||||F
OBX|33|CE|IMP|tst6747183|M85003^^SNO||||||||1||A
OBX|34|CE|IMP|tst6747183|P1140^^SNO||||||||1||A
OBX|35|CE|IMP|tst6747183|T04020^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004711|P|2.3
PID|1||100013570^^^RG|tst1278394|CIDSIX^PATIENT||19790215|F||MWU|660 MAIN STREET^^PITTSBURGH^PA^15213^United States||(412)555-7874|||||||||||||||||N
PV1|1||MWSPC||||MW001107^MCINTYRE-SELTMAN^KATHLEEN||||||||||pmc58662^MCINTYRE-SELTMAN^KATHLEEN|MWO|71397780|MWI||||||||||||||||||||||||200511011400
ORC|RE|00003|MWS05-94^CoPathPlus||CM||||200511011644|^LASSIGE^KAREN||MW001107^MCINTYRE-SELTMAN^KATHLEEN
OBR|1|00003|MWS05-94^CoPathPlus^tst7747183|MWSP^MW Pathology|||200511011644|||||||200511011644||MW001107||||^26^Y|-1|200511011650||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst7747183.1|^Cervix Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst7747183.1.1|A||||||||1^A|200512121425
OBX|3|CE|PROCESS|tst7747183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|4|TX|GDT|tst7747183|The specimen is received in formalin in one part labeled with the patient's name, initials AB and "3 o'clock cervix biopsy".  It consists of a rubbery gray tissue fragment measuring 0.5 x 0.2 x 0.1 cm.  The specimen is entirely submitted in cassette A.\.br\\.br\||||||F
OBX|5|TX|MDT|tst7747183|Microscopic examination substantiates the above diagnosis\.br\\.br\\.br\||||||F
OBX|6|TX|FIN|tst7747183|CERVIX, 3 O'CLOCK, COLPOSCOPIC BIOPSY \.br\A. CERVICAL INTRAEPITHELIAL NEOPLASIA 1 (CIN 1).\.br\B. CHRONIC CERVICITIS.\.br\\.br\||||||F
OBX|7|CE|IMP|tst7747183|M43000^^SNO||||||||1||A
OBX|8|CE|IMP|tst7747183|M74000^^SNO||||||||1||A
OBX|9|CE|IMP|tst7747183|P1140^^SNO||||||||1||A
OBX|10|CE|IMP|tst7747183|T83000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004712|P|2.3
PID|1||100013609^^^RG|tst8088394|CIDEIGHT^PATIENT||19790219|F||MWW|200 MAIN RD^^PITTSBURGH^PA^15213^United States||(412)457-8288|||||||||||||||||N
PV1|1||MW3700^3204||||MW240020586^SIMHAN^HYAGRIV||||||||||tst87363^SIMHAN^HYAGRIV|MWL|71398226|MWI||||||||||||||||||||||||200511091349|200512010800
ORC|RE|00001|MWS05-96^CoPathPlus||CM||||200511091357|^LASSIGE^KAREN||MW240017616^JEYABALAN^ARUNDHATH/PRS
OBR|1|00001|MWS05-96^CoPathPlus^tst1947183|MWSP^MW Pathology|||200511091356|||||||200511091356|PLAC|MW240017616||||^26^Y|-1|200511091420||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst1947183.1|PLAC^Placenta - 39+weeks^L||||||F||1^1
OBX|2|ST|BLOCK|tst1947183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst1947183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tst1947183.1.3|C||||||||3^C|200512121425
OBX|5|ST|BLOCK|tst1947183.1.4|A||||||||4^A|200512121425
OBX|6|ST|BLOCK|tst1947183.1.5|B||||||||5^B|200512121425
OBX|7|ST|BLOCK|tst1947183.1.6|C||||||||6^C|200512121425
OBX|8|CE|PROCESS|tst1947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|9|CE|PROCESS|tst1947183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|10|CE|PROCESS|tst1947183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|11|CE|PROCESS|tst1947183.1.1.4|$hinit^Initial H&E^L||||||||2^H&E|200512121431
OBX|12|CE|PROCESS|tst1947183.1.2.5|$hinit^Initial H&E^L||||||||3^H&E|200512121431
OBX|13|CE|PROCESS|tst1947183.1.3.6|$hinit^Initial H&E^L||||||||4^H&E|200512121431
OBX|14|TX|GDT|tst1947183|Received fresh labeled with the patient's name with the initials PM is a single-lobed placenta with membranes and umbilical cord. The 3-vessel, yellow-tan cord inserts eccentrically, 3.5 cm from the nearest margin, is 18.0 cm in length and 1.0 cm in diameter. The membranes insert marginally, are complete and the point of rupture is 2.0 cm from the nearest margin.  Minimal subchorionic fibrin plaques are noted.  The fetal surface is green-yellow with normal distribution of vessels. The placental disc is ovoid, 16.0 x 15.0 x 1.0 cm and weighs 350 grams, less than 10th percentile (normal placental weight for this gestational age is 451 +/- 76 gms). There is an accessory lobe measuring 6.2 x 4.5 x 1.2 cm separated from the main placental disc with a membrane distance of 1.5 cm.  The maternal surface is intact with minimal calcification. On cut section, two small marginal white lesions, up to 1.7 cm in maximum dimension are identified.  The parenchymal color and consistency are unremarkable. Representative sections are submitted labeled as follows:\.br\A - full thickness adjacent to cord insertion B - full thickness of periphery C - rolled membranes and cord.\.br\\.br\||||||F
OBX|15|TX|MDT|tst1947183|Microscopic examination substantiates the above diagnosis.\.br\\.br\||||||F
OBX|16|TX|FIN|tst1947183|PLACENTA, POST DATES (41 1/7 WEEKS) \.br\A.350 GRAMS (LESS THAN 10TH PERCENTILE FOR 41 WEEKS).\.br\B.TERM VILLOUS MATURATION WITH HYPERMATURE FEATURES INCLUDING INCREASED SYNCYTIAL KNOTS.\.br\C.ACCESSORY LOBE (6.2 X 4.5 X 1.2 CM IN DIMENSION).\.br\D.MECONIUM CONTAINING MACROPHAGES IN CHORIONIC PLATE AND EXTRAPLACENTAL MEMBRANES.\.br\E.MARGINAL INFARCT (TWO; UP TO 1.7 CM IN MAXIMUM DIMENSION).\.br\F.FOCAL ACUTE FETAL ENDOVASCULITIS INVOLVING AT LEAST ONE CHORIONIC PLATE VESSEL, PATCHY AMNION EPITHELIAL NECROSIS.\.br\G.THREE VESSEL UMBILICAL CORD WITH SMALL AMNION EPITHELIAL INCLUSION "CYSTS" AND RARE NEUTROPHILS IN MEDIA OF UMBILICAL VEIN.\.br\\.br\||||||F
OBX|17|CE|IMP|tst1947183|T05128^^SNO||||||||1||A
OBX|18|CE|IMP|tst1947183|T88100^^SNO||||||||1||A
OBX|19|CE|IMP|tst1947183|M29720^^SNO||||||||1||A
OBX|20|CE|IMP|tst1947183|M33410^^SNO||||||||1||A
OBX|21|CE|IMP|tst1947183|M41000^^SNO||||||||1||A
OBX|22|CE|IMP|tst1947183|M54000^^SNO||||||||1||A
OBX|23|CE|IMP|tst1947183|M54700^^SNO||||||||1||A
OBX|24|CE|IMP|tst1947183|T0X160^^SNO||||||||1||A
OBX|25|CE|IMP|tst1947183|T48000^^SNO||||||||1||A
OBX|26|CE|IMP|tst1947183|T88210^^SNO||||||||1||A
OBX|27|CE|IMP|tst1947183|T88300^^SNO||||||||1||A
OBX|28|CE|IMP|tst1947183|T88800^^SNO||||||||1||A
OBX|29|CE|IMP|tst1947183|T89000^^SNO||||||||1||A
OBX|30|CE|IMP|tst1947183|TY4230^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004713|P|2.3
PID|1||100013611^^^RG|tst0188394|CIDTEN^PATIENT||19881015|F||MWU|200 MAIN^^PITTSBURGH^PA^15213^United States||(412)457-8454|||||||||||||||||N
PV1|1||MWSPC||||MW320001107^MCINTYRE-SELTMAN^KATHLEEN||||||||||tst28363^MCINTYRE-SELTMAN^KATHLEEN|MWO|71398242|MWI||||||||||||||||||||||||200511091000
ORC|RE|00002|MWS05-97^CoPathPlus||CM||||200511091454|^LASSIGE^KAREN||MW001107^MCINTYRE-SELTMAN^KATHLEEN
OBR|1|00002|MWS05-97^CoPathPlus^tst2947183|MWSP^MW Pathology|||200511091452|||||||200511091452||MW001107||||^17^Y|-1|200511091510||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst2947183.1|^Vulvar Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tst2947183.1.1|A||||||||1^A|200512121425
OBX|3|CE|PROCESS|tst2947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|4|TX|GDT|tst2947183|The specimen is received in formalin in one part labeled with the patient's name, initials BH and "vulvar tissue".  It consists of two rubbery/firm brown tissue fragments measuring up to 0.4 x 0.3 x 0.1 cm.  The specimen is submitted entirely in cassette A.\.br\\.br\||||||F
OBX|5|TX|MDT|tst2947183|Microscopic examination substantiates the above diagnosis.\.br\\.br\||||||F
OBX|6|TX|FIN|tst2947183|VULVA, BIOPSY \.br\VULVAR INTRAEPITHELIAL NEOPLASIA 1 (VIN 1).\.br\\.br\||||||F
OBX|7|CE|IMP|tst2947183|M80002^^SNO||||||||1||A
OBX|8|CE|IMP|tst2947183|P1140^^SNO||||||||1||A
OBX|9|CE|IMP|tst2947183|T80100^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004714|P|2.3
PID|1||100013618^^^RG|tst0288394|CIDSIXTEEN^PATIENT||20051110|F||MWW|12111 GREENLEAF AVENUE^^BETHEL PARK^PA^15102^United States||(412)555-1212|||||||||||||||||N
PV1|1||MWLDR^LD01||||MW075887^HUGO^MARY ANN||||||||||pmc48162^HUGO^MARY ANN|MWL|71398341|MWI||||||||||||||||||||||||200511101414|200511101429
ORC|RE|00002|MWS05-98^CoPathPlus||CM||||200511101422|^LASSIGE^KAREN||MW075887^HUGO^MARY ANN
OBR|1|00002|MWS05-98^CoPathPlus^tst6947183|MWSP^MW Pathology|||200511101421|||||||200511101421|PLAC|MW075887||||^0^D|-1|200511101426||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst6947183.1|PLAC^Placenta - 40 weeks^L||||||F||1^1
OBX|2|ST|BLOCK|tst6947183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tst6947183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tst6947183.1.3|C||||||||3^C|200512121425
OBX|5|CE|PROCESS|tst6947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|6|CE|PROCESS|tst6947183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|7|CE|PROCESS|tst6947183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|8|TX|GDT|tst6947183|Received fresh labeled with the patient's name initials "AA" is a single-lobed placenta with membranes and umbilical cord. The 3-vessel, tan-white cord inserts eccentrically, 6.0 cm from the nearest margin, is 56.0 cm in length and 1.2 cm in diameter. The cord shows two areas of possible flattening.  The first measures 10.0 cm in length and is located approximately 11.0 cm from the placental insertion site and the second is on a separately received, un-oriented portion of cord and measures approximately 16.0 cm. in length.  The membranes show partial circummarginate insertion, do not appear complete, are partially torn from the disc and the point of rupture cannot be assessed.  The amnion is partially separated from the chorion.   No subchorionic fibrin plaques are noted.  The fetal surface is minimally dull with normal distribution of vessels. The placental disc is ovoid, 21.0 x 15.5 x 2.1 cm, and weighs 600 grams, greater than the 90th percentile (normal placental weight for this gestational age is 453 +/- 75 gms). The maternal surface is intact with minimal calcification. On cut section, the parenchymal color and consistency are unremarkable.  No discrete lesions are noted grossly. Representative sections are submitted labeled as follows:\.br\A - full thickness adjacent to cord insertion B - full thickness of periphery C - rolled membranes and cord, includes flattened areas.\.br\\.br\||||||F
OBX|9|TX|FIN|tst6947183|PLACENTA, TERM (40 WEEKS) \.br\A.600 GRAMS (>90TH PERCENTILE FOR 40 WEEKS).\.br\B.APPROPRIATE VILLOUS MATURATION FOR GESTATIONAL AGE.\.br\C.MECONIUM CONTAINING MACROPHAGES IN CHORIONIC PLATE, STRIPPED REACTIVE AMNION, AND EXTRAPLACENTAL MEMBRANES.\.br\D.MINIMAL TO MILD ACUTE CHORIOAMNIONITIS (STAGE 1) INVOLVING CHORIONIC PLATE.\.br\E.FOCALLY REACTIVE CHORIONIC PLATE AMNION.\.br\F.PARTIAL CIRCUMMARGINATE INSERTION OF EXTRAPLACENTAL MEMBRANES.\.br\G.THREE-VESSEL UMBILICAL CORD (TOTAL LENGTH OF SEGMENTS RECEIVED 56 CM WITH TWO FLATTENED AREAS 10 AND 16 CM. IN LENGTH, RESPECTIVELY); MILD EDEMA OF WHARTON' S JELLY.\.br\\.br\||||||F
OBX|10|CE|IMP|tst6947183|M41000^^SNO||||||||1||A
OBX|11|CE|IMP|tst6947183|T05128^^SNO||||||||1||A
OBX|12|CE|IMP|tst6947183|T88100^^SNO||||||||1||A
OBX|13|CE|IMP|tst6947183|M36500^^SNO||||||||1||A
OBX|14|CE|IMP|tst6947183|T88210^^SNO||||||||1||A
OBX|15|CE|IMP|tst6947183|T88300^^SNO||||||||1||A
OBX|16|CE|IMP|tst6947183|T88800^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004715|P|2.3
PID|1||100013617^^^RG|tst8188394|CIDFIFTEEN^PATIENT||19551110|F||MWU|3112 GREENLEAF AVENUE^^BETHEL PARK^PA^15102^United States||(412)555-1212|||||||||||||||||N
PV1|1||MWSPC||||MW012922^BRUFSKY^ADAM||||||||||pmc13362^BRUFSKY^ADAM|MWO|71398325|MWI||||||||||||||||||||||||200511101358
ORC|RE|00003|MWS05-99^CoPathPlus||CM||||200511101624|^LASSIGE^KAREN||MW012922^BRUFSKY^ADAM
OBR|1|00003|MWS05-99^CoPathPlus^tst7947183|MWSP^MW Pathology|||200511101623|||||||200511101623||MW012922||||^50^Y|-1|200511110803||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tst7947183.1|^Endocervical Curettings^L||||||F||1^1
OBX|2|ST|BLOCK|tst7947183.1.1|A||||||||1^A|200512121425
OBX|3|CE|PROCESS|tst7947183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E Lvs|200512121431
OBX|4|TX|GDT|tst7947183|The specimen is received in formalin in one part labeled with the patient's name, initials AA and "Endocervical currettings".  It consists of a 0.6 x 0.4 x 0.2 cm aggregate of tan mucoid material.  The specimen is submitted entirely in cassette A.\.br\||||||F
OBX|5|TX|MDT|tst7947183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|6|TX|FIN|tst7947183|ENDOCERVIX, ENDOCERVICAL CURETTINGS \.br\A.BENIGN ENDOCERVICAL TISSUE.\.br\B.MUCUS AND DESQUAMATED SQUAMOUS CELLS (see comment).\.br\||||||F
OBX|7|CE|IMP|tst7947183|P1154^^SNO||||||||1||A
OBX|8|CE|IMP|tst7947183|T83300^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004717|P|2.3
PID|1||100003654^^^RG|tpmc9388394|TESTRED^ANITA^M||19540314|F||MWB|1234 BACK STREET^^PITTSBURGH^PA^99999^United States||(412)555-1212|||||||||||||||||N
PV1|1||MWSURG^3610||||MW091900^KRUPSKI^CAROL||||||||||pmc12162^KRUPSKI^CAROL|MWM|71398465|MWR||||||||||||||||||||||||200511150740
ORC|RE|00001|MWS05-100^CoPathPlus||CM||||200511161405|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1|00001|MWS05-100^CoPathPlus^tpmc0157183|MWSP^MW Pathology|||200511161404|||||||200511161404||505074||||^51^Y|-1|200511161503||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc0157183.1|^Colon - Neoplastic^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc0157183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tpmc0157183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tpmc0157183.1.3|C||||||||3^C|200512121425
OBX|5|ST|BLOCK|tpmc0157183.1.4|D||||||||4^D|200512121425
OBX|6|ST|BLOCK|tpmc0157183.1.5|E||||||||5^E|200512121425
OBX|7|ST|BLOCK|tpmc0157183.1.6|F||||||||6^F|200512121425
OBX|8|ST|BLOCK|tpmc0157183.1.7|G||||||||7^G|200512121425
OBX|9|ST|BLOCK|tpmc0157183.1.8|H||||||||8^H|200512121425
OBX|10|ST|BLOCK|tpmc0157183.1.9|I||||||||9^I|200512121425
OBX|11|ST|BLOCK|tpmc0157183.1.10|J||||||||10^J|200512121425
OBX|12|CE|PROCESS|tpmc0157183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|13|CE|PROCESS|tpmc0157183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|14|CE|PROCESS|tpmc0157183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|15|CE|PROCESS|tpmc0157183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|16|CE|PROCESS|tpmc0157183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|17|CE|PROCESS|tpmc0157183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|18|CE|PROCESS|tpmc0157183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|19|CE|PROCESS|tpmc0157183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|20|CE|PROCESS|tpmc0157183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|21|CE|PROCESS|tpmc0157183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|22|TX|GDT|tpmc0157183|\.br\This is the Gross Description\.br\||||||F
OBX|23|TX|MDT|tpmc0157183|This is the Microscopic Description     \.br\||||||F
OBX|24|TX|FIN|tpmc0157183|THIS IS THE FINAL DIAGNOSIS\.br\||||||F
OBR|2|00001|tpmc0157183^CoPathPlus^tpmc0157183.A1|ADD^Addendum||||||||||200511161503|||||||1|200511161503||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc0157183|Radioactive Serum Asphalt Test123.4 millibars\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004719|P|2.3
PID|1||112233445^^^RS|tpmc6198394|TESTVTWOFIVE^PATRICIA||19650502|F||||||||||||||||||||||N
PV1|1||SUR||||987654^PATHOID^DOCTOR||||||||||pmc3304^PATHOID^DOCTOR|I|1800555121202|||||||||||||||||||||||||200511160629
ORC|RE||MWS05-101^CoPathPlus||CM||||200511161636|^LASSIGE^KAREN||987654^PATHOID^DOCTOR
OBR|1||MWS05-101^CoPathPlus^tpmc2357183|MWSP^MW Pathology|||200511161621|||||||200511161621|BCW|987654||||^40^Y|-1|200511180730||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc2357183.1|BCW^3:00 LB Core Bx w/Calcification^L||||||F||1^1
OBX|2|CE|ANT|tpmc2357183.2|BCWO^3:00 LB Core Bx w/o Calcification^L||||||F||2^2
OBX|3|ST|BLOCK|tpmc2357183.1.1|A||||||||1^A|200512121425
OBX|4|ST|BLOCK|tpmc2357183.2.2|A||||||||1^A|200512121425
OBX|5|ST|BLOCK|tpmc2357183.2.3|B||||||||2^B|200512121425
OBX|6|ST|BLOCK|tpmc2357183.2.4|C||||||||3^C|200512121425
OBX|7|CE|PROCESS|tpmc2357183.1.1.1|pmc4115^Blank Slide (MW)^L||||||||4^BLANK|200512121428
OBX|8|CE|PROCESS|tpmc2357183.1.1.2|$hinit^Initial H&E^L||||||||5^H&E Lv1|200512121431
OBX|9|CE|PROCESS|tpmc2357183.1.1.3|pmc4115^Blank Slide (MW)^L||||||||6^BLANK|200512121428
OBX|10|CE|PROCESS|tpmc2357183.1.1.4|pmc5553^HH&E (HISTO)^L||||||||7^H&E Lv2|200512121431
OBX|11|CE|PROCESS|tpmc2357183.1.1.5|pmc4115^Blank Slide (MW)^L||||||||8^BLANK|200512121428
OBX|12|CE|PROCESS|tpmc2357183.1.1.6|pmc5553^HH&E (HISTO)^L||||||||9^H&E Lv3|200512121431
OBX|13|CE|PROCESS|tpmc2357183.1.1.7|pmc4115^Blank Slide (MW)^L||||||||10^BLANK|200512121428
OBX|14|CE|PROCESS|tpmc2357183.1.1.8|pmc5553^HH&E (HISTO)^L||||||||11^H&E Lv4|200512121431
OBX|15|CE|PROCESS|tpmc2357183.2.2.9|pmc4115^Blank Slide (MW)^L||||||||1^BLANK|200512121428
OBX|16|CE|PROCESS|tpmc2357183.2.2.10|$hinit^Initial H&E^L||||||||2^H&E Lv1|200512121431
OBX|17|CE|PROCESS|tpmc2357183.2.2.11|pmc4115^Blank Slide (MW)^L||||||||3^BLANK|200512121428
OBX|18|CE|PROCESS|tpmc2357183.2.2.12|pmc5553^HH&E (HISTO)^L||||||||4^H&E Lv2|200512121431
OBX|19|CE|PROCESS|tpmc2357183.2.2.13|pmc4115^Blank Slide (MW)^L||||||||5^BLANK|200512121428
OBX|20|CE|PROCESS|tpmc2357183.2.2.14|pmc5553^HH&E (HISTO)^L||||||||6^H&E Lv3|200512121431
OBX|21|CE|PROCESS|tpmc2357183.2.2.15|pmc4115^Blank Slide (MW)^L||||||||7^BLANK|200512121428
OBX|22|CE|PROCESS|tpmc2357183.2.2.16|pmc5553^HH&E (HISTO)^L||||||||8^H&E Lv4|200512121431
OBX|23|CE|PROCESS|tpmc2357183.2.3.17|pmc4115^Blank Slide (MW)^L||||||||16^BLANK|200512121428
OBX|24|CE|PROCESS|tpmc2357183.2.3.18|$hinit^Initial H&E^L||||||||17^H&E Lv1|200512121431
OBX|25|CE|PROCESS|tpmc2357183.2.3.19|pmc4115^Blank Slide (MW)^L||||||||18^BLANK|200512121428
OBX|26|CE|PROCESS|tpmc2357183.2.3.20|pmc5553^HH&E (HISTO)^L||||||||19^H&E Lv2|200512121431
OBX|27|CE|PROCESS|tpmc2357183.2.3.21|pmc4115^Blank Slide (MW)^L||||||||20^BLANK|200512121428
OBX|28|CE|PROCESS|tpmc2357183.2.3.22|pmc5553^HH&E (HISTO)^L||||||||21^H&E Lv3|200512121431
OBX|29|CE|PROCESS|tpmc2357183.2.3.23|pmc4115^Blank Slide (MW)^L||||||||22^BLANK|200512121428
OBX|30|CE|PROCESS|tpmc2357183.2.3.24|pmc5553^HH&E (HISTO)^L||||||||23^H&E Lv4|200512121431
OBX|31|CE|PROCESS|tpmc2357183.2.4.25|pmc4115^Blank Slide (MW)^L||||||||31^BLANK|200512121428
OBX|32|CE|PROCESS|tpmc2357183.2.4.26|$hinit^Initial H&E^L||||||||32^H&E Lv1|200512121431
OBX|33|CE|PROCESS|tpmc2357183.2.4.27|pmc4115^Blank Slide (MW)^L||||||||33^BLANK|200512121428
OBX|34|CE|PROCESS|tpmc2357183.2.4.28|pmc5553^HH&E (HISTO)^L||||||||34^H&E Lv2|200512121431
OBX|35|CE|PROCESS|tpmc2357183.2.4.29|pmc4115^Blank Slide (MW)^L||||||||35^BLANK|200512121428
OBX|36|CE|PROCESS|tpmc2357183.2.4.30|pmc5553^HH&E (HISTO)^L||||||||36^H&E Lv3|200512121431
OBX|37|CE|PROCESS|tpmc2357183.2.4.31|pmc4115^Blank Slide (MW)^L||||||||37^BLANK|200512121428
OBX|38|CE|PROCESS|tpmc2357183.2.4.32|pmc5553^HH&E (HISTO)^L||||||||38^H&E Lv4|200512121431
OBX|39|CE|PROCESS|tpmc2357183.1.1.33|pmc4115^Blank Slide (MW)^L||||||||12^BLANK|200512121428
OBX|40|CE|PROCESS|tpmc2357183.1.1.34|$hinit^Initial H&E^L||||||||13^H&E Lv1|200512121431
OBX|41|CE|PROCESS|tpmc2357183.1.1.35|pmc4115^Blank Slide (MW)^L||||||||14^BLANK|200512121428
OBX|42|CE|PROCESS|tpmc2357183.1.1.36|pmc5553^HH&E (HISTO)^L||||||||15^H&E Lv2|200512121431
OBX|43|CE|PROCESS|tpmc2357183.1.1.37|pmc4115^Blank Slide (MW)^L||||||||16^BLANK|200512121428
OBX|44|CE|PROCESS|tpmc2357183.1.1.38|pmc5553^HH&E (HISTO)^L||||||||17^H&E Lv3|200512121431
OBX|45|CE|PROCESS|tpmc2357183.1.1.39|pmc4115^Blank Slide (MW)^L||||||||18^BLANK|200512121428
OBX|46|CE|PROCESS|tpmc2357183.1.1.40|pmc5553^HH&E (HISTO)^L||||||||19^H&E Lv4|200512121431
OBX|47|CE|PROCESS|tpmc2357183.2.2.41|pmc4115^Blank Slide (MW)^L||||||||9^BLANK|200512121428
OBX|48|CE|PROCESS|tpmc2357183.2.2.42|$hinit^Initial H&E^L||||||||10^H&E Lv1|200512121431
OBX|49|CE|PROCESS|tpmc2357183.2.2.43|pmc4115^Blank Slide (MW)^L||||||||11^BLANK|200512121428
OBX|50|CE|PROCESS|tpmc2357183.2.2.44|pmc5553^HH&E (HISTO)^L||||||||12^H&E Lv2|200512121431
OBX|51|CE|PROCESS|tpmc2357183.2.2.45|pmc4115^Blank Slide (MW)^L||||||||13^BLANK|200512121428
OBX|52|CE|PROCESS|tpmc2357183.2.2.46|pmc5553^HH&E (HISTO)^L||||||||14^H&E Lv3|200512121431
OBX|53|CE|PROCESS|tpmc2357183.2.2.47|pmc4115^Blank Slide (MW)^L||||||||15^BLANK|200512121428
OBX|54|CE|PROCESS|tpmc2357183.2.2.48|pmc5553^HH&E (HISTO)^L||||||||16^H&E Lv4|200512121431
OBX|55|CE|PROCESS|tpmc2357183.2.3.49|pmc4115^Blank Slide (MW)^L||||||||24^BLANK|200512121428
OBX|56|CE|PROCESS|tpmc2357183.2.3.50|$hinit^Initial H&E^L||||||||25^H&E Lv1|200512121431
OBX|57|CE|PROCESS|tpmc2357183.2.3.51|pmc4115^Blank Slide (MW)^L||||||||26^BLANK|200512121428
OBX|58|CE|PROCESS|tpmc2357183.2.3.52|pmc5553^HH&E (HISTO)^L||||||||27^H&E Lv2|200512121431
OBX|59|CE|PROCESS|tpmc2357183.2.3.53|pmc4115^Blank Slide (MW)^L||||||||28^BLANK|200512121428
OBX|60|CE|PROCESS|tpmc2357183.2.3.54|pmc5553^HH&E (HISTO)^L||||||||29^H&E Lv3|200512121431
OBX|61|CE|PROCESS|tpmc2357183.2.3.55|pmc4115^Blank Slide (MW)^L||||||||30^BLANK|200512121428
OBX|62|CE|PROCESS|tpmc2357183.2.3.56|pmc5553^HH&E (HISTO)^L||||||||31^H&E Lv4|200512121431
OBX|63|CE|PROCESS|tpmc2357183.2.4.57|pmc4115^Blank Slide (MW)^L||||||||39^BLANK|200512121428
OBX|64|CE|PROCESS|tpmc2357183.2.4.58|$hinit^Initial H&E^L||||||||40^H&E Lv1|200512121431
OBX|65|CE|PROCESS|tpmc2357183.2.4.59|pmc4115^Blank Slide (MW)^L||||||||41^BLANK|200512121428
OBX|66|CE|PROCESS|tpmc2357183.2.4.60|pmc5553^HH&E (HISTO)^L||||||||42^H&E Lv2|200512121431
OBX|67|CE|PROCESS|tpmc2357183.2.4.61|pmc4115^Blank Slide (MW)^L||||||||43^BLANK|200512121428
OBX|68|CE|PROCESS|tpmc2357183.2.4.62|pmc5553^HH&E (HISTO)^L||||||||44^H&E Lv3|200512121431
OBX|69|CE|PROCESS|tpmc2357183.2.4.63|pmc4115^Blank Slide (MW)^L||||||||45^BLANK|200512121428
OBX|70|CE|PROCESS|tpmc2357183.2.4.64|pmc5553^HH&E (HISTO)^L||||||||46^H&E Lv4|200512121431
OBX|71|CE|PROCESS|tpmc2357183.1.9.65|$hinit^Initial H&E^L||||||||21^H&E|200512121431
OBX|72|CE|PROCESS|tpmc2357183.1.9.66|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||22^H&E Recut|200512121428
OBX|73|CE|PROCESS|tpmc2357183.1.10.67|$hinit^Initial H&E^L||||||||21^H&E|200512121431
OBX|74|CE|PROCESS|tpmc2357183.1.1.68|pmc1884^Her-2/neu (IPEX)^L||||||||20^Her- 2/neu|200512121428
OBX|75|CE|PROCESS|tpmc2357183.1.1.69|pmc0884^Her-2/neu (WLO) (IPEX)^L||||||||21^Her-2/neu|200512121428
OBX|76|CE|PROCESS|tpmc2357183.1.0.70|pmc2043^Estrogen Receptor (IPEX)^L||||||||1^AER|200512121428
OBX|77|CE|PROCESS|tpmc2357183.1.0.71|pmc8784^Estrogen Receptor (WLO) (IPEX)^L||||||||2^ER|200512121428
OBX|78|TX|GDT|tpmc2357183|The specimen is received in formalin in two parts.\.br\\.br\Part 1 is labeled with the patient's name with initials JW and "Left Breast 3 o'clock, calcifications".  It consists of multiple cylindrical, tan-yellow breast core biopsy fragments ranging from 0.3 cm in length x less than 0.1 cm in diameter up to 0.8 cm in length x 0.4 cm in diameter.  The specimen is totally submitted in a cassettes labeled 1A and 1B.\.br\\.br\Part 2 is labeled with the patient's name, initials, JW and "Left Breast 3 o'clock, without calcification".  It consists of multiple cylindrical, tan-yellow breast core biopsy fragments ranging from 0.3 cm in length x 0.2 cm in diameter up to 3.0 cm in length x 0.3 cm in diameter.  The specimen is totally submitted in cassettes labeled 2A ,2B and 2C.\.br\||||||F
OBX|79|TX|MDT|tpmc2357183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|80|TX|FIN|tpmc2357183|PART 1:  BREAST, LEFT, 3 O' CLOCK, WITH CALCIFICATIONS, STEREOTACTIC CORE BIOPSY\.br\A.           ATYPICAL DUCT EPITHELIAL HYPERPLASIA WITH MICROCALCIFICATIONS.\.br\B.     SCLEROSING ADENOSIS.\.br\C.     COLUMNAR CELL HYPERPLASIA.\.br\\.br\\.br\PART 2:  BREAST, LEFT, 3 O' CLOCK, WITHOUT CALCIFICATIONS, STEREOTACTIC CORE BIOPSY\.br\A.          ATYPICAL DUCT EPITHELIAL HYPERPLASIA.\.br\B.     COLUMNAR CELL CHANGE WITH MICROCALCIFICATIONS.\.br\C.     DUCT EPITHELIAL HYPERPLASIA.\.br\||||||F
OBX|81|CE|IMP|tpmc2357183|M55400^^SNO||||||||1||A
OBX|82|CE|IMP|tpmc2357183|M72000^^SNO||||||||1||A
OBX|83|CE|IMP|tpmc2357183|M72175^^SNO||||||||1||A
OBX|84|CE|IMP|tpmc2357183|M74220^^SNO||||||||1||A
OBX|85|CE|IMP|tpmc2357183|P1140^^SNO||||||||1||A
OBX|86|CE|IMP|tpmc2357183|T04030^^SNO||||||||1||A
OBX|87|CE|IMP|tpmc2357183|M55400^^SNO||||||||1||A
OBX|88|CE|IMP|tpmc2357183|M72175^^SNO||||||||1||A
OBX|89|CE|IMP|tpmc2357183|P1140^^SNO||||||||1||A
OBX|90|CE|IMP|tpmc2357183|T04030^^SNO||||||||1||A
OBX|91|CE|IMP|tpmc2357183|V72.84^^ICD||||||||1
OBR|2||tpmc2357183^CoPathPlus^tpmc2357183.A1|ADD^Addendum||||||||||200511180842|||||||1|200511180842||SP|F||||||||987654^PATHOID^DOCTOR
OBX|1|TX|ADX|tpmc2357183|ESTROGEN / PROGESTERONE AND HER-2/NEU REPORT\.br\\.br\Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is performed by the immunoperoxidase method, and reported according to the NIH consensus statement on adjuvant therapy for breast cancer, of November 3, 2000.  A positive ER or PR tumor shows any nuclear immunostaining, and is semiquantitated as indicated below.\.br\\.br\ResultSemiquantitative Statement\.br\\.br\ER POSITIVEPercent cells staining as: (0  0%; 1+  0%, 2+  10%, 3+  90%)\.br\\.br\PR NEGATIVEPercent cells staining as: (0  100%, 1+  0%, 2+  0%, 3+  0%)\.br\\.br\Estrogen receptor antibody 6F11, an IVD, is performed using the IVIEW detection on the Benchmark XT (Ventana, Tucson, AZ).\.br\Progesterone receptor antibody 1A6 , an IVD, is performed using the IVEW detection on the Benchmark XT, (Ventana, Tucson, AZ).\.br\\.br\HER-2/NEU TEST:  A FAINT/BARELY PERCEPTIBLE MEMBRANE STAINING IS DETECTED IN MORE THAN 10% OF THE TUMOR CELLS.  THE CELLS ARE ONLY STAINED IN PART OF THEIR MEMBRANE.  HER-2/NEU IS INTERPRETED AS NEGATIVE (SCORE 1+).\.br\\.br\Interpretation of Her2/neu immunostaining: Using clone CB11 as an ASR validated against the Herceptest with Basic DAB detection on the Benchmark XT (Ventana, Tucson, AZ).\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004720|P|2.3
PID|1||N0000085^^^RV|tpmc3531494|TESTVTWOFIVE^PASSAVANT^PAUL||19300520|M||PVW|888 STREET^^PITTSBURGH^PA^15237^United States||412-367-6100|724-625-3184|||||888-55-2223|||||||||||N
PV1|1||PVLAB||||ABU.KA^ABU-HAMAD^GHASSAN|||||||||||PVSDC|N00000001370|PVBC||||||||||||||||||||||||200511210857
ORC|RE||MWS05-103^CoPathPlus||CM||||200511301755|z41^LOSOS^FRANK
OBR|1||MWS05-103^CoPathPlus^tpmc2067183|MWSP^MW Pathology|||200511301755|||||||200511301755||||||^75^Y|-1|200511301758||SP|C|||||||987654^PATHOID^DOCTOR|z41^LOSOS^FRANK
OBX|1|CE|ANT|tpmc2067183.1|^Colon - Neoplastic^L||||||C||1^1
OBX|2|ST|BLOCK|tpmc2067183.1.1|A||||||||1^A|200512121425
OBX|3|ST|BLOCK|tpmc2067183.1.2|B||||||||2^B|200512121425
OBX|4|ST|BLOCK|tpmc2067183.1.3|C||||||||3^C|200512121425
OBX|5|ST|BLOCK|tpmc2067183.1.4|D||||||||4^D|200512121425
OBX|6|ST|BLOCK|tpmc2067183.1.5|E||||||||5^E|200512121425
OBX|7|ST|BLOCK|tpmc2067183.1.6|F||||||||6^F|200512121425
OBX|8|ST|BLOCK|tpmc2067183.1.7|G||||||||7^G|200512121425
OBX|9|ST|BLOCK|tpmc2067183.1.8|H||||||||8^H|200512121425
OBX|10|ST|BLOCK|tpmc2067183.1.9|I||||||||9^I|200512121425
OBX|11|ST|BLOCK|tpmc2067183.1.10|J||||||||10^J|200512121425
OBX|12|CE|PROCESS|tpmc2067183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|13|CE|PROCESS|tpmc2067183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|14|CE|PROCESS|tpmc2067183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|15|CE|PROCESS|tpmc2067183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|16|CE|PROCESS|tpmc2067183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|17|CE|PROCESS|tpmc2067183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|18|CE|PROCESS|tpmc2067183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|19|CE|PROCESS|tpmc2067183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|20|CE|PROCESS|tpmc2067183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|21|CE|PROCESS|tpmc2067183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|22|TX|GDT|tpmc2067183|THIS IS THE GROSS DESCRIPTION\.br\||||||C
OBX|23|TX|MDT|tpmc2067183|Microscopic Descrtiption entered here     \.br\||||||C
OBX|24|TX|FIN|tpmc2067183|THIS IS THE FINAL DIAGNOSIS\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004721|P|2.3
PID|1||185185185^^^RA|tst8415394|TEST^BATGIRL||19500731|F||W|100 MAIN STREET^^PITTSBURGH^PA^15216^United States||(412)555-8888|(412)555-2222|||||185-18-5185|||||||||||N
PV1|1||A3B^363||||080750^WERNER^KATHLEEN||||||||||pmc68581^WERNER^KATHLEEN|I|0056718335109|P||||||||||||||||||||||||200504191052
ORC|RE||PHS05-103^CoPathPlus||CM||||200506071354|UXD^Cerner^User||080750^WERNER^KATHLEEN
OBR|1||PHS05-103^CoPathPlus^tst3507183|PHSP^PH Surgical Pathology|||200506071350|||||||200506071350|APP|080750||||^54^Y|-1|200506071415||SP|F|||||||000906^BAKER^EVAN|UXD^Cerner^User
OBX|1|CE|ANT|tst3507183.1|APP^Appendix^L||||||F||1^1
OBX|2|ST|BLOCK|tst3507183.1.1|A||||||||1^A|200507221753
OBX|3|CE|PROCESS|tst3507183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|4|TX|FIN|tst3507183|\.br\46,X#,t(11;19)(q23;p13)[#]\.br\\.br\The 11;19 translocation has been reported in therapy-related AML and in childhood ALL [Behm EG et al. (1996) Blood 87:1134-1139; Rowley JD (1998) Annu Rev Genet 32:495-519].  The breakpoint at band 11q23 splits the MLL gene that might be responsible for the development of leukemia that is frequently characterized by mixed markers and a poor prognosis [Bernard OA, Berger R (1995) Genes Chromosomes Cancer 13:75-85; Ziemin-van der Poel S et al. (1991) Proc Ntl Acad Sci USA 88:10735-10739].\.br\||||||F
OBX|5|CE|IMP|tst3507183|M98003^^SNO||||||||1||A
OBX|6|CE|IMP|tst3507183|M98613^^SNO||||||||1||A
OBX|7|CE|IMP|tst3507183|T0X000^^SNO||||||||1||A
OBX|8|CE|IMP|tst3507183|000^^ICD||||||||1
OBR|2||tst3507183^CoPathPlus^tst3507183.A1|ADD^Addendum||||||||||200506071356|||||||1|200506071356||SP|F|||||||000906^BAKER^EVAN|UXD^Cerner^User
OBX|1|TX|ADX|tst3507183|\.br\\.br\COLONIC MUCOSA.\.br\NEGATIVE FOR LYMPHOCYTIC/COLLAGENOUS COLITIS. \.br\||||||F
OBR|3||tst3507183^CoPathPlus^tst3507183.P2|ADVPCR^Adenovirus||||||||||200506071358|||||||2|200506071358||SP|F|||||||000906^BAKER^EVAN|UXD^Cerner^User
OBX|1|TX|PIN|tst3507183|\.br\\.br\Negative for high/intermediate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68\.br\\.br\The sample, a crude cell lysate, was tested for the presence of Human Papillomavirus  (HPV) using the Hybrid Capture 2 (HC2) High Risk HPV DNA test from Digene.  The technology utilizes a specific HPV RNA probe cocktail to detect types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 in cervical specimens.  The target DNA hybridizes with a specific RNA probe that is captured by antibodies specific for RNA:DNA hybrids.  Hybrid detection occurs via chemiluminescent substrate and subsequent light emission.\.br\\.br\The Digene HC2 assay is an FDA-cleared, qualitative, in vitro diagnostic test for the detection  of HPV from cervical specimens.  \.br\Negative for high/intermediate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68\.br\\.br\The sample, a crude cell lysate, was tested for the presence of Human Papillomavirus  (HPV) using the Hybrid Capture 2 (HC2) High Risk HPV DNA test from Digene.  The technology utilizes a specific HPV RNA probe cocktail to detect types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 in cervical specimens.  The target DNA hybridizes with a specific RNA probe that is captured by antibodies specific for RNA:DNA hybrids.  Hybrid detection occurs via chemiluminescent substrate and subsequent light emission.\.br\\.br\The Digene HC2 assay is an FDA-cleared, qualitative, in vitro diagnostic test for the detection  of HPV from cervical specimens.  \.br\||||||F
OBR|4||tst3507183^CoPathPlus^tst3507183.P3|CANA^Canavan||||||||||200506071400|||||||3|200506071400||SP|F|||||||000906^BAKER^EVAN|UXD^Cerner^User
OBX|1|TX|PIN|tst3507183|Negative for high/intermediate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68\.br\\.br\The sample, a crude cell lysate, was tested for the presence of Human Papillomavirus  (HPV) using the Hybrid Capture 2 (HC2) High Risk HPV DNA test from Digene.  The technology utilizes a specific HPV RNA probe cocktail to detect types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 in cervical specimens.  The target DNA hybridizes with a specific RNA probe that is captured by antibodies specific for RNA:DNA hybrids.  Hybrid detection occurs via chemiluminescent substrate and subsequent light emission.\.br\\.br\The Digene HC2 assay is an FDA-cleared, qualitative, in vitro diagnostic test for the detection  of HPV from cervical specimens.  \.br\\.br\\.br\Negative for high/intermediate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68\.br\\.br\The sample, a crude cell lysate, was tested for the presence of Human Papillomavirus  (HPV) using the Hybrid Capture 2 (HC2) High Risk HPV DNA test from Digene.  The technology utilizes a specific HPV RNA probe cocktail to detect types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 in cervical specimens.  The target DNA hybridizes with a specific RNA probe that is captured by antibodies specific for RNA:DNA hybrids.  Hybrid detection occurs via chemiluminescent substrate and subsequent light emission.\.br\\.br\The Digene HC2 assay is an FDA-cleared, qualitative, in vitro diagnostic test for the detection  of HPV from cervical specimens.  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004722|P|2.3
PID|1||112233445^^^RR|tpmc6198394|TESTVTWOFIVE^PATRICIA||19650502|F||||||||||||||||||||||N
PV1|1||10N^N1073||||505071^PLANET^MERCURY||||||||||pmc58361^PLANET^NIBIRU|I|0277645553017|||||||||||||||||||||||||200512011455
ORC|RE||MWS05-104^CoPathPlus||CM||||200512020734|^LASSIGE^KAREN||505071^PLANET^MERCURY
OBR|1||MWS05-104^CoPathPlus^tpmc2267183|MWSP^MW Pathology|||200512020732|||||||200512020732||505071||||^40^Y|-1|200512020815||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc2267183.1|^1paraffin block and 2 slides, left breast^L||||||F||1^1
OBX|2|TX|MDT|tpmc2267183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|3|TX|FIN|tpmc2267183|BREAST, LEFT, MASS, CORE BIOPSY (OSS R05-8141, 11/23/05, THE WESTERN PENNSYLVANIA HOSPITAL  FORBES REGIONAL CAMPUS) \.br\INFILTRATING DUCTAL CARCINOMA, NUCLEAR GRADE 3 (see comment).\.br\||||||F
OBX|4|CE|IMP|tpmc2267183|710.0^^ICD||||||||1
OBR|2||tpmc2267183^CoPathPlus^tpmc2267183.A2|ADD^Addendum||||||||||200512061505|||||||2|200512061505||SP|F||||||||^LASSIGE^KAREN
OBX|1|TX|ADX|tpmc2267183|ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT\.br\\.br\Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is performed by the immunoperoxidase method, and reported according to the NIH consensus statement on adjuvant therapy for breast cancer, of November 3, 2000.  A positive ER or PR tumor shows any nuclear immunostaining, and is semiquantitated as indicated below.\.br\\.br\Result          Semiquantitative Statement\.br\\.br\ER Positive     Percent cells staining as: (0  0%; 1+  0%, 2+  10%, 3+  90%)\.br\\.br\PR Negative     Percent cells staining as: (0  0%, 1+  0%, 2+  0%, 3+  0%)\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004723|P|2.3
PID|1||112233456^^^SY|tpmc8198394|TESTVTWOFIVE^MAURICE||19660912|M|||||||||||112-23-3456|||||||||||N
PV1|1||I7P||||987654^PATHOID^DOCTOR||||||||||pmc3304^PATHOID^DOCTOR|SYA|1800555121204|||||||||||||||||||||||||200511160636
ORC|RE||MWS05-105^CoPathPlus||CM||||200512021139|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||MWS05-105^CoPathPlus^tpmc4267183|MWSP^MW Pathology|||200512020000|||||||200512021417|BNBXMW|505074||||^39^Y|-1|200512051017||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc4267183.2|BNBXMW^Breast Core Biopsy^L||||||C||1^1
OBX|2|TX|GDT|tpmc4267183|The specimen is received in formalin in one part labeled with the patient's name, initials WJ, and "Left breast at 12 o'clock".  It consists of three cylindrical cores of white-tan tissue ranging from 1.1 to 1.4 cm in length and up to 0.2 cm in diameter.  The entire specimen is submitted in cassette A.\.br\||||||C
OBX|3|TX|MDT|tpmc4267183|Microscopic examination substantiates the diagnosis indicated above.\.br\||||||C
OBX|4|TX|FIN|tpmc4267183|BREAST, LEFT, 12 O' CLOCK, CORE BIOPSY \.br\GYNECOMASTIA WITH DUCTAL EPITHELIAL HYPERPLASIA.\.br\||||||C
OBX|5|CE|IMP|tpmc4267183|M71000^^SNO||||||||1||A
OBX|6|CE|IMP|tpmc4267183|M72170^^SNO||||||||1||A
OBX|7|CE|IMP|tpmc4267183|P1140^^SNO||||||||1||A
OBX|8|CE|IMP|tpmc4267183|T04060^^SNO||||||||1||A
OBX|9|CE|IMP|tpmc4267183|V72.6^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004724|P|2.3
PID|1||123456790^^^RR|tpmc5198394|TESTVTWOFIVE^BARBARA||19501215|F||||||||||||||||||||||N
PV1|1||PPAT||||^PLANET^VENUS||||||||||pmc28361^PLANET^NEPTUNE|OSD|0244276653054|||||||||||||||||||||||||200512011506
ORC|RE||MWS05-106^CoPathPlus||CM||||200512051621|^LASSIGE^KAREN||^PLANET^VENUS
OBR|1||MWS05-106^CoPathPlus^tpmc5367183|MWSP^MW Pathology|||200512051000|||||||200512051611||||||^55^Y|-1|200512061209||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc5367183.1|^1Consult block and 4 slides^L||||||C||1^1
OBX|2|CE|PROCESS|tpmc5367183.1.0.1|pmc7533^Reticulin Stain (Histo)^L||||||||1^Retic|200512061137
OBX|3|CE|PROCESS|tpmc5367183.1.0.2|pmc4115^Blank Slide (MW)^L||||||||2^BLANK|200512061137
OBX|4|TX|MDT|tpmc5367183|Microscopic examination substantiates the above diagnosis.\.br\||||||C
OBX|5|TX|FIN|tpmc5367183|BREAST, RIGHT, LUMPECTOMY (OSS S-05-6154, 11/10/05, JAMESON HOSPITAL) \.br\A.DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES WITH COMEDO NECROSIS AND CANCERIZATION OF LOBULES.\.br\B.NEOPLASM EXTENDS TO THE POSTERIOR MARGIN.\.br\C.      ALL OTHER SURGICAL MARGINS OF RESECTION ARE NEGATIVE (SEE COMMENT).\.br\D.ONE (1) BENIGN LYMPH NODE NEGATIVE FOR TUMOR (0/1).\.br\E.FIBROCYSTIC CHANGES.\.br\||||||C
OBX|6|CE|IMP|tpmc5367183|280.9^^ICD||||||||1
OBR|2||tpmc5367183^CoPathPlus^tpmc5367183.P1|FISH^FISH (PCL)||||||||||200512061142|||||||1|200512061142||SP|F||||||||987654^PATHOID^DOCTOR
OBX|1|TX|PIN|tpmc5367183|No amplification of the HER-2/NEU gene was seen by interphase FISH analysis.\.br\\.br\RESULTS:\.br\\.br\Fluorescence in situ hybridization (FISH) analysis was performed on MWH Surgical  MWS05-106  ,(Breast Cancer) using the DNA probe for the HER-2/NEU gene (Vysis, Inc., lot 12345).  The ratio of HER-2/NEU signals to chromosome 17 centromere signals was determined to be 1.35.  A ratio of 2.2 or greater is considered to be amplified; therefore, this specimen is not amplified.\.br\\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004725|P|2.3
PID|1||123456790^^^RR|tpmc5198394|TESTVTWOFIVE^BARBARA||19501215|F||||||||||||||||||||||N
PV1|1||PPAT||||^PLANET^VENUS||||||||||pmc28361^PLANET^NEPTUNE|OSD|0244276653054|||||||||||||||||||||||||200512011506
ORC|RE||MWS05-109^CoPathPlus||CM||||200512091316|^LASSIGE^KAREN||^PLANET^VENUS
OBR|1||MWS05-109^CoPathPlus^tpmc0767183|MWSP^MW Pathology|||200512091349|||||||200512091349|BRSEGMW|||||^55^Y|-1|200512091444||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc0767183.2|BRSEGMW^Breast, Segmental Biopsy^L||||||F||1^1
OBX|2|TX|GDT|tpmc0767183|The specimen is received unfixed labeled with the patient's name, initials RC and "right segmental mastectomy tissue-new posteriorl margin".  It consists of a 6.0 x 5.5 x 1.4 cm oriented portion of pink-yellow fibrofatty tissue.  The medial aspect is dense and indurated, grossly consistent with a previous excision site.  Margins are inked and the specimen is serially sectioned from superior to inferior.  Cut surfaces show predominantly yellow lobular adipose and scant pink-white fibrous tissue.  No lesions or nodules are seen grossly.  The specimen is submitted entirely from superior to inferior in sequential cut sections as follows:\.br\A- two slices\.br\B- one slice\.br\C- one slice\.br\D- one slice\.br\E- one slice\.br\F-G- one slice\.br\H-I- one slice\.br\J-K- one slice\.br\L-N- one slice\.br\O-P- one slice\.br\Q- one slice. \.br\Inking Key:  red-superior, orange-anterior, yellow-lateral, green-inferior, blue-medial, black-posterior.\.br\||||||F
OBX|3|TX|MDT|tpmc0767183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Segmental\.br\LOCATION:      Not specified\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  0 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: \.br\     No\.br\TUMOR TYPE (invasive component): \.br\     Ductal adenocarcinoma, NOS\.br\ANGIOLYMPHATIC INVASION:      No\.br\DERMAL LYMPHATIC INVASION:      Not applicable\.br\CALCIFICATION:      No\.br\TUMOR TYPE, IN SITU:      Papillary\.br\     Ductal carcinoma in situ, multifocal\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: \.br\     No\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT: \.br\     No\.br\PAGET'S DISEASE OF NIPPLE:      No\.br\LYMPH NODES EXAMINED:      0\.br\METHOD(S) OF LYMPH NODE EXAMINATION: \.br\     Other: none\.br\SENTINEL NODE METASTASIS:      No\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT: \.br\     No\.br\T STAGE, PATHOLOGIC:      pT0\.br\N STAGE, PATHOLOGIC:      pN0(i-)\.br\M STAGE, PATHOLOGIC:      pM0\.br\ESTROGEN RECEPTORS:      unknown\.br\PROGESTERONE RECEPTORS:      unknown\.br\HER2/NEU:      zero or 1+\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|CE|IMP|tpmc0767183|280.9^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004726|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-109^CoPathPlus||CM||||200506291429|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-109^CoPathPlus^tst8807183|PHSP^PH Surgical Pathology|||200506291427|||||||200506291427|VALV|505075||||^49^Y|-1|200507051756||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst8807183.1|VALV^Aortic valve^L||||||F||1^1
OBX|2|CE|ANT|tst8807183.2|AAA^Ascending aortic aneurysm^L||||||F||2^2
OBX|3|ST|BLOCK|tst8807183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst8807183.2.2|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst8807183.1.3|B||||||||2^B|200507221753
OBX|6|CE|PROCESS|tst8807183.1.1.1|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|7|CE|PROCESS|tst8807183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|8|CE|PROCESS|tst8807183.1.1.3|pmc2233^Acid Fast Stain (Histo)^L||||||||3^AcidFast|200512191038
OBX|9|CE|PROCESS|tst8807183.1.3.4|$hinit^Initial H&E^L||||||||4^H&E|200508180859
OBX|10|CE|PROCESS|tst8807183.1.3.5|pmc2233^Acid Fast Stain (Histo)^L||||||||5^AcidFast|200512191038
OBX|11|CE|PROCESS|tst8807183.1.1.6|pmc2233^Acid Fast Stain (Histo)^L||||||||4^AcidFast|200512191038
OBX|12|CE|PROCESS|tst8807183.1.3.7|pmc9333^Giemsa Stain (Histo)^L||||||||6^Giemsa|200512191038
OBX|13|CE|PROCESS|tst8807183.1.3.8|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||7^H&E Recut|200601132341
OBX|14|CE|PROCESS|tst8807183.1.0.9|pmc3904^Eber Probe for EBV mRNA (PHIS)^L||||||||1^EBER Probe|200506291603
OBX|15|CE|PROCESS|tst8807183.1.0.10|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||2^IBNKNC|200601132341
OBX|16|TX|GDT|tst8807183|specimen is mid-unfixed in two parts.\.br\\.br\Part 1 is identified as "aortic valve" and is labeled with the patient's name and initials JLM. Received are two, opaque,calcific, yellow, semi-lunar, cardiac valve cusps 3.6 x 1.6 x 0.5 cm and 3.0 x 1.5 x 0.2 cm.  A representative cross-section of each cusp is submitted after decalcification labeled 1A.\.br\\.br\Part 2 is identified as "ascending aortic aneurysm" and is labeled with the patient's name and initials JLM.  Received are three, unoriented excisions of rubbery, arterial vascular tissue 10.0 x 2.6 x 0.3 cm in aggregate.  The intimal surfaces are smooth and uniformly yellow.  The adventitial surfaces are grossly hemorrhagic.  Representative tissue is submitted in one cassette labeled 2A.\.br\HAS  \.br\||||||F
OBX|17|TX|MDT|tst8807183|\.br\||||||F
OBX|18|TX|FIN|tst8807183|CARDIOMYOPATHY\.br\\.br\||||||F
OBX|19|CE|IMP|tst8807183|D7100^^SNO||||||||1||A
OBX|20|CE|IMP|tst8807183|380.12^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004727|P|2.3
PID|1||357159258^^^UPCMWH|tpmc6250305|SMITH^DANA^A||19660529|F|||||||||||357-15-9258|||||||||||N
PV1|1||PATHOS||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|OSD|0002357159258|||||||||||||||||||||||||200512211523
ORC|RE||MWS05-112^CoPathPlus||CM||||200512211630|^FRANCIS^DANA||505074^PLANET^MARS
OBR|1||MWS05-112^CoPathPlus^tpmc2477183|MWSP^MW Pathology|||200512211603|||||||200512211603|BRE|505074||||^39^Y|-1|200512221112||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc2477183.1|BRE^RT 3:00 Breast, Excisional Biopsy^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc2477183.1.1|A||||||||1^A|200512211610
OBX|3|ST|BLOCK|tpmc2477183.1.2|B||||||||2^B|200512211613
OBX|4|ST|BLOCK|tpmc2477183.1.3|C||||||||3^C|200512211613
OBX|5|CE|PROCESS|tpmc2477183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200601031433
OBX|6|CE|PROCESS|tpmc2477183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200601031433
OBX|7|CE|PROCESS|tpmc2477183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200601031433
OBX|8|CE|PROCESS|tpmc2477183.1.0.4|pmc7764^Frozen Sect Single Block (Surg)^L||||||||1^FRZ Single|200601031433
OBX|9|TX|GDT|tpmc2477183|The specimen is received in formalin labeled with the patient's name, initials AD and "right breast at 3 o'clock".  It consists of a 3.0 x 2.8 x 0.6 cm aggregate of minimally hemorrhagic tan-yellow irregular soft tissue fragments. The specimen is submitted entirely in cassettes A and B.\.br\||||||F
OBX|10|TX|MDT|tpmc2477183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|11|TX|FIN|tpmc2477183|BREAST, RIGHT 3 O'CLOCK, MRI GUIDED CORE BIOPSY \.br\A.MIXED NFILTRATING CARCINOMA, WITH DUCTAL(NUCLEAR GRADE 3) AND PLEOMORPHIC LOBULAR CARCINOMA TYPES ( SEE COMMENT)\.br\B.DUCTAL CARCINOMA IN-SITU, CRIBRIFORM TYPE WITH ASSOCIATED WITH COMEDONECROSIS, NUCLEAR GRADE 3 (See comment).\.br\C.LOBULAR CARCINOMA-IN-SITU\.br\D.MICROCALCIFICATIONS ASSOCIATED WITH IN-SITU AS WELL AS INVASIVE COMPONENTS.\.br\||||||F
OBX|12|CE|IMP|tpmc2477183|M80102^^SNO||||||||1||A
OBX|13|CE|IMP|tpmc2477183|M82013^^SNO||||||||1||A
OBX|14|CE|IMP|tpmc2477183|M85003^^SNO||||||||1||A
OBX|15|CE|IMP|tpmc2477183|M85202^^SNO||||||||1||A
OBX|16|CE|IMP|tpmc2477183|P1140^^SNO||||||||1||A
OBX|17|CE|IMP|tpmc2477183|T04020^^SNO||||||||1||A
OBX|18|CE|IMP|tpmc2477183|M55400^^SNO||||||||1||A
OBX|19|CE|IMP|tpmc2477183|V65.9^^ICD||||||||1
OBR|2||tpmc2477183^CoPathPlus^tpmc2477183.P1|FISH^FISH (PCL)||||||||||200512221110|||||||1|200512221110||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|TX|PIN|tpmc2477183|No amplification of the HER-2/NEU gene was seen by interphase FISH analysis.\.br\\.br\RESULTS:\.br\\.br\Fluorescence in situ hybridization (FISH) analysis was performed on MWH Surgical  MWS05-112  , Block A (Breast Cancer) using the DNA probe for the HER-2/NEU gene (Vysis, Inc., lot 1234321).  The ratio of HER-2/NEU signals to chromosome 17 centromere signals was determined to be 1.3.  A ratio of 2.2 or greater is considered to be amplified; therefore, this specimen is not amplified.\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004728|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-112^CoPathPlus||CM||||200506291433|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-112^CoPathPlus^tst0907183|PHSP^PH Surgical Pathology|||200506291432|||||||200506291432|VALV|505075||||^49^Y|-1|200507051758||SP|F||||||||z196^DEVINE^LISA
OBX|1|CE|ANT|tst0907183.1|VALV^Aortic valve^L||||||F||1^1
OBX|2|CE|ANT|tst0907183.2|AAA^Ascending aortic aneurysm^L||||||F||2^2
OBX|3|ST|BLOCK|tst0907183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst0907183.2.2|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst0907183.1.3|B||||||||2^B|200507221753
OBX|6|ST|BLOCK|tst0907183.1.4|C||||||||3^C|200507221753
OBX|7|CE|PROCESS|tst0907183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|8|CE|PROCESS|tst0907183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|9|CE|PROCESS|tst0907183.1.3.3|$hinit^Initial H&E^L||||||||3^H&E|200508180859
OBX|10|CE|PROCESS|tst0907183.1.4.4|$hinit^Initial H&E^L||||||||3^H&E|200508180859
OBX|11|CE|PROCESS|tst0907183.1.4.5|pmc9333^Giemsa Stain (Histo)^L||||||||4^Giemsa|200506291552
OBX|12|CE|PROCESS|tst0907183.2.2.6|pmc1333^Congo Red Stain (Histo)^L||||||||2^CongoRed|200512191038
OBX|13|CE|PROCESS|tst0907183.2.2.7|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||3^H&E Recut|200601132341
OBX|14|TX|GDT|tst0907183|The specimen is mid-unfixed in two parts.\.br\\.br\Part 1 is identified as "aortic valve" and is labeled with the patient's name and initials JLM. Received are two, opaque, rubbery to calcific, yellow, semi-lunar, cardiac valve cusps 3.6 x 1.6 x 0.5 cm and 3.0 x 1.5 x 0.2 cm.  A representative cross-section of each cusp is submitted after decalcification labeled 1A.\.br\\.br\Part 2 is identified as "ascending aortic aneurysm" and is labeled with the patient's name and initials JLM.  Received are three, unoriented excisions of rubbery, arterial vascular tissue 10.0 x 2.6 x 0.3 cm in aggregate.  The intimal surfaces are smooth and uniformly yellow.  The adventitial surfaces are grossly hemorrhagic.  Representative tissue is submitted in one cassette labeled 2A.\.br\\.br\Part 3 is not finished\.br\HAS\.br\||||||F
OBX|15|TX|MDT|tst0907183|     SYNOPTIC - PRIMARY OVARIAN TUMORS INCLUDING BORDERLINE TUMORS\.br\TUMOR LOCATION:      Right\.br\PROCEDURE:      Salpingo-oophorectomy\.br\TUMOR SIZE:      Maximum dimension:  7 cm\.br\TUMOR TYPE:      Papillary serous carcinoma\.br\HISTOLOGIC SILVERBERG GRADE:      Moderately differentiated (6-7 pts)\.br\     ARCHITECTURAL PATTERN:           Papillary (2)\.br\     CYTOLOGIC ATYPIA:           Moderate (2)\.br\     MITOTIC COUNTS / 10hpf:           10-24 (2)\.br\VASCULAR INVASION:      Yes\.br\TUMOR CAPSULE:      Ruptured\.br\SURFACE IMPLANTS:      Invasive\.br\SURFACE IMPLANT SITE:      Fallopian Tubes\.br\SURFACE IMPLANT SIZE:      < 2 cm.\.br\ASSOCIATED OTHER LESION:      Atypical endometriosis\.br\MALIGNANT CELLS IN ASCITES OR\.br\PERITONEAL WASHING:      No\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 23\.br\LYMPH NODES POSITIVE:      Number of positive lymph nodes, Right: 7\.br\     Number of positive lymph nodes, Left: 1\.br\LYMPH NODE GROUPS INVOLVED:      Pelvic, Right, Pelvic, Left, Obturator, Right, Obturator, Left, Common iliac, Right\.br\EXTRANODAL EXTENSION:      Yes\.br\T STAGE, PATHOLOGIC:      pT1c\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM1\.br\FIGO STAGE:      IIC\.br\--------------------------------------------------------\.br\Blue cells\.br\||||||F
OBX|16|TX|FIN|tst0907183|AORTIC VALVE REPLACEMENT\.br\||||||F
OBX|17|CE|IMP|tst0907183|P1279^^SNO||||||||1||A
OBX|18|CE|IMP|tst0907183|T39000^^SNO||||||||1||A
OBX|19|CE|IMP|tst0907183|380.12^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004729|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-113^CoPathPlus||CM||||200506291434|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-113^CoPathPlus^tst1907183|PHSP^PH Surgical Pathology|||200506291434|||||||200506291434|VALV|505075||||^49^Y|-1|200507051758||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst1907183.1|VALV^Aortic valve^L||||||F||1^1
OBX|2|CE|ANT|tst1907183.2|AAA^Ascending aortic aneurysm^L||||||F||2^2
OBX|3|ST|BLOCK|tst1907183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst1907183.2.2|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst1907183.1.3|B||||||||2^B|200507221753
OBX|6|TX|GDT|tst1907183|The specimen is mid-unfixed in two parts.\.br\\.br\Part 1 is identified as "aortic valve" and is labeled with the patient's name and initials JLM. Received are two, opaque, rubbery to calcific, yellow, semi-lunar, cardiac valve cusps 3.6 x 1.6 x 0.5 cm and 3.0 x 1.5 x 0.2 cm.  A representative cross-section of each cusp is submitted after decalcification labeled 1A.\.br\\.br\Part 2 is identified as "ascending aortic aneurysm" and is labeled with the patient's name and initials JLM.  Received are three, unoriented excisions of rubbery, arterial vascular tissue 10.0 x 2.6 x 0.3 cm in aggregate.  The intimal surfaces are smooth and uniformly yellow.  The adventitial surfaces are grossly hemorrhagic.  Representative tissue is submitted in one cassette labeled 2A.\.br\HAS  \.br\||||||F
OBX|7|TX|MDT|tst1907183|     SYNOPTIC - BREAST NEOADJUVANT TREATMENT\.br\MAXIMUM PREADJUVANT TUMOR SIZE:      Maximum dimension invasive component: 8 cm\.br\TUMOR VOLUME REDUCTION: \.br\     Tumor necrosis: 5%\.br\STROMAL ELASTOSIS/FIBROSIS:      No\.br\HORMONAL THERAPY EFFECT**:      Yes, adjacent non-neoplastic breast tissue shows chemotherapy effect\.br\     Metaplasia\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|8|TX|FIN|tst1907183|CARDIOMYOPATHY\.br\||||||F
OBX|9|CE|IMP|tst1907183|380.12^^ICD||||||||1
OBR|2||tst1907183^CoPathPlus^tst1907183.A1|ADD^Addendum||||||||||200506291540|||||||1|200506291540||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|TX|ADX|tst1907183|ME KA MEKA MEKA MEKOW!!! GIVE ME BACK MY LITTER PAN!\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004730|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-114^CoPathPlus||CM||||200506291436|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-114^CoPathPlus^tst2907183|PHSP^PH Surgical Pathology|||200506291435|||||||200506291435|VALV|505075||||^49^Y|-1|200507051759||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst2907183.1|VALV^Aortic valve^L||||||F||1^1
OBX|2|CE|ANT|tst2907183.2|AAA^Ascending aortic aneurysm^L||||||F||2^2
OBX|3|ST|BLOCK|tst2907183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst2907183.2.2|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst2907183.1.3|B||||||||2^B|200507221753
OBX|6|CE|PROCESS|tst2907183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst2907183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|8|TX|GDT|tst2907183|The specimen is mid-unfixed in two parts.\.br\\.br\Part 1 is identified as "huge booger" and is labeled with the patient's name and initials JLM. Received are two, opaque, to calcific, yellow, semi-lunar, cardiac valve cusps 3.6 x 1.6 x 0.5 cm and 3.0 x 1.5 x 0.2 cm.  A representative cross-section of each cusp is submitted after decalcification labeled 1A.\.br\\.br\Part 2 is identified as "ascending aortic pimple" and is labeled with the patient's name and initials JLM.  Received are free, unoriented excisions of chubby, arterial vascular tissue 10.0 x 2.6 x 0.3 cm in aggregate.  The intimal surfaces are smooth and uniformly boring.  The adventitial surfaces are grossly hemorrhagic.  Representative tissue is submitted in one cassette labeled "What  dis???"2A.\.br\HAS  \.br\||||||F
OBX|9|TX|MDT|tst2907183|     SYNOPTIC DATA - LARYNX RESECTIONS\.br\TYPE OF LARYNGECTOMY:      Hemilaryngectomy\.br\TUMOR LOCATION:      Left, Midline\.br\ATTACHED STRUCTURES:      Neck dissection, Pyriform sinus, Base of tongue, Thyroid\.br\TUMOR LOCATION/SEGMENT:      Supraglottic, Glottic-subglottic (greater than 1 cm subglottic extension)\.br\TUMOR SIZE:      Maximum dimension:  7.2 cm\.br\HISTOLOGIC TYPE OF TUMOR:      Carcinoid or atypical carcinoid\.br\HISTOLOGIC GRADE:      Well differentiated\.br\STRUCTURES INVOLVED BY TUMOR:      Anterior commissure, Paraglottic space\.br\LYMPH NODES POSITIVE:      Number of lymph nodes positive:: 2\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 1\.br\METASTASES\.br\     Yes\.br\INTRA-PERINEURAL INVASION:      Present\.br\VASCULAR INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      Free (2 mm or more)\.br\T STAGE, PATHOLOGIC:      Subglottis, pT4a\.br\N STAGE, PATHOLOGIC:      pN2\.br\M STAGE, PATHOLOGIC:      pM0\.br\--------------------------------------------------------\.br\There are many small cells present ..... \.br\\.br\||||||F
OBX|10|TX|FIN|tst2907183|CARDIOMYOPATHY\.br\||||||F
OBX|11|CE|IMP|tst2907183|D7100^^SNO||||||||1||A
OBX|12|CE|IMP|tst2907183|380.12^^ICD||||||||1
OBR|2||tst2907183^CoPathPlus^tst2907183.A1|ADD^Addendum||||||||||200506291540|||||||1|200506291540||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|TX|ADX|tst2907183|This is an addendum.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004731|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-115^CoPathPlus||CM||||200506291437|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-115^CoPathPlus^tst3907183|PHSP^PH Surgical Pathology|||200506291437|||||||200506291437|VALV|505075||||^49^Y|-1|200507051759||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst3907183.1|VALV^Aortic valve^L||||||F||1^1
OBX|2|CE|ANT|tst3907183.2|AAA^Ascending aortic aneurysm^L||||||F||2^2
OBX|3|ST|BLOCK|tst3907183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst3907183.2.2|A||||||||1^A|200507221753
OBX|5|ST|BLOCK|tst3907183.1.3|B||||||||2^B|200507221753
OBX|6|CE|PROCESS|tst3907183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst3907183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|8|CE|PROCESS|tst3907183.1.3.3|$hinit^Initial H&E^L||||||||9^H&E|200508180859
OBX|9|CE|PROCESS|tst3907183.1.1.4|pmc9333^Giemsa Stain (Histo)^L||||||||2^Giemsa|200512191038
OBX|10|CE|PROCESS|tst3907183.2.2.5|pmc1333^Congo Red Stain (Histo)^L||||||||2^CongoRed|200512191038
OBX|11|CE|PROCESS|tst3907183.2.2.6|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||3^H&E Recut|200601132341
OBX|12|CE|PROCESS|tst3907183.2.2.7|pmc5174^11q, FISH (PHIS)^L||||||||4^I11Q|200506291603
OBX|13|CE|PROCESS|tst3907183.2.2.8|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||5^IBNKNC|200601132341
OBX|14|TX|GDT|tst3907183|The specimen is mid-unfixed in two parts.\.br\\.br\Part 1 is identified as "aortic valve" and is labeled with the patient's name and initials JLM. Received are two, opaque, rubbery to calcific, yellow, semi-lunar, cardiac valve cusps 3.6 x 1.6 x 0.5 cm and 3.0 x 1.5 x 0.2 cm.  A representative cross-section of each cusp is submitted after decalcification labeled 1A.  I am a great pathologist.\.br\\.br\Part 2 is identified as "ascending aortic aneurysm" and is labeled with the patient's name and initials JLM.  Received are three, unoriented excisions of rubbery, arterial vascular tissue 10.0 x 2.6 x 0.3 cm in aggregate.  The intimal surfaces are smooth and uniformly yellow.  The adventitial surfaces are grossly hemorrhagic.  Representative tissue is submitted in one cassette labeled 2A.\.br\HAS  \.br\||||||F
OBX|15|TX|MDT|tst3907183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Superior\.br\PROCEDURE:      Lobectomy\.br\TUMOR SIZE:      Maximum dimension:  5 cm\.br\     Minor dimension: 2 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 2\.br\TUMOR TYPE:      Invasive adenocarcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES: \.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\TUMOR NECROSIS:      > 50%\.br\SURGICAL MARGIN INVOLVEMENT:      Yes\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Moderate\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 4\.br\     Number of N1 lymph nodes examined: 4\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      Yes\.br\N2 LYMPH NODE GROUPS INVOLVED:      Level 2R\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 4\.br\     Number of N2 lymph nodes examined: 5\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      Yes\.br\UNDERLYING DISEASE(S):      Atypical alveolar hyperplasia\.br\T STAGE, PATHOLOGIC:      pT0\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pM0\.br\ANCILLARY STUDIES:      Histochemical stains\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|16|TX|FIN|tst3907183|BAD AORTA\.br\||||||F
OBX|17|CE|IMP|tst3907183|T42000^^SNO||||||||1||A
OBX|18|CE|IMP|tst3907183|380.12^^ICD||||||||1
OBR|2||tst3907183^CoPathPlus^tst3907183.A1|ADD^Addendum||||||||||200506291540|||||||1|200506291540||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|TX|ADX|tst3907183|Here' s my addendum.  JTE\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004732|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-116^CoPathPlus||CM||||200506291439|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-116^CoPathPlus^tst4907183|PHSP^PH Surgical Pathology|||200506291438|||||||200506291438|VALV|505075||||^49^Y|-1|200507051803||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst4907183.1|VALV^Aortic valve^L||||||F||1^1
OBX|2|CE|ANT|tst4907183.2|AAA^Ascending aortic aneurysm^L||||||F||2^2
OBX|3|ST|BLOCK|tst4907183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst4907183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst4907183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|CE|PROCESS|tst4907183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst4907183.1.1.3|pmc5633^Verhoff Van Geison Stain (Histo)^L||||||||2^VVG|200512191038
OBX|8|TX|GDT|tst4907183|The specimen is mid-unfixed in two parts.\.br\\.br\Part 1 is identified as "aortic valve" and is labeled with the patient's name and initials JLM. Received are two, opaque, rubbery to calcific, yellow, semi-lunar, cardiac valve cusps 3.6 x 1.6 x 0.5 cm and 3.0 x 1.5 x 0.2 cm.  A representative cross-section of each cusp is submitted after decalcification labeled 1A.\.br\\.br\Part 2 is identified as "ascending aortic aneurysm" and is labeled with the patient's name and initials JLM.  Received are three, unoriented excisions of rubbery, arterial vascular tissue 10.0 x 2.6 x 0.3 cm in aggregate.  The intimal surfaces are smooth and uniformly yellow.  The adventitial surfaces are grossly hemorrhagic.  Representative tissue is submitted in one cassette labeled 2A.  this is a test for class.\.br\HAS  \.br\||||||F
OBX|9|TX|MDT|tst4907183|\.br\||||||F
OBX|10|CE|IMP|tst4907183|380.12^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004733|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-119^CoPathPlus||CM||||200507051117|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-119^CoPathPlus^tst0017183|PHSP^PH Surgical Pathology|||200507051117|||||||200507051117|VALV|505075||||^49^Y|-1|200507051806||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst0017183.1|VALV^Aortic Valve^L||||||F||1^1
OBX|2|CE|ANT|tst0017183.2|VALV^Ascending aorta^L||||||F||2^2
OBX|3|ST|BLOCK|tst0017183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst0017183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst0017183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|CE|PROCESS|tst0017183.2.2.2|$hinit^Initial H&E^L||||||||2^H&E|200508180859
OBX|7|CE|PROCESS|tst0017183.1.1.3|pmc2043^Estrogen Receptor (IPEX)^L||||||||2^AER|200601132341
OBX|8|CE|PROCESS|tst0017183.1.1.4|pmc9133^Vimentin (IPEX)^L||||||||3^Vimentin|200601132341
OBX|9|CE|PROCESS|tst0017183.2.0.5|pmc8243^mRNA Kappa Chn Restr (PHIS)^L||||||||1^IRKAP|200507051556
OBX|10|CE|PROCESS|tst0017183.2.0.6|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||2^IBNKNC|200601132341
OBX|11|CE|PROCESS|tst0017183.1.1.7|pmc1073^Cytomegalovirus (IPEX)^L||||||||4^CMV|200601132341
OBX|12|CE|PROCESS|tst0017183.1.1.8|pmc1333^Congo Red Stain (Histo)^L||||||||5^CongoRed|200512191038
OBX|13|CE|PROCESS|tst0017183.1.1.9|pmc6734^Elastic Trichrome^L||||||||6^ElsTri|200512191038
OBX|14|CE|PROCESS|tst0017183.2.2.10|pmc1073^Cytomegalovirus (IPEX)^L||||||||3^CMV|200601132341
OBX|15|CE|PROCESS|tst0017183.2.2.11|pmc1333^Congo Red Stain (Histo)^L||||||||4^CongoRed|200512191038
OBX|16|CE|PROCESS|tst0017183.2.2.12|pmc6734^Elastic Trichrome^L||||||||5^ElsTri|200512191038
OBX|17|TX|GDT|tst0017183|The specimen is received unfixed in two parts.\.br\Derin caglar\.br\Part 1 is labeled with the patient's name, initials TH and " aortic valve".  The specimen consists of two tan-gray, irregular, rubbery to firm portions of valve tissue measuring 3.5 x 1.5 x 0.4 cm and 4.5 x 2.0 x 0.5 cm.  The walls are thickened and calcified yellow plaquing present.  The wall thickness ranges from 0.1 to 0.5 cm.  Following adequate decalcification representative cross sections are submitted in decal cassette labeled 1A.\.br\\.br\Part 2 is labeled with the patient's name, initials TH and " ascending aorta".  The specimen consists of multiple tan-pink, irregular, rubbery and hemorrhagic portions of vascular tissue measuring 5.5 x 3.5 x 1.5 cm in aggregate.  There is slight separation of layers.  Representative cross sections are submitted in cassette labeled 2A.\.br\mam\.br\||||||F
OBX|18|TX|MDT|tst0017183|Microscopic examination substantiates the above diagnosis.\.br\SD/dme\.br\||||||F
OBX|19|TX|FIN|tst0017183|PART 1: VALVE, AORTIC, REPLACEMENT \.br\PENDING DECALCIFICATION.  ADDENDUM REPORT TO FOLLOW.\.br\\.br\PART 2: AORTA, ASCENDING, REPAIR \.br\VASCULAR TISSUE WITH ADVENTITIAL HEMORRHAGE.\.br\SD/dme\.br\||||||F
OBX|20|CE|IMP|tst0017183|P1279^^SNO||||||||1||A
OBX|21|CE|IMP|tst0017183|T39000^^SNO||||||||1||A
OBX|22|CE|IMP|tst0017183|T42000^^SNO||||||||1||A
OBX|23|CE|IMP|tst0017183|M37000^^SNO||||||||1||A
OBX|24|CE|IMP|tst0017183|T40000^^SNO||||||||1||A
OBX|25|CE|IMP|tst0017183|T42100^^SNO||||||||1||A
OBX|26|CE|IMP|tst0017183|380.12^^ICD||||||||1
OBR|2||tst0017183^CoPathPlus^tst0017183.A1|ADD^Addendum||||||||||200507051535|||||||1|200507051535||SP|F|||||||002150^BARNES^LEON|z196^DEVINE^LISA
OBX|1|TX|ADX|tst0017183|This is an addendum\.br\||||||F
OBR|3||tst0017183^CoPathPlus^tst0017183.A2|ADD^Addendum||||||||||200510171250|||||||2|200510171250||SP|F|||||||MD.AMIN.RA^AMIN^RAJNIKANT|UXD^Cerner^User
OBX|1|TX|ADX|tst0017183|This is the addendum text....  Line one\.br\Line two\.br\Line three\.br\Line four\.br\Line five\.br\Line six\.br\Line seven\.br\Line eight\.br\Line nine\.br\Line ten\.br\Line eleven\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004734|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-120^CoPathPlus||CM||||200507051120|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-120^CoPathPlus^tst1017183|PHSP^PH Surgical Pathology|||200507051120|||||||200507051120|VALV|505075||||^49^Y|-1|200507051800||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst1017183.1|VALV^Aortic Valve^L||||||F||1^1
OBX|2|CE|ANT|tst1017183.2|VALV^Ascending aorta^L||||||F||2^2
OBX|3|ST|BLOCK|tst1017183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst1017183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst1017183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|CE|PROCESS|tst1017183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst1017183.1.1.3|pmc3633^Trichrome Stain (Histo)^L||||||||2^Trichrome|200512191038
OBX|8|CE|PROCESS|tst1017183.1.1.4|pmc8233^Gram Stain (Histo)^L||||||||3^Gram|200512191038
OBX|9|CE|PROCESS|tst1017183.2.2.5|pmc9873^Amyloid A (IPEX)^L||||||||2^AAMY|200601132341
OBX|10|CE|PROCESS|tst1017183.2.2.6|pmc0383^Amyloid P (IPEX)^L||||||||3^AAMP|200601132341
OBX|11|CE|PROCESS|tst1017183.2.2.7|pmc0973^amyloid transthyretin prealbumin(IPEX)^L||||||||4^APREA|200601132341
OBX|12|CE|PROCESS|tst1017183.2.2.8|pmc3834^Kappa amyloid (IPEX)^L||||||||5^AKAPY|200601132341
OBX|13|CE|PROCESS|tst1017183.2.2.9|pmc9724^Amyloid lambda (IPEX)^L||||||||6^ALAMY|200601132341
OBX|14|CE|PROCESS|tst1017183.2.2.10|pmc1333^Congo Red Stain (Histo)^L||||||||7^CongoRed|200512191038
OBX|15|CE|PROCESS|tst1017183.2.2.11|pmc6933^HPV Probe Panel (PHIS)^L||||||||8^IHPV|200507051556
OBX|16|CE|PROCESS|tst1017183.2.2.12|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||9^IBNKNC|200601132341
OBX|17|CE|PROCESS|tst1017183.1.1.13|pmc1073^Cytomegalovirus (IPEX)^L||||||||4^CMV|200601132341
OBX|18|CE|PROCESS|tst1017183.1.1.14|pmc1333^Congo Red Stain (Histo)^L||||||||5^CongoRed|200512191038
OBX|19|CE|PROCESS|tst1017183.1.1.15|pmc3633^Trichrome Stain (Histo)^L||||||||6^Trichrome|200512191038
OBX|20|CE|PROCESS|tst1017183.2.2.16|pmc1073^Cytomegalovirus (IPEX)^L||||||||10^CMV|200601132341
OBX|21|CE|PROCESS|tst1017183.2.2.17|pmc1333^Congo Red Stain (Histo)^L||||||||11^CongoRed|200512191038
OBX|22|CE|PROCESS|tst1017183.2.2.18|pmc3633^Trichrome Stain (Histo)^L||||||||12^Trichrome|200512191038
OBX|23|TX|GDT|tst1017183|1.  Aortic Valve:  46,X #,t(1;19)(q23;p13.3)[#]\.br\\.br\Abnormal #male bone marrow chromosome analysis with a translocation between the long arm of one chromosome 1 and the short arm of one chromosome 19.  The translocation, t(1;19)(q23;p13.3) is strongly associated with ALL, pre-B immunological phenotype, but may be found occasionally in T cell ALL.  The 1;19 translocation disrupts the normal functions of the E2A and PBX1 genes, located on band 19p13.3 and 1q23, respectively, and leads to formation of a fusion gene that encodes a hybrid transcription factor with oncogenic potential [Nichols J, Nimer SD (1992) Blood 80:2953-2963; Privitera E et al. (1992) Blood 79:1781-1788].  The prognostic value of this translocation appears to be obscure [Sharma P et al. (2001) Cancer Genet Cytogenet 124:132-136; Uckun F et al. (1998) J Clin Oncol 16:527-535].\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 #\.br\No. of Cells Karyotyped:              #\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:             #       #      #\.br\\.br\# trypsin-Giemsa banded metaphase cells were analyzed from # hour harvests of unstimulated # cell cultures.  # cells had a 46,X#,t(1;19)(q23;p13.3) chromosome complement.  # cells, each with the same abnormality, had hypodiploid karyotypes, likely as a result of random chromosomal loss.\.br\\.br\Average band level/haploid set:     #\.br\46,X #,t(1;19)(q23;p13.3)[#]\.br\\.br\Abnormal #male bone marrow chromosome analysis with a translocation between the long arm of one chromosome 1 and the short arm of one chromosome 19.  The translocation, t(1;19)(q23;p13.3) is strongly associated with ALL, pre-B immunological phenotype, but may be found occasionally in T cell ALL.  The 1;19 translocation disrupts the normal functions of the E2A and PBX1 genes, located on band 19p13.3 and 1q23, respectively, and leads to formation of a fusion gene that encodes a hybrid transcription factor with oncogenic potential [Nichols J, Nimer SD (1992) Blood 80:2953-2963; Privitera E et al. (1992) Blood 79:1781-1788].  The prognostic value of this translocation appears to be obscure [Sharma P et al. (2001) Cancer Genet Cytogenet 124:132-136; Uckun F et al. (1998) J Clin Oncol 16:527-535].\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 #\.br\No. of Cells Karyotyped:              #\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:             #       #      #\.br\\.br\# trypsin-Giemsa banded metaphase cells were analyzed from # hour harvests of unstimulated # cell cultures.  # cells had a 46,X#,t(1;19)(q23;p13.3) chromosome complement.  # cells, each with the same abnormality, had hypodiploid karyotypes, likely as a result of random chromosomal loss.\.br\\.br\Average band level/haploid set:     #\.br\\.br\2.  Ascending aorta:   \.br\The specimen is received unfixed in two parts.\.br\\.br\Part 1 is labeled with the patient's name, initials TH and " aortic valve".  The specimen consists of two tan-gray, irregular, rubbery to firm portions of valve tissue measuring 3.5 x 1.5 x 0.4 cm and 4.5 x 2.0 x 0.5 cm.  The walls are thickened and calcified yellow plaquing present.  The wall thickness ranges from 0.1 to 0.5 cm.  Following adequate decalcification representative cross sections are submitted in decal cassette labeled 1A.\.br\\.br\Part 2 is labeled with the patient's name, initials TH and " ascending aorta".  The specimen consists of multiple tan-pink, irregular, rubbery and hemorrhagic portions of vascular tissue measuring 5.5 x 3.5 x 1.5 cm in aggregate.  There is slight separation of layers.  Representative cross sections are submitted in cassette labeled 2A.\.br\mam\.br\||||||F
OBX|24|TX|MDT|tst1017183|     SYNOPTIC DATA - LARYNX RESECTIONS\.br\TYPE OF LARYNGECTOMY:      Total\.br\TUMOR LOCATION:      Bilateral\.br\ATTACHED STRUCTURES:      Thyroid\.br\TUMOR LOCATION/SEGMENT:      Transglottic\.br\TUMOR SIZE:      Maximum dimension:  3 cm\.br\HISTOLOGIC TYPE OF TUMOR:      Basaloid squamous carcinoma\.br\HISTOLOGIC GRADE:      Poorly differentiated/Undifferentiated\.br\STRUCTURES INVOLVED BY TUMOR:      Vallecula-base of tumor, Thyroid cartilage, Pre-epiglottic space, Paraglottic space\.br\LYMPH NODES POSITIVE:      Number of lymph nodes positive:: 4\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 4\.br\METASTASES\.br\     Yes\.br\INTRA-PERINEURAL INVASION:      Present\.br\VASCULAR INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      Free (2 mm or more)\.br\T STAGE, PATHOLOGIC:      Glottis, pT3\.br\N STAGE, PATHOLOGIC:      pN2b\.br\M STAGE, PATHOLOGIC:      pMX\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.\.br\SD/dme\.br\||||||F
OBX|25|TX|FIN|tst1017183|PART 1: VALVE, AORTIC, REPLACEMENT \.br\PENDING DECALCIFICATION.  ADDENDUM REPORT TO FOLLOW.\.br\\.br\PART 2: AORTA, ASCENDING, REPAIR \.br\VASCULAR TISSUE WITH ADVENTITIAL HEMORRHAGE.\.br\SD/dme\.br\||||||F
OBX|26|CE|IMP|tst1017183|P1279^^SNO||||||||1||A
OBX|27|CE|IMP|tst1017183|T39000^^SNO||||||||1||A
OBX|28|CE|IMP|tst1017183|T42000^^SNO||||||||1||A
OBX|29|CE|IMP|tst1017183|M37000^^SNO||||||||1||A
OBX|30|CE|IMP|tst1017183|T40000^^SNO||||||||1||A
OBX|31|CE|IMP|tst1017183|T42100^^SNO||||||||1||A
OBX|32|CE|IMP|tst1017183|380.12^^ICD||||||||1
OBR|2||tst1017183^CoPathPlus^tst1017183.A1|ADD^Addendum||||||||||200507051535|||||||1|200507051535||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|TX|ADX|tst1017183|This is an addendum for training. Okay.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004736|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-122^CoPathPlus||CM||||200507051126|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-122^CoPathPlus^tst3017183|PHSP^PH Surgical Pathology|||200507051125|||||||200507051125|VALV|505075||||^49^Y|-1|200507051801||SP|C|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst3017183.1|VALV^Aortic Valve^L||||||C||1^1
OBX|2|CE|ANT|tst3017183.2|VALV^Ascending aorta^L||||||C||2^2
OBX|3|ST|BLOCK|tst3017183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst3017183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst3017183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|CE|PROCESS|tst3017183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst3017183.1.1.3|pmc2043^Estrogen Receptor (IPEX)^L||||||||2^AER|200507051547
OBX|8|CE|PROCESS|tst3017183.1.1.4|pmc9133^Vimentin (IPEX)^L||||||||3^Vimentin|200601132341
OBX|9|CE|PROCESS|tst3017183.2.2.5|pmc8664^I3P (PHIS)^L||||||||2^I3P|200507051556
OBX|10|CE|PROCESS|tst3017183.2.2.6|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||3^IBNKNC|200601132341
OBX|11|CE|PROCESS|tst3017183.2.2.7|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||4^H&E Recut|200601132341
OBX|12|CE|PROCESS|tst3017183.2.2.8|pmc1073^Cytomegalovirus (IPEX)^L||||||||5^CMV|200601132341
OBX|13|CE|PROCESS|tst3017183.2.2.9|pmc1333^Congo Red Stain (Histo)^L||||||||6^CongoRed|200512191038
OBX|14|CE|PROCESS|tst3017183.2.2.10|pmc3633^Trichrome Stain (Histo)^L||||||||7^Trichrome|200512191038
OBX|15|TX|GDT|tst3017183|specimen is received unfixed in two parts.\.br\\.br\Part 1 is labeled with the patient's \.br\[[\E\\E\\.br\\E\\.br\\E\\.br\][;[p' ojhtyfrzaasA\.br\\.br\46,X#,t(11;14)(q13;q32)[#]/46,X#[#]\.br\\.br\Mosaic abnormal #male bone marrow chromosome analysis with an apparently normal cell line and one that has a translocation between the long arms of chromosomes 11 and 14.\.br\\.br\The translocation, t(11;14)(q13;q32) has been seen in advanced stages of multiple myeloma with a very poor prognosis [Lai JL et al. (1998) Cancer Genet Cytogenet 104:133-138].  As a result ofM,,, this translocation in multiple myeloma, the PRAD-1/CCND1 gene at band 11q13 is juxtaposed to an IgH-switch region at band 14q32 [Hallek M et al. (1998) Blood 91:3-21].  Approximately 30% of patients with multiple myeloma, with or without the 11;14 translocation, were shown to have the CCND1 gene amplification [Hoechtlen-Volmar W et al. (2000) Brit J Halematol 109:30-38].\.br\\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 #\.br\No. of Cells Karyotyped:              #\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:             #       #      #\.br\\.br\# trypsin-Giemsa banded metaphase cells were analyzed from # hour harvests of unstimulated # cell cultures.  # cells had an apparently normal male chromosome complement.  # cells had hypodiploid karyotypes, likely as a result of random chromosomal loss.  # cells had a 46,XY,\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\\.br\ls TH and " aortic valve".  The specimen consists of two tan-gray, irregular, rubbery to firm portions of valve tissue measuring 3.5 x 1.5 x 0.4 cm and 4.5 x 2.0 x 0.5 cm.  The walls are thickened and calcified yellow plaquing present.  The wall thickness ranges from 0.1 to 0.5 cm.  Following adequate decalcification representative cross sections are submitted in decal cassette labeled 1A.\.br\\.br\Part 2 is labeled with the patient's name, initials TH and " ascending aorta".  The specimen consists of multiple tan-pink, irregular, rubbery and hemorrhagic portions of vascular tissue measuring 5.5 x 3.5 x 1.5 cm in aggregate.  There is slight separation of layers.  Representative cross sections are submitted in cassette labeled 2A.\.br\mam\.br\||||||C
OBX|16|TX|MDT|tst3017183|     SYNOPTIC DATA - LARYNX RESECTIONS\.br\TYPE OF LARYNGECTOMY:      Hemilaryngectomy\.br\TUMOR LOCATION:      Right\.br\ATTACHED STRUCTURES:      Neck dissection\.br\TUMOR LOCATION/SEGMENT:      Glottic, Subglottic, Glottic-subglottic (greater than 1 cm subglottic extension)\.br\TUMOR SIZE:      Maximum dimension:  2 cm\.br\HISTOLOGIC TYPE OF TUMOR:      Squamous cell carcinoma\.br\HISTOLOGIC GRADE:      Well differentiated\.br\STRUCTURES INVOLVED BY TUMOR:      True cord, Vallecula-base of tumor\.br\LYMPH NODES POSITIVE:      Number of lymph nodes positive:: 5\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 8\.br\METASTASES\.br\     No\.br\INTRA-PERINEURAL INVASION:      Present\.br\VASCULAR INVASION:      No\.br\SURGICAL MARGIN INVOLVEMENT:      Free (2 mm or more)\.br\T STAGE, PATHOLOGIC:      pTX\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pMX\.br\--------------------------------------------------------\.br\IIIIIIIIMicroscopic examination substantiates the above diagnosis.\.br\SD/dme\.br\\E\\E\\E\\E\\.br\||||||C
OBX|17|TX|FIN|tst3017183|   PART 1: VALVE, AORTIC, REPLACEMENT \.br\PENDING DECALCIFICATION.  ADDENDUM REPORT TO FOLLOW.\.br\\.br\PART 2: AORTA, ASCENDING, REPAIR \.br\VASCULAR TISSUE WITH ADVENTITIAL HEMORRHAGE.\.br\SD/dme\.br\||||||C
OBX|18|CE|IMP|tst3017183|P1279^^SNO||||||||1||A
OBX|19|CE|IMP|tst3017183|T39000^^SNO||||||||1||A
OBX|20|CE|IMP|tst3017183|T42000^^SNO||||||||1||A
OBX|21|CE|IMP|tst3017183|M37000^^SNO||||||||1||A
OBX|22|CE|IMP|tst3017183|T40000^^SNO||||||||1||A
OBX|23|CE|IMP|tst3017183|T42100^^SNO||||||||1||A
OBX|24|CE|IMP|tst3017183|380.12^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004737|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-123^CoPathPlus||CM||||200507051142|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-123^CoPathPlus^tst4017183|PHSP^PH Surgical Pathology|||200507051141|||||||200507051141|VALV|505075||||^49^Y|-1|200507051801||SP|C|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|CE|ANT|tst4017183.1|VALV^Aortic Valve^L||||||C||1^1
OBX|2|CE|ANT|tst4017183.2|VALV^Ascending aorta^L||||||C||2^2
OBX|3|ST|BLOCK|tst4017183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst4017183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst4017183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|CE|PROCESS|tst4017183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst4017183.1.1.3|pmc2043^Estrogen Receptor (IPEX)^L||||||||2^AER|200601132341
OBX|8|CE|PROCESS|tst4017183.1.1.4|pmc9133^Vimentin (IPEX)^L||||||||3^Vimentin|200601132341
OBX|9|CE|PROCESS|tst4017183.2.2.5|pmc9564^I8 (PHIS)^L||||||||2^I8|200507051556
OBX|10|CE|PROCESS|tst4017183.2.2.6|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||3^IBNKNC|200601132341
OBX|11|CE|PROCESS|tst4017183.2.2.7|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||4^H&E Recut|200601132341
OBX|12|CE|PROCESS|tst4017183.1.1.8|pmc1073^Cytomegalovirus (IPEX)^L||||||||4^CMV|200601132341
OBX|13|CE|PROCESS|tst4017183.1.1.9|pmc1333^Congo Red Stain (Histo)^L||||||||5^CongoRed|200512191038
OBX|14|CE|PROCESS|tst4017183.1.1.10|pmc3633^Trichrome Stain (Histo)^L||||||||6^Trichrome|200512191038
OBX|15|CE|PROCESS|tst4017183.2.2.11|pmc1073^Cytomegalovirus (IPEX)^L||||||||5^CMV|200601132341
OBX|16|CE|PROCESS|tst4017183.2.2.12|pmc1333^Congo Red Stain (Histo)^L||||||||6^CongoRed|200512191038
OBX|17|CE|PROCESS|tst4017183.2.2.13|pmc3633^Trichrome Stain (Histo)^L||||||||7^Trichrome|200512191038
OBX|18|TX|GDT|tst4017183|The specimen is received unfixed in two parts.\.br\\.br\Part 1 is labeled with the patient's name, initials TH and " aortic valve".  The specimen consists of two tan-gray, irregular, rubbery to firm portions of valve tissue measuring 3.5 x 1.5 x 0.4 cm and 4.5 x 2.0 x 0.5 cm.  The walls are thickened and calcified yellow plaquing present.  The wall thickness ranges from 0.1 to 0.5 cm.  Following adequate decalcification representative cross sections are submitted in decal cassette labeled 1A.\.br\\.br\Part 2 is labeled with the patient's name, initials TH and " ascending aorta".  The specimen consists of multiple tan-pink, irregular, rubbery and hemorrhagic portions of vascular tissue measuring 5.5 x 3.5 x 1.5 cm in aggregate.  There is slight separation of layers.  Representative cross sections are submitted in cassette labeled 2A.\.br\mam\.br\||||||C
OBX|19|TX|MDT|tst4017183|     SYNOPTIC DATA - LARYNX RESECTIONS\.br\TYPE OF LARYNGECTOMY:      Hemilaryngectomy\.br\TUMOR LOCATION:      Right, Midline\.br\ATTACHED STRUCTURES:      Pyriform sinus\.br\TUMOR LOCATION/SEGMENT:      Subglottic\.br\TUMOR SIZE:      Maximum dimension:  2 cm\.br\HISTOLOGIC TYPE OF TUMOR:      Mucoepidermoid or adenosquamous carcinoma\.br\HISTOLOGIC GRADE:      Well differentiated\.br\STRUCTURES INVOLVED BY TUMOR:      True cord\.br\LYMPH NODES POSITIVE:      Number of lymph nodes positive:: 8\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 4\.br\METASTASES\.br\     No\.br\INTRA-PERINEURAL INVASION:      Present\.br\VASCULAR INVASION:      Yes\.br\SURGICAL MARGIN INVOLVEMENT:      Positive (invasive tumor)\.br\T STAGE, PATHOLOGIC:      Glottis, pT4a\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pMX\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.\.br\SD/dme\.br\||||||C
OBX|20|TX|FIN|tst4017183|PART 1: VALVE, AORTIC, REPLACEMENT \.br\PENDING DECALCIFICATION.  ADDENDUM REPORT TO FOLLOW.\.br\\.br\PART 2: AORTA, ASCENDING, REPAIR \.br\VASCULAR TISSUE WITH ADVENTITIAL HEMORRHAGE.\.br\SD/dme\.br\||||||C
OBX|21|CE|IMP|tst4017183|P1279^^SNO||||||||1||A
OBX|22|CE|IMP|tst4017183|T39000^^SNO||||||||1||A
OBX|23|CE|IMP|tst4017183|T42000^^SNO||||||||1||A
OBX|24|CE|IMP|tst4017183|M37000^^SNO||||||||1||A
OBX|25|CE|IMP|tst4017183|T40000^^SNO||||||||1||A
OBX|26|CE|IMP|tst4017183|T42100^^SNO||||||||1||A
OBX|27|CE|IMP|tst4017183|380.12^^ICD||||||||1
OBR|2||tst4017183^CoPathPlus^tst4017183.P2|BK^BK Virus (PH)||||||||||200507051540|||||||2|200507051540||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBR|3||tst4017183^CoPathPlus^tst4017183.P3|FC^Flow Cytometry||||||||||200507051540|||||||3|200507051540||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004738|P|2.3
PID|1||333333333^^^RR|tst1704394|RUBBLE^BARNEY^R||19560304|M|||||||||||333-33-3333|||||||||||N
PV1|1||C1017RR^10C 8-1||||505075^PLANET^JUPITER||||||||||pmc08361^PLANET^JUPITER|I|1234333333333|||||||||||||||||||||||||200503151514
ORC|RE||PHS05-124^CoPathPlus||CM||||200507051147|z196^DEVINE^LISA||505075^PLANET^JUPITER
OBR|1||PHS05-124^CoPathPlus^tst6017183|PHSP^PH Surgical Pathology|||200507051147|||||||200507051147|VALV|505075||||^49^Y|-1|200507051805||SP|F|||||||012453^SEPULVEDA^ANTONIA|z196^DEVINE^LISA
OBX|1|CE|ANT|tst6017183.1|VALV^Aortic Valve^L||||||F||1^1
OBX|2|CE|ANT|tst6017183.2|VALV^Ascending aorta^L||||||F||2^2
OBX|3|ST|BLOCK|tst6017183.1.1|A||||||||1^A|200507221753
OBX|4|ST|BLOCK|tst6017183.2.2|A||||||||1^A|200507221753
OBX|5|CE|PROCESS|tst6017183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|6|CE|PROCESS|tst6017183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|7|CE|PROCESS|tst6017183.1.1.3|pmc1333^Congo Red Stain (Histo)^L||||||||2^CongoRed|200512191038
OBX|8|CE|PROCESS|tst6017183.1.1.4|pmc3474^ABCL6 (IPEX)^L||||||||3^ABCL6|200601132341
OBX|9|CE|PROCESS|tst6017183.1.1.5|pmc9133^Vimentin (IPEX)^L||||||||4^Vimentin|200601132341
OBX|10|CE|PROCESS|tst6017183.2.2.6|pmc6405^46300 Mycoplasma Pneumae DNA PCR (PH)^L||||||||2^Mycopl Pneu DNA PCR|200507051550
OBX|11|CE|PROCESS|tst6017183.2.2.7|pmc5174^11q, FISH (PHIS)^L||||||||3^I11Q|200507051555
OBX|12|CE|PROCESS|tst6017183.2.2.8|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||4^IBNKNC|200601132341
OBX|13|CE|PROCESS|tst6017183.2.2.9|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||5^H&E Recut|200601132341
OBX|14|CE|PROCESS|tst6017183.2.2.10|pmc0383^Amyloid P (IPEX)^L||||||||6^AAMP|200601132341
OBX|15|CE|PROCESS|tst6017183.2.2.11|pmc8724^Amyloid kappa (IPEX)^L||||||||7^AKAMY|200601132341
OBX|16|CE|PROCESS|tst6017183.1.1.12|pmc9133^Vimentin (IPEX)^L||||||||5^Vimentin|200601132341
OBX|17|CE|PROCESS|tst6017183.1.1.13|pmc1073^Cytomegalovirus (IPEX)^L||||||||6^CMV|200601132341
OBX|18|CE|PROCESS|tst6017183.2.2.14|pmc1073^Cytomegalovirus (IPEX)^L||||||||8^CMV|200601132341
OBX|19|CE|PROCESS|tst6017183.2.2.15|pmc1073^Cytomegalovirus (IPEX)^L||||||||9^CMV|200601132341
OBX|20|CE|PROCESS|tst6017183.2.2.16|pmc1333^Congo Red Stain (Histo)^L||||||||10^CongoRed|200512191038
OBX|21|CE|PROCESS|tst6017183.2.2.17|pmc3633^Trichrome Stain (Histo)^L||||||||11^Trichrome|200512191038
OBX|22|TX|GDT|tst6017183|The specimen is received unfixed in two parts.\.br\\.br\Part 1 is labeled with the patient's name, initials TH and " aortic valve".  The specimen consists of two tan-gray, irregular, rubbery to firm portions of valve tissue measuring 3.5 x 1.5 x 0.4 cm and 4.5 x 2.0 x 0.5 cm.  The walls are thickened and calcified yellow plaques are present.  The wall thickness ranges from 0.1 to 0.5 cm.  Following adequate decalcification representative cross sections are submitted in decal cassette labeled 1A.\.br\\.br\Part 2 is labeled with the patient's name, initials TH and "ascending aorta".  The specimen consists of multiple tan-pink, irregular, rubbery and hemorrhagic portions of vascular tissue measuring 5.5 x 3.5 x 1.5 cm in aggregate.  There is slight separation of layers.  Representative cross sections are entirely submitted in cassette labeled 2A.\.br\mam\.br\||||||F
OBX|23|TX|MDT|tst6017183|     SYNOPTIC DATA - PRIMARY CUTANEOUS MELANOMA\.br\     Family history of melanoma is unknown.\.br\     Family history of dysplastic nevi is unknown.\.br\TUMOR LOCATION:      Head and Neck\.br\TYPE OF PROCEDURE:      Punch biopsy\.br\SIZE OF TUMOR:      Maximum surface diameter of neoplasm: 8 mm\.br\GROSS ULCERATION:      No\.br\GROSS SATELLITES:      Yes\.br\HISTOLOGIC TYPE:      Acral lentiginous, Desmoplastic, Nevoid\.br\SURFACE ULCERATION:      < 50%\.br\CLARK'S LEVEL:      3\.br\BRESLOW'S THICKNESS:      12 mm\.br\ANGIOLYMPHATIC INVASION:      Present\.br\PERINEURAL INVASION:      No\.br\EVIDENCE OF REGRESSION:      No\.br\MICROSCOPIC SATELLITES:      No\.br\PREEXISTING NEVUS:      No preexisting nevus\.br\TUMOR INFILTRATING LYMPHOID INFILTRATE:      Marked (Brisk)\.br\MITOTIC RATE:      5 / 10 HPF\.br\VASCULARITY:      Not increased to focally increased\.br\SURGICAL MARGIN INVOLVEMENT:      Deep margin is free of tumor\.br\SENTINEL LYMPH NODE MAPPING:      Yes\.br\SENTINEL LYMPH NODE INVOLVEMENT:      Yes\.br\     Number of sentinel lymph nodes positive: 8\.br\LYMPH NODES EXAMINED:      Total number of lymph nodes examined: 8\.br\COMPLETION DISSECTION:      Yes\.br\EXTRACAPSULAR SPREAD:      Micro <3 foci\.br\LYMPH NODES POSITIVE:      Number of lymph nodes positive at completion dissection: 8\.br\SIZE OF NODAL METASTASES:      < 2mm\.br\T STAGE, PATHOLOGIC:      pTX\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pM1c\.br\--------------------------------------------------------\.br\SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Left\.br\PROCEDURE:      Segmental\.br\LOCATION:      Central subareolar\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  8 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR AGGREGATE SIZE:      Sum of the sizes of multiple invasive tumors: 8 cm\.br\TUMOR TYPE (invasive component):      Papillary carcinoma\.br\HISTOLOGIC TYPE:      Pleomorphic\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 7\.br\     Tubule formation: 2\.br\     Mitotic activity score: 2\.br\     Total Nottingham score: 5\.br\     Nottingham grade (1, 2, 3): 1\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\DERMAL LYMPHATIC INVASION:      Yes\.br\CALCIFICATION:      Yes, malignant zones\.br\TUMOR TYPE, IN SITU:      Solid\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      Yes, focal\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      Yes, focal\.br\PAGET'S DISEASE OF NIPPLE:      Yes\.br\LYMPH NODES POSITIVE:      8\.br\LYMPH NODES EXAMINED:      8\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      Keratin stain\.br\SENTINEL NODE METASTASIS:      Yes\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT:      Yes\.br\SIZE OF NODAL METASTASES:      Diameter of largest lymph node metastasis: 8 mm\.br\LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:      Yes\.br\METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE): \.br\     Yes\.br\SKIN INVOLVED (ULCERATION):      Yes\.br\NON-NEOPLASTIC BREAST TISSUE:      Fibroadenoma\.br\T STAGE, PATHOLOGIC:      pT0\.br\N STAGE, PATHOLOGIC:      pN0(mol+)\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      positive\.br\PROGESTERONE RECEPTORS:      positive\.br\HER2/NEU:      zero or 1+\.br\--------------------------------------------------------\.br\Microscopic examination substantiates the above diagnosis.\.br\SD/dme\.br\||||||F
OBX|24|TX|FIN|tst6017183|PART 1: VALVE, AORTIC, REPLACEMENT \.br\PENDING DECALCIFICATION.  ADDENDUM REPORT TO FOLLOW.\.br\\.br\PART 2: AORTA, ASCENDING, REPAIR \.br\VASCULAR TISSUE WITH ADVENTITIAL HEMORRHAGE.\.br\SD/dme\.br\||||||F
OBX|25|CE|IMP|tst6017183|P1279^^SNO||||||||1||A
OBX|26|CE|IMP|tst6017183|T39000^^SNO||||||||1||A
OBX|27|CE|IMP|tst6017183|T42000^^SNO||||||||1||A
OBX|28|CE|IMP|tst6017183|M37000^^SNO||||||||1||A
OBX|29|CE|IMP|tst6017183|T40000^^SNO||||||||1||A
OBX|30|CE|IMP|tst6017183|T42100^^SNO||||||||1||A
OBX|31|CE|IMP|tst6017183|380.12^^ICD||||||||1
OBR|2||tst6017183^CoPathPlus^tst6017183.P1|CMVPCR^Cytomegalovirus||||||||||200507051535|||||||1|200507051535||SP|F|||||||SHEKHTER-PCL^SHEKHTER-LEVIN^SOFIA|z196^DEVINE^LISA
OBX|1|TX|PIN|tst6017183|This is an addendumeeeeeeee\.br\||||||F
OBX|2|TX|PRC|tst6017183|eeeee\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004739|P|2.3
PID|1||605458532^^^SY|tst9604394|KOKAL^ELLEN^M||19650305|F||W|||||||||605-45-8532|||||||||||N
PV1|1||OP-REG||||999006052^VOGEL^VICTOR||||||||||pmc81802^VOGEL^VICTOR|SY2|0000123456789|||||||||||||||||||||||||200503110834
ORC|RE||PHS05-152^CoPathPlus||CM||||200507221005|z40^KOKAL^ELLEN||999006052^VOGEL^VICTOR
OBR|1||PHS05-152^CoPathPlus^tst7617183|PHSP^PH Surgical Pathology|||200507221005|||||||200507221005|STOBX|999006052||||^40^Y|-1|200512141212||SP|F|||||||052050^YOUSEM^SAMUEL|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst7617183.1|STOBX^Biopsy^L||||||F||1^1
OBX|2|TX|GDT|tst7617183|The specimen is received in buffered formalin labeled with the patient's name, initials EC and "proximal sigmoid polyp". Received is a single soft, tan, tissue fragment measuring 0.5 cm in greatest dimension.  The specimen is entirely submitted for processing in the cassette labeled A.\.br\||||||F
OBX|3|TX|MDT|tst7617183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst7617183|COLON, PROXIMAL SIGMOID, POLYP, POLYPECTOMY \.br\HYPERPLASTIC POLYP.\.br\||||||F
OBX|5|CE|IMP|tst7617183|M72040^^SNO||||||||1||A
OBX|6|CE|IMP|tst7617183|M76800^^SNO||||||||1||A
OBX|7|CE|IMP|tst7617183|P1100^^SNO||||||||1||A
OBX|8|CE|IMP|tst7617183|T67700^^SNO||||||||1||A
OBR|2||tst7617183^CoPathPlus^tst7617183.A1|ADD^Addendum||||||||||200601121056|||||||1|200601121056||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|ADX|tst7617183|Immunostains for CMV, RSV, HSV and adenovirus are negative.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004740|P|2.3
PID|1||100004582^^^RG|tst3508394|TESTRED^ANITA||19540313|F||MWW|12TH STREET^^COULTERS^PA^15028^United States||(412)469-1231|||||||||||||||||N
PV1|1||MW5300^5313||||MW000612^SEIAVITCH^SAMUEL||||||||||pmc28852^SEIAVITCH^SAMUEL|MWW|71391940|MWR||||||||||||||||||||||||200508011144|200508011600
ORC|RE||PHS05-153^CoPathPlus||CM||||200508011513|z41^LOSOS^FRANK||MW000612^SEIAVITCH^SAMUEL
OBR|1||PHS05-153^CoPathPlus^tst4917183|PHSP^PH Surgical Pathology|||200508011513|||||||200508011513|COBX|MW000612||||^51^Y|-1|200508011533||SP|C|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst4917183.1|COBX^Biopsy Colon^L||||||C||1^1
OBX|2|ST|BLOCK|tst4917183.1.1|A||||||||1^A|200508311407
OBX|3|CE|PROCESS|tst4917183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|4|TX|GDT|tst4917183|\.br\This is the Gross Description     \.br\||||||C
OBX|5|TX|MDT|tst4917183|This is the Microscopic Description\.br\||||||C
OBX|6|TX|FIN|tst4917183|\.br\THIS IS THE FINAL DIAGNOSIS          \.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004741|P|2.3
PID|1||080520051^^^RR|tst1418394|TWIST^OLIVER||19830503|M|||||||||||080-52-0051|||||||||||N
PV1|1||SDS||||||||||||||pmc97361^PLANET^MARS|S|0001080520051|||||||||||||||||||||||||200508051646
ORC|RE||PHS05-154^CoPathPlus||CM||||200508051700|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PHS05-154^CoPathPlus^tst5027183|PHSP^PH Surgical Pathology|||200508051655|||||||200508051655|LNENT|505074||||^22^Y|-1|200508121507||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst5027183.1|LNENT^Lymph Node, Biopsy or Excision, ENT^L||||||F||1^1
OBX|2|CE|ANT|tst5027183.2|LNENT^Lymph Node, Biopsy or Excision, ENT^L||||||F||2^2
OBX|3|CE|ANT|tst5027183.3|LNENT^Lymph Node, Biopsy or Excision, ENT^L||||||F||3^3
OBX|4|CE|ANT|tst5027183.4|LNENT^Lymph Node, Biopsy or Excision, ENT^L||||||F||4^4
OBX|5|CE|ANT|tst5027183.5|THYLO^Thyroid^L||||||F||5^5
OBX|6|ST|BLOCK|tst5027183.1.1|A||||||||1^A|200508311407
OBX|7|ST|BLOCK|tst5027183.2.2|A||||||||1^A|200508311407
OBX|8|ST|BLOCK|tst5027183.3.3|A||||||||1^A|200508311407
OBX|9|CE|PROCESS|tst5027183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|10|CE|PROCESS|tst5027183.1.1.2|pmc7764^Frozen Sect Single Block (Surg)^L||||||||2^FRZ Single|200508180859
OBX|11|CE|PROCESS|tst5027183.2.2.3|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|12|CE|PROCESS|tst5027183.2.2.4|pmc7764^Frozen Sect Single Block (Surg)^L||||||||2^FRZ Single|200508180859
OBX|13|CE|PROCESS|tst5027183.3.3.5|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|14|CE|PROCESS|tst5027183.3.3.6|pmc7764^Frozen Sect Single Block (Surg)^L||||||||2^FRZ Single|200508180859
OBX|15|TX|MDT|tst5027183|I am adding this line from signout worklist using the edit option\.br\Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|16|TX|FIN|tst5027183|PART 1:  NECK, LEFT LEVELS 2 THRU 4, NECK DISSECTION \.br\A.METASTATIC SQUAMOUS CELL CARCINOMA IN THREE OF THIRTY-SEVEN LYMPH NODES (3/37).\.br\B.POSITIVE LYMPH NODES IN LEVEL 3, NO EXTRANODAL SPREAD IS SEEN\.br\\.br\PART 2:  NECK, RIGHT LEVELS 2 THRU 4, NECK DISSECTION \.br\THIRTY-FIVE (35) BENIGN LYMPH NODES.\.br\\.br\PART 3:  NECK, BILATERAL LEVEL 1, NECK DISSECTION \.br\A.METASTATIC SQUAMOUS CELL CARCINOMA IN THREE OF THREE (3/3) LYMPH NODES.\.br\B.ALL POSITIVE LYMPH NODES ON IN LEFT LEVEL 1.\.br\C.SALIVARY GLAND WITH FIBROSIS, ATROPHY AND CHRONIC INFLAMMATION.\.br\\.br\PART 4:  "SUBMENTAL NODE", EXCISION \.br\FIBRIN BLOOD CLOT, NO LYMPH NODE OR TUMOR SEEN.\.br\\.br\PART 5: RIGHT  MANDIBLE AND PORTION OF MAXILLA WITH ATTACHED BUCCAL MUCOSA , LIP, AND    \.br\                 AND SKIN,  COMPOSITE RESECTION \.br\A.EXOPHYTIC MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF BUCCAL MUCOSA LIP  WITH INVASION INTO DERMIS OF ATTACHED SKIN (5.5 CM).\.br\B.PERINEURAL INVASION IDENTIFIED.\.br\C.MANDIBLE NOT INVOLVED.\.br\D.FINAL MARGINS OF RESECTION FREE OF TUMOR (See parts 6 and 7).\.br\E.PATHOLOGIC STAGE: T4, N2c, Mx.\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004742|P|2.3
PID|1||080520051^^^RR|tst1418394|TWIST^OLIVER||19830503|M|||||||||||080-52-0051|||||||||||N
PV1|1||SDS||||||||||||||pmc97361^PLANET^MARS|S|0001080520051|||||||||||||||||||||||||200508051646
ORC|RE||PHS05-156^CoPathPlus||CM||||200508121500|z41^LOSOS^FRANK||505070^PLANET^NIBIRU
OBR|1||PHS05-156^CoPathPlus^tst7127183|PHSP^PH Surgical Pathology|||200508121458|||||||200508121458|COLTOT|505070||||^22^Y|-1|200508121510||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst7127183.1|COLTOT^Colon^L||||||F||1^1
OBX|2|ST|BLOCK|tst7127183.1.1|A||||||||1^A|200508311407
OBX|3|CE|PROCESS|tst7127183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200508180859
OBX|4|CE|PROCESS|tst7127183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200508180859
OBX|5|CE|PROCESS|tst7127183.1.1.3|pmc9333^Giemsa Stain (Histo)^L||||||||3^Giemsa|200512191038
OBX|6|CE|PROCESS|tst7127183.1.1.4|tst2625^in-myc, FISH (PHIS)^L||||||||4^INMYC|200510121746
OBX|7|CE|PROCESS|tst7127183.1.1.5|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||5^IBNKNC|200601132341
OBX|8|CE|PROCESS|tst7127183.1.1.6|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||6^H&E Recut|200601132341
OBX|9|TX|GDT|tst7127183|\.br\This is the gross description\.br\||||||F
OBX|10|TX|MDT|tst7127183|This is the Microscopic Description\.br\||||||F
OBX|11|TX|FIN|tst7127183|THIS IS THE FINAL DIAGNOSIS\.br\||||||F
OBR|2||tst7127183^CoPathPlus^tst7127183.P1|FC^Flow Cytometry||||||||||200508121513|||||||1|200508121513||SP|F|||||||987654^PATHOID^DOCTOR|z196^DEVINE^LISA
OBX|1|TX|PIN|tst7127183|Spellcheck   melanoma muulanoma adinamous booger \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004743|P|2.3
PID|1||999998888|tst2477394|TRAINING^MARIE^LISA||19591002|F|||||||||||999-99-8888|||||||||||N
PV1|1||PATHOS||||505077^PLANET^NEPTUNE||||||||||pmc28361^PLANET^NEPTUNE|OSD|0002999998888|||||||||||||||||||||||||200506221457
ORC|RE||PHS05-187^CoPathPlus||CM||||200511161554|z196^DEVINE^LISA||505079^PLANET^PLUTO
OBR|1||PHS05-187^CoPathPlus^tpmc6157183|^PH Dental Pathology|||200511131530|||||||200511161540|LFM|505079||||^46^Y|-1|200511301444||SP|F|||||||^PRASAD^JOANNE|^PRASAD^JOANNE
OBX|1|CE|ANT|tpmc6157183.1|LFM^Mouth, Left Floor^L||||||F||1^1
OBX|2|CE|ANT|tpmc6157183.2|MXLLI^Maxillary, Left Lateral Incisor^L||||||F||2^2
OBX|3|CE|ANT|tpmc6157183.3|MO^Mouth^L||||||F||3^3
OBX|4|CE|ANT|tpmc6157183.4|AMX^Maxilla, Anterior^L||||||F||4^4
OBX|5|ST|BLOCK|tpmc6157183.1.1|A||||||||1^A|200511181341
OBX|6|CE|PROCESS|tpmc6157183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200511181407
OBX|7|TX|GDT|tpmc6157183|1.  Mouth, Left Floor:   \.br\2.  Maxillary, Left Lateral Incisor:   \.br\3.  Mouth:   \.br\4.  Maxilla, Anterior:   \.br\The specimen is received in formalin labeled blah blah blah and consists of more stuff\.br\\.br\||||||F
OBX|8|TX|MDT|tpmc6157183|     There are many small, pretty cells.\.br\||||||F
OBX|9|TX|FIN|tpmc6157183|GRANULAR CELL TUMOR\.br\||||||F
OBX|10|CE|IMP|tpmc6157183|M95800^^SNO||||||||1||A
OBX|11|CE|IMP|tpmc6157183|873.63^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004744|P|2.3
PID|1||222221^^^RF|tst5745394|PITSTOP^PENELOPE||19880218|F|||||||||||222-22-2221|||||||||||N
PV1|1||BMOP||||505074^PLANET^MARS||||||||||pmc97361^PLANET^MARS|BMC|0000001222221|||||||||||||||||||||||||200510051015
ORC|RE||PHS05-199^CoPathPlus||CM||||200511281609|^LASSIGE^KAREN||505074^PLANET^MARS
OBR|1||PHS05-199^CoPathPlus^tpmc0757183|PHSP^PH Surgical Pathology|||200511281606|||||||200511281606||505074||||^17^Y|-1|||SP|F
OBX|1|CE|ANT|tpmc0757183.1|^Brushing^L||||||F||1^1
OBR|2||tpmc0757183^CoPathPlus^tpmc0757183.P1|HPV^HPV Testing||||||||||200511281609|||||||1|200511281609||SP|F||||||||^LASSIGE^KAREN
OBX|1|TX|PIN|tpmc0757183|Negative for high/intermediate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and/or 68\.br\\.br\The sample, a crude cell lysate, was tested for the presence of Human Papillomavirus  (HPV) using the Hybrid Capture 2 (HC2) High Risk HPV DNA test from Digene.  The technology utilizes a specific HPV RNA probe cocktail to detect types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 in cervical specimens.  The target DNA hybridizes with a specific RNA probe that is captured by antibodies specific for RNA:DNA hybrids.  Hybrid detection occurs via chemiluminescent substrate and subsequent light emission.\.br\\.br\The Digene HC2 assay is an FDA-cleared, qualitative, in vitro diagnostic test for the detection  of HPV from cervical specimens.  \.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004745|P|2.3
PID|1||185540310^^^RZ|tst0507394|SYNOPTEST^HORIZON^ONE||19400811|M||W|||||||||185-54-0310||||||||||20050829|Y
PV1|1||Z2WE^0218||||505073^PLANET^EARTH|^PLANET^VENUS|||||||||pmc87361^PLANET^EARTH|I|0001185540310|||||||||||||||||||||||||200503101743
ORC|RE||HHS05-200^CoPathPlus||CM||||200505111821|z32^PICCOLI^ANTHONY||505073^PLANET^EARTH
OBR|1||HHS05-200^CoPathPlus^tst7596183|^HH Histology|||200505111819|||||||200505111819|ILN|505073||||^64^Y|-1|200506031654||SP|F|||||||000760^PERRY^LINA|000760^PERRY^LINA
OBX|1|CE|ANT|tst7596183.1|ILN^Right Iliac Lymph Nodes - Frozen^L||||||F||1^1
OBX|2|CE|ANT|tst7596183.2|ILN^Left Iliac Lymph Nodes - Frozen^L||||||F||2^2
OBX|3|CE|ANT|tst7596183.3|PROST^Prostate^L||||||F||3^3
OBX|4|ST|BLOCK|tst7596183.1.1|A||||||||1^A|200601132338
OBX|5|ST|BLOCK|tst7596183.2.2|A||||||||1^A|200601132338
OBX|6|ST|BLOCK|tst7596183.3.3|A||||||||1^A|200601132338
OBX|7|ST|BLOCK|tst7596183.3.4|B||||||||2^B|200601132338
OBX|8|ST|BLOCK|tst7596183.3.5|C||||||||3^C|200601132338
OBX|9|ST|BLOCK|tst7596183.3.6|D||||||||4^D|200601132338
OBX|10|ST|BLOCK|tst7596183.3.7|E||||||||5^E|200601132338
OBX|11|ST|BLOCK|tst7596183.3.8|F||||||||6^F|200601132338
OBX|12|ST|BLOCK|tst7596183.3.9|G||||||||7^G|200601132338
OBX|13|ST|BLOCK|tst7596183.3.10|H||||||||8^H|200601132338
OBX|14|ST|BLOCK|tst7596183.3.11|I||||||||9^I|200601132338
OBX|15|ST|BLOCK|tst7596183.3.12|J||||||||10^J|200601132338
OBX|16|ST|BLOCK|tst7596183.3.13|K||||||||11^K|200601132338
OBX|17|ST|BLOCK|tst7596183.3.14|L||||||||12^L|200601132338
OBX|18|ST|BLOCK|tst7596183.3.15|M||||||||13^M|200601132338
OBX|19|ST|BLOCK|tst7596183.3.16|N||||||||14^N|200601132338
OBX|20|ST|BLOCK|tst7596183.3.17|O||||||||15^O|200601132338
OBX|21|ST|BLOCK|tst7596183.3.18|P||||||||16^P|200601132338
OBX|22|ST|BLOCK|tst7596183.3.19|Q||||||||17^Q|200601132338
OBX|23|ST|BLOCK|tst7596183.3.20|R||||||||18^R|200601132338
OBX|24|ST|BLOCK|tst7596183.3.21|S||||||||19^S|200601132338
OBX|25|ST|BLOCK|tst7596183.3.22|T||||||||20^T|200601132338
OBX|26|CE|PROCESS|tst7596183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|27|CE|PROCESS|tst7596183.1.1.2|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|28|CE|PROCESS|tst7596183.2.2.3|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|29|CE|PROCESS|tst7596183.2.2.4|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|30|CE|PROCESS|tst7596183.3.3.5|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|31|CE|PROCESS|tst7596183.3.4.6|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|32|CE|PROCESS|tst7596183.3.5.7|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|33|CE|PROCESS|tst7596183.3.6.8|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|34|CE|PROCESS|tst7596183.3.7.9|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|35|CE|PROCESS|tst7596183.3.8.10|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|36|CE|PROCESS|tst7596183.3.9.11|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|37|CE|PROCESS|tst7596183.3.10.12|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|38|CE|PROCESS|tst7596183.3.11.13|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|39|CE|PROCESS|tst7596183.3.12.14|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|40|CE|PROCESS|tst7596183.3.13.15|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|41|CE|PROCESS|tst7596183.3.14.16|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|42|CE|PROCESS|tst7596183.3.15.17|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|43|CE|PROCESS|tst7596183.3.16.18|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|44|CE|PROCESS|tst7596183.3.17.19|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|45|CE|PROCESS|tst7596183.3.18.20|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|46|CE|PROCESS|tst7596183.3.19.21|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|47|CE|PROCESS|tst7596183.3.20.22|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|48|CE|PROCESS|tst7596183.3.21.23|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|49|CE|PROCESS|tst7596183.3.22.24|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|50|TX|GDT|tst7596183|\.br\The specimen is received fresh for frozen section in two parts and in buffered formalin in one part.  All three parts are identified with the patients name and initials H.S.\.br\\.br\Part 1: Received labeled with right iliac node specimen frozen section.  FS1A  one lymph node, bisected for frozen section.\.br\\.br\\.br\Part 2: labeled left iliac node.  FS2A  one lymph node bisected\.br\\.br\\.br\Part 3: labeled prostate.  Lots more information.\.br\||||||F
OBX|51|TX|MDT|tst7596183|     SYNOPTIC DATA - PRIMARY PROSTATE TUMORS\.br\CLINICAL DATA:      PSA value: 0.0\.br\INVASIVE CA IDENTIFIED?:      Yes\.br\TUMOR HISTOLOGY:      Adenocarcinoma NOS\.br\PRIMARY GLEASON GRADE:      3.0\.br\SECONDARY GLEASON GRADE:      3.0\.br\GLEASON SUM SCORE:      6.0\.br\GLEASON 4/5 PERCENTAGE:      0%\.br\WEIGHT OF PROSTATE:      34.0gm\.br\TUMOR SIZE:      Maximum dimension:  0.0 cm\.br\LOBE LATERALITY:      Right and Left Lobes\.br\PERCENT OF SPECIMEN INVOLVED BY TUMOR:      5 - 25%\.br\MULTIFOCAL DISEASE:      Unknown\.br\HIGH GRADE PIN:      Yes - 1 or 2 foci away from tumor\.br\EXTRAPROSTATIC EXTENSION:      No\.br\PERINEURAL INVASION:      No\.br\ANGIOLYMPHATIC INVASION:      No\.br\SEMINAL VESICLE INVASION:      No\.br\SURGICAL MARGIN INVOLVEMENT:      All surgical margins free of tumor\.br\LYMPH NODES EXAMINED:      2.0\.br\LYMPH NODES POSITIVE:      0.0\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|52|CE|IMP|tst7596183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004746|P|2.3
PID|1||200160194^^^RS|tst7857394|SYNOPTEST^SOUTHSIDE^ONE||19171108|M||W|||||||||200-16-0194|||||||||||N
PV1|1||SDSS||||505075^PLANET^JUPITER||||||||||pmc18361^PLANET^SATURN|S|0001200160194|||||||||||||||||||||||||200506011607
ORC|RE||SSS05-200^CoPathPlus||CM||||200506021615|z32^PICCOLI^ANTHONY||505075^PLANET^JUPITER
OBR|1||SSS05-200^CoPathPlus^tst6407183|SSHS^SS Histology|||200506011213|||||||200506021613||505075||||^87^Y|-1|200507111300||SP|F|||||||010728^KHASNABIS^SUKAMAL|010728^KHASNABIS^SUKAMAL
OBX|1|CE|ANT|tst6407183.1|^right breast mass nipple in nss^L||||||F||1^1
OBX|2|CE|ANT|tst6407183.2|AXILLA^right axillarynode in nss^L||||||F||2^2
OBX|3|ST|BLOCK|tst6407183.1.1|A||||||||1^A|200506021614
OBX|4|ST|BLOCK|tst6407183.1.2|B||||||||2^B|200506021614
OBX|5|ST|BLOCK|tst6407183.1.3|C||||||||3^C|200506021614
OBX|6|ST|BLOCK|tst6407183.1.4|D||||||||4^D|200506021614
OBX|7|ST|BLOCK|tst6407183.1.5|E||||||||5^E|200506021614
OBX|8|ST|BLOCK|tst6407183.1.6|F||||||||6^F|200506021614
OBX|9|ST|BLOCK|tst6407183.1.7|G||||||||7^G|200506021614
OBX|10|ST|BLOCK|tst6407183.2.8|A||||||||1^A|200506021614
OBX|11|ST|BLOCK|tst6407183.2.9|B||||||||2^B|200506021614
OBX|12|ST|BLOCK|tst6407183.2.10|C||||||||3^C|200506021614
OBX|13|ST|BLOCK|tst6407183.2.11|D||||||||4^D|200506021614
OBX|14|ST|BLOCK|tst6407183.2.12|E||||||||5^E|200506021614
OBX|15|CE|PROCESS|tst6407183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200506021614
OBX|16|CE|PROCESS|tst6407183.1.2.2|$hinit^Initial H&E^L||||||||2^H&E|200506021614
OBX|17|CE|PROCESS|tst6407183.1.3.3|$hinit^Initial H&E^L||||||||5^H&E|200506021614
OBX|18|CE|PROCESS|tst6407183.1.4.4|$hinit^Initial H&E^L||||||||5^H&E|200506021614
OBX|19|CE|PROCESS|tst6407183.1.5.5|$hinit^Initial H&E^L||||||||5^H&E|200506021614
OBX|20|CE|PROCESS|tst6407183.1.6.6|$hinit^Initial H&E^L||||||||5^H&E|200506021614
OBX|21|CE|PROCESS|tst6407183.1.7.7|$hinit^Initial H&E^L||||||||5^H&E|200506021614
OBX|22|CE|PROCESS|tst6407183.2.8.8|$hinit^Initial H&E^L||||||||1^H&E|200506021614
OBX|23|CE|PROCESS|tst6407183.2.9.9|$hinit^Initial H&E^L||||||||1^H&E|200506021614
OBX|24|CE|PROCESS|tst6407183.2.10.10|$hinit^Initial H&E^L||||||||1^H&E|200506021614
OBX|25|CE|PROCESS|tst6407183.2.11.11|$hinit^Initial H&E^L||||||||1^H&E|200506021614
OBX|26|CE|PROCESS|tst6407183.2.12.12|$hinit^Initial H&E^L||||||||1^H&E|200506021614
OBX|27|CE|PROCESS|tst6407183.1.1.13|pmc3324^Frozen Section Consult (Surg)^L||||||||2^FR|200506021614
OBX|28|CE|PROCESS|tst6407183.1.2.14|pmc2043^Estrogen Receptor (IPEX)^L||||||||3^AER|200601132341
OBX|29|CE|PROCESS|tst6407183.1.2.15|pmc9043^Progesterone Receptor (IPEX)^L||||||||4^APR|200601132341
OBX|30|CE|PROCESS|tst6407183.1.2.16|pmc7624^Her-2/neu c-erb (IPEX)^L||||||||5^ANEU|200601132341
OBX|31|TX|GDT|tst6407183|Part 1 is labeled as "right breast with nipple".  It consists of an irregularly shaped piece of fibrofatty breast tissue which includes the overlying skin with nipple and areola.  The breast tissue measures 5.5 cm in maximum diameter and the ellipse of skin measures 4.0 x 2.2 cm.  The superior margin is identified by two metallic staples and the lateral margin is identified by one metallic staple.  The excisional surfaces are painted by green ink.  On section, and underneath the nipple, there is a circumscribed but unencapsulated firm grayish-white, slightly concave tumor measuring 2.0 cm in maximum diameter.  The overlying skin shows fine granularity.  The nipple is somewhat deformed and retracted.  Frozen section done on block "1A".  Representative sections are submitted as follows:\.br\1B,1C          -     tumor,\.br\1D          -     superior margin,\.br\1E          -     lateral margin,\.br\1F,1G          -     additional tumor.\.br\\.br\Part 2 is labeled as "right axillary nodes".  It consists of a fairly large piece of adipose tissue which measures 7.5 cm in maximum diameter.  Nine lymph nodes are dissected and submitted in cassettes "2A" through "2E".\.br\||||||F
OBX|32|TX|MDT|tst6407183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Segmental\.br\LOCATION:      Not specified\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  2.0 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 3\.br\     Tubule formation: 2\.br\     Mitotic activity score: 3\.br\     Total Nottingham score: 8\.br\     Nottingham grade (1, 2, 3): 3\.br\ANGIOLYMPHATIC INVASION:      No\.br\DERMAL LYMPHATIC INVASION:      No\.br\CALCIFICATION:      No\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      No\.br\LYMPH NODES POSITIVE:      0\.br\LYMPH NODES EXAMINED:      9\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E stain\.br\LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:      No\.br\SKIN INVOLVED (ULCERATION):      No\.br\T STAGE, PATHOLOGIC:      pT1c\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      positive\.br\PROGESTERONE RECEPTORS:      positive\.br\HER2/NEU:      zero or 1+\.br\--------------------------------------------------------\.br\12 H\T\E) - Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|33|TX|FIN|tst6407183|PART 1:          BREAST, RIGHT, COMPLETE EXCISION LESS THAN TOTAL MASTECTOMY WITH AXILLARY \.br\          CONTENTS \.br\A.          INVASIVE DUCTAL CARCINOMA (2.0 CM).\.br\B.     HISTOLOGIC GRADE (NOTTINGHAM SCORE):\.br\               TUBULE FORMATION:  MODERATE (SCORE 2).\.br\          NUCLEAR PLEOMORPHISM:  MARKED (SCORE 3).\.br\          MITOTIC COUNT:  GREATER THAN 10 MITOSIS/10 HPF (SCORE 3).\.br\     TOTAL NOTTINGHAM SCORE (8):  GREADE III/III.\.br\C.          PATHOLOGIC STAGING (pTMN):\.br\               PRIMARY TUMOR:  pT1c (TUMOR MORE THAN 1.0 CM BUT NOT MORE THAN 2.0 CM\.br\          IN GREATEST DIMENSION.\.br\          NOTE:  THE TUMOR SHOWS DERMAL INVASION.  DERMAL INVASION ALONE \.br\     WITHOUT ULCERATION, SATELLETE NODULES OR INFLAMMATORY BREAST CANCER DOES NOT ALTER T CATEGORY.\.br\D.          REGIONAL LYMPH NODES (pN):\.br\               NO REGIONAL LYMPH NODE METASTASIS (pNO).\.br\          NUMBER EXAMINED:  NINE (9).\.br\E.          DISTANT METASTASIS (pM):\.br\               CANNOT BE ASSESSED (pMX).\.br\F.          MARGINS:  UNINVOLVED BY INVASIVE CARCINOMA.\.br\G.     VENOUS/LYMPHATIC INVASION:  NOT IDENTIFIED.\.br\H.     MICROCALCIFICATIONS:  ABSENT.\.br\I.     ADDITIONAL PATHOLOGIC FINDINGS:  NONE.\.br\\.br\PART 2:          SEE ABOVE.\.br\     \.br\||||||F
OBX|34|CE|IMP|tst6407183|M85003^^SNO||||||||1||A
OBX|35|CE|IMP|tst6407183|P1100^^SNO||||||||1||A
OBX|36|CE|IMP|tst6407183|T04050^^SNO||||||||1||A
OBX|37|CE|IMP|tst6407183|TY8100^^SNO||||||||1||A
OBX|38|CE|IMP|tst6407183|M40000^^SNO||||||||1||A
OBX|39|CE|IMP|tst6407183|M80003^^SNO||||||||1||A
OBX|40|CE|IMP|tst6407183|T04000^^SNO||||||||1||A
OBX|41|CE|IMP|tst6407183|T04040^^SNO||||||||1||A
OBX|42|CE|IMP|tst6407183|T08000^^SNO||||||||1||A
OBX|43|CE|IMP|tst6407183|M55400^^SNO||||||||1||A
OBX|44|CE|IMP|tst6407183|M80103^^SNO||||||||1||A
OBX|45|CE|IMP|tst6407183|T00100^^SNO||||||||1||A
OBX|46|CE|IMP|tst6407183|T09010^^SNO||||||||1||A
OBX|47|CE|IMP|tst6407183|T48000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004747|P|2.3
PID|1||162808395^^^RY|tst1507394|SYNOPTEST^HORIZON^TWO||19510718|M||W|||||||||162-80-8395|||||||||||N
PV1|1||Y3CC^Y3CC||||505078^PLANET^URANUS|505074^PLANET^MARS|||||||||pmc38361^PLANET^URANUS|I|0001162808395|||||||||||||||||||||||||200503161746
ORC|RE||HHS05-201^CoPathPlus||CM||||200505111825|z32^PICCOLI^ANTHONY||505078^PLANET^URANUS
OBR|1||HHS05-201^CoPathPlus^tst8596183|^HH Histology|||200503161122|||||||200505111822||505078||||^53^Y|-1|200506031646||SP|F|||||||000760^PERRY^LINA|000760^PERRY^LINA
OBX|1|CE|ANT|tst8596183.1|^#7 Node - Frozen^L||||||F||1^1
OBX|2|CE|ANT|tst8596183.2|^#4 Node - Frozen^L||||||F||2^2
OBX|3|CE|ANT|tst8596183.3|HEBB^Proximal Bronchus Right Lung - Frozen^L||||||F||3^3
OBX|4|CE|ANT|tst8596183.4|^Parietal Pleura (Tumor Site) - Frozen^L||||||F||4^4
OBX|5|CE|ANT|tst8596183.5|LUNL^Right Lung^L||||||F||5^5
OBX|6|ST|BLOCK|tst8596183.1.1|A||||||||1^A|200601132338
OBX|7|ST|BLOCK|tst8596183.2.2|A||||||||1^A|200601132338
OBX|8|ST|BLOCK|tst8596183.3.3|A||||||||1^A|200601132338
OBX|9|ST|BLOCK|tst8596183.4.4|A||||||||1^A|200601132338
OBX|10|ST|BLOCK|tst8596183.5.5|A||||||||1^A|200601132338
OBX|11|ST|BLOCK|tst8596183.5.6|B||||||||2^B|200601132338
OBX|12|ST|BLOCK|tst8596183.5.7|C||||||||3^C|200601132338
OBX|13|ST|BLOCK|tst8596183.5.8|D||||||||4^D|200601132338
OBX|14|ST|BLOCK|tst8596183.5.9|E||||||||5^E|200601132338
OBX|15|ST|BLOCK|tst8596183.5.10|F||||||||6^F|200601132338
OBX|16|ST|BLOCK|tst8596183.5.11|G||||||||7^G|200601132338
OBX|17|ST|BLOCK|tst8596183.5.12|H||||||||8^H|200601132338
OBX|18|ST|BLOCK|tst8596183.5.13|I||||||||9^I|200601132338
OBX|19|ST|BLOCK|tst8596183.5.14|J||||||||10^J|200601132338
OBX|20|ST|BLOCK|tst8596183.5.15|K||||||||11^K|200601132338
OBX|21|ST|BLOCK|tst8596183.5.16|L||||||||12^L|200601132338
OBX|22|ST|BLOCK|tst8596183.5.17|M||||||||13^M|200601132338
OBX|23|CE|PROCESS|tst8596183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|24|CE|PROCESS|tst8596183.1.1.2|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|25|CE|PROCESS|tst8596183.2.2.3|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|26|CE|PROCESS|tst8596183.2.2.4|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|27|CE|PROCESS|tst8596183.3.3.5|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|28|CE|PROCESS|tst8596183.3.3.6|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|29|CE|PROCESS|tst8596183.4.4.7|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|30|CE|PROCESS|tst8596183.4.4.8|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|31|CE|PROCESS|tst8596183.5.5.9|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|32|CE|PROCESS|tst8596183.5.6.10|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|33|CE|PROCESS|tst8596183.5.7.11|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|34|CE|PROCESS|tst8596183.5.8.12|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|35|CE|PROCESS|tst8596183.5.9.13|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|36|CE|PROCESS|tst8596183.5.10.14|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|37|CE|PROCESS|tst8596183.5.11.15|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|38|CE|PROCESS|tst8596183.5.12.16|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|39|CE|PROCESS|tst8596183.5.13.17|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|40|CE|PROCESS|tst8596183.5.14.18|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|41|CE|PROCESS|tst8596183.5.15.19|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|42|CE|PROCESS|tst8596183.5.16.20|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|43|CE|PROCESS|tst8596183.5.17.21|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|44|TX|GDT|tst8596183|The specimen is received fresh for frozen section in five parts.  All five parts are identified with the patient' s name and initials R.C.\.br\\.br\Part 1:  is labeled #7 node.  It consists of a grossly recognizable lymph node  which is black in color and measures 9.0 x6.0 x4.0 mm.  The specimen is bisected and entirely submitted for frozen section as FS1A.\.br\\.br\\.br\Part 2: is labeled #4 node.  It consists of two grossly recognizable lymph nodes which are black in color and measure 8.0 x 6.0 mm in maximum dimension.  Each node is bisected and entirely submitted in cassette FS2A\.br\\.br\\.br\Part 3: is labeled proximal bronchus frozen section.  It consists of two tan-red semi-circular rings of tissue, the second is just a strip and they measure approximately 1.5 cm in diameter, and 0.3cm in thickness.  The specimen is entirely submitted for frozen section.\.br\\.br\\.br\Part 4: is labeled parietal pleura tumor site.  It consists of three pieces of bright red soft tissue fragments measuring in aggregate 1.0 x 0.2x 0.4 cm.  The specimen is entirely submitted for frozen section as FS4A.\.br\\.br\\.br\Part 5: is labeled right lung.  Lots more information that I' m not going to bother typing in.\.br\||||||F
OBX|45|TX|MDT|tst8596183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Right Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Basilar\.br\PROCEDURE:      Pneumonectomy\.br\TUMOR SIZE:      Maximum dimension:  0.5 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 0.0\.br\TUMOR TYPE:      Invasive squamous carcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES:      Number of microscopic satellite lesions: 0\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Distance of invasive tumor to closest margin: 10.0 mm, Bronchial margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Mild\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 0.0\.br\     Number of N1 lymph nodes examined: 3.0\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 2.0\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      No\.br\UNDERLYING DISEASE(S):      Obstructive pneumonia, focal\.br\T STAGE, PATHOLOGIC:      pT1\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004748|P|2.3
PID|1||195974845^^^RA|tst8208394|SYNOPTEST^STMARGARET^TWO||19590703|F||W|||||||||195-97-4845|||||||||||N
PV1|1||A6A^613||||505077^PLANET^NEPTUNE|505079^PLANET^PLUTO|||||||||pmc28361^PLANET^NEPTUNE|S|0001195974845|||||||||||||||||||||||||200507141740
ORC|RE||SMS05-201^CoPathPlus||CM||||200507151501|z32^PICCOLI^ANTHONY||505077^PLANET^NEPTUNE
OBR|1||SMS05-201^CoPathPlus^tst3217183|^SM Histology|||200507121300|||||||200507151455|BRSEG|505077||||^46^Y|-1|200510041710||SP|F|||||||^PRIMAVERA^JAMES|^PRIMAVERA^JAMES
OBX|1|CE|ANT|tst3217183.1|BRSEG^RIGHT BREAST MASS^L||||||F||1^1
OBX|2|CE|ANT|tst3217183.2|^RIGHT ADDITIONAL NIPPLE MARGIN^L||||||F||2^2
OBX|3|CE|ANT|tst3217183.3|SLNBSM^SENTINEL NODE #1^L||||||F||3^3
OBX|4|CE|ANT|tst3217183.4|^FAT^L||||||F||4^4
OBX|5|CE|ANT|tst3217183.5|SLNBSM^SENTINEL NODE #2^L||||||F||5^5
OBX|6|ST|BLOCK|tst3217183.2.1|A||||||||1^A|200507151456
OBX|7|ST|BLOCK|tst3217183.3.2|A||||||||1^A|200507151456
OBX|8|ST|BLOCK|tst3217183.4.3|A||||||||1^A|200507151456
OBX|9|ST|BLOCK|tst3217183.5.4|A||||||||1^A|200507151456
OBX|10|ST|BLOCK|tst3217183.1.5|A||||||||1^A|200507151457
OBX|11|ST|BLOCK|tst3217183.1.6|B||||||||2^B|200507151457
OBX|12|ST|BLOCK|tst3217183.1.7|C||||||||3^C|200507151457
OBX|13|ST|BLOCK|tst3217183.1.8|D||||||||4^D|200507151457
OBX|14|ST|BLOCK|tst3217183.1.9|E||||||||5^E|200507151457
OBX|15|ST|BLOCK|tst3217183.1.10|F||||||||6^F|200507151457
OBX|16|ST|BLOCK|tst3217183.1.11|G||||||||7^G|200507151457
OBX|17|ST|BLOCK|tst3217183.1.12|H||||||||8^H|200507151457
OBX|18|ST|BLOCK|tst3217183.1.13|I||||||||9^I|200507151457
OBX|19|CE|PROCESS|tst3217183.2.1.1|$hinit^Initial H&E^L||||||||1^H&E|200507151456
OBX|20|CE|PROCESS|tst3217183.3.2.2|$hinit^Initial H&E^L||||||||1^H&E|200507151456
OBX|21|CE|PROCESS|tst3217183.3.2.3|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200507151456
OBX|22|CE|PROCESS|tst3217183.3.2.4|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||3^HBNKNC|200507151456
OBX|23|CE|PROCESS|tst3217183.3.2.5|pmc1554^CONTROL NEG IMMUNO SM^L||||||||4^-CONT|200507151456
OBX|24|CE|PROCESS|tst3217183.3.2.6|pmc4873^Blank Slide (HISTO) (WLO)^L||||||||5^HBNKNC|200507151456
OBX|25|CE|PROCESS|tst3217183.4.3.7|$hinit^Initial H&E^L||||||||1^H&E|200507151456
OBX|26|CE|PROCESS|tst3217183.5.4.8|$hinit^Initial H&E^L||||||||1^H&E|200507151456
OBX|27|CE|PROCESS|tst3217183.5.4.9|pmc5553^HH&E (HISTO)^L||||||||2^HHE|200507151456
OBX|28|TX|GDT|tst3217183|1.  RIGHT BREAST MASS:  The specimen is received unfixed labeled with the patient' s name and "right breast mass."  It consists of an irregularly shaped portion of yellow-pink, lobulated, fibrofatty tissue with an attached portion of skin, measuring 7 x 5.5 x 5 cm. in total dimension.  The attached skin measures 3.5 x 1 cm.  The specimen is oriented by one long black stitch designated lateral, and one short black stitch designated superior.  The tissue has been previously injected with blue dye. The skin is centrally located and the epidermal surface is tan, smooth and unremarkable.   The anterior aspect is inked blue and the posterior aspect is inked black for orientation.  Multiple cross sections reveal an ill-defined stellate pale white-tan, gritty mass, centrally located, directly subjacent to the skin, measuring approximately 2.5 cm. in greatest dimension.  The mass measures 1 cm. from the lateral margin, 2 cm. from the medial margin, 1 cm. from the deep margin, 0.2 cm. from the anterior margin, 2 cm. from the superior margin, and 1 cm. from the inferior margin at the nearest points.  The remainder of the cross sections show yellow-pink, lobulated adipose tissue with interlacing white fibrous tissue.  Representative sections submitted, labeled:  1A-C-mass, anterior aspect (A contains mass nearest anterior margin), 1D-inferior margin, 1E-random section of dense fibrous tissue adjacent to mass, 1F-lateral margin to include fibrous tissue, 1G-medial margin to include fibrous tissue, 1H-lateral margin directly adjacent mass, 1I-deep margin directly adjacent to mass.  \.br\2.  RIGHT ADDITIONAL NIPPLE MARGIN: The specimen is received unfixed labeled with the patient' s name and "additional right breast margin."  It consists of an irregularly shaped portion of yellow-pink, lobulated, fibrofatty tissue, measuring 3 x 1.4 x 0.4 cm.  The exterior surface is inked black.  The specimen is serially sectioned and entirely submitted, labeled 2A.\.br\3.  SENTINEL NODE #1:  The specimen is received unfixed labeled with the patient' s name and "sentinel node #1."  It consists of an irregularly shaped portion of yellow-pink, finely lobulated, rubbery tissue, measuring 2.7 x 1.5 x 0.8 cm.  Within the finely lobulated adipose tissue is pink-tan, rubbery, presumed lymph node which measures 2 x 0.8 x 0.4 cm.  The specimen is bisected and entirely submitted, labeled 3A.\.br\4.  FAT: The specimen is received unfixed labeled with the patient' s name and "fat."  It consists of 2, similar, irregularly shaped portions of finely lobulated, yellow-pink, fatty and rubbery tissue, measuring 2.2 x 2.4 x 0.9 cm. and 2 x 1 x 0.6 cm.  Thorough inspection of the lobulated adipose tissue reveals 2 presumed lymph nodes, measuring 1 x 0.7 x 0.5 cm. and 0.5 x 0.4 x 0.3 cm.  The lymph nodes are entirely submitted exclusive the adipose tissue, in block labeled 4A-presumed lymph nodes, larger lymph node inked black and bisected.   \.br\5.  SENTINEL NODE #2:   The specimen is received unfixed labeled with the patient' s name and "sentinel node #2."  It consists of an irregularly shaped portion of yellow-pink, lobulated, adipose tissue and rubbery tissue, measuring 1.9 x 1.2 x 0.3 cm.   Thorough inspection of the lobulated adipose tissue reveals one, pink-tan, rubbery lymph node, which measures 0.5 x 0.4 cm.  The lymph node is entirely submitted, exclusive of the adipose tissue in block labeled 5A.\.br\||||||F
OBX|29|TX|MDT|tst3217183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Segmental\.br\LOCATION:      Not specified\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  2.5 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 2\.br\     Tubule formation: 3\.br\     Mitotic activity score: 1\.br\     Total Nottingham score: 6\.br\     Nottingham grade (1, 2, 3): 2\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\DERMAL LYMPHATIC INVASION:      No\.br\CALCIFICATION:      Yes, malignant zones\.br\TUMOR TYPE, IN SITU:      Cribriform, Solid\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      Yes, focal\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      Yes, focal\.br\PAGET'S DISEASE OF NIPPLE:      No\.br\LYMPH NODES POSITIVE:      1\.br\LYMPH NODES EXAMINED:      4\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E stain\.br\SENTINEL NODE METASTASIS:      Yes\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT:      No\.br\SIZE OF NODAL METASTASES:      Diameter of largest lymph node metastasis: 0.7 mm\.br\LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:      No\.br\METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE): \.br\     No\.br\SKIN INVOLVED (ULCERATION):      No\.br\NON-NEOPLASTIC BREAST TISSUE:      FCD\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pN1\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      unknown\.br\PROGESTERONE RECEPTORS:      unknown\.br\HER2/NEU:      unknown\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004749|P|2.3
PID|1||171474264^^^RS|tst8857394|SYNOPTEST^SOUTHSIDE^TWO||19320709|F||W|||||||||171-47-4264|||||||||||N
PV1|1||3A^A0312||||505071^PLANET^MERCURY||||||||||pmc48361^PLANET^PLUTO|S|0001171474264|||||||||||||||||||||||||200506011610
ORC|RE||SSS05-201^CoPathPlus||CM||||200506021618|z32^PICCOLI^ANTHONY||505071^PLANET^MERCURY
OBR|1||SSS05-201^CoPathPlus^tst7407183|SSHS^SS Histology|||200506011130|||||||200506021616|BRMSS|505071||||^72^Y|-1|200507111301||SP|F|||||||010728^KHASNABIS^SUKAMAL|010728^KHASNABIS^SUKAMAL
OBX|1|CE|ANT|tst7407183.1|BRMSS^right lower inner quadrant breast mass^L||||||F||1^1
OBX|2|CE|ANT|tst7407183.2|^lesion right shoulder^L||||||F||2^2
OBX|3|ST|BLOCK|tst7407183.1.1|A||||||||1^A|200506021617
OBX|4|ST|BLOCK|tst7407183.1.2|B||||||||2^B|200506021617
OBX|5|ST|BLOCK|tst7407183.1.3|C||||||||3^C|200506021617
OBX|6|ST|BLOCK|tst7407183.1.4|D||||||||4^D|200506021617
OBX|7|ST|BLOCK|tst7407183.1.5|E||||||||5^E|200506021617
OBX|8|ST|BLOCK|tst7407183.1.6|F||||||||6^F|200506021617
OBX|9|ST|BLOCK|tst7407183.2.7|A||||||||1^A|200506021617
OBX|10|CE|PROCESS|tst7407183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200506021617
OBX|11|CE|PROCESS|tst7407183.1.2.2|$hinit^Initial H&E^L||||||||4^H&E|200506021617
OBX|12|CE|PROCESS|tst7407183.1.3.3|$hinit^Initial H&E^L||||||||4^H&E|200506021617
OBX|13|CE|PROCESS|tst7407183.1.4.4|$hinit^Initial H&E^L||||||||4^H&E|200506021617
OBX|14|CE|PROCESS|tst7407183.1.5.5|$hinit^Initial H&E^L||||||||4^H&E|200506021617
OBX|15|CE|PROCESS|tst7407183.1.6.6|$hinit^Initial H&E^L||||||||4^H&E|200506021617
OBX|16|CE|PROCESS|tst7407183.2.7.7|$hinit^Initial H&E^L||||||||1^H&E|200506021617
OBX|17|CE|PROCESS|tst7407183.1.1.8|pmc2043^Estrogen Receptor (IPEX)^L||||||||2^AER|200601132341
OBX|18|CE|PROCESS|tst7407183.1.1.9|pmc9043^Progesterone Receptor (IPEX)^L||||||||3^APR|200601132341
OBX|19|CE|PROCESS|tst7407183.1.1.10|pmc7624^Her-2/neu c-erb (IPEX)^L||||||||4^ANEU|200601132341
OBX|20|TX|GDT|tst7407183|Part 1 is labeled as "right lower inner quadrant breast mass".  It consists of a spherical piece of breast tissue measuring 4.5 x 4.2 x 4.2 cm.  The external surfaces are covered by a generous amount of adipose tissue.  It also includes a separate piece of skin and adipose tissue.  The external surface of the breast mass is painted by green ink.  On section, there is a well-circumscribed but unencapsulated, firm, grayish-pink tumor which measures 2.7 cm in maximum diameter.  The cut surface of the tumor is slightly concave and solid with very fine linear chalky streaks.  The separate piece of skin measures 4.5 cm in m maximum diameter and\.br\0.6 cm in maximum width.  Representative sections from the breast tumor are placed in cassettes "1A" through "1D" and the separate piece of skin and adipose tissue is submitted in cassettes "1E" and "1F".\.br\\.br\Part 2  is labeled as "lesion right shoulder".  It consists of a piece of papillary grayish-pink tissue measuring 0.8 cm in maximum diameter.  It is entirely submitted in cassette "2A".\.br\||||||F
OBX|21|TX|MDT|tst7407183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Right\.br\PROCEDURE:      Segmental\.br\LOCATION:      Not specified\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  2.7 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 3\.br\     Tubule formation: 3\.br\     Mitotic activity score: 3\.br\     Total Nottingham score: 9\.br\     Nottingham grade (1, 2, 3): 3\.br\ANGIOLYMPHATIC INVASION:      No\.br\DERMAL LYMPHATIC INVASION:      No\.br\CALCIFICATION:      No\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      No\.br\LYMPH NODES POSITIVE:      0\.br\LYMPH NODES EXAMINED:      0\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E stain\.br\LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:      No\.br\SKIN INVOLVED (ULCERATION):      No\.br\T STAGE, PATHOLOGIC:      pT2\.br\N STAGE, PATHOLOGIC:      pNX\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      negative\.br\PROGESTERONE RECEPTORS:      negative\.br\HER2/NEU:      zero or 1+\.br\--------------------------------------------------------\.br\(7 H\T\E) - Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|22|TX|FIN|tst7407183|PART 1:          BREAST, RIGHT, LESS THAN TOTAL  MASTECTOMY WITHOUT AXILLARY CONTENTS \.br\A.          INVASIVE DUCTAL CARCINOMA (2.7 CM).\.br\B.     NOTTINGHAM HISTOLOGIC SCORE:\.br\               TUBULE OFRMATION MINIMAL LESS THAN 10% (SCORE 3).\.br\          NUCLEAR PLEOMORPHISM:  MARGINED VARIATION IN SIZE, NUCLEOLI,\.br\          CHROMATIN CLUMPING (SCORE 3).\.br\          MITOTIC COUNT FOR A 40 X OBJECTIVE GREATER THAN 10 MITOSIS/10 HPF\.br\          (SCIRE 3),\.br\     TOTAL NOTTINGHAM SCORE:  NINE (9).\.br\     GRADE III OF III.\.br\C.          PATHOLOGIC STAGING (pTNM):\.br\               pT2 - TUMOR MORE THAN 2.0 CM BUT NOT MORE THAN 5.0 CM IN GREATEST\.br\          DIMENSION.\.br\D.          REGIONAL LYIMPH NODES (pN):\.br\               NOT REMOVED FOR PATHOLOGIC STUDY.\.br\E.          DISTANT METASTASIS (pMX):\.br\               CANNOT BE ASSESSED.\.br\F.          MARGINS UNINVOLVED BY INVASIVE CARCINOMA.\.br\               DISTANCE FROM CLOSEST MARGIN:  0.6 MM.\.br\G.          VENOUS/LYMPHATIC INVASION:  ABSENT.\.br\H.     MICROCALCIFICATIONS:  NOT IDENTIFIED.\.br\I.     ADDITIONAL PATHOLOGIC FINDINGS:  DCIS LESS THAN 1%.\.br\\.br\PART 2:          SKIN, RIGHT SHOULDER, EXCISION \.br\          FIBROEPITHELIAL PAPILLOMA.\.br\||||||F
OBX|23|CE|IMP|tst7407183|M85003^^SNO||||||||1||A
OBX|24|CE|IMP|tst7407183|P1100^^SNO||||||||1||A
OBX|25|CE|IMP|tst7407183|T04000^^SNO||||||||1||A
OBX|26|CE|IMP|tst7407183|T04020^^SNO||||||||1||A
OBX|27|CE|IMP|tst7407183|M80001^^SNO||||||||1||A
OBX|28|CE|IMP|tst7407183|M80006^^SNO||||||||1||A
OBX|29|CE|IMP|tst7407183|M55400^^SNO||||||||1||A
OBX|30|CE|IMP|tst7407183|M80103^^SNO||||||||1||A
OBX|31|CE|IMP|tst7407183|T00100^^SNO||||||||1||A
OBX|32|CE|IMP|tst7407183|T09010^^SNO||||||||1||A
OBX|33|CE|IMP|tst7407183|T48000^^SNO||||||||1||A
OBX|34|CE|IMP|tst7407183|M76810^^SNO||||||||1||A
OBX|35|CE|IMP|tst7407183|P1100^^SNO||||||||1||A
OBX|36|CE|IMP|tst7407183|T02410^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004750|P|2.3
PID|1||N0000085^^^RV|tpmc3531494|TESTVTWOFIVE^PASSAVANT^PAUL||19300520|M||PVW|888 STREET^^PITTSBURGH^PA^15237^United States||412-367-6100|724-625-3184|||||888-55-2223|||||||||||N
PV1|1||PVLAB||||ABU.KA^ABU-HAMAD^GHASSAN|||||||||||PVSDC|N00000001370|PVBC||||||||||||||||||||||||200511210857
ORC|RE||PHS05-201^CoPathPlus||CM||||200511301743|z41^LOSOS^FRANK||505074^PLANET^MARS
OBR|1||PHS05-201^CoPathPlus^tpmc1067183|PHSP^PH Surgical Pathology|||200511301743|||||||200511301743|FBM|505074||||^75^Y|-1|||SP|F
OBX|1|CE|ANT|tpmc1067183.1|FBM^Filtered Bone Marrow^L||||||F||1^1
OBX|2|CE|PROCESS|tpmc1067183.1.0.1|pmc7904^Alcian Blue pH 1.0 (Histo)^L||||||||1^AlBlue1.0|200512151343
OBX|3|CE|PROCESS|tpmc1067183.1.0.2|pmc9333^Giemsa Stain (Histo)^L||||||||2^Giemsa|200512151343
OBX|4|CE|PROCESS|tpmc1067183.1.0.3|pmc2233^Acid Fast Stain (Histo)^L||||||||3^AcidFast|200512151343
OBX|5|CE|PROCESS|tpmc1067183.1.0.4|pmc4014^Bielschowsky Stain (Histo)^L||||||||4^Biels|200512151343
OBR|2||tpmc1067183^CoPathPlus^tpmc1067183.A2|ADD^Addendum||||||||||200511301747|||||||2|200511301747||SP|F|||||||987654^PATHOID^DOCTOR|z41^LOSOS^FRANK
OBX|1|TX|ADX|tpmc1067183|THIS IS A TEST ADDENDUM TO CHECK STATUS OF OBX:11 FLAGGING ALGORITHM\.br\||||||F
OBR|3||tpmc1067183^CoPathPlus^tpmc1067183.P1|FC^Flow Cytometry||||||||||200511301743|||||||1|200511301743||SP|F|||||||987654^PATHOID^DOCTOR|z41^LOSOS^FRANK
OBX|1|TX|PIN|tpmc1067183|# OF Events/Cells: _______________     Flow File Name:______________________\.br\TOPOGRAPHY: ________________     \.br\TECHNOLOGIST FLOW__________________\.br\\.br\============================================================================\.br\INTERPRETATION: DNA analysis was performed on ___________ using\.br\flow cytometry.\.br\\.br\Reference:\.br\\.br\============================================================================\.br\\.br\Representation of tumor on slide  __________________________________________\.br\FLOW  Test Date: ____________  \.br\\.br\Normal Control - G0/G1 ______________   DNA Index of Normal Cells __________\.br\\.br\Reference Peak ______________           CV _________________________________\.br\\.br\\.br\.             FLOW\.br\\.br\.            PEAK 1\.br\\.br\G0/G1 peak   ________\.br\\.br\CV           ________\.br\\.br\DNA Index    ________\.br\\.br\.       Cell Cycle Statistics\.br\\.br\G0/G1        ________\.br\\.br\S            ________\.br\\.br\G2M          ________\.br\\.br\============================================================================\.br\||||||F
OBX|2|TX|PRC|tpmc1067183|\.br\DNA analysis was performed on # using flow cytometry.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004751|P|2.3
PID|1||204544381^^^RZ|tst2507394|SYNOPTEST^HORIZON^THREE||19441231|F||W|||||||||204-54-4381|||||||||||N
PV1|1||Z2WE^0212||||505071^PLANET^MERCURY||||||||||pmc07361^PLANET^MERCURY|I|0001204544381|||||||||||||||||||||||||200503181748
ORC|RE||HHS05-202^CoPathPlus||CM||||200505111829|z32^PICCOLI^ANTHONY||505071^PLANET^MERCURY
OBR|1||HHS05-202^CoPathPlus^tst9596183|^HH Histology|||200503181027|||||||200505111827|BRBX|505071||||^60^Y|-1|200506061459||SP|F|||||||^PETRICK^MARCIA|^PETRICK^MARCIA
OBX|1|CE|ANT|tst9596183.1|BRBX^Portion of Left Pectoris Major - Frozen^L||||||F||1^1
OBX|2|CE|ANT|tst9596183.2|BRRED^Left Breast - Suture is Medial Aspect^L||||||F||2^2
OBX|3|CE|ANT|tst9596183.3|AXILLA^Left Breast Tissue - Inlet to Axilla^L||||||F||3^3
OBX|4|CE|ANT|tst9596183.4|FASMUS^Portions of Pectoralis Left^L||||||F||4^4
OBX|5|ST|BLOCK|tst9596183.1.1|A||||||||1^A|200601132338
OBX|6|ST|BLOCK|tst9596183.2.2|A||||||||1^A|200601132338
OBX|7|ST|BLOCK|tst9596183.2.3|B||||||||2^B|200601132338
OBX|8|ST|BLOCK|tst9596183.2.4|C||||||||3^C|200601132338
OBX|9|ST|BLOCK|tst9596183.2.5|D||||||||4^D|200601132338
OBX|10|ST|BLOCK|tst9596183.2.6|E||||||||5^E|200601132338
OBX|11|ST|BLOCK|tst9596183.2.7|F||||||||6^F|200601132338
OBX|12|ST|BLOCK|tst9596183.2.8|G||||||||7^G|200601132338
OBX|13|ST|BLOCK|tst9596183.2.9|H||||||||8^H|200601132338
OBX|14|ST|BLOCK|tst9596183.2.10|I||||||||9^I|200601132338
OBX|15|ST|BLOCK|tst9596183.2.11|J||||||||10^J|200601132338
OBX|16|ST|BLOCK|tst9596183.2.12|K||||||||11^K|200601132338
OBX|17|ST|BLOCK|tst9596183.3.13|A||||||||1^A|200601132338
OBX|18|ST|BLOCK|tst9596183.3.14|B||||||||2^B|200601132338
OBX|19|ST|BLOCK|tst9596183.3.15|C||||||||3^C|200601132338
OBX|20|ST|BLOCK|tst9596183.3.16|D||||||||4^D|200601132338
OBX|21|ST|BLOCK|tst9596183.3.17|E||||||||5^E|200601132338
OBX|22|ST|BLOCK|tst9596183.4.18|A||||||||1^A|200601132338
OBX|23|ST|BLOCK|tst9596183.4.19|B||||||||2^B|200601132338
OBX|24|ST|BLOCK|tst9596183.4.20|C||||||||3^C|200601132338
OBX|25|ST|BLOCK|tst9596183.3.21|F||||||||6^F|200601132338
OBX|26|CE|PROCESS|tst9596183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|27|CE|PROCESS|tst9596183.1.1.2|pmc5044^Frozen Section Initial Slide (HH)^L||||||||2^FS|200512191416
OBX|28|CE|PROCESS|tst9596183.2.2.3|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|29|CE|PROCESS|tst9596183.2.3.4|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|30|CE|PROCESS|tst9596183.2.4.5|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|31|CE|PROCESS|tst9596183.2.5.6|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|32|CE|PROCESS|tst9596183.2.6.7|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|33|CE|PROCESS|tst9596183.2.7.8|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|34|CE|PROCESS|tst9596183.2.8.9|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|35|CE|PROCESS|tst9596183.2.9.10|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|36|CE|PROCESS|tst9596183.2.10.11|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|37|CE|PROCESS|tst9596183.2.11.12|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|38|CE|PROCESS|tst9596183.2.12.13|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|39|CE|PROCESS|tst9596183.3.13.14|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|40|CE|PROCESS|tst9596183.3.14.15|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|41|CE|PROCESS|tst9596183.3.15.16|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|42|CE|PROCESS|tst9596183.3.16.17|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|43|CE|PROCESS|tst9596183.3.17.18|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|44|CE|PROCESS|tst9596183.4.18.19|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|45|CE|PROCESS|tst9596183.4.19.20|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|46|CE|PROCESS|tst9596183.4.20.21|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|47|CE|PROCESS|tst9596183.3.21.22|$hinit^Initial H&E^L||||||||1^H&E|200512191416
OBX|48|TX|GDT|tst9596183|The specimen is received fresh for frozen section in one part and in formalin in three parts.  The part is identified with the patient's name and initials\.br\\.br\Part 1:  Received labeled "portion left pectoralis major".  It consists of a beefy red piece of muscle and attached bright yellow adipose tissue measuring 2.5 x 1.7 x 1.2 cm in overall dimensions.  The tissue has a somewhat rubbery consistency that is throughout with some firm rubbery possible tan nodules seen within the specimen.  The specimen is entirely submitted for frozen section.\.br\FS1A  Remainder of the frozen section\.br\\.br\\.br\Part 2:  is labeled "left breast".  It consists of a 1298.7 gram modified radical mastectomy specimen.  It has a suture indicating the medial aspect.  There is an ellipse of skin on the specimen including the nipple.  The ellipse measures 21.0 x 10.0 cm with a centrally located nipple measuring 1.5 cm and an areola measures approximately 3.2 cm.  The skin is mottled with brown and the nipple is somewhat partially inverted with erythema on the skin surface as well as focal areas of indentation and a firm indurated area particularly lateral to the nipple.  A palpable mass is noted from the skin surface.  The overall specimen dimensions are 30.0 x 27.0 x 7.5 cm.  The lateral portion/axillary tail is removed and will be submitted in GEWF fixative.  There is a tan-white node that appears to be grossly involved by tumor measuring 2.2 x 1.0 x 1.5 cm present in the middle of the node dissection.  The specimen is inked.  The entire deep posterior aspect is inked black, superior portion is inked red, medial portion is inked blue and the inferior portion is inked green.  On sectioning, there is a large ill-defined gray-white gritty and calcific area located at the deep mid portion of the specimen.  On sectioning, a serous type fluid filled cavity is also identified.  This overall area by palpation measures at least 11.0 x 7.0 x 11.0 cm.  The serous filled cavity and prior biopsy cavity site is approximately 2.0 cm in diameter.  Sections are submitted as follows:\.br\\.br\2A  Section across the nipple and areola\.br\2B  Section across the skin scar\.br\2C, 2D and 2E  Sections of the tumor mass\.br\2F  Section of the tumor in its relationship to the deep margin of resection\.br\2G and 2H  Representative sections of breast tissue not involved by tumor\.br\2I, 2J and 2K  Sections of axillary lymph nodes\.br\\.br\Part 3:  is labeled "left breast tissue-inlet to axilla".  Verbal communication with Dr. Henwood indicates that this is a possible area of sentinal node.  The overall specimen dimensions are 5.5 x 3.0 x 1.5 cm.  The specimen is entirely submitted in 3A through 3F.\.br\3A through 3F  Toto\.br\\.br\Part 4:  is labeled "pectoralis major muscle".  It consists of seven fragments of soft tissue consisting of an admixture of brown tissue, hemorrhagic tissue, and bright yellow adipose tissue with intervening areas of gray-white.  The specimen in aggregate is 7.0 x 5.5 x 2.5 cm.  The margin of resection is not denoted on the specimen.  Representative sections are submitted in cassettes 4A through 4C.\.br\4A through 4C  Representative sections\.br\||||||F
OBX|49|TX|MDT|tst9596183|     SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST\.br\LATERALITY:      Left\.br\PROCEDURE:      Modified radical mastectomy\.br\LOCATION:      Not specified\.br\SIZE OF TUMOR:      Maximum dimension invasive component:  2.2 cm\.br\MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:      No\.br\TUMOR AGGREGATE SIZE:      Sum of the sizes of multiple invasive tumors: 2.2 cm\.br\TUMOR TYPE (invasive component):      Ductal adenocarcinoma, NOS\.br\NOTTINGHAM SCORE\.br\     Nuclear grade: 3\.br\     Tubule formation: 2\.br\     Mitotic activity score: 2\.br\     Total Nottingham score: 7\.br\     Nottingham grade (1, 2, 3): 2\.br\ANGIOLYMPHATIC INVASION:      Yes\.br\DERMAL LYMPHATIC INVASION:      Yes\.br\CALCIFICATION:      No\.br\TUMOR TYPE, IN SITU:      Apocrine, Comedo\.br\SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:      No\.br\SURG MARGINS INVOLVED BY IN SITU COMPONENT:      No\.br\PAGET'S DISEASE OF NIPPLE:      No\.br\LYMPH NODES POSITIVE:      4\.br\LYMPH NODES EXAMINED:      6\.br\METHOD(S) OF LYMPH NODE EXAMINATION:      H/E stain\.br\SENTINEL NODE METASTASIS:      No\.br\ONLY KERATIN POSITIVE CELLS ARE PRESENT:      No\.br\SIZE OF NODAL METASTASES:      Diameter of largest lymph node metastasis: 2 mm\.br\LYMPH NODE METASTASIS(-ES) WITH\.br\EXTRACAPSULAR EXTENSION:      No\.br\METASTASES TO IPSILATERAL INTERNAL\.br\MAMMARY LYMPH NODE (IF APPLICABLE):      No\.br\SKIN INVOLVED (ULCERATION):      No\.br\NON-NEOPLASTIC BREAST TISSUE:      FCD\.br\T STAGE, PATHOLOGIC:      pT4\.br\N STAGE, PATHOLOGIC:      pN3b\.br\M STAGE, PATHOLOGIC:      pMX\.br\ESTROGEN RECEPTORS:      unknown\.br\PROGESTERONE RECEPTORS:      unknown\.br\HER2/NEU:      unknown\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|50|CE|IMP|tst9596183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004752|P|2.3
PID|1||123456790^^^RR|tpmc5198394|TESTVTWOFIVE^BARBARA||19501215|F||||||||||||||||||||||N
PV1|1||PPAT||||^PLANET^VENUS||||||||||pmc28361^PLANET^NEPTUNE|OSD|0244276653054|||||||||||||||||||||||||200512011506
ORC|RE||PHS05-202^CoPathPlus||CM||||200512021211|z37^ANDERSON^RALPH||^PLANET^VENUS
OBR|1||PHS05-202^CoPathPlus^tpmc6267183|^PH Transcription|||200512011206|||||||200512021206|CS8|||||^55^Y|-1|200512111201||SP|F|||||||987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc6267183.1|CS8^4 CONSULT SLIDES^L||||||F||1^1
OBX|2|CE|ANT|tpmc6267183.2|COM^1 CONSULT SLIDESl^L||||||F||2^2

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004753|P|2.3
PID|1||195248681^^^RA|tst0308394|SYNOPTEST^STMARGARET^FOUR||19231005|M||W|||||||||195-24-8681|||||||||||N
PV1|1||A6A^634||||505073^PLANET^EARTH|505074^PLANET^MARS|||||||||pmc87361^PLANET^EARTH|I|0001195248681|||||||||||||||||||||||||200507111745
ORC|RE||SMS05-203^CoPathPlus||CM||||200507151513|z32^PICCOLI^ANTHONY||505073^PLANET^EARTH
OBR|1||SMS05-203^CoPathPlus^tst5217183|^SM Histology|||200507111400|||||||200507151509|LN|505073||||^81^Y|-1|200510041721||SP|F|||||||^PRIMAVERA^JAMES|^PRIMAVERA^JAMES
OBX|1|CE|ANT|tst5217183.1|LN^LYMPH NODE, LEFT AP WINDOW, F.S.^L||||||F||1^1
OBX|2|CE|ANT|tst5217183.2|LUNL^UPPER DIVISION SEGMENTECTOMY LEFT LOBE, F.S.^L||||||F||2^2
OBX|3|CE|ANT|tst5217183.3|SURGBXB^LEFT SECONDARY CARINA^L||||||F||3^3
OBX|4|CE|ANT|tst5217183.4|LN^AP WINDOW LYMPH NODE LEFT^L||||||F||4^4
OBX|5|CE|ANT|tst5217183.5|LN^LEFT LEVEL 10 NODE^L||||||F||5^5
OBX|6|CE|ANT|tst5217183.6|RIB^PORTION LEFT THIRD RIB^L||||||F||6^6
OBX|7|CE|ANT|tst5217183.7|LN^LEVEL 11 NODE^L||||||F||7^7
OBX|8|ST|BLOCK|tst5217183.1.1|A||||||||1^A|200507151511
OBX|9|ST|BLOCK|tst5217183.2.2|AFS||||||||1^AFS|200507151511
OBX|10|ST|BLOCK|tst5217183.2.3|B||||||||2^B|200507151511
OBX|11|ST|BLOCK|tst5217183.2.4|C||||||||3^C|200507151511
OBX|12|ST|BLOCK|tst5217183.2.5|D||||||||4^D|200507151511
OBX|13|ST|BLOCK|tst5217183.2.6|E||||||||5^E|200507151511
OBX|14|ST|BLOCK|tst5217183.2.7|F||||||||6^F|200507151511
OBX|15|ST|BLOCK|tst5217183.2.8|G||||||||7^G|200507151511
OBX|16|ST|BLOCK|tst5217183.2.9|H||||||||8^H|200507151511
OBX|17|ST|BLOCK|tst5217183.2.10|I||||||||9^I|200507151511
OBX|18|ST|BLOCK|tst5217183.3.11|A||||||||1^A|200507151511
OBX|19|ST|BLOCK|tst5217183.4.12|A||||||||1^A|200507151511
OBX|20|ST|BLOCK|tst5217183.5.13|A||||||||1^A|200507151511
OBX|21|ST|BLOCK|tst5217183.6.14|ADC||||||||1^ADC|200507151511
OBX|22|ST|BLOCK|tst5217183.7.15|A||||||||1^A|200507151511
OBX|23|ST|BLOCK|tst5217183.7.16|B||||||||2^B|200507151511
OBX|24|ST|BLOCK|tst5217183.6.17|B||||||||2^B|200507151513
OBX|25|CE|PROCESS|tst5217183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|26|CE|PROCESS|tst5217183.2.2.2|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|27|CE|PROCESS|tst5217183.2.3.3|$hinit^Initial H&E^L||||||||2^H&E|200507151511
OBX|28|CE|PROCESS|tst5217183.2.4.4|$hinit^Initial H&E^L||||||||3^H&E|200507151511
OBX|29|CE|PROCESS|tst5217183.2.5.5|$hinit^Initial H&E^L||||||||3^H&E|200507151511
OBX|30|CE|PROCESS|tst5217183.2.6.6|$hinit^Initial H&E^L||||||||3^H&E|200507151511
OBX|31|CE|PROCESS|tst5217183.2.7.7|$hinit^Initial H&E^L||||||||3^H&E|200507151511
OBX|32|CE|PROCESS|tst5217183.2.8.8|$hinit^Initial H&E^L||||||||3^H&E|200507151511
OBX|33|CE|PROCESS|tst5217183.2.9.9|$hinit^Initial H&E^L||||||||3^H&E|200507151511
OBX|34|CE|PROCESS|tst5217183.2.10.10|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|35|CE|PROCESS|tst5217183.3.11.11|$hinit^Initial H&E^L||||||||1^H&E L1,L2,L3|200507151511
OBX|36|CE|PROCESS|tst5217183.3.11.12|pmc6805^HH&E WLO^L||||||||2|200507151511
OBX|37|CE|PROCESS|tst5217183.4.12.13|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|38|CE|PROCESS|tst5217183.5.13.14|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|39|CE|PROCESS|tst5217183.6.14.15|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|40|CE|PROCESS|tst5217183.6.14.16|pmc7453^Decal Routine (Surg)^L||||||||2^Decal|200507151511
OBX|41|CE|PROCESS|tst5217183.7.15.17|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|42|CE|PROCESS|tst5217183.7.16.18|$hinit^Initial H&E^L||||||||1^H&E|200507151511
OBX|43|CE|PROCESS|tst5217183.1.1.19|pmc7344^Frozen Section (SM)^L||||||||2^FZN|200507151511
OBX|44|CE|PROCESS|tst5217183.2.2.20|pmc7344^Frozen Section (SM)^L||||||||2^FZN|200507151512
OBX|45|CE|PROCESS|tst5217183.2.3.21|pmc5633^Verhoff Van Geison Stain (Histo)^L||||||||3^VVG|200507151512
OBX|46|CE|PROCESS|tst5217183.2.0.22|pmc2554^CONTROL + SM^L||||||||1^+ CONT|200507151512
OBX|47|CE|PROCESS|tst5217183.6.17.23|$hinit^Initial H&E^L||||||||2^H&E|200507151513
OBX|48|TX|GDT|tst5217183|1.  LYMPH NODE, LEFT AP WINDOW, F.S.:  The specimen is received in saline labeled with the patient' s name and "lymph node left AP window."  It consists of multiple soft, anthracotic pink fragments of tissue, 1.6 x 0.9 x 0.6 cm. in aggregate.  The specimen is totally submitted for frozen section diagnosis, labeled 1A-FS. \.br\2.  UPPER DIVISION SEGMENTECTOMY LEFT LOBE, F.S.:  The specimen is received unfixed labeled with the patient' s name and "upper division segmentectomy left upper lobe, suture at lesion."  It consists of a lung segment, 14.1 x 8.7 x 4.1 cm.  The external surface shows a focal pleural defect with an underlying gray tan nodule.  The nodule has been marked with a stitch.  The nodule is 1 cm. in maximum dimension, and is 1.3 cm. beneath the pleural surface.  The nodule is 4.1 cm. from the bronchial and staple resection lines.  The pleura surrounding the mass is inked in blue.  Multiple sections through the remainder of the lung show a pale gray to pink cut surface.  Edema fluid readily exudes from the cut section.  Other masses are not identified.  Representative sections are submitted, with the frozen section control in block 2A.  Sections of the tumor and the surrounding parenchyma are submitted in blocks 2B-E, bronchial, vascular, and hilar soft tissues are submitted in blocks 2F.  Sections of the suture line nearest to the neoplasm are submitted in block 2G.  Random sections of the lung are submitted in block 2H-I.  Note:  A sample is submitted to Oncotech Laboratories.  However, the small size of the neoplasm, the necrotic nature of the neoplasm and the marked subjacent fibrosis and inflammatory change limit the tissue available for analysis.  Viability cannot be assured. 1.   \.br\3.  LEFT SECONDARY CARINA:  The specimen is received in saline labeled with the patient' s name and "left secondary carina."  It consists of a soft tan fragment of tissue, 0.2 cm. in greatest dimension.  The specimen is totally submitted, labeled   3A.  \.br\4.  AP WINDOW LYMPH NODE LEFT:  The specimen is received in saline labeled with the patient' s name and "lymph node left AP window."  It consists of multiple soft anthracotic pink fragments of tissue, 0.6 x 0.4 x 0.2 cm. in aggregate.  The specimen is totally submitted, labeled  4A.\.br\5.  LEFT LEVEL 10 NODE:  The specimen is received in saline labeled with the patient' s name and "left level 10."  It consists of a soft anthracotic pink fragment of tissue, 0.3 cm. in greatest dimension.  The specimen is totally submitted, labeled  5A.\.br\6.  PORTION LEFT THIRD RIB:  The specimen is received in saline labeled with the patient' s name and "portion left 3rd rib."  It consists of 3 segments of rib with a minimal amount of attached skeletal muscle, 2 x 1.5 x 0.6 cm. to 7 x 1.6 x 0.4 cm.  Representative sections submitted, labeled:   6A-bone marrow, 6B-skeletal muscle. \.br\7.  LEVEL 11 NODE:  The specimen is received in saline labeled with the patient' s name and "node level 11."  It consists of multiple firm anthracotic gray pink pieces of tissue, 2 x 1 x 0.4 cm. in aggregate.  The specimen is totally submitted, labeled  7A-B.\.br\||||||F
OBX|49|TX|MDT|tst5217183|     SYNOPTIC DATA - PRIMARY LUNG TUMORS\.br\TUMOR LOCATION:      Left Upper Lobe\.br\LUNG SEGMENT(S) INVOLVED:      Upper Division\.br\PROCEDURE:      Segmental\.br\TUMOR SIZE:      Maximum dimension:  0.4 cm\.br\GROSS SATELLITES:      Number of gross satellite lesions: 0\.br\TUMOR TYPE:      Invasive squamous carcinoma\.br\HISTOLOGIC GRADE:      G2, Moderately differentiated\.br\MICROSCOPIC SATELLITES:      Number of microscopic satellite lesions: 0\.br\EXTRAPULMONARY PARENCHYMAL\.br\EXTENSION/INVASION OF TUMOR:      None identified\.br\ANGIOLYMPHATIC INVASION:      No\.br\TUMOR NECROSIS:      < or = to 50%\.br\SURGICAL MARGIN INVOLVEMENT:      No\.br\SURGICAL MARGIN SITE:      Distance of invasive tumor to closest margin: 14 mm, Bronchial margin, Parenchymal margin\.br\INFLAMMATORY(DESMOPLASTIC) REACTION:      Moderate\.br\N1 LYMPH NODES:      Number of N1 lymph nodes positive:: 0\.br\     Number of N1 lymph nodes examined: 4\.br\EXTRACAPSULAR SPREAD OF N1 METASTASES:      No\.br\N2 LYMPH NODES:      Number of N2 lymph nodes positive: 0\.br\     Number of N2 lymph nodes examined: 2\.br\EXTRACAPSULAR SPREAD OF N2 METASTASES:      No\.br\UNDERLYING DISEASE(S):      Pneumoconiosis, NOS\.br\T STAGE, PATHOLOGIC:      pT1\.br\N STAGE, PATHOLOGIC:      pN0\.br\M STAGE, PATHOLOGIC:      pMX\.br\--------------------------------------------------------\.br\ \.br\\.br\||||||F
OBX|50|CE|IMP|tst5217183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004754|P|2.3
PID|1||123123654^^^RR|tpmc0426005|KRINGLE^KRIS^N||19201206|M|||||||||||123-12-3654|||||||||||N
PV1|1||OSD||||505073^PLANET^EARTH||||||||||pmc87361^PLANET^EARTH|OSD|0001123123654|||||||||||||||||||||||||200512120930
ORC|RE||PHS05-204^CoPathPlus||CM||||200512120938|^LASSIGE^KAREN||505073^PLANET^EARTH
OBR|1||PHS05-204^CoPathPlus^tpmc3767183|PHSP^PH Surgical Pathology|||200512120935|||||||200512120935|SB|505073||||^85^Y|-1|200512121009||SP|F|||||||^LASSIGE^KAREN|^LASSIGE^KAREN
OBX|1|CE|ANT|tpmc3767183.1|SB^Biopsy Small Bowel^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc3767183.1.1|A||||||||1^A|200601061423
OBX|3|CE|PROCESS|tpmc3767183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512120936
OBX|4|TX|GDT|tpmc3767183|The specimen labeled " Small Bowel " and the initials "LL".  The specimen measures 0.5 cm x 0/4 cm and is submitted entirely is cassette A. \.br\||||||F
OBX|5|TX|MDT|tpmc3767183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|6|TX|FIN|tpmc3767183|PART 1: SMALL BOWEL BIOPSY\.br\A.          NEGATIVE FOR MALIGANCY\.br\B.          INFLAMATION.\.br\||||||F
OBX|7|CE|IMP|tpmc3767183|P1140^^SNO||||||||1||A
OBX|8|CE|IMP|tpmc3767183|T64000^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004755|P|2.3
PID|1||000999911^^^RR|tpmc9326005|TUBA^TUBBIE||19230101|M|||||||||||121-21-3222|||||||||||N
PV1|1||9D||||505075^PLANET^JUPITER||||||||||pmc87361^PLANET^EARTH|I|9898989898989|||||||||||||||||||||||||200512120928
ORC|RE||PHS05-205^CoPathPlus||CM||||200512120939|z37^ANDERSON^RALPH||505075^PLANET^JUPITER
OBR|1||PHS05-205^CoPathPlus^tpmc4767183|PHSP^PH Surgical Pathology|||200512120937|||||||200512120937|ABD|505075||||^83^Y|-1|200512121009||SP|F|||||||987654^PATHOID^DOCTOR|z37^ANDERSON^RALPH
OBX|1|CE|ANT|tpmc4767183.1|ABD^Soft Tissue Mass, Resection^L||||||F||1^1
OBX|2|ST|BLOCK|tpmc4767183.1.1|A||||||||1^A|200601061423
OBX|3|CE|PROCESS|tpmc4767183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512120937
OBX|4|TX|GDT|tpmc4767183|This is a test refresher cause I forgot how to make a macro\.br\Kjkjkjehhjheihohidjklhkljhwiuhyebn hjhe jkhk e  hehhhjw  \.br\||||||F
OBX|5|TX|MDT|tpmc4767183|This is a test refresher cause I forgot how to make a macro\.br\||||||F
OBX|6|TX|FIN|tpmc4767183|This is a test refresher, so enter on the fly.\.br\||||||F
OBR|2||tpmc4767183^CoPathPlus^tpmc4767183.A1|ADD^Addendum||||||||||200601121051|||||||1|200601121051||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|TX|ADX|tpmc4767183|Trichrome stain highlights large airway scarring.\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004756|P|2.3
PID|1||999987654^^^SY|tpmc0681594|TESTVTWOFIVE^SY TWO||19560701|M||W|||||||||222-88-9999|||||||||||N
PV1|1||I6P||||505079^PLANET^PLUTO||||||||||pmc48361^PLANET^PLUTO|SYA|0192222222222|||||||||||||||||||||||||200511231642
ORC|RE||PHS05-210^CoPathPlus||CM||||200512141605|z196^DEVINE^LISA||505079^PLANET^PLUTO
OBR|1||PHS05-210^CoPathPlus^tpmc2967183|PHSP^PH Surgical Pathology|||200512141557|||||||200512141557|LNFC|505079||||^49^Y|-1|200601041129||SP|C|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|CE|ANT|tpmc2967183.1|LNFC^Submental neck lymph node^L||||||C||1^1
OBX|2|CE|ANT|tpmc2967183.2|CLNF^Submental Neck Lymph Node for FISH^L||||||C||2^2
OBX|3|ST|BLOCK|tpmc2967183.1.1|ACMB/DNA||||||||1^ACMB/DNA|200601061423
OBX|4|ST|BLOCK|tpmc2967183.1.2|BB+||||||||2^BB+|200601061423
OBX|5|ST|BLOCK|tpmc2967183.1.3|C||||||||3^C|200601061423
OBX|6|ST|BLOCK|tpmc2967183.1.4|D||||||||4^D|200512141558
OBX|7|CE|PROCESS|tpmc2967183.1.1.1|$hinit^Initial H&E^L||||||||15^H&E|200512141557
OBX|8|CE|PROCESS|tpmc2967183.1.1.2|pmc5553^HH&E (HISTO)^L||||||||16^HHE|200512141557
OBX|9|CE|PROCESS|tpmc2967183.1.2.3|$hinit^Initial H&E^L||||||||30^H&E|200512141557
OBX|10|CE|PROCESS|tpmc2967183.1.3.4|$hinit^Initial H&E^L||||||||32^H&E|200512141557
OBX|11|CE|PROCESS|tpmc2967183.1.0.5|pmc0753^Touch Preparation (Surg)^L||||||||1|200512141557
OBX|12|CE|PROCESS|tpmc2967183.1.0.6|pmc4653^Tissue Banked OCT Frozen (Surg)^L||||||||2|200512141557
OBX|13|CE|PROCESS|tpmc2967183.1.0.7|pmc6553^CMB Tissue Prep (PHSP)^L||||||||3|200512141557
OBX|14|CE|PROCESS|tpmc2967183.1.0.8|pmc1273^DNA Tissue Frozen (Surg)^L||||||||4^DNAFR|200512141557
OBX|15|CE|PROCESS|tpmc2967183.1.0.9|pmc0534^Flow Cyto Tissue Prep (Surg)^L||||||||5^FLOWCY|200512141557
OBX|16|CE|PROCESS|tpmc2967183.1.2.10|tst8525^B+ Fixation (Surg)^L||||||||31^B5|200512141557
OBX|17|CE|PROCESS|tpmc2967183.1.4.11|$hinit^Initial H&E^L||||||||33^H&E|200512141558
OBX|18|CE|PROCESS|tpmc2967183.1.0.12|pmc2424^DNA Purification (PHMO)^L||||||||6^DNAPUR|200512141558
OBX|19|CE|PROCESS|tpmc2967183.1.0.13|pmc8425^Flow Cytometry, First Marker^L||||||||7^FCFRSTM|200512141558
OBX|20|CE|PROCESS|tpmc2967183.1.0.14|pmc9425^Flow Cyto, Add'l Markers (PHFC)^L||||||||8^FCADDLM|200512141558
OBX|21|CE|PROCESS|tpmc2967183.1.0.15|pmc6893^Lymphoma/CLL (WLO) (PHFC)^L||||||||9^LYMPH|200512141559
OBX|22|CE|PROCESS|tpmc2967183.1.2.16|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||32^H&E Recut|200601132341
OBX|23|CE|PROCESS|tpmc2967183.1.3.17|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||33^H&E Recut|200601132341
OBX|24|CE|PROCESS|tpmc2967183.1.4.18|pmc0653^Hematoxylin & Eosin Recut (Histo)^L||||||||34^H&E Recut|200601132341
OBX|25|CE|PROCESS|tpmc2967183.1.1.19|pmc3323^CD3 T Lymphocytes (IPEX)^L||||||||17^CD3|200601132341
OBX|26|CE|PROCESS|tpmc2967183.1.1.20|pmc8623^L26 B lymphocyte (IPEX)^L||||||||18^L26|200601132341
OBX|27|CE|PROCESS|tpmc2967183.1.1.21|pmc6604^CD5 T/some B Lymphocytes (IPEX)^L||||||||19^ACD5|200601132341
OBX|28|CE|PROCESS|tpmc2967183.1.1.22|pmc8624^CD10 CALLA paraffin (IPEX)^L||||||||20^CD10|200601132341
OBX|29|CE|PROCESS|tpmc2967183.1.1.23|pmc6323^CD43 L60 T Lymphocytes (IPEX)^L||||||||21^CD43|200601132341
OBX|30|CE|PROCESS|tpmc2967183.1.1.24|pmc8733^Bcl-2 Oncoprotein (IPEX)^L||||||||22^Bcl-2|200601132341
OBX|31|CE|PROCESS|tpmc2967183.1.1.25|pmc3474^ABCL6 (IPEX)^L||||||||23^ABCL6|200601132341
OBX|32|CE|PROCESS|tpmc2967183.1.1.26|pmc6324^cyclin D1 Bcl-1 (IPEX)^L||||||||24^ACYCLD1|200601132341
OBX|33|CE|PROCESS|tpmc2967183.1.1.27|pmc3923^Control NEG (WLO) (IPEX)^L||||||||25^ANEG|200601132341
OBX|34|CE|PROCESS|tpmc2967183.1.1.28|pmc6623^Kappa Light Chain (IPEX)^L||||||||26^Kappa|200601132341
OBX|35|CE|PROCESS|tpmc2967183.1.1.29|pmc1723^Lambda Light Chain (IPEX)^L||||||||27^Lambda|200601132341
OBX|36|CE|PROCESS|tpmc2967183.1.1.30|pmc8104^Kappa-Lambda Chn Dbl Lbl (PHIS)^L||||||||28^IKPLM|200512141602
OBX|37|CE|PROCESS|tpmc2967183.1.1.31|pmc7873^In situ Blank Slide (IPEX) (WLO)^L||||||||29^IBNKNC|200601132341
OBX|38|CE|PROCESS|tpmc2967183.1.1.32|pmc1073^Cytomegalovirus (IPEX)^L||||||||30^CMV|200601132341
OBX|39|CE|PROCESS|tpmc2967183.1.4.33|pmc1073^Cytomegalovirus (IPEX)^L||||||||35^CMV|200601132341
OBX|40|CE|PROCESS|tpmc2967183.1.4.34|pmc3923^Control NEG (WLO) (IPEX)^L||||||||36^ANEG|200601132341
OBX|41|CE|PROCESS|tpmc2967183.1.0.35|pmc9124^Immunoglobulin Heavy Chain,PCR (PHMO)^L||||||||10^IGHP|200512141603
OBX|42|CE|PROCESS|tpmc2967183.1.0.36|pmc0224^Immunoglobulin Heavy Chain,SB (PHMO)^L||||||||11^IGHS|200512141603
OBX|43|CE|PROCESS|tpmc2967183.1.0.37|pmc0174^T-Cell Receptor Gamma PCR (PHMO)^L||||||||12^T-Cell Receptor Gamma PCR|200512141604
OBX|44|CE|PROCESS|tpmc2967183.1.0.38|pmc9224^TCell Receptor B-Chain SB  (PHMO)^L||||||||13^TCS|200512141604
OBX|45|CE|PROCESS|tpmc2967183.1.0.39|pmc9425^Flow Cyto, Add'l Markers (PHFC)^L||||||||14^FCADDLM|200512141604
OBX|46|CE|PROCESS|tpmc2967183.1.0.40|pmc0143^ISH CNTRL Insitu Hybrid (WLO) (PHIS)^L||||||||15^IISH|200512141604
OBX|47|TX|GDT|tpmc2967183|The specimen is received in RPMI labeled with the patient' s name, initials JW, medical record number and submental neck lymph node.  It consists of two pieces of fleshy tan, soft tissue, the largest measuring 2.0 x 1.1 x 1.0 cm and the other measuring 1.5 x 1.3 x 1.0 cm.  Touch preparations are performed.  Material is snap frozen (3 blocks), and sent for cell suspension immunophenotypic studies (flow cytometry).  A portion is sent to the molecular diagnostics laboratory with an adjacent section submitted in formalin fixative labeled A (CMB/DNA).  Additional material is sent for cytogenetic studies.  The remainder of the lymph node is submitted in cassette BB+ after B+ fixation and in blocks C and D after formalin fixation.  \.br\LF/kmr\.br\||||||C
OBX|48|TX|MDT|tpmc2967183|Histologic sections of the submental lymph node specimen show overall basic preservation of the lymph node architecture with many large reactive-appearing germinal centers, some with attenuated mantle zones and some T-zone nodules.  Focally prominent monocytoid B-cell areas with occasional large cells that contain intranuclear and focal cytoplasmic inclusions are also identified.  Interfollicular areas with many small lymphocytes and moderately numerous plasma cells are also seen.\.br\DM/js\.br\\.br\PARAFFIN SECTION IMMUNOHISTOCHEMISTRY\.br\\.br\In order to characterize the lymphoid/plasma cell population, paraffin section immunohistologic  studies were performed on the submental lymph node biopsy specimen.  The following results were found:\.br\\.br\Antigen/Antibody        Usual Reactivity                   Result\.br\\.br\anti-kappa              B-cell subset                      Scattered positive plasma cells.\.br\\.br\anti-lambda             B-cell subset                      Scattered positive plasma cells;\.br\somewhat less than kappa.\.br\\.br\double kappa/lambda     Lambda staining is too weak to \.br\accurately assess.\.br\\.br\CD20/L26                B-cells                            Numerous positive cells in follicles\.br\and monocytoid B-cell areas.\.br\\.br\bcl-2                   Lymphocyte subset, other           Monocytoid B-cell areas and germinal\.br\centers mostly negative; numerous\.br\positive cells between germinal\.br\centers.\.br\\.br\bcl-6                   Follicular center cells, other     Highlights germinal center cells and\.br\scattered interfollicular cells.\.br\\.br\CD10                    B-cell subset                      Highlights germinal center cells.\.br\\.br\Cyclin D1               Mantle cell lymphoma, other        Negative.\.br\\.br\CD3                     T-cells                            Numerous positive cells between\.br\follicles; scattered positive cells\.br\in follicles and monocytoid\.br\B-cell areas.\.br\\.br\CD5                     T-cells, B-cell subset             Similar to CD3.\.br\\.br\CD43/Leu 22             T cells, some       \.br\                        B cells, myeloid                   B-cells appear negative.\.br\\.br\CMV                     Cytomegalovirus                    (Blocks 1A \T\ 1D)\.br\       Scattered large positive cells.\.br\_______________________________________________________________________________\.br\\.br\Medical necessity justification for the immunohistochemical stains that were needed in addition to the flow cytometric immunophenotypic studies for the best diagnosis possible is as follows:  The flow cytometric studies did not define the precise nature of all the cellular elements of concern in this specimen.\.br\\.br\RS/shm\.br\||||||C
OBX|49|TX|FIN|tpmc2967183|LYMPH NODE, SUBMENTAL, EXCISION  \.br\FOLLICULAR HYPERPLASIA AND OTHER REACTIVE CHANGES ASSOCIATED WITH CYTOMEGALOVIRUS INCLUSIONS (see comment).\.br\DM/js/RS/shm\.br\||||||C
OBX|50|CE|IMP|tpmc2967183|E3222^^SNO||||||||1||A
OBX|51|CE|IMP|tpmc2967183|M72020^^SNO||||||||1||A
OBX|52|CE|IMP|tpmc2967183|P1100^^SNO||||||||1||A
OBX|53|CE|IMP|tpmc2967183|T08170^^SNO||||||||1||A
OBX|54|CE|IMP|tpmc2967183|000^^ICD||||||||1
OBR|2||tpmc2967183^CoPathPlus^tpmc2967183.P1|FC^Flow Cytometry||||||||||200512141607|||||||1|200512141607||SP|F|||||||^PARWANI^ANIL|z491^NESTLER^RICK
OBX|1|TX|PIN|tpmc2967183|Amending the flow cytometry on this case for cabig testing purposes. This is the interpretation amended text.\.br\\.br\Flow cytometric immunophenotypic studies performed on the submental lymph node demonstrate polyclonal B-cells, surface immunoglobulin negative B-cells, heterogeneous T-cells.  The CD10 positive B-cells are Bcl-2 negative.  A final report will follow after additional pending ancillary studies are completed and reviewed.\.br\DM/js\.br\||||||C
OBX|2|TX|PRC|tpmc2967183|Cell suspension immunophenotypic studies were performed on the submental lymph node and two regions were analyzed.\.br\\.br\     Region 1 represents the small non-complex cells. (78% of the events)\.br\     Region 2 represents the larger non-complex cells. (19% of the events)\.br\\.br\     VIABILITY:  83%\.br\\.br\   -----------------------------B Cells---------------------R1-----R2\.br\\.br\   Antigen+                  Usual Specificity                % Positive\.br\\.br\   Kappa+....................B cell subset................. 8      14      \.br\   Lambda+...................B cell subset................. 4      10      \.br\   Kappa:Lambda\S\........................................... 1.7    1.4      \.br\   CD19+.....................B cell........................ 32     77      \.br\   CD19+/CD5+................B cell subset................. 1      1      \.br\   CD20+.....................B cell........................ 26     78      \.br\   CD20+/CD10+...............B cell subset................. 12     55\.br\   CD19+/CD23+...............B cell subset................. 17     35      \.br\   CD19+/FMC7+...............B cell subset................. 17     49  \.br\   BCL2+/CD10+*............................................ 8      19\.br\   BCL2+/CD20+*............................................ 26     26    \.br\\.br\   -----------------------------T cells---------------------R1-----R2\.br\\.br\   Antigen                   Usual Specificity                % Positive\.br\\.br\   CD2+......................T cell........................ 64     13      \.br\   CD3+......................T cell........................ 65     15      \.br\   CD5+/CD19-................T cell........................ 64     11      \.br\   CD7+......................T cell........................ 58     15      \.br\   CD4+/CD3+.................T helper...................... 52     12      \.br\   CD8+/CD3+.................T cytotoxic/suppressor........ 12     4      \.br\   CD4+/CD8+.................T cell subset................. 1      1      \.br\   CD4:CD8\S\..................T helper:suppressor ratio..... 4.4    3.2      \.br\   CD16,CD57+/CD3+...........T cell subset................. 5      7     \.br\   CD16,CD57+/CD3-...........NK cell, other................ 0      1      \.br\   CD56+/CD3+................NK-like T cell................ 1      3      \.br\   CD56+/CD3-................NK cell, other................ 1      2 \.br\\.br\   -----------------------------Myeloid---------------------R1-----R2\.br\\.br\   Antigen                   Usual Specificity               % Positive\.br\\.br\   CD14+.....................Myeloid,monocyte.............. 3      11     \.br\ \.br\   ------------------------Additional Antibodies------------R1-----R2\.br\\.br\   Antigen                   Usual Specificity                % Positive\.br\\.br\   CD45+.....................Leukocytes.................... 100    100      \.br\ \.br\\S\\R\The results for all antigens are rounded to the nearest whole number.  However, the ratio values (kappa:lambda and CD4:CD8) are calculated using the original results (including two decimal places).\.br\\.br\* The gates used for these antibodies may differ from those used for the other antibodies because of different fixation and/or permeabilization procedures.  Cytoplasmic staining denoted with a "Cyto" can detect both surface and cytoplasmic expression.\.br\\.br\Antigen/Antibody\.br\CD1/BL6         CD13/L138      CD33/P67.6            CD138/B-B4 \.br\CD2/S5.2        CD14+/MOP9     CD34/8G12             Glycophorin A/D2.10\.br\CD3/SK7         CD15/PM81      CD43/DF-T1            HLA-DR/L243\.br\CD4/SK3         CD15s/CSLex1   CD45/2D1              FMC7/FMC7\.br\CD5/L17F12      CD16/B73.1     CD45RA/L48            Kappa/TB 28-2\.br\CD5/BL1a        CD18/L130      CD45RO/UCHL-1         Lambda/1-155-2\.br\CD7/4H9         CD19/J4.119    CD56/Ncam-16.2        MPO/H-43-5\.br\CD7/8H8.1       CD20/L27       CD56/MY31             TCR1,alpha-beta/WT31\.br\CD8/SK1         CD22/S-HCL-1   CD57/HNK-1            TCR,gamma-delta-1/11F2\.br\CD10/SS2/36     CD23/EBVCS-5   CD61/RUU-PL7F12       TdT/HTdT-6\.br\CD11c/S-HCL-3   CD25/3G10      CD103/B-ly7           BCL2/124\.br\\.br\This test was developed and its performance characteristics determined by the Flow Cytometry Laboratory at the University of Pittsburgh Medical Center.  It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes.  It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity testing.\.br\\.br\The results of these studies should be used in the context of the clinical history, and routine morphologic analysis.\.br\\.br\||||||C
OBR|3||tpmc2967183^CoPathPlus^tpmc2967183.P2|MOPR^Molecular Oncology||||||||||200512141608|||||||2|200512141608||SP|F|||||||^PARWANI^ANIL|^PARWANI^ANIL
OBX|1|TX|PIN|tpmc2967183|Tissue from submental lymph node, 15 x 10 x 3 mm (MO05-1099):\.br\Immunoglobulin heavy chain gene rearrangement is NOT detected by Southern Blot and PCR.\.br\T-cell receptor gene rearrangement is NOT detected by Southern Blot and PCR.\.br\||||||C
OBX|2|TX|PRC|tpmc2967183|TESTS:DNA purification\.br\Immunoglobulin heavy chain gene rearrangement (Southern \T\ PCR)\.br\T-cell receptor gamma chain gene rearrangement (PCR)\.br\T-cell receptor beta chain gene rearrangement (Southern Blot)\.br\\.br\Gene rearrangement studies:  Southern blot analysis of the immunoglobulin heavy chain gene using a probe to the J region shows only germline bands with three restriction enzymes (Bam HI, Hind III and Bgl II).  Sensitivity of the current run is below the normal 10% threshold.  Negative sample performs as expected.  A longer exposure of the blot has been ordered and if the results are not consistent, they will be reported in the amended report. \.br\IGH PCR using consensus framework III and J region primers also shows a ladder pattern indicating a polyclonal B-cell population. The measured limit of sensitivity for this assay in our laboratory is approximately 1% clonal cells, although values this low may be difficult to discern unequivocally on new specimens without a known prior positive sample.  Controls for DNA amplification performed within acceptable limits. \.br\Southern blot analysis of the T-cell receptor beta chain gene using a probe to the TCR-Beta constant region shows only germline bands with three restriction enzymes (EcoRV, NdeI and BamHI).  Controls perform within expected limits.\.br\Extended PCR analysis for the T-cell receptor gamma chain gene was performed using oligonucleotide primers for the V1-8, V9, V10, V11 and J1/2 regions under homoduplex conditions.  A polyclonal pattern is observed with all primers tested. This assay should detect the vast majority of clonally rearranged T-cell gamma chain genes; rare rearrangements involving the JP locus may not be detected.  Amplification controls performed within expected ranges.\.br\\.br\PCR gel # 05-275/276/277\.br\SB gel #    05-101/102/103\.br\\.br\This test(s) was developed and its performance characteristics determined by the Division of Molecular Diagnostics at the University of Pittsburgh Medical Center.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test(s) is used for clinical purposes.  It should not be regarded as investigational or for research.  This laboratory is certified under the Clinical Laboratory Improvements Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing.\.br\||||||C
OBR|4||tpmc2967183^CoPathPlus^tpmc2967183.P3|CG^Cytogenetics||||||||||200512191430|||||||3|200512191430||SP|F|||||||GOLLIN-PCL^GOLLIN^SUSANNE|GOLLIN-PCL^GOLLIN^SUSANNE
OBX|1|TX|PIN|tpmc2967183|This specimen yielded no metaphases, precluding classical chromosome analysis.\.br\\.br\\.br\FINAL RESULTS:\.br\\.br\                                            G-Banding        \.br\No. of Cells Analyzed:                 #\.br\No. of Cells Karyotyped:              #\.br\\.br\No. of Chromosomes:     <46     46     >46\.br\No. of Cells:             #       #      #\.br\\.br\Twenty-four hour harvests of unstimulated lymph node cell cultures yielded no metaphase cells.  Harvests of specimens from other patients cultured the same day resulted in analyzable metaphase cells.\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004757|P|2.3
PID|1||163263398^^^RR|tpmc9445694|SMITH^LORETTA^M||19321028|F||W|637 PARK STREET^^MONONGAHELA^PA^15063^United States||(724)258-2398|(888)888-8888|||||163-26-3399|||||||||||N
PV1|1||SDSP||||083743^HOLETS^JOHN|||||||||||S|0263110125327|MS
ORC|RE||PHS05-215^CoPathPlus||CM||||200512161611|z41^LOSOS^FRANK||083743^HOLETS^JOHN
OBR|1||PHS05-215^CoPathPlus^tpmc4077183|PHSP^PH Surgical Pathology|||200512161611|||||||200512161611|COBX|083743||||^73^Y|-1|200512161633||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tpmc4077183.1|COBX^Biopsy Colon^L||||||F||1^1
OBX|2|TX|GDT|tpmc4077183|\.br\THIS IS THE GROSS DESCRIPTION\.br\||||||F
OBX|3|TX|MDT|tpmc4077183|THIS IS THE MICROSCOPIC DESCRIPTION\.br\||||||F
OBX|4|TX|FIN|tpmc4077183|THIS IS THE FINAL DIAGNOSIS.  TESTING ADT CONSISTENCY CHECKS.\.br\...\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004758|P|2.3
PID|1||100013259^^^RG|tst4608394|MAGEEPATIENT^TESTSIX||19500726|F||MWU|123 POWERCHART CT^^PITTSBURGH^PA^15213^United States||(412)641-1000||||||102-00-1020|||||||||||N
PV1|1||MWSURG^3195|||||||||||||||MWH|71391684|MWI||||||||||||||||||||||||200507261330
ORC|RE||MWS05-300^CoPathPlus||CM||||200507291726|z32^PICCOLI^ANTHONY||999001697^ARAI^YOSHIO
OBR|1||MWS05-300^CoPathPlus^tst2917183|MWSP^MW Pathology|||200507261725|||||||200507291725|POCS|999001697||||^55^Y|-1|200507291733||SP|F|||||||987654^PATHOID^DOCTOR|987654^PATHOID^DOCTOR
OBX|1|CE|ANT|tst2917183.1|POCS^Uterine Contents^L||||||F||1^1
OBX|2|ST|BLOCK|tst2917183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst2917183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst2917183.1.3|C||||||||3^C|200508311407
OBX|5|CE|PROCESS|tst2917183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|6|CE|PROCESS|tst2917183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|7|CE|PROCESS|tst2917183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|8|TX|GDT|tst2917183|The specimen is received fresh labeled with the patient' s name and "uterine contents at 19.1 weeks."  It consists of placental fragments and nonmacerated fetal parts. A request for genetic studies does not accompany the specimen.  An ultrasound dated 7/14/2005 indicates a composite gestational age of 15.0 weeks and suspected premature rupture of membranes.\.br\\.br\The placental fragments aggregate 12.0 x 7.0 x 3.0 cm. Abundant decidua is included. Separately received is soft, dark red blood clot aggregating 11.0 x 8.0 x 3.5 cm.  The placental tissue is hemorrhagic with rare areas of normal appearing placenta. A 15.5 cm segment of umbilical cord is identified.  It is 0.3 cm in diameter and three vessels are present on cut section.\.br\\.br\The fetus is male by external and internal genitalia. The gestational age is determined as follows:\.br\1)LMP = 3/2/05 is consistent with 19.1 weeks\.br\2)Foot length = 1.45 cm is consistent with 14 weeks gestation (left foot only)\.br\3)Long bone lengths = composite gestational age of 12 weeks\.br\4)Ultrasound of 7/14/05 = composite gestational age of 15 weeks.\.br\\.br\The entire specimen is previously fragmented and the right foot is not identified.  No gross external abnormalities are noted.  Identifiable organs include: heart, lung, spleen, portion of GI tract, kidney, adrenal glands, stomach, pancreas, thymus, bladder and testes.  A fragment of liver is noted.  No gross abnormalities are noted.  Photographs and x-rays are obtained. The case is reviewed with Dr. T. Macpherson. A portion of placenta is submitted for routine microbacterial cultures.  A portion of lung and placental tissue are retained in media for possible further studies.  Opening of the heart shows no abnormalities.  Representative sections are submitted as follows:\.br\A-C -  placenta with hemorrhage and blood clot\.br\D -umbilical cord\.br\E -kidney, adrenal glands, lung, spleen and testes\.br\F -liver, thymus and ?\.br\||||||F
OBX|9|TX|MDT|tst2917183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|10|TX|FIN|tst2917183|SEPTIC ABORTION, 19.1 WEEKS GESTATIONAL AGE BY LAST MENSTRUAL PERIOD \.br\A.FRAGMENTED MALE FETUS WITH FOOT LENGTH OF 1.45 CM CONSISTENT WITH 14 WEEKS GESTATION.\.br\B.PLACENTA:\.br\1.FOCAL ACUTE CHORIOAMNIONITIS\.br\2.RETROPLACENTAL HEMORRHAGE WITH ADJACENT PERIVILLOUS FIBRIN DEPOSITION.\.br\3.LARGE IMMATURE VILLI WITH SCALLOPING EDEMA, TROPHOBLASTIC INCLUSIONS AND HYPERVASCULARITY, INCLUDING THICK-WALLED VESSELS (see comment).\.br\4.INFLAMMATION AND DEGENERATION OF CHORIONIC PLATE WITH PIGMENT CONSISTENT WITH HEMOSIDERIN.\.br\5.FOCAL INTERVILLOUSITIS.\.br\6.THREE (3) VESSEL CORD, 1.5 CM.\.br\7.KARYOTYPING AND FISH PENDING.\.br\||||||F
OBX|11|CE|IMP|tst2917183|F31000^^SNO||||||||1||A
OBX|12|CE|IMP|tst2917183|F31600^^SNO||||||||1||A
OBX|13|CE|IMP|tst2917183|M40600^^SNO||||||||1||A
OBX|14|CE|IMP|tst2917183|M41001^^SNO||||||||1||A
OBX|15|CE|IMP|tst2917183|M55040^^SNO||||||||1||A
OBX|16|CE|IMP|tst2917183|T89000^^SNO||||||||1||A
OBX|17|CE|IMP|tst2917183|TY9700^^SNO||||||||1||A
OBX|18|CE|IMP|tst2917183|M36500^^SNO||||||||1||A
OBX|19|CE|IMP|tst2917183|M40001^^SNO||||||||1||A
OBX|20|CE|IMP|tst2917183|M50000^^SNO||||||||1||A
OBX|21|CE|IMP|tst2917183|M57500^^SNO||||||||1||A
OBX|22|CE|IMP|tst2917183|T88110^^SNO||||||||1||A
OBX|23|CE|IMP|tst2917183|T88210^^SNO||||||||1||A
OBX|24|CE|IMP|tst2917183|T88230^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004759|P|2.3
PID|1||303030033^^^RS|tst6793394|TEST^AGAIN^J||19400101|F||W|1000 TEST^^BETHEL PARK^PA^15102^United States||(724)954-7854|(999)099-9999|||||103-03-0033|||||||||||N
PV1|1||SPAT||||030910^REDDY^SUDHAKAR||||||||||pmc1276^REDDY^SUDHAKAR|O|0056556255053|B||||||||||||||||||||||||200502221733
ORC|RE||BDS05-1034^CoPathPlus||CM||||200508031240|z491^NESTLER^RICK||030910^REDDY^SUDHAKAR
OBR|1||BDS05-1034^CoPathPlus^tst8917183|^BD Histology|||200508031240|||||||200508031240|ANAS|030910||||^65^Y|-1|200508031244||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst8917183.1|ANAS^Anastomosis^L||||||F||1^1
OBX|2|TX|GDT|tst8917183|Cerner testing\.br\||||||F
OBX|3|TX|MDT|tst8917183|\.br\Cerner testing\.br\||||||F
OBX|4|TX|FIN|tst8917183|Cerner testing\.br\||||||F
OBX|5|CE|IMP|tst8917183|250.00^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004760|P|2.3
PID|1||000735917^^^CHPADT|tst4683394|ORACLE^TESTING^J||19980829|M||W|123 ADDRESS^^PITTSBURGH^PA^15220^United States||2345324523||||||544-54-4111|||||||||||N
PV1|1||CHEMRG^7620||||C001305^HOYSON^GREGORY||||||||||pmc42222^HOYSON^GREGORY|CHH|1022628489|||||||||||||||||||||||||200503031429|200503071021
ORC|RE||CHS05-1800^CoPathPlus||CM||||200503081354|z40^KOKAL^ELLEN||C001305^HOYSON^GREGORY
OBR|1||CHS05-1800^CoPathPlus^tst7446183|^CHP Histology|||200503080000|||||||200503081354|CDOBX|C001305||||^6^Y|-1|200503081358||SP|F|||||||C006429^JAFFE^RONALD|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst7446183.1|CDOBX^Duodenal biopsy^L||||||F||1^1
OBX|2|CE|ANT|tst7446183.2|CATBX^Gastric antral biopsy^L||||||F||2^2
OBX|3|CE|ANT|tst7446183.3|CESBX^Esophageal biopsy^L||||||F||3^3
OBX|4|ST|BLOCK|tst7446183.1.1|A||||||||1^A|200507141634
OBX|5|ST|BLOCK|tst7446183.2.2|A||||||||1^A|200507141634
OBX|6|ST|BLOCK|tst7446183.3.3|A||||||||1^A|200507141634
OBX|7|CE|PROCESS|tst7446183.1.1.1|pmc3154^Blank Slide (CHP)^L||||||||1^Blank|200510141024
OBX|8|CE|PROCESS|tst7446183.1.1.2|pmc2154^H&E (CHP)^L||||||||2^Lvl 2|200510141024
OBX|9|CE|PROCESS|tst7446183.1.1.3|pmc2154^H&E (CHP)^L||||||||3^Lvl 4/6|200510141024
OBX|10|CE|PROCESS|tst7446183.2.2.4|pmc3154^Blank Slide (CHP)^L||||||||1^Blank|200510141024
OBX|11|CE|PROCESS|tst7446183.2.2.5|pmc2154^H&E (CHP)^L||||||||2^Lvl 2|200510141024
OBX|12|CE|PROCESS|tst7446183.2.2.6|pmc2154^H&E (CHP)^L||||||||3^Lvl 4/6|200510141024
OBX|13|CE|PROCESS|tst7446183.3.3.7|pmc3154^Blank Slide (CHP)^L||||||||1^Blank|200510141024
OBX|14|CE|PROCESS|tst7446183.3.3.8|pmc2154^H&E (CHP)^L||||||||2^Lvl 2|200510141024
OBX|15|CE|PROCESS|tst7446183.3.3.9|pmc2154^H&E (CHP)^L||||||||3^Lvl 4/6|200510141024
OBX|16|TX|GDT|tst7446183|The specimen is received in three parts.\.br\\.br\Part 1 is received in formalin, labeled with patient's name, and is designated "duodenal biopsy."  It consists of three pieces of pink tan mucosa, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 1A.\.br\\.br\Part 2 is received in formalin, labeled with the patient's name, and is designated "gastric antral biopsy."  It consists of three pieces of pink tan mucosa, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 2A.\.br\\.br\Part 3 is received in formalin, labeled with the patient's name, and is designated "esophageal biopsy."  It consists of three pieces of pink tan mucosa, which measure 0.2 cm in diameter.  The specimen is entirely submitted in cassette 3A.\.br\||||||F
OBX|17|TX|MDT|tst7446183|1.There are three fragments of small bowel mucosa; none of them has Brunner' s glands.  The villous pattern is preserved.  There are no organisms and there is no excess of intraepithelial inflammatory cells.  The crypts are intact.  The lamina propria has normal cellularity.\.br\\.br\2.There are three fragments of gastric body-type mucosa with preserved architecture.  Rare inflammatory infiltrates are observed.  The glands are intact.\.br\\.br\3.There are three fragments of esophageal mucosa.  There are no proliferative or inflammatory changes.\.br\||||||F
OBX|18|TX|FIN|tst7446183|Duodenal biopsy (#1):  UNREMARKABLE DUODENAL MUCOSA.\.br\Gastric antral biopsy (#2):  UNREMARKABLE GASTRIC MUCOSA.\.br\Esophageal biopsy (#3):  UNREMARKABLE ESOPHAGEAL MUCOSA.\.br\\.br\My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation.\.br\||||||F
OBX|19|CE|IMP|tst7446183|M00100^^SNO||||||||1||A
OBX|20|CE|IMP|tst7446183|P1140^^SNO||||||||1||A
OBX|21|CE|IMP|tst7446183|T62000^^SNO||||||||1||A
OBX|22|CE|IMP|tst7446183|T62010^^SNO||||||||1||A
OBX|23|CE|IMP|tst7446183|T63010^^SNO||||||||1||A
OBX|24|CE|IMP|tst7446183|T63600^^SNO||||||||1||A
OBX|25|CE|IMP|tst7446183|T64300^^SNO||||||||1||A
OBX|26|CE|IMP|tst7446183|T64310^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004761|P|2.3
PID|1||001202114^^^CHPADT|tst1948394|INTEGRATION^PCOFIVE||20041018|F||B|123 IT LANE^^PITTSBURGH^PA^15220^United States||2345234234||||||111-41-1234|||||||||||N
PV1|1||CH10ST^0749|||||||||||||||CHQ|1022628711|||||||||||||||||||||||||200508251515|200508261659
ORC|RE||CHS05-7000^CoPathPlus||CM||||200509011623|z40^KOKAL^ELLEN||C017293^MENDELSON^STEPHEN
OBR|1||CHS05-7000^CoPathPlus^tst0727183|^CHP Histology|||200509010000|||||||200509011623|CHBON|C017293||||^318^D|-1|200509011628||SP|F|||||||031969^GALAMBOS^CSABA|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst0727183.1|CHBON^(location) bone^L||||||F||1^1
OBX|2|ST|BLOCK|tst0727183.1.1|A||||||||1^A|200510251134
OBX|3|CE|PROCESS|tst0727183.1.1.1|pmc2154^H&E (CHP)^L||||||||1^H&E|200510141024
OBX|4|TX|GDT|tst0727183|The specimen is received fresh, labeled with the patient's name, and is designated "bone aspiration right foot."  It consists of several minute pieces of pink-tan and firm bone, which measure in aggregate 0.3 x 0.2 x 0.1 cm.  The fresh specimen is fixed in formalin and is decalcified in formic acid, and is submitted in cassette 1A.\.br\||||||F
OBX|5|TX|MDT|tst0727183|Sections show three tiny fragments of bone with bone marrow, one of which shows marked neutrophilic infiltration and damage with adjacent granulation tissue and edema. The findings correlate with the corresponding aspirate specimen (CHC-5450).\.br\\.br\Dr. Mendelson was notified on 8/5/05.  \.br\||||||F
OBX|6|TX|FIN|tst0727183|Bone aspiration, right foot:  ACUTE OSTEOMYELITIS (SEE NOTE).\.br\\.br\NOTE: The cultures grew Pseudomonas aeruginosa.\.br\\.br\My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation.\.br\||||||F
OBX|7|CE|IMP|tst0727183|M41000^^SNO||||||||1||A
OBX|8|CE|IMP|tst0727183|P1144^^SNO||||||||1||A
OBX|9|CE|IMP|tst0727183|T1X500^^SNO||||||||1||A
OBX|10|CE|IMP|tst0727183|TY9710^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004762|P|2.3
PID|1||001202123^^^CHPADT|tst8948394|INTEGRATION^PCOONE||20050801|F||4|137 TEMPORARY WAY^^PITTSBURGH^PA^15213^United States||4123231234||||||301-36-1234|||||||||||N
PV1|1||CHRHEU||||C030007^ROSEN^PAUL||||||||||pmc82543^ROSEN^PAUL|CHO|1021253859|||||||||||||||||||||||||200508291532
ORC|RE||CHS05-7001^CoPathPlus||CM||||200509011633|z40^KOKAL^ELLEN||C030007^ROSEN^PAUL
OBR|1||CHS05-7001^CoPathPlus^tst1727183|^CHP Histology|||200509010000|||||||200509011633|CLTHR|C030007||||^31^D|-1|200509011640||SP|F|||||||^OZOLEK^JOHN|z40^KOKAL^ELLEN
OBX|1|CE|ANT|tst1727183.1|CLTHR^Left inguinal soft tissue^L||||||F||1^1
OBX|2|ST|BLOCK|tst1727183.1.1|A||||||||1^A|200510251134
OBX|3|ST|BLOCK|tst1727183.1.2|B||||||||2^B|200510251134
OBX|4|CE|PROCESS|tst1727183.1.1.1|pmc2154^H&E (CHP)^L||||||||1^H&E|200510141024
OBX|5|CE|PROCESS|tst1727183.1.2.2|pmc2154^H&E (CHP)^L||||||||1^H&E|200510141024
OBX|6|TX|GDT|tst1727183|The specimen is received in formalin, labeled with the patient' s name and designated "left inguinal hernia sac."  It consists of two irregular pieces of gray-tan, soft fibroconnective tissue, measuring 1.5 x 1.2 x 0.1 cm in aggregate.  No unexpected structures are palpable.  No tissue is submitted for paraffin block.  Gross diagnosis only.\.br\||||||F
OBX|7|TX|MDT|tst1727183|Gross diagnosis only.\.br\||||||F
OBX|8|TX|FIN|tst1727183|GROSS DIAGNOSIS:  Left inguinal soft tissue, excision:  HERNIA SAC.\.br\||||||F
OBX|9|CE|IMP|tst1727183|M31680^^SNO||||||||1||A
OBX|10|CE|IMP|tst1727183|P1100^^SNO||||||||1||A
OBX|11|CE|IMP|tst1727183|TY7020^^SNO||||||||1||A
OBX|12|CE|IMP|tst1727183|TY7960^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004763|P|2.3
PID|1||165334444^^^RA|tst7977394|CARENET^CAROL|||F||||||||||||||||||||||N
PV1|1||A3B||||987654^PATHOID^DOCTOR||||||||||pmc3304^PATHOID^DOCTOR|I|1673344449999|||||||||||||||||||||||||200506281421
ORC|RE||SMS05-10004^CoPathPlus||CM||||200506281423|z491^NESTLER^RICK||987654^PATHOID^DOCTOR
OBR|1||SMS05-10004^CoPathPlus^tst0807183|^SM Histology|||200506281423|||||||200506281423||987654|||||-1|200506281426||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst0807183.1|^Bunion^L||||||F||1^1
OBX|2|TX|GDT|tst0807183|RIGHT LOWER EXTREMITY TISSUE:  The specimen is received unfixed labeled with the patient' s name "and "tissue right lower extremity."  It consists of multiple rough dull hemorrhagic yellow green pieces of skin with subcutaneous tissue, 22 x 11 x 0.6 cm. in aggregate.  Sectioning reveals soft dull yellow hemorrhagic tissue.  Representative sections submitted, labeled:   1A.  (rr)\.br\||||||F
OBX|3|TX|MDT|tst0807183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|4|TX|FIN|tst0807183|SKIN AND SUBCUTANEOUS TISSUE, RIGHT LOWER EXTREMITY, DEBRIDEMENT \.br\SKIN AND SUBCUTANEOUS TISSUE WITH ACUTE INFLAMMATION, HEMORRHAGE AND NECROSIS.\.br\||||||F
OBX|5|CE|IMP|tst0807183|M41000^^SNO||||||||1||A
OBX|6|CE|IMP|tst0807183|M54040^^SNO||||||||1||A
OBX|7|CE|IMP|tst0807183|P1130^^SNO||||||||1||A
OBX|8|CE|IMP|tst0807183|T01000^^SNO||||||||1||A
OBX|9|CE|IMP|tst0807183|T02800^^SNO||||||||1||A
OBX|10|CE|IMP|tst0807183|T03800^^SNO||||||||1||A
OBX|11|CE|IMP|tst0807183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004764|P|2.3
PID|1||145875214^^^RD|tst7046394|BDK^JACKIE||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||145-87-5214|||||||||||N
PV1|1||D4WD^401||||084760^LEVARI^ISAAC|002103^TULSKY^ASHER|||||||||pmc52661^LEVARI^ISAAC|ID|0059109785115|P||||||||||||||||||||||||200504251129
ORC|RE||BDS05-10004^CoPathPlus||CM||||200504251416|z491^NESTLER^RICK||084760^LEVARI^ISAAC
OBR|1||BDS05-10004^CoPathPlus^tst7286183|^BD Histology|||200504251416|||||||200504251416|ADH|084760||||^31^Y|-1|200504251417||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst7286183.1|ADH^Adhesion^L||||||F||1^1
OBX|2|TX|GDT|tst7286183|Cerner Testing\.br\\.br\||||||F
OBX|3|TX|MDT|tst7286183|Cerner Testing\.br\||||||F
OBX|4|TX|FIN|tst7286183|Cerner Testing\.br\\.br\||||||F
OBX|5|CE|IMP|tst7286183|000^^ICD||||||||1

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004765|P|2.3
PID|1||100013261^^^RG|tst1118394|MAGEEPATIENT^TESTSEVEN||19850101|F||MWU|123 POWERCHART DR^^PITTSBURGH^PA^15213^United States||(412)641-1000||||||999-11-2222|||||||||||N
PV1|1||MWLDR^NB01||||MW000109^AMORTEGUI^ANTONIO||||||||||pmc85381^AMORTEGUI^ANTONIO|MWQ|71391700|MWE||||||||||||||||||||||||200508051430
ORC|RE||MWS05-10041^CoPathPlus||CM||||200508051111|z491^NESTLER^RICK||MW000109^AMORTEGUI^ANTONIO
OBR|1||MWS05-10041^CoPathPlus^tst2027183|MWSP^MW Pathology|||200508051111|||||||200508051111|ANTEX|MW000109||||^20^Y|-1|200508051113||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst2027183.1|ANTEX^Anterior Exenteration^L||||||F||1^1
OBX|2|ST|BLOCK|tst2027183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst2027183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst2027183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst2027183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst2027183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst2027183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst2027183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst2027183.1.8|H||||||||8^H|200508311407
OBX|10|ST|BLOCK|tst2027183.1.9|I||||||||9^I|200508311407
OBX|11|ST|BLOCK|tst2027183.1.10|J||||||||10^J|200508311407
OBX|12|ST|BLOCK|tst2027183.1.11|K||||||||11^K|200508311407
OBX|13|ST|BLOCK|tst2027183.1.12|L||||||||12^L|200508311407
OBX|14|ST|BLOCK|tst2027183.1.13|M||||||||13^M|200508311407
OBX|15|ST|BLOCK|tst2027183.1.14|N||||||||14^N|200508311407
OBX|16|ST|BLOCK|tst2027183.1.15|O||||||||15^O|200508311407
OBX|17|CE|PROCESS|tst2027183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|18|CE|PROCESS|tst2027183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|19|CE|PROCESS|tst2027183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|20|CE|PROCESS|tst2027183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|21|CE|PROCESS|tst2027183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|22|CE|PROCESS|tst2027183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|23|CE|PROCESS|tst2027183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|24|CE|PROCESS|tst2027183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|25|CE|PROCESS|tst2027183.1.9.9|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|26|CE|PROCESS|tst2027183.1.10.10|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|27|CE|PROCESS|tst2027183.1.11.11|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|28|CE|PROCESS|tst2027183.1.12.12|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|29|CE|PROCESS|tst2027183.1.13.13|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|30|CE|PROCESS|tst2027183.1.14.14|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|31|CE|PROCESS|tst2027183.1.15.15|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|32|TX|GDT|tst2027183|Result for Cerner Testing.\.br\\.br\||||||F
OBX|33|TX|MDT|tst2027183|Result for Cerner Testing.\.br\||||||F
OBX|34|TX|FIN|tst2027183|Result for Cerner Testing.\.br\\.br\||||||F

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004766|P|2.3
PID|1||114616166|tst1005394|POWERCHART^PETER||19730510|M||W|200 MEDIPAC DRIVE^APARTMENT 701^PITTSBURGH^PA^15206^United States||(412)555-1212|(412)828-1300|||||114-61-6166|||||||||||N
PV1|1||HIVDC||||987654^PATHOID^DOCTOR||||||||||pmc3304^PATHOID^DOCTOR|I|0000000000000|||||||||||||||||||||||||200504110747
ORC|RE||PHS05-100029^CoPathPlus||CM||||200504081450|z491^NESTLER^RICK||987654^PATHOID^DOCTOR
OBR|1||PHS05-100029^CoPathPlus^tst6476183|PHSP^PH Surgical Pathology|||200504081450|||||||200504081450|NOMA|987654||||^31^Y|-1|200504110752||SP|C|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst6476183.1|NOMA^Neuroma^L||||||C||1^1
OBX|2|TX|MDT|tst6476183|Cerner Testing\.br\||||||C
OBX|3|TX|FIN|tst6476183|Amended Report for Cerner Testing\.br\\.br\||||||C

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004767|P|2.3
PID|1||100013253^^^RG|tst7508394|MAGEEPATIENT^TESTONE||19640708|F||MWM|333 HAPPY RD^^PITTSBURGH^PA^15234^United States||(412)897-8972||||||998-90-8903|||||||||||N
PV1|1||MW3700^3738||||MW015081^DALBOW^RANDALL|||||||||||MWL|71391619|MWB||||||||||||||||||||||||200507251000
ORC|RE||MWS05-100037^CoPathPlus||CM||||200507261239|z491^NESTLER^RICK||MW015081^DALBOW^RANDALL
OBR|1||MWS05-100037^CoPathPlus^tst0717183|MWSP^MW Pathology|||200507261239|||||||200507261239|BOFRG|MW015081||||^41^Y|-1|200507261241||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst0717183.1|BOFRG^Bone Fragments & Soft Tissue^L||||||F||1^1
OBX|2|ST|BLOCK|tst0717183.1.1|A||||||||1^A|200508311407
OBX|3|CE|PROCESS|tst0717183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|4|CE|PROCESS|tst0717183.1.1.2|pmc7453^Decal Routine (Surg)^L||||||||2^Decal|200601051046
OBX|5|TX|GDT|tst0717183|The specimen is received in two parts.\.br\\.br\Part 1 is received in fresh, identified with the patient's name with the initials "", and labeled as "prostate tissue". It consists of multiple irregular fragments of firm pink/gray tissue, which weigh 61.3 g. Representative sections are submitted in cassettes 1A-1L.\.br\\.br\Part 2 is received in fresh, identified with the patient's name with the initials A", and labeled as "prostate tissue". It consists of multiple irregular fragments of firm pink/gray tissue, which weigh 14.7 g. Representative sections are submitted in cassettes 2A-2J.\.br\||||||F
OBX|6|TX|MDT|tst0717183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|7|TX|FIN|tst0717183|PARTS 1 AND 2:  PROSTATE, TRANSURETHRAL RESECTION \.br\BENIGN PROSTATIC TISSUE WITH MILD CHRONIC AND FOCAL ACUTE INFLAMMATION.\.br\||||||F
OBX|8|CE|IMP|tst0717183|M42101^^SNO||||||||1||A
OBX|9|CE|IMP|tst0717183|P1100^^SNO||||||||1||A
OBX|10|CE|IMP|tst0717183|T77100^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004768|P|2.3
PID|1||100013253^^^RG|tst7508394|MAGEEPATIENT^TESTONE||19640708|F||MWM|333 HAPPY RD^^PITTSBURGH^PA^15234^United States||(412)897-8972||||||998-90-8903|||||||||||N
PV1|1||MW3700^3738||||MW015081^DALBOW^RANDALL|||||||||||MWL|71391619|MWB||||||||||||||||||||||||200507251000
ORC|RE||MWS05-100038^CoPathPlus||CM||||200507261352|z491^NESTLER^RICK||MW015081^DALBOW^RANDALL
OBR|1||MWS05-100038^CoPathPlus^tst1717183|MWSP^MW Pathology|||200507261352|||||||200507261352|MALAD|MW015081||||^41^Y|-1|200507261354||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst1717183.1|MALAD^Adnexa^L||||||F||1^1
OBX|2|ST|BLOCK|tst1717183.1.1|A||||||||1^A|200508311407
OBX|3|ST|BLOCK|tst1717183.1.2|B||||||||2^B|200508311407
OBX|4|ST|BLOCK|tst1717183.1.3|C||||||||3^C|200508311407
OBX|5|ST|BLOCK|tst1717183.1.4|D||||||||4^D|200508311407
OBX|6|ST|BLOCK|tst1717183.1.5|E||||||||5^E|200508311407
OBX|7|ST|BLOCK|tst1717183.1.6|F||||||||6^F|200508311407
OBX|8|ST|BLOCK|tst1717183.1.7|G||||||||7^G|200508311407
OBX|9|ST|BLOCK|tst1717183.1.8|H||||||||8^H|200508311407
OBX|10|CE|PROCESS|tst1717183.1.1.1|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|11|CE|PROCESS|tst1717183.1.2.2|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|12|CE|PROCESS|tst1717183.1.3.3|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|13|CE|PROCESS|tst1717183.1.4.4|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|14|CE|PROCESS|tst1717183.1.5.5|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|15|CE|PROCESS|tst1717183.1.6.6|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|16|CE|PROCESS|tst1717183.1.7.7|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|17|CE|PROCESS|tst1717183.1.8.8|$hinit^Initial H&E^L||||||||1^H&E|200512121431
OBX|18|TX|MDT|tst1717183|Microscopic examination substantiates the above diagnosis.\.br\||||||F
OBX|19|TX|FIN|tst1717183|TERM PLACENTA 470 GRAMS, 50-75TH PERCENTILE \.br\A.FOCAL ACUTE CHORIOAMNIONITIS STAGE 1, GRADE 1.\.br\B.VILLOUS MATURATION APPROPRIATE FOR GESTATIONAL AGE.\.br\C.DECIDUA.\.br\D.THREE VESSEL CORD 45 CM.\.br\||||||F
OBX|20|CE|IMP|tst1717183|M41000^^SNO||||||||1||A
OBX|21|CE|IMP|tst1717183|T88100^^SNO||||||||1||A

MSH|^~\&|CoPathPlus|X|caBIG||20060210135109||ORU^R01|1000000004769|P|2.3
PID|1||100013253^^^RG|tst7508394|MAGEEPATIENT^TESTONE||19640708|F||MWM|333 HAPPY RD^^PITTSBURGH^PA^15234^United States||(412)897-8972||||||998-90-8903|||||||||||N
PV1|1||MW3700^3738||||MW015081^DALBOW^RANDALL|||||||||||MWL|71391619|MWB||||||||||||||||||||||||200507251000
ORC|RE||MWS05-100039^CoPathPlus||CM||||200507270534|z491^NESTLER^RICK||MW015081^DALBOW^RANDALL
OBR|1||MWS05-100039^CoPathPlus^tst2717183|MWSP^MW Pathology|||200507270534|||||||200507270534|CATH|MW015081||||^41^Y|-1|200507270536||SP|F|||||||987654^PATHOID^DOCTOR|z491^NESTLER^RICK
OBX|1|CE|ANT|tst2717183.1|CATH^Catheter^L||||||F||1^1
OBX|2|TX|GDT|tst2717183|Text for Cerner Testing.\.br\\.br\||||||F
OBX|3|TX|MDT|tst2717183|Text for Cerner Testing.\.br\||||||F
OBX|4|TX|FIN|tst2717183|Text for Cerner Testing.\.br\\.br\||||||F

FTS|442
